Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

    
          Number of people
          
122 762 (52.01% female)
          
          People with ≥2 records
          54.74%

          Median duration from first to last measurement
          2.79 years

Coding

Definition

OMOP Concept ID: 3029187— open in OHDSI Athena.
Part of collection: Natriuretic peptide.B prohormone N-Terminal with 1 other OMOP concept — open in OHDSI Athena.

OMOP mapping QC

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3029187	p-probnp	ng/l (ng/l)	98258	304211	0.18%
3029187	p-probnp	— (—)	33879	61133	100.00%	Distribution not available
3029187	p-probnp	ng/l______ (ng/l)	3655	10604	0.00%
3029187	s-probnp	ng/l (ng/l)	1349	1597	0.00%
3029187	p-probnp	NG/L (ng/l)	822	1530	0.00%
3029187	p-pbnp-lb	ng/l (ng/l)	583	1243	0.00%
3029187	p-probnp	ng/L (ng/l)	527	1253	0.00%
3029187	b-probnp	ng/l (ng/l)	516	1200	0.00%
3029187	b-ntprobnp	ng/l (ng/l)	449	898	0.00%
3029187	s-probnp	pg/ml (ng/l)	436	495	0.00%
3029187	p-ntprobnp	ng/l (ng/l)	409	1429	0.00%
3029187	p-probnp(ksks)	ng/l (ng/l)	297	593	0.00%
3029187	p-pro-bnp	ng/l (ng/l)	262	715	0.00%
3029187	b-ntprobnp	— (—)	258	434	100.00%	Distribution not available
3029187	s-probnp	— (—)	212	216	100.00%	Distribution not available
3029187	p-probnp	pg/ml (ng/l)	201	324	0.00%
3029187	p-pbnp-o	ng/l (ng/l)	165	223	0.00%
3029187	b-probnp	— (—)	160	195	100.00%	Distribution not available
3029187	p-probnp(k	ng/l (ng/l)	145	199	0.00%
3029187	p-pbnp-lb	— (—)	141	174	100.00%	Distribution not available
3029187	p-ntprobnp	— (—)	104	204	100.00%	Distribution not available
3029187	p-prbnpvt	ng/l (ng/l)	80	92	0.00%
3029187	b-probnp-o	ng/l (ng/l)	79	107	0.00%
3029187	p-probnp	pg/mL (ng/l)	78	101	0.00%
3029187	b-probnp	pg/ml (ng/l)	75	138	0.00%
3029187	p-probnp(ksks)	— (—)	68	75	100.00%	Distribution not available
3029187	b-probnp-o	— (—)	64	85	100.00%	Distribution not available
3029187	p-probnp(pika)	ng/l (ng/l)	61	103	0.00%
3029187	p-probnpvt	NG/L (ng/l)	55	97	0.00%
3029187	p-natriureettinenpeptidi,b-tyypinn-termin.prop	pg/mL (ng/l)	52	64	0.00%
3029187	p-vprobnp	ng/l (ng/l)	46	109	0.00%
3029187	p-probnpvt	ng/l (ng/l)	42	64	0.00%
3029187	p-prbnpvt	— (—)	41	57	100.00%	Distribution not available
3029187	b-probnpo	ng/l (ng/l)	38	44	9.09%
3029187	p-pbnp-o	— (—)	33	36	100.00%	Distribution not available
3029187	p-natriureettinenpeptidi,b-tyypin(32-)	ng/l (ng/l)	32	37	0.00%
3029187	p-pro-bnp	— (—)	30	31	100.00%	Distribution not available
3029187	b-probnp-o	pg/mL (ng/l)	28	32	0.00%
3029187	p-probnpvt	— (—)	24	33	100.00%	Distribution not available
3029187	p-probnp(	ng/l (ng/l)	19	22	0.00%
3029187	p-probnp-pika	pg/ml (ng/l)	19	22	0.00%	Distribution not available
3029187	p-probnpvt	pg/ml (ng/l)	18	35	0.00%
3029187	p-natriureettinenpeptidi,b-tyypinn-terminaalinenpropepti(ko)	ng/l (ng/l)	18	19	0.00%
3029187	p-natriureettinenpeptidi,b-tyypinn-terminaalinenpropeptidi	ng/l (ng/l)	17	18	0.00%
3029187	-bnp	pg/ml (ng/l)	15	43	0.00%
3029187	p-natriureettinenpeptidi,b-tyypin(32-)(pi)	ng/l (ng/l)	14	14	0.00%
3029187	-probnppoc	ng/l (ng/l)	14	17	0.00%	Distribution not available
3029187	p-prbnp-vt	ng/l (ng/l)	13	17	0.00%	Distribution not available
3029187	p-natriureettinenpeptidi,b-tyypinn-termin.prop	ng/l (ng/l)	13	16	0.00%
3029187	p-probnp(pi)	ng/l (ng/l)	13	14	0.00%
3029187	nt-probnp	ng/l (ng/l)	11	14	0.00%
3029187	p-probnp(pika)	— (—)	11	15	100.00%	Distribution not available
3029187	p-probnpviitasaari	ng/l (ng/l)	9	10	0.00%	Distribution not available
3029187	p-probnpv	pg/ml (ng/l)	9	13	0.00%	Distribution not available
3029187	p-probnp-pika	— (—)	9	12	100.00%	Distribution not available
3029187	probnp	pg/ml (ng/l)	9	25	0.00%
3029187	p-natriureettinenpeptidi,b-tyypin(32-)	— (—)	9	9	100.00%	Distribution not available
3029187	p-natriureettinenpeptidi,b-tyypinn-termin.prop	— (—)	9	10	100.00%	Distribution not available
3029187	s-natriureettinenpeptidi,b-tyypinn-terminaalinenpropeptidi	ng/l (ng/l)	9	12	0.00%
3029187	b-pbnp-pt	ng/l (ng/l)	9	9	0.00%	Distribution not available
3029187	p-probnp(k	— (—)	8	8	100.00%	Distribution not available
3029187	natriureettinenpeptidi(p-probnp)	— (—)	8	8	100.00%	Distribution not available
3029187	p-prbnpvt	pg/ml (ng/l)	7	11	0.00%	Distribution not available
3029187	ps-probnp	ng/l (ng/l)	7	10	0.00%	Distribution not available
3029187	p-prbnpvt	NG/L (ng/l)	7	7	0.00%	Distribution not available
3029187	p-probnp-o	pg/ml (ng/l)	7	8	0.00%	Distribution not available
3029187	p-probnp-p	pg/ml (ng/l)	6	7	0.00%	Distribution not available
3029187	natriureettinenpeptidi(p-probnp)	ng/l (ng/l)	6	6	0.00%
3029187	p-natriureettinenpeptidi,b-tyypinn-terminaalinenpropeptidi	— (—)	5	5	100.00%	Distribution not available
3029187	s-natriureettinenpeptidi,b-tyypinn-terminaalinenpropeptidi	pg/ml (ng/l)	5	5	0.00%
3029187	p-natriureettinenpeptidi,b-tyypinn-terminaalinenpropepti(ko)	— (—)	5	5	100.00%	Distribution not available
3029187	p-pbnp-hy	ng/l (ng/l)	5	5	0.00%	Distribution not available	Distribution not available
3029187	p-probnpv	— (—)	5	7	100.00%	Distribution not available	Distribution not available
3029187	p-probnp(	— (—)	5	5	100.00%	Distribution not available	Distribution not available
3029187	natriureettinenpeptidi(4760p-probnp)	ng/l (ng/l)	5	5	0.00%

Cohort

Number of people: 122 762 (52.01% female)

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

People with ≥2 records: 54.74%
Median number of measurements per person: 2.0
Median duration from first to last measurement: 2.79 years

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Reference range

N people

N records

—

106446

289937

0-900/50-75v

3870

10042

<486/miehetyli75

2691

6604

<376/miehet65-74

2396

5890

<738/naisetyli75

2341

5371

<229/Miehetyli65V

2278

4463

0-1800/yli75v

2098

5064

<301/naiset65-74

1935

4193

0-486

1833

4274

<352/Naisetyli65V

1687

3166

0-738

1592

3473

0-241

1436

3154

Alle125ng/l,katsoohjekirja/kaikki

1357

3555

<194/Miehet50-65V

1275

4532

0-285

1137

2505

<210/miehet55-64

1077

2451

<222/Naiset50-65V

955

2456

mies

953

1356

nainen

931

1304

<287/naiset55-64

891

1803

0-161

824

1854

<155/Naisetalle50V

745

2185

0-247

712

1614

<84/Miehetalle50V

710

3085

<194/miehet50-65v

618

1180

0-450/alle50v

585

1460

<486/miehetyli74v

579

1076

0-116

533

1335

<222/naiset50-65v

520

833

<738/naisetyli74v

492

849

<249/naiset45-54

490

959

<130/naiset18-44

484

932

<241/miehet65-74v

443

824

0-169

423

878

<121/miehet45-54

401

902

<285/naiset65-74v

401

634

0-84

376

855

0-63

295

922

<86/miehet18-44

252

593

<247/naiset55-64v

216

345

<161/miehet55-64v

203

396

<155/naisetalle50v

189

316

<84/miehetalle50v

153

223

<116/naisetalle45v

143

251

<169/naiset45-54v

102

158

<84/miehet45-54v

155

<63/miehetalle45v

121

<194

<222

<155

katsoohjekirjastakohtaTulkinta/kaikki

<84

Value range per person

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Non-allergic asthma (mode)

3778

20661

2.28

323.31

3.6

2.6

1189.14

1176.81

ng/l

0.05

3317

17576

Cystitis

16209

72199

1.48

317.50

3.4

3.1

1383.98

1386.89

ng/l

0.03

14017

61864

Disorders of the thyroid gland

18134

89825

1.44

316.16

3.5

3.1

1318.60

1430.43

ng/l

2.64

15462

76985

Gout, strict definition

4596

28494

2.37

315.21

5.5

3.3

3296.64

1633.77

ng/l

40.42

4188

25018

Dermatitis

12555

89939

1.55

315.11

3.5

3.1

1479.29

1332.03

ng/l

2.67

10803

77178

Congenital malformations of cardiac septa

1390

5034

4.25

314.75

5.9

3.2

1190.22

1111.96

ng/l

0.25

1235

4201

Falls/tendency to fall

19317

73832

1.42

311.78

3.3

3.0

1439.85

1227.94

ng/l

7.88

16355

62874

Intestinal infectious diseases

18084

103118

1.43

309.48

3.9

3.1

1849.89

1300.31

ng/l

28.53

15565

87806

Other diseases of the respiratory system

4937

30866

2.18

309.31

5.3

3.3

2145.49

1800.25

ng/l

4.06

4495

26897

Other respiratory disorders and diseases

4937

30866

2.18

309.31

5.3

3.3

2145.49

1800.25

ng/l

4.06

4495

26897

Insulin, fast-acting

7176

47785

1.80

308.43

4.3

3.2

2800.10

1345.16

ng/l

43.91

6309

41025

Asthma-related infections

13928

80042

2.14

307.65

4.2

3.1

1383.86

1489.76

ng/l

1.99

12224

68215

Symptoms and signs involving the skin and subcutaneous tissue

14502

99233

1.57

307.65

3.4

3.1

1253.23

1354.46

ng/l

1.83

12556

84890

Intracranial injury

11942

79631

1.60

307.65

3.5

3.2

1598.34

1435.54

ng/l

3.58

10196

68365

Sensorineural hearing loss

16970

80529

1.65

307.65

3.4

3.2

1404.80

1479.84

ng/l

1.39

14522

69718

Provisional assignment of new diseases of uncertain etiology

12455

73267

2.16

307.65

4.4

3.1

1790.20

1428.23

ng/l

12.52

11310

62475

Dental caries, including avohilmo

15256

56988

1.55

307.65

3.4

3.2

1634.10

1615.82

ng/l

0.15

13173

49304

Disorders of thyroid, IBD co-morbidities

3298

7578

3.82

307.65

4.5

2.4

1157.74

973.82

ng/l

2.11

2848

6444

Left ventricular outflow tract obstruction, narrow definition

1433

4404

8.72

307.65

5.9

3.4

998.29

1153.63

ng/l

0.69

1344

3723

Left ventricular outflow tract obstruction (LVOTO), broad definition

2904

9748

7.01

307.65

5.2

3.2

1169.74

1031.90

ng/l

0.91

2687

8198

Type 2 diabetes, definitions combined, including avohilmo

21399

74871

2.01

307.65

3.8

2.7

1480.82

1108.86

ng/l

24.16

18237

63514

Angina pectoris

15441

49018

3.22

307.65

4.1

2.4

1705.20

1042.23

ng/l

42.31

13921

40856

Renal failure

13925

67251

2.66

307.65

5.6

3.1

4546.86

1225.25

ng/l

290.34

12865

58233

Later onset COPD, excluding more controls

5441

25083

2.36

307.65

4.4

2.8

2354.28

1409.20

ng/l

26.58

4927

21759

Intracranial trauma

11474

41693

2.22

307.65

3.3

2.9

1355.54

1285.17

ng/l

0.91

9731

35649

Transplanted organ and tissue status

2117

9382

3.49

307.65

8.8

2.6

4483.88

1022.51

ng/l

32.74

2016

7883

Codes for special purposes

12471

73347

2.16

307.65

4.4

3.1

1789.19

1428.23

ng/l

12.48

11324

62545

Pain, not elsewhere classified

6092

32373

2.42

307.65

3.6

2.8

1163.56

1203.88

ng/l

0.27

5352

27433

Explicit Sepsis, including avohilmo

11706

61126

2.35

307.65

4.5

2.9

2998.38

1280.15

ng/l

98.22

10670

52397

Abnormalities of heart beat

9621

38976

3.56

307.65

3.9

2.6

1373.72

1430.30

ng/l

0.58

8253

33105

Nausea and vomiting

5975

35289

2.06

307.65

4.2

3.1

1957.35

1580.95

ng/l

4.68

5199

30426

Depression or dysthymia

13128

50173

1.62

307.65

3.3

3.2

1131.86

1422.28

ng/l

11.17

11020

43645

Abdominal and pelvic pain

19725

70617

1.57

307.65

3.4

3.0

1340.18

1417.32

ng/l

1.25

16778

60373

Other CVD (FINNGEN)

3133

5442

8.44

307.65

4.5

1.5

1886.56

342.96

ng/l

46.94

2810

4139

Diseases of pulp and periapical tissues, including avohilmo

20065

79516

1.43

307.65

3.3

3.2

1397.86

1459.82

ng/l

0.95

17092

68169

Abnormal findings on diagnostic imaging of lung

11925

75198

1.93

307.65

4.0

3.2

1568.15

1541.86

ng/l

0.24

10668

65280

Viral Sepsis

5633

29207

2.94

307.65

5.5

3.0

2626.06

1370.15

ng/l

30.57

5118

25069

Implicit viral Sepsis, including avohilmo

8200

44193

2.71

307.65

5.0

3.0

2327.33

1333.03

ng/l

31.94

7394

37933

Asthma, hospital admissions 3, pneumonia

9149

53868

2.26

307.65

4.6

3.2

1679.27

1724.13

ng/l

0.37

8234

46419

Iron deficiency anaemia

10462

64801

2.04

307.65

4.7

3.1

2332.69

1508.19

ng/l

36.64

9288

55915

Other and unspecified anaemias

11295

66824

2.14

307.65

4.4

3.2

2663.43

1563.83

ng/l

59.02

10285

58027

Biguanides

20735

84818

1.72

307.65

3.4

3.0

1491.97

1269.73

ng/l

9.38

17466

72734

Excluding asthma or asthma-COPD overlap

15680

47125

1.94

307.65

3.5

2.5

1341.95

1028.20

ng/l

12.73

13462

39589

Hypertensive Heart Disease

7341

23744

4.19

307.65

5.0

2.8

2777.97

1166.07

ng/l

91.78

6728

20246

Bleeding

19535

88988

1.89

307.65

4.0

3.0

1948.39

1295.70

ng/l

45.82

17250

76148

Oxycodone

10439

49419

2.51

307.65

4.0

2.9

1685.83

1475.82

ng/l

3.67

9415

42498

STROKE

12661

40055

2.87

307.65

3.7

2.2

1560.86

738.90

ng/l

58.76

11142

32592

Concussion

10022

41475

2.25

307.65

3.4

2.9

1328.99

1288.80

ng/l

0.40

8460

35476

Asthma, hospital admissions , main diagnosis only

17472

99573

1.80

307.65

3.7

3.1

1133.09

1416.57

ng/l

17.11

15086

84701

Abnormalities of breathing

24548

53714

3.73

307.65

3.9

2.6

1364.96

1321.96

ng/l

0.61

21107

45167

General examination and investigation of persons without complaint and reported diagnosis

13342

38777

2.14

307.65

3.8

2.8

1437.47

1447.33

ng/l

0.07

11507

32919

Hypertensive diseases

17342

46463

2.71

307.65

3.4

2.6

1412.47

802.00

ng/l

36.46

14821

38345

Parasetamol

14234

36198

2.36

307.65

3.4

2.7

1435.96

1261.82

ng/l

3.31

12003

30155

General symptoms and signs

23330

67039

2.09

307.65

3.6

2.8

1378.32

1208.80

ng/l

5.45

20047

56499

Congenital malformations of the circulatory system

3250

13095

3.76

307.65

5.2

3.2

1050.62

1166.93

ng/l

0.79

2941

11046

Tramadol

18954

60820

2.39

307.65

3.5

2.9

1441.28

1314.89

ng/l

2.19

16225

51469

Bicuspidal aortic valve syndrome

1101

3440

9.32

307.65

4.4

3.2

931.58

1169.26

ng/l

1.01

1031

2903

Pain (limb, back, neck, head abdominally)

14098

47042

1.69

307.65

3.4

3.1

1403.50

1524.27

ng/l

1.91

12014

40292

Hypothyroidism and >3 levothyroxin purchases

3391

3425

6.71

307.65

3.3

1.3

752.21

182.16

ng/l

13.23

2711

2486

Primary gonarthrosis, bilateral

11959

71213

1.71

307.65

3.3

3.2

1300.55

1536.11

ng/l

7.18

10388

61980

Sleep apnoea

22785

84733

2.15

307.65

3.5

3.0

1019.77

1377.96

ng/l

29.81

18881

73338

Asthma, hospital admission 2, infections

13928

80042

2.14

307.65

4.2

3.1

1383.86

1489.76

ng/l

1.99

12224

68215

Codeine

20288

62147

2.14

307.65

3.5

2.8

1314.21

1290.07

ng/l

0.30

17331

52388

Gastro-oesophageal reflux disease

15736

83286

1.96

307.65

3.3

3.1

1216.28

1329.61

ng/l

2.18

13143

71509

Oral corticosteroids

26212

86654

2.24

307.65

4.1

2.8

1370.62

1358.38

ng/l

0.15

22949

73185

Continuous positive airway pressure

4847

10355

6.62

307.65

4.3

1.8

1893.44

488.01

ng/l

49.95

3902

8318

Early onset COPD, excluding more controls

4571

23121

2.75

307.65

4.0

2.6

1496.61

1097.49

ng/l

5.17

4037

19812

Amiodarone users

2986

14094

5.06

307.65

8.7

3.3

2381.46

1646.19

ng/l

12.47

2862

12354

9619

54647

2.18

307.65

4.2

3.1

1155.45

1401.65

ng/l

8.86

8325

46272

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

6509

37807

2.23

307.65

3.6

2.9

880.08

949.65

ng/l

1.12

5351

32518

Autoimmune diseases excluding thyroid diseases, strict definition

19561

77786

1.51

307.65

3.4

3.1

1731.62

1318.23

ng/l

17.77

16949

66066

Oedema, not elsewhere classified

9240

43513

3.18

307.65

4.0

2.9

1689.85

1374.58

ng/l

5.40

8129

37312

Other chronic obstructive pulmonary disease

10554

56924

1.96

307.65

4.3

3.1

2048.11

1613.00

ng/l

11.78

9432

49466

Any reimbursement code in KELA

9072

20527

2.56

307.65

3.4

1.9

1021.37

481.82

ng/l

28.26

7541

15978

Other diseases of pericardium

1270

3759

8.04

307.65

5.7

1.8

2113.81

506.14

ng/l

12.46

1203

3044

Benzodiazepine use

20871

100055

1.60

307.65

3.3

3.1

1288.03

1395.12

ng/l

2.45

17551

85670

Any operation in hilmo

546

247

13.27

307.65

3.1

1.3

1625.35

447.24

ng/l

5.55

445

180

Dizziness and giddiness

17900

85772

2.02

307.65

3.5

3.1

1347.87

1402.28

ng/l

0.86

15441

73531

Cough

9037

42688

2.56

307.65

3.6

2.6

1184.73

1335.04

ng/l

2.62

7752

36294

Type 2 diabetes

22234

76751

2.04

307.65

3.8

2.7

1678.63

1101.34

ng/l

42.52

19023

64979

Ischemic heart diseases

25555

59707

4.28

307.65

4.4

2.3

1479.07

930.94

ng/l

50.22

23047

49156

Cerebrovascular diseases (FINNGEN)

6574

11961

5.55

307.65

3.7

1.5

1595.77

267.38

ng/l

61.45

5747

8960

Caries of dentine, including avohilmo

16091

60409

1.53

307.65

3.4

3.2

1599.94

1575.25

ng/l

0.23

13843

52237

Polyarthrosis

4870

25795

2.30

307.65

3.6

3.0

1230.55

1447.24

ng/l

3.49

4266

22303

Non-rheumatic valve diseases

17056

34856

8.28

307.65

4.8

1.8

1836.52

512.35

ng/l

187.34

15849

28101

Disorders of gallbladder, biliary tract and pancreas

21044

93032

1.62

307.65

3.4

3.1

1499.81

1361.74

ng/l

3.30

18158

79674

Other pulmonary diagnosis

15749

47125

1.96

307.65

3.5

2.5

1347.96

1028.20

ng/l

13.24

13529

39589

Congenital malformations of aortic and mitral valves

1245

3737

9.56

307.65

5.6

3.2

931.55

1149.09

ng/l

1.01

1172

3146

Diabetes mellitus

22469

77910

2.00

307.65

3.8

2.7

1689.82

1094.41

ng/l

43.18

19229

65824

Heart failure, not strict

27059

62342

6.49

307.65

5.4

2.0

2297.04

516.14

ng/l

307.65

25095

51750

Undetermined asthma

2752

13685

2.70

307.65

3.6

2.6

1073.64

1105.53

ng/l

0.18

2364

11636

COPD, hospital admissions

10598

62866

1.77

307.65

4.3

3.2

2032.88

1609.64

ng/l

12.01

9472

54921

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

24152

79791

2.47

307.65

4.5

2.6

1676.83

1115.03

ng/l

43.22

21321

66874

Asthma

17347

46698

2.38

307.65

3.6

2.5

1048.05

1029.30

ng/l

0.25

14946

39229

Conductive and sensorineural hearing loss

17477

82529

1.64

307.65

3.4

3.2

1387.68

1459.45

ng/l

1.31

14958

71298

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

21152

68827

2.25

307.65

4.1

2.7

1839.65

1077.55

ng/l

67.13

18822

58084

All influenza

5813

33406

2.27

307.65

4.6

2.9

2039.46

1276.45

ng/l

19.95

5155

28376

Pacemaker

12549

56611

4.34

307.65

6.6

3.1

2383.92

1702.82

ng/l

37.87

11675

49266

Persons encountering health services for examination and investigation

12561

38940

1.85

307.65

3.4

2.8

1470.79

1458.35

ng/l

0.09

10748

33037

Myocarditis

1186

2042

11.29

307.65

10.0

1.5

1168.13

297.50

ng/l

15.83

1091

1514

Transient ischemic attack

12227

69492

1.71

307.65

3.8

3.2

1806.48

1497.54

ng/l

8.55

10935

60310

Pulmonary embolism

7858

44850

2.60

307.65

4.1

3.2

1384.94

1642.54

ng/l

6.01

7106

38874

Implicit Sepsis, including avohilmo

22002

82874

2.58

307.65

4.4

2.8

2063.29

1073.15

ng/l

103.99

19465

70107

Venous thromboembolism

13289

82533

1.99

307.65

3.7

3.2

1515.29

1552.43

ng/l

0.33

11862

71253

Asthma-related pneumonia or sepsis

9149

53868

2.26

307.65

4.6

3.2

1679.27

1724.13

ng/l

0.37

8234

46419

Asthma (only as main-diagnosis)

16089

46698

2.40

307.65

3.6

2.5

1065.92

1029.30

ng/l

0.53

13832

39229

Complications of medical and surgical care

16470

98309

1.81

307.65

3.8

3.1

1844.57

1325.39

ng/l

25.50

14293

84229

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

7864

14701

4.35

307.65

3.2

1.5

1075.11

243.27

ng/l

42.81

6728

10910

Paroxysmal tachycardia

5949

10056

8.55

307.65

5.8

1.5

1434.74

285.38

ng/l

87.23

5384

7569

Thoracic aortic aneurysm

4099

20221

3.89

307.65

3.9

3.2

1381.16

1290.29

ng/l

0.66

3744

17583

Nonischemic cardiomyopathy

3502

11096

10.88

307.65

7.8

2.6

2419.38

1114.23

ng/l

28.78

3377

9324

Artificial joint operation, meniscal resection

19360

92612

1.52

307.65

3.2

1203.30

1463.04

ng/l

13.54

16676

79653

Symptoms and signs involving the digestive system and abdomen

19818

70620

1.57

307.65

3.5

3.0

1400.41

1417.61

ng/l

0.18

16854

60376

ILD differential diagnosis

15552

47085

1.93

307.65

3.5

2.5

1341.25

1031.63

ng/l

12.27

13361

39555

Persons encountering health services for specific procedures and health care

24765

83874

2.14

307.65

4.0

2.8

1866.52

1071.60

ng/l

70.99

21826

70067

Fitting and adjustment of other devices

9361

52123

2.09

307.65

3.8

3.0

1619.05

1405.80

ng/l

4.97

8280

44753

Other antidepressants

21126

75733

1.61

307.65

3.3

3.2

1227.62

1487.38

ng/l

13.94

17751

65419

Cerebrovascular diseases

16941

83178

1.69

307.65

3.8

3.1

1938.39

1357.93

ng/l

32.40

14968

71804

Implicit bacterial Sepsis

12034

57356

2.66

307.65

5.2

3.0

2970.86

1336.52

ng/l

104.33

10989

49430

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

16312

91453

1.96

307.65

3.8

3.1

1524.53

1450.18

ng/l

1.14

14447

78700

Cardiodefibrillation

10558

56640

3.32

307.65

5.3

3.2

2039.18

1571.66

ng/l

24.67

9802

49376

Chronic kidney disease

9278

50199

2.76

307.65

5.9

3.1

5419.28

1347.34

ng/l

224.25

8633

43604

Hypertensive heart and/or renal disease

7994

24914

4.13

307.65

5.0

2.7

3144.71

1144.64

ng/l

106.93

7327

21211

Diseases of arteries, arterioles and capillaries

17394

79217

2.14

307.65

4.1

3.1

2566.04

1315.00

ng/l

93.24

15819

68147

Antihypertensive medication - note that there are other indications

9811

17091

3.62

307.65

3.6

1.8

1083.91

395.42

ng/l

36.98

8094

13137

Neurological diseases, wide definition

4350

8817

2.87

307.65

3.4

2.6

1141.99

936.41

ng/l

1.90

3520

7359

COPD related to multimorbidity

9619

56067

1.86

307.65

4.5

3.2

2227.45

1671.61

ng/l

16.35

8639

49107

COPD/asthma related infections

20779

68827

1.74

307.65

3.7

2.7

1537.84

1077.55

ng/l

31.37

18012

58084

Spondylosis

12382

62293

1.91

307.65

3.2

3.1

1032.49

1524.00

ng/l

39.94

10682

53658

Certain infectious and parasitic diseases, including avohilmo

13956

47055

1.67

307.65

3.5

2.8

1570.86

1111.23

ng/l

20.33

12052

39559

Other specific joint derangements/joint disorders

13791

54496

1.81

307.65

3.1

3.0

1069.47

1258.50

ng/l

5.89

11497

46081

Opioids

19814

62575

1.90

307.65

3.4

2.8

1387.03

1294.64

ng/l

1.65

16930

52692

Sciatica+with lumbago

10732

60922

1.86

307.65

3.2

3.1

932.91

1382.91

ng/l

31.03

9298

52066

Other heart diseases, wide

27863

49744

5.54

307.65

4.2

1.8

1424.74

443.17

ng/l

169.27

24864

39094

Presence of other functional implants

14359

62554

1.98

307.65

3.6

2.7

1788.37

1300.32

ng/l

20.88

12332

53655

Fever of other and unknown origin

13768

61201

2.55

307.65

4.2

2.8

1905.95

1266.29

ng/l

25.80

12237

51879

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

23652

89015

2.23

307.65

4.2

2.8

1874.92

1051.20

ng/l

88.63

21088

74704

Ischaemic Stroke, excluding all haemorrhages

12991

69736

1.65

307.65

3.9

3.2

2191.17

1502.13

ng/l

31.49

11506

60535

Coxarthrosis [arthrosis of hip](FG)

12732

57807

1.85

307.65

3.4

3.0

1449.33

1433.82

ng/l

0.14

11199

49707

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

11928

86375

1.60

307.65

3.7

3.1

1881.76

1369.01

ng/l

18.09

10349

74461

Medical observation and evaluation for suspected diseases and conditions

14977

38923

2.46

307.65

3.7

2.8

1410.52

1457.36

ng/l

0.50

12629

33027

Symptoms and signs involving the urinary system

17710

87949

1.85

307.65

3.5

3.2

1691.94

1374.10

ng/l

12.53

15240

75579

COPD, early/later onset

10685

63262

1.77

307.65

4.3

3.2

2066.16

1603.96

ng/l

13.43

9547

55254

Implicit Sepsis

20768

81318

2.61

307.65

4.6

2.8

2204.07

1107.81

ng/l

113.26

18494

69068

COPD (mode)

8096

33517

2.72

307.65

4.2

2.7

2093.72

1214.60

ng/l

32.42

7235

28789

Hypertensive diseases (excluding secondary)

10685

15401

5.56

307.65

3.5

1.5

1253.71

241.22

ng/l

60.35

8998

11346

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

24570

92837

2.30

307.65

4.3

2.9

1997.40

1159.17

ng/l

91.44

21767

78513

COPD differential diagnosis

15565

47096

1.93

307.65

3.5

2.5

1343.33

1031.68

ng/l

12.43

13374

39564

21152

68827

2.25

307.65

4.1

2.7

1839.65

1077.55

ng/l

67.13

18822

58084

Implicit bacterial Sepsis, including avohilmo

13330

60694

2.71

307.65

5.1

3.0

2837.43

1298.80

ng/l

109.48

12153

52215

Type 2 diabetes, strict (exclude DM1)

21730

76176

2.03

307.65

3.9

2.7

1505.17

1112.35

ng/l

26.33

18569

64606

Asthma (mode)

16797

47085

2.31

307.65

3.5

2.5

1036.89

1031.63

ng/l

0.06

14423

39555

Major coronary heart disease event excluding revascularizations

16894

53542

3.22

307.65

4.3

2.4

2242.52

1097.89

ng/l

98.42

15482

44726

Disorders of lens

14441

59501

1.81

307.65

3.5

2.9

1746.00

1140.96

ng/l

29.71

12588

51102

Implicit viral Sepsis

5629

29174

2.95

307.65

5.5

3.0

2627.97

1371.19

ng/l

30.56

5114

25042

Pneumonias (Asthma/COPD co-morbidities)

23996

88323

2.23

307.65

4.2

2.8

1856.24

1040.23

ng/l

88.46

21361

74039

Acute tubulo-interstitial nephritis

14208

76906

1.90

307.65

3.8

2.9

2190.58

1002.05

ng/l

104.21

12548

65578

Cardiomyopathies, Primary/intrinsic

4232

10971

12.53

307.65

9.5

1.9

2616.02

563.15

ng/l

103.18

4080

8899

All chronic kidney diseases

14636

65519

2.45

307.65

5.0

2.9

4055.39

1035.75

ng/l

271.96

13374

56074

Complications of surgical and medical care, not elsewhere classified

23362

96768

1.97

307.65

3.7

3.0

1786.57

1286.59

ng/l

32.21

20389

82353

Nutritional anaemias

11923

74659

1.91

307.65

4.6

3.1

2301.09

1512.06

ng/l

39.66

10599

64488

Explicit Sepsis

11443

60266

2.34

307.65

4.6

3.0

3032.90

1290.78

ng/l

96.94

10431

51687

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

22432

80648

2.44

307.65

4.2

2.8

1851.46

1015.19

ng/l

79.34

19682

67749

Conduction disorders

9645

25187

6.16

307.65

5.4

1.9

1937.98

570.87

ng/l

138.07

8745

20484

Asthma/COPD (KELA code 203)

20690

89053

1.82

307.65

3.5

3.0

1207.40

1356.77

ng/l

5.27

17878

75445

Acute bronchitis

9026

57504

1.87

307.65

4.5

3.2

1773.27

1597.86

ng/l

2.66

7794

49362

Diseases of the musculoskeletal system and connective tissue

8816

27602

1.78

307.65

3.3

3.0

1319.83

1419.19

ng/l

1.02

7326

23249

Stroke, including SAH

14181

74423

1.62

307.65

3.8

3.2

2052.49

1435.47

ng/l

29.81

12549

64372

Stroke, excluding SAH

13684

71928

1.64

307.65

3.8

3.2

2084.61

1470.06

ng/l

28.33

12121

62312

Unstable angina pectoris

9581

40009

2.79

307.65

4.3

2.5

2082.90

1265.27

ng/l

34.65

8708

33751

Coronary revascularization (ANGIO or CABG)

25831

58624

4.87

307.65

4.6

2.3

1513.64

941.50

ng/l

56.38

23424

48350

Other arrhythmias

18233

45381

4.75

307.65

4.0

1.8

1186.13

452.66

ng/l

117.59

16051

36075

Myocardial infarction, strict

12423

42554

3.20

307.65

4.4

2.4

2447.14

1117.19

ng/l

88.83

11473

35573

Calcific aortic valvular stenosis, operated

9919

48915

3.91

307.65

4.8

3.3

2476.96

1828.84

ng/l

20.26

9331

42644

Cardiomyopathy

6135

16368

10.96

307.65

8.4

1.9

2513.17

575.66

ng/l

132.35

5868

13246

Bacterial infection, other or unspecified, including avohilmo

15669

72359

2.43

307.65

4.4

2.9

2611.23

1190.71

ng/l

104.74

14159

61736

Dilated cardiomyopathy

3795

15708

6.92

307.65

9.6

3.2

2670.87

1604.77

ng/l

22.96

3661

13669

Atrial fibrillation and flutter

9913

11312

11.61

307.65

4.7

1.5

1624.07

274.00

ng/l

138.08

9102

8463

Diarrhoea and gastroenteritis of presumed infectious origin

13684

88124

1.56

307.65

4.0

3.1

1887.23

1335.78

ng/l

20.55

11780

74958

Erysipelas, including avohilmo

18857

79028

2.32

307.65

4.0

2.9

2032.72

1098.10

ng/l

87.82

16732

66845

Coronary artery bypass grafting

6571

25725

2.86

307.65

4.6

2.5

2723.26

1341.37

ng/l

54.58

6115

21701

Percutaneous Coronary Intervention

25960

58602

4.94

307.65

4.6

2.3

1521.59

941.73

ng/l

58.16

23537

48334

Major coronary heart disease event

26581

63893

4.24

307.65

4.5

2.4

1555.29

996.87

ng/l

53.70

24078

52910

Atrial fibrillation and flutter with reimbursement

8759

9622

13.85

307.65

4.9

1.5

1592.77

294.73

ng/l

177.28

8137

7255

AV-block

5996

16923

6.48

307.65

5.7

1.9

2303.17

658.60

ng/l

98.34

5515

13843

Coxarthrosis

11537

47871

1.90

307.65

3.4

3.1

1459.63

1484.39

ng/l

0.22

10134

41345

Cardiomyopathy, other and unspecified

2508

6659

11.54

307.65

8.7

1.9

2423.89

530.07

ng/l

49.03

2377

5393

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

20531

91256

1.64

307.65

3.4

3.1

1460.12

1371.66

ng/l

1.59

17832

77881

Ulcer of lower limb, not elsewhere classified

3853

21751

2.81

307.65

4.5

3.4

3860.75

1642.65

ng/l

40.03

3540

18929

Heart failure, strict

22230

61797

6.18

307.65

6.4

2.3

3181.96

778.37

ng/l

307.65

21098

52463

Secondary hypertension

1568

3911

6.03

307.65

3.7

1.5

5689.38

324.30

ng/l

42.04

1418

2956

Hypertension, essential

17795

45942

2.90

307.65

3.2

2.6

1393.96

803.55

ng/l

37.27

15216

37939

Cholelithiasis, broad definition with cholecystitis

18341

88781

1.57

307.65

3.4

3.1

1484.59

1394.85

ng/l

1.63

15736

76248

Diseases of the skin and subcutaneous tissue

19079

70528

1.50

307.65

3.4

3.0

1559.30

1279.33

ng/l

10.41

16327

59938

Chronic periodontitis, including avohilmo

19966

95655

1.49

307.65

3.3

3.1

1336.32

1329.66

ng/l

0.06

17004

82013

Any mental disorder

20924

80631

1.42

307.65

3.3

3.1

1322.21

1356.06

ng/l

0.43

17750

69312

Status post-ami

6526

26627

2.73

307.65

5.4

2.5

2809.63

1336.47

ng/l

60.30

6034

22448

Aplastic and other anaemias

12106

70081

2.11

307.65

4.4

3.2

2764.70

1535.45

ng/l

74.58

11032

60778

Diabetes medication

21934

85289

1.74

307.65

3.4

3.0

1676.29

1200.31

ng/l

26.63

18514

72744

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

20420

76121

1.90

307.65

3.5

2.7

1760.26

1113.48

ng/l

40.72

17348

64527

Spinal stenosis

12882

58749

2.12

307.65

3.5

3.1

1291.56

1646.95

ng/l

19.14

11364

50863

Acute renal failure

5933

34125

2.61

307.65

6.1

3.1

4170.44

1249.67

ng/l

105.69

5491

29564

Dipeptidyl peptidase 4 (DPP-4) inhibitors

13960

69407

2.09

307.65

4.0

3.1

2260.05

1392.81

ng/l

50.94

12190

60419

Diabetes, varying definitions

22404

77951

2.01

307.65

3.8

2.7

1690.37

1095.93

ng/l

42.88

19181

65851

Lumbar disc prolapse

12384

64179

1.63

307.65

3.2

3.1

919.03

1405.16

ng/l

38.71

10603

54839

Missing teeth due to accident, extraction or parodontitis

13698

88045

1.65

307.65

3.5

3.2

1216.76

1387.89

ng/l

5.31

11623

76433

Non-invasive ventilation

4101

12927

3.43

307.65

4.3

1.7

1981.07

401.21

ng/l

63.38

3772

10323

Non-allergic asthma (mode), excluding more controls

3778

18347

2.64

307.65

3.6

2.0

1189.14

652.58

ng/l

9.27

3317

15249

Other nutritional deficiencies

14989

77531

2.23

307.65

3.7

3.0

1183.60

1151.01

ng/l

0.39

12566

66031

Hernia

19381

91080

1.62

307.65

3.4

3.1

1440.44

1353.08

ng/l

1.62

16720

77549

Hypertension

17321

46454

2.70

307.65

3.4

2.6

1413.90

802.11

ng/l

36.51

14798

38338

Coronary atherosclerosis

18982

52279

3.77

307.65

4.2

2.4

1809.75

1012.11

ng/l

64.68

17250

43401

Other anaemias

11386

67203

2.13

307.65

4.4

3.2

2655.12

1560.00

ng/l

59.36

10369

58345

Gonarthrosis,primary

20039

86943

1.63

307.65

3.3

3.2

1243.29

1495.32

ng/l

12.67

17242

75138

Heart failure and coronary heart disease

15636

41870

6.61

307.65

7.2

2.6

3516.86

1255.00

ng/l

250.51

14906

35327

Type 2 diabetes, definitions combined

21654

75760

2.03

307.65

3.9

2.7

1495.84

1109.03

ng/l

26.62

18500

64247

Other (not insulin) diabetes medications

21124

83408

1.74

307.65

3.4

3.0

1526.20

1214.03

ng/l

14.81

17778

71377

Hypothyroidism, drug reimbursement

2070

2632

7.00

307.65

3.2

1.3

851.28

200.46

ng/l

9.96

1738

1971

Left bundle-branch block

2311

7067

8.33

307.65

5.5

1.9

1537.88

565.44

ng/l

32.80

2104

5763

Cardiac arrest

1488

3352

6.05

307.65

5.8

1.5

3001.74

381.73

ng/l

34.00

1378

2558

Covid-19 confirmed case

9813

55033

2.55

307.65

4.7

3.2

1981.34

1579.84

ng/l

11.35

8997

47492

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

3604

15162

3.44

307.65

4.9

3.2

1683.17

1195.27

ng/l

4.66

3295

12789

Other intervertebral disc disorders

17192

68075

1.75

307.65

3.2

3.1

1044.42

1516.84

ng/l

40.55

14728

58117

Diverticular disease of intestine

17334

68763

1.95

307.65

3.5

3.0

1464.05

1415.25

ng/l

0.67

15156

59134

Gonarthrosis

13926

51219

1.82

307.65

3.2

3.0

1257.80

1425.84

ng/l

4.19

11913

43955

Use of hypnotics and sedatives

21350

89794

1.52

307.65

3.4

3.1

1403.94

1335.80

ng/l

1.14

18144

76815

Endocrine, nutritional and metabolic diseases

14593

40151

2.13

307.65

3.5

2.5

1423.90

956.31

ng/l

19.47

12218

33458

COPD

11047

58551

1.99

307.65

4.2

3.1

2031.17

1595.12

ng/l

12.46

9865

50849

Other cataract

10059

47769

1.96

307.65

3.7

3.0

1791.52

1262.58

ng/l

16.56

8817

41320

Statin medication

12129

37876

2.11

307.65

3.5

2.6

1398.86

1013.03

ng/l

12.50

10198

31393

Chronic apical periodontitis

21992

91944

1.49

307.65

3.3

3.1

1328.97

1372.96

ng/l

0.60

18715

78601

Senile cataract

13538

55770

1.78

307.65

3.5

3.0

1727.09

1184.87

ng/l

25.80

11822

48117

Any gastric operation

14764

44196

1.92

307.65

3.5

2.7

1464.44

1118.13

ng/l

11.91

12410

37179

Gout, idiopatic and unspecified

6262

40072

2.19

307.65

5.2

3.3

3160.42

1601.41

ng/l

48.74

5678

35069

Meniscus derangement

10951

50052

1.68

307.65

3.1

3.0

1055.25

1366.29

ng/l

14.22

9328

42932

Other disorders of urethra and urinary system

14993

69699

1.75

307.65

3.4

3.0

1587.33

1402.69

ng/l

4.10

12904

59736

Disorders of choroid and retina

18050

89986

1.65

307.65

3.5

3.1

2032.46

1338.04

ng/l

39.84

15719

77419

Gout, unspecified

5121

32230

2.27

307.65

5.3

3.3

3232.65

1610.89

ng/l

41.91

4653

28213

Low back pain

17147

68943

2.03

307.65

3.4

3.1

1149.57

1487.38

ng/l

18.40

14576

58685

Gonarthrosis [arthrosis of knee](FG)

16614

63394

1.79

307.65

3.2

3.0

1236.10

1363.90

ng/l

3.15

14237

54113

Neurological diseases

15761

50526

1.77

307.65

3.3

3.0

1194.54

1442.46

ng/l

8.29

13174

43320

Other and unspecified iron deficiency

8236

50617

2.13

307.65

4.5

3.1

2237.99

1520.08

ng/l

25.71

7295

43709

Congenital malformations of heart and great arteries

3103

11286

4.56

307.65

5.4

3.2

1115.32

1165.59

ng/l

0.25

2826

9487

Myalgia

4558

26522

2.10

307.65

3.3

3.0

959.47

1267.71

ng/l

6.90

3779

22643

Rotator cuff syndrome

13169

62788

1.69

307.65

3.2

3.1

1067.18

1447.83

ng/l

24.12

11502

54048

Obesity and other hyperalimentation

14331

74935

2.29

307.65

3.7

3.0

1170.34

1143.68

ng/l

0.31

11996

63803

Pain in limb

19319

69193

2.21

307.65

3.5

3.1

1375.21

1451.44

ng/l

1.17

16534

58965

Malaise and fatigue

14344

55190

2.88

307.65

4.0

2.9

1797.06

1344.36

ng/l

21.25

12526

47048

All kidney diseases

22968

89298

2.14

307.65

4.2

2.8

2457.60

882.81

ng/l

197.08

20255

75233

Codeine or tramadol medication

25330

86073

1.91

307.65

3.5

3.0

1346.57

1398.68

ng/l

0.94

21698

73274

Other disorders of fluid, electrolyte and acid-base balance

8517

44125

2.65

307.65

4.5

3.0

2614.47

1413.20

ng/l

49.33

7662

37866

Nerve, nerve root and plexus disorders

22664

95805

1.63

307.65

3.3

3.1

1335.50

1408.09

ng/l

1.37

19385

81909

Pure hypercholesterolaemia

19313

69840

2.31

307.65

3.4

2.9

1535.03

1222.73

ng/l

15.42

17032

59291

Obesity, other/unspecified

6740

35859

2.39

307.65

3.6

2.9

1048.16

1085.61

ng/l

0.33

5634

30395

All pneumoniae

24068

88246

2.22

307.65

4.2

2.8

1857.01

1039.22

ng/l

88.39

21424

73965

Shoulder lesions

16316

65626

1.75

307.65

3.2

3.1

1103.75

1460.00

ng/l

24.06

14081

56269

Gout, FINNGEN

7372

47257

2.10

307.65

5.2

3.2

3101.01

1622.86

ng/l

52.66

6693

41311

Obesity due to excess calories

10892

55193

2.64

307.65

3.8

2.9

1175.20

1092.47

ng/l

1.22

9068

46959

Other dorsopathies, not elsewhere classified

20093

70033

1.70

307.65

3.2

3.1

1152.90

1506.49

ng/l

25.17

17099

59532

Used for control exclusion in common control thyroid runs

20052

74447

1.50

307.65

3.5

3.1

1541.39

1326.69

ng/l

6.74

17099

63221

Other joint disorders

15567

56655

1.58

307.65

3.1

3.0

1187.91

1346.37

ng/l

4.27

13035

47899

Disorders of lipoprotein metabolism and other lipidaemias

21355

71923

2.39

307.65

3.5

2.9

1590.15

1207.57

ng/l

20.24

18712

60881

Hypo-osmolality and hyponatraemia

4482

25434

2.54

307.65

4.2

3.1

2190.82

1488.44

ng/l

13.44

3987

21883

Non-ischemic cardiomyopathy

11395

31810

7.58

307.65

5.7

2.2

2629.29

717.40

ng/l

247.27

10762

26441

Valvular heart disease excluding rheumatic fever

17172

34943

8.35

307.65

4.8

1.8

1833.65

513.01

ng/l

188.50

15962

28170

Dorsalgia

20531

69984

1.80

307.65

3.3

3.1

1131.19

1507.82

ng/l

29.01

17532

59496

Benign neoplasm of colon, rectum, anus and anal canal

14917

89056

1.72

307.65

3.6

3.2

1592.54

1459.02

ng/l

2.37

13083

77156

Benign neoplasm: Colon

12532

85009

1.67

307.65

3.7

3.2

1610.57

1479.41

ng/l

1.92

10997

73920

Gastrointestinal diseases

9719

31362

1.72

307.65

3.3

2.7

1291.77

1147.21

ng/l

1.89

8093

26299

Diabetes, insulin treatment (Kela reimbursement)

22064

87559

1.76

307.65

3.5

3.0

1786.37

1219.63

ng/l

34.63

18777

74800

Other diseases of pleura

11659

64201

2.13

307.65

4.8

3.2

2265.83

1609.40

ng/l

28.08

10630

55825

Polyarthropathies

15167

54331

2.23

307.65

4.0

3.0

2069.04

1379.09

ng/l

31.25

13319

46218

Diseases of pulp and periapical tissues and dental caries

13887

50924

1.59

307.65

3.4

3.2

1706.53

1647.13

ng/l

0.60

12016

44049

Pulmonary heart disease

7858

45016

2.58

307.65

4.1

3.3

1384.94

1654.77

ng/l

6.55

7106

39035

Vocal cord dysfunction

2681

6802

4.79

307.65

3.6

1.7

1044.09

318.64

ng/l

22.86

2284

5473

Lower back pain or/and sciatica

23555

97447

1.76

307.65

3.3

3.1

1109.69

1431.79

ng/l

24.72

20162

83080

Bronchitis

22457

97380

1.56

307.65

3.9

3.0

1532.65

1351.68

ng/l

6.35

19277

83029

Aortic aneurysm

6073

35359

2.44

307.65

3.9

3.2

1831.01

1600.03

ng/l

2.68

5515

30791

Type 2 diabetes, wide definition

19418

70869

2.23

307.65

3.7

2.7

1907.11

1152.00

ng/l

57.93

16926

60448

Diseases of the respiratory system

12239

39654

1.76

307.65

3.4

2.6

1404.18

1092.96

ng/l

9.85

10535

33478

Other neurological diseases

16624

89133

1.74

307.65

3.6

3.2

1609.51

1465.86

ng/l

3.27

14700

76707

Other disorders of ear

19564

88718

1.64

307.65

3.3

3.1

1311.63

1399.57

ng/l

1.95

16670

76122

Other acute lower respiratory infections

11464

72655

1.78

307.65

4.5

3.2

1770.23

1520.79

ng/l

5.70

9946

62158

Periodontitis

20004

95614

1.49

307.65

3.3

3.1

1342.30

1329.96

ng/l

0.12

17039

81976

Other bacterial diseases, including avohilmo

24926

85240

2.33

307.65

4.0

2.8

1975.80

1041.22

ng/l

98.71

22078

71479

Sleep disorders (combined)

23792

82487

1.75

307.65

3.5

3.1

1155.58

1489.49

ng/l

26.87

19939

71307

Other soft tissue disorders, not elsewhere classified

21091

69938

2.09

307.65

3.4

3.1

1338.04

1457.77

ng/l

2.61

17920

59517

Constipation

20357

91406

1.80

307.65

3.4

3.1

1335.90

1425.52

ng/l

1.84

17423

78580

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

3794

16574

3.25

307.65

4.9

3.2

1659.43

1210.24

ng/l

4.36

3452

14004

Gout

7372

35392

2.58

307.65

5.2

3.2

3101.01

1712.72

ng/l

45.46

6693

30834

Other/unspecified dorsalgia

7691

47788

1.91

307.65

3.5

3.1

1162.67

1518.49

ng/l

14.27

6543

40829

Other arthrosis

11078

49257

1.78

307.65

3.2

3.0

1149.82

1370.66

ng/l

6.24

9544

42324

Heart failure and bmi 25plus

12165

34231

5.64

307.65

6.4

2.4

2864.93

733.40

ng/l

279.36

11512

28407

Arthrosis

14524

53057

1.73

307.65

3.2

3.0

1269.54

1399.43

ng/l

2.94

12432

45298

Gonarthrosis, primary, with knee surgery

13350

75333

1.66

307.65

3.3

3.2

1289.00

1545.40

ng/l

9.57

11550

65660

Artrosis, including avohilmo

16055

61276

1.62

307.65

3.1

3.2

1280.37

1523.29

ng/l

9.28

13653

52308

Renal tubulo-interstitial diseases

21705

89643

2.30

307.65

4.4

2.8

2864.94

922.35

ng/l

247.79

19427

75905

GASTRO-related operations

14764

44196

1.92

307.65

3.5

2.7

1464.44

1118.13

ng/l

11.91

12410

37179

Other disorders of skin and subcutaneous tissue

16361

94796

1.74

307.65

3.7

3.1

2029.78

1337.71

ng/l

36.02

14378

81307

Episodal and paroxysmal disorders

22969

73866

1.84

307.65

3.4

3.0

1193.94

1499.08

ng/l

19.35

19316

63374

Soft tissue disorders

19752

70414

1.61

307.65

3.3

3.1

1324.26

1467.36

ng/l

3.65

16696

59882

Other headache syndromes

8009

48233

1.98

307.65

3.1

2.9

871.76

1270.76

ng/l

17.75

6751

41283

Other heart diseases

14991

15304

12.11

307.65

4.7

1.5

1365.19

245.41

ng/l

103.46

13524

11270

Diseases of arteries, arterioles and capillaries (FINNGEN)

6662

9454

8.94

307.65

4.1

1.5

2372.72

296.84

ng/l

84.05

6094

7107

Cardiomyopathy (excluding other)

4307

11909

10.96

307.65

9.4

1.9

2633.97

550.57

ng/l

107.31

4152

9680

Cardiac arrhythmias

16672

25751

6.64

307.65

4.1

1.8

1250.89

397.70

ng/l

109.08

14697

20009

Hard cardiovascular diseases

24460

58189

3.95

307.65

4.3

2.3

1480.20

890.54

ng/l

53.39

21910

47811

Other chronic obstructive pulmonary disease, including avohilmo

12931

72704

1.84

307.65

4.1

3.2

1888.52

1507.53

ng/l

12.33

11415

63280

Infections of the skin and subcutaneous tissue

11025

76804

1.60

307.65

3.8

3.1

1837.63

1233.18

ng/l

19.46

9473

65377

Intestinal infectious diseases, including avohilmo, including avohilmo

22508

97308

1.41

307.65

3.6

3.1

1629.27

1324.97

ng/l

13.15

19332

83034

Asthma-related pneumonia

9136

53785

2.26

307.65

4.6

3.2

1679.44

1721.45

ng/l

0.34

8223

46350

Asthma, unspecified (mode)

13939

45599

3.03

307.65

3.8

2.5

1223.58

1038.07

ng/l

6.50

12142

38427

Obesity related asthma

8808

44221

2.91

307.65

4.0

3.0

1005.86

1243.38

ng/l

6.78

7562

37773

COPD/asthma/ILD related infections

20779

68827

1.74

307.65

3.7

2.7

1537.84

1077.55

ng/l

31.37

18012

58084

ILD medications

25717

82410

2.03

307.65

4.0

2.8

1474.45

1306.31

ng/l

5.43

22346

69436

Other bacterial diseases

24163

87754

2.39

307.65

4.1

2.9

2156.19

1072.34

ng/l

121.11

21558

74040

Other diseases of intestines

21539

78277

1.76

307.65

3.4

3.0

1358.24

1319.41

ng/l

0.51

18336

66244

Caries of dentine

4722

24894

2.35

307.65

4.9

3.0

2453.71

1359.25

ng/l

16.54

4211

21520

Disorders of eyelid, lacrimal system and orbit

18284

96762

1.58

307.65

3.3

3.2

1230.40

1433.06

ng/l

8.20

15662

83029

Hernia of abdominal wall, postoperative

4206

21737

2.59

307.65

3.6

2.7

1618.30

1132.20

ng/l

6.06

3651

18712

Influenza and pneumonia

24576

86283

2.18

307.65

4.1

2.8

1791.92

1026.38

ng/l

79.20

21786

72241

Insulin medication

13273

71515

1.86

307.65

4.1

3.1

2537.03

1325.72

ng/l

67.43

11646

61577

Asthma (diagnoses ohter than nonallergic)

20204

99932

2.00

307.65

3.7

3.1

1209.28

1420.68

ng/l

11.28

17577

85005

Other septicaemia

9943

55105

2.33

307.65

4.6

3.0

3143.57

1369.34

ng/l

82.24

9079

47416

Dental caries

5295

27739

2.29

307.65

4.8

3.0

2347.83

1364.75

ng/l

16.29

4721

23949

Glucagon-like peptide-1 (GLP-1) analogues

6509

37807

2.23

307.65

3.6

2.9

880.08

949.65

ng/l

1.12

5351

32518

Autoimmune diseases

21215

80516

1.47

307.65

3.4

3.1

1546.37

1311.51

ng/l

8.63

18120

68398

Chronic lower respiratory diseases

25875

89110

1.78

307.65

3.6

3.0

1295.13

1357.74

ng/l

1.20

22297

75489

Valvular operations

4994

13753

11.07

307.65

5.7

1.9

1831.12

609.09

ng/l

72.59

4791

11170

Pneumonia, organism unspecified

22475

84614

2.34

307.65

4.3

2.8

1925.22

1034.99

ng/l

98.29

20048

71039

Autoimmune diseases excluding thyroid diseases

20243

80157

1.52

307.65

3.4

3.1

1712.03

1314.03

ng/l

17.41

17553

68107

Arthropathies

15730

56715

1.54

307.65

3.2

3.1

1391.39

1348.78

ng/l

0.44

13292

47949

Liquid cancers, including Hilmo

8203

48555

1.87

307.65

3.8

3.3

1772.08

1502.13

ng/l

4.87

7444

41865

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2950

5901

6.24

307.65

4.4

2.5

1552.11

1207.13

ng/l

3.04

2672

5105

ILD medications: prednisolone, methylprednisolone, prednisone

25643

82063

2.14

307.65

4.1

2.8

1485.48

1308.86

ng/l

5.91

22340

69190

Calcific aortic valvular stenosis, including rheumatic fever

9924

49007

3.88

307.65

4.7

3.3

2477.30

1828.74

ng/l

20.30

9335

42732

Other CVD

5233

33009

2.25

307.65

4.6

3.4

2107.90

1881.85

ng/l

1.90

4687

28874

Operations 2 for CAVS

9897

48888

3.89

307.65

4.7

3.3

2480.08

1829.14

ng/l

20.35

9310

42623

Bacterial infection, other or unspecified

14416

69534

2.41

307.65

4.5

3.0

2712.02

1222.28

ng/l

101.54

13044

59518

Pulmonary heart disease, diseases of pulmonary circulation

8763

49397

2.67

307.65

4.6

3.2

1546.02

1671.46

ng/l

1.80

7961

42833

Heart failure and antihypertensive medication

9658

10325

20.35

307.65

7.1

1.8

2886.69

515.05

ng/l

171.69

9208

8332

Insulin, intermediate and long-acting

12271

79643

1.82

307.65

4.1

3.2

2528.03

1391.41

ng/l

58.19

10753

68621

Other systemic involvement of connective tissue (FG)

5886

33231

2.30

307.65

3.7

3.0

1227.66

1412.31

ng/l

3.58

5191

28437

Myocardial infarction, without ST-elevation

11658

61405

2.62

307.65

4.5

3.3

3031.66

1591.89

ng/l

81.00

10734

53473

Inflammatory bowel disease treatment related agents

26378

87403

2.03

307.65

4.0

2.8

1379.86

1352.56

ng/l

0.39

23005

73735

Hypothyroidism (congenital or acquired)

3428

3436

6.76

307.65

3.4

1.3

784.37

181.89

ng/l

14.45

2739

2491

Diseases of oesophagus, stomach and duodenum

24021

88841

1.91

307.65

3.4

3.1

1448.89

1341.03

ng/l

2.28

20486

75794

Endocarditis

985

2900

7.87

307.65

5.7

1.8

3653.95

558.67

ng/l

15.40

933

2349

Aortic valve malfunction, age under 60 years

2700

9177

7.02

307.65

4.9

3.2

1161.24

1023.57

ng/l

0.86

2499

7730

Diseases of the ear and mastoid process

21045

81060

1.41

307.65

3.2

3.1

1227.01

1386.22

ng/l

5.04

17657

69181

DVT of lower extremities and pulmonary embolism

10572

65596

2.16

307.65

3.9

3.2

1457.53

1616.78

ng/l

2.60

9461

56801

Calcific aortic valvular stenosis, diagnosis (helper)

9897

48888

3.89

307.65

4.7

3.3

2480.08

1829.14

ng/l

20.35

9310

42623

Cardiovascular diseases (excluding rheumatic etc)

12992

17442

5.74

307.65

3.6

1.5

918.12

234.07

ng/l

59.29

10895

12686

Insulin, combination of fast acting with intermediate-acting or long-acting

13309

84821

1.67

307.65

4.1

3.2

2537.39

1399.65

ng/l

60.42

11677

72952

Diseases of oral cavity, salivary glands and jaws

12238

44392

1.62

307.65

3.5

3.2

1718.24

1733.98

ng/l

0.11

10603

38459

Sleep apnoea, including avohilmo

23303

85000

2.06

307.65

3.5

3.0

983.46

1390.78

ng/l

44.64

19277

73545

Osteopathies and chondropathies

12374

76849

1.77

307.65

3.8

3.1

1694.18

1345.88

ng/l

11.69

10803

65834

Asthma, including avohilmo

25481

94116

1.72

307.65

3.5

3.1

1140.48

1451.13

ng/l

24.48

21813

80126

Depression medications

3553

3540

5.92

307.65

2.9

1.3

705.05

176.97

ng/l

11.46

2761

2536

Asthma (only as main-diagnosis), excluding more controls

15338

38997

2.77

307.65

3.6

2.0

1014.86

563.38

ng/l

43.54

13164

31977

All-cause Heart Failure

21827

60883

6.11

307.65

6.2

2.3

3176.01

780.11

ng/l

307.65

20700

51671

Other functional intestinal disorders

10366

59597

1.93

307.65

3.7

3.1

1528.73

1494.42

ng/l

0.25

8992

51231

Cardiovascular diseases

11165

13300

5.75

307.65

3.6

1.5

883.37

235.60

ng/l

44.03

9224

9576

Systemic connective tissue disorders

7934

50626

2.01

307.65

3.8

3.2

1304.56

1453.14

ng/l

2.58

7047

43622

Infections, IBD-co-morbidities

3277

7265

4.38

307.65

4.4

2.5

2286.79

1036.45

ng/l

19.50

2901

6213

Benign neoplasms

18029

73320

1.46

307.65

3.4

3.1

1479.81

1374.14

ng/l

1.73

15351

62279

Asthma, excluding more controls

16355

38997

2.73

307.65

3.5

2.0

993.46

563.38

ng/l

46.65

14065

31977

ILD medications: immunosuppressive drugs

13191

73598

1.94

307.65

4.3

2.7

1647.18

1138.22

ng/l

17.53

11651

62070

Visual disturbances and blindness

10890

77145

1.65

307.65

3.6

3.2

1349.13

1418.11

ng/l

0.79

9381

66396

Peripheral artery disease

10378

58610

1.73

307.65

4.4

3.2

3463.98

1523.61

ng/l

100.14

9475

50911

Emergency coronary revascularization (for ACS)

28198

67467

4.44

307.65

4.6

2.5

1626.16

1160.18

ng/l

36.54

25560

56091

Hypothyroidism, levothyroxine purchases

3391

3425

6.71

307.65

3.3

1.3

752.21

182.16

ng/l

13.23

2711

2486

Dental operations

12959

47137

1.62

307.65

3.5

3.1

1681.63

1730.68

ng/l

0.45

11236

40815

Other diseases of urinary system

19619

79815

1.55

307.65

3.4

3.1

1528.39

1337.77

ng/l

5.67

16880

68151

Other retinal disorders

14847

79650

1.69

307.65

3.6

3.2

2198.23

1436.19

ng/l

35.29

12969

68909

Dorsopathies

19471

70148

1.56

307.65

3.2

3.1

1159.03

1507.19

ng/l

25.83

16526

59628

Cholelithiasis

17606

87746

1.56

307.65

3.4

3.1

1449.92

1399.67

ng/l

0.68

15079

75385

Spondylopathies

18175

66586

1.97

307.65

3.3

3.1

1173.22

1544.95

ng/l

26.30

15732

57040

Other septicaemia, including avohilmo

10180

56009

2.34

307.65

4.6

3.0

3106.52

1358.23

ng/l

83.35

9297

48170

Calcific aortic valvular stenosis

9919

48915

3.91

307.65

4.8

3.3

2476.96

1828.84

ng/l

20.26

9331

42644

Fall on same level

22031

85554

1.52

307.65

3.4

3.0

1528.65

1230.11

ng/l

14.66

18727

72745

Asthma, unspecified (mode), excluding more controls

13325

38056

3.53

307.65

3.8

2.0

1161.37

568.80

ng/l

68.02

11587

31315

Hyperlipidaemia, other/unspecified

10726

53835

2.64

307.65

3.9

3.0

1858.26

1364.35

ng/l

15.04

9457

46337

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

13058

89836

1.68

307.65

3.7

3.1

1911.11

1342.21

ng/l

23.04

11346

77315

Factors influencing health status and contact with health services

5765

14234

2.41

307.65

3.4

2.3

1603.18

1240.64

ng/l

5.49

4895

11912

Anaemias

4175

3377

10.88

307.65

4.1

1.3

1752.05

197.34

ng/l

42.13

3628

2460

Complications of procedures, not elsewhere classified

17958

94802

1.82

307.65

3.7

3.0

1807.58

1278.70

ng/l

27.10

15673

80824

Injuries to the head

22593

96965

1.55

307.65

3.4

3.1

1505.85

1316.55

ng/l

8.00

19289

82614

Condition for Implicit Sepsis (Organ dysfunction codes)

21933

82435

2.43

307.65

4.3

2.8

2008.28

1049.74

ng/l

96.32

19343

69614

Bacterial Sepsis

13514

61583

2.63

307.65

5.1

2.9

2891.16

1288.29

ng/l

119.11

12321

52922

Other medical care

11767

62205

2.03

307.65

4.1

2.9

2057.65

1260.04

ng/l

51.46

10815

53114

Adjustment and management of implanted device

5944

27915

4.44

307.65

6.5

3.1

2486.46

1597.25

ng/l

28.44

5530

24119

Other special examinations and investigations of persons without complaint or reported diagnosis

13391

38936

2.06

307.65

3.5

2.8

1463.11

1458.24

ng/l

0.04

11499

33036

Certain infectious and parasitic diseases

19014

65017

1.65

307.65

3.6

2.7

1599.08

1043.80

ng/l

39.60

16414

54691

Care involving use of rehabilitation procedures

12905

78700

1.71

307.65

3.6

2.8

1562.08

1094.63

ng/l

20.30

11366

66265

Examination and observation for other reasons

12611

38402

2.26

307.65

3.6

2.8

1381.27

1426.61

ng/l

0.42

11008

32613

Persons encountering health services in other circumstances

8521

50571

2.03

307.65

3.7

3.0

1397.72

1285.57

ng/l

1.65

7206

43081

Follow-up examination after treatment for conditions other than malignant neoplasms

8069

33366

1.86

307.65

3.2

2.8

1319.35

1405.22

ng/l

0.86

6868

28383

Obesity

14278

74580

2.30

307.65

3.7

3.0

1171.33

1142.21

ng/l

0.34

11949

63500

Unspecified haematuria

9666

53749

1.80

307.65

3.7

3.3

2083.52

1563.15

ng/l

14.69

8512

46809

Erysipelas

14276

73288

2.21

307.65

4.2

2.9

2205.08

1186.07

ng/l

74.50

12677

62503

Persons encountering health services in other circumstances, wide

25298

85279

1.78

307.65

3.6

3.0

1464.00

1363.23

ng/l

2.49

21823

72544

Persons encountering health services for other counselling and medical advice, not elsewhere classified

24237

84539

1.78

307.65

3.5

3.0

1479.57

1342.61

ng/l

3.67

20991

71965

Presence of cardiac and vascular implants and grafts

15684

50302

4.80

307.65

6.1

2.8

2272.29

1469.40

ng/l

57.96

14670

43441

Syncope and collapse

11785

51973

2.57

307.65

4.0

2.9

1687.10

1390.13

ng/l

9.00

10288

44445

Septicaemia

11221

59318

2.37

307.65

4.6

3.0

3058.41

1326.43

ng/l

94.09

10235

50971

Heart failure,strict

20277

48654

7.96

307.65

6.5

2.0

3103.12

580.70

ng/l

307.65

19304

40762

Metabolic disorders

23732

75921

2.44

307.65

3.6

2.9

1664.22

1171.15

ng/l

32.32

20728

63919

Symptoms and signs involving the nervous and musculoskeletal systems

11959

85781

1.62

307.65

3.3

3.2

1252.41

1426.60

ng/l

3.63

10340

73847

Undetermined asthma, excluding more controls

2752

12286

3.08

307.65

3.6

2.0

1073.64

615.01

ng/l

11.46

2364

10221

Pain in throat and chest

22191

53400

3.40

307.65

3.5

2.6

1213.65

1324.07

ng/l

2.54

18922

44934

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6121

12786

2.81

307.65

3.2

2.4

1188.35

1028.28

ng/l

1.80

5079

10583

Dyspnoea

29016

87710

3.88

307.65

4.3

2.8

1550.20

1331.71

ng/l

10.38

25501

74434

Headache

13346

61096

2.00

307.65

3.3

2.7

963.28

1149.71

ng/l

6.43

11187

51429

Finngen Rheumatological endpoints

19329

69664

1.82

307.65

3.4

2.9

1368.05

1296.97

ng/l

1.10

16534

58667

Symptoms and signs involving the circulatory and respiratory systems

22648

53757

2.65

307.65

3.5

2.6

1266.17

1321.36

ng/l

0.88

19153

45196

First line medication for Crohn's disease

24611

79689

1.99

307.65

3.9

2.8

1434.21

1318.75

ng/l

2.82

21410

66943

24149

85408

1.63

307.65

3.8

2.9

1494.17

1350.77

ng/l

4.28

20765

72856

Pain in joint

11594

44547

1.86

307.65

3.1

3.0

1079.43

1402.03

ng/l

13.29

9663

38182

Ischaemic heart disease, wide definition

22181

65403

3.24

307.65

4.0

2.7

1642.78

1011.70

ng/l

53.50

20016

55001

Haemorrhage from respiratory passages

8998

38942

2.91

307.65

4.5

2.7

2020.26

1553.61

ng/l

11.90

7986

33424

Myocardial infarction

13675

44660

3.42

307.65

4.5

2.4

2465.35

1091.10

ng/l

101.76

12631

37252

Symptoms and signs involving cognition, perception, emotional state and behaviour

22081

91988

1.94

307.65

3.4

3.1

1336.27

1357.40

ng/l

0.26

18898

78444

Respiratory insufficiency

2127

10144

3.38

305.27

6.3

2.8

2106.08

1550.02

ng/l

4.95

1972

8808

Other diseases of hard tissues of teeth

11756

43574

1.59

303.89

3.4

3.2

1481.26

1690.75

ng/l

4.25

10112

37826

Psychiatric diseases

18560

71013

1.43

303.26

3.3

3.2

1372.57

1356.32

ng/l

0.15

15723

61214

Diseases of the eye and adnexa

12636

45117

1.52

302.00

3.2

2.9

1324.11

1049.44

ng/l

7.50

10590

37852

Other systemic involvement of connective tissue

5967

38768

1.95

301.91

3.7

3.2

1226.77

1473.34

ng/l

6.19

5262

33484

Dysphagia

5665

36298

1.97

301.68

3.7

3.1

1353.24

1548.63

ng/l

2.97

4884

31523

Mood disorders, excluding more controls

17584

78779

1.44

301.38

3.2

3.1

1073.73

1310.55

ng/l

10.01

14625

67633

Visual disturbances

9828

70032

1.63

298.19

3.6

3.2

1215.95

1368.60

ng/l

3.23

8488

60214

ILD, hospital admission 2, with pulmonary infections

2549

13351

3.09

297.72

4.8

3.0

1945.28

1482.76

ng/l

4.21

2332

11617

Autoimmune diseases related-to ILD

16039

101938

1.45

295.78

3.4

3.1

1313.01

1356.93

ng/l

0.58

13775

86689

Other or ill-defined heart diseases

1147

3955

4.47

295.23

6.7

1.8

2054.99

535.13

ng/l

12.40

1028

3143

Allergic asthma (mode), excluding more controls

3307

17039

2.17

294.96

3.1

2.0

833.46

507.86

ng/l

8.14

2792

13841

Other external causes of accidental injury

14770

54752

1.48

292.74

3.3

3.0

1493.15

1250.62

ng/l

6.66

12498

46994

Hypothyroidism, strict autoimmune

13942

67932

1.49

292.58

3.3

3.0

1316.88

1357.99

ng/l

0.47

11782

58050

Diaphragmatic hernia

7934

55286

1.77

291.06

3.5

3.2

1339.58

1454.66

ng/l

1.53

6905

47915

Hypotension

4595

29081

2.27

288.56

4.5

3.4

2081.66

1930.31

ng/l

1.08

4111

25456

Malignant neoplasm, including Hilmo

15911

70152

1.45

286.94

3.1

1273.83

1240.16

ng/l

0.39

13796

59133

Pleural effusion

3853

23240

2.41

285.52

4.8

3.2

2755.60

1731.08

ng/l

17.80

3557

20267

Malignant neoplasm, wide definition

15919

70293

1.45

283.01

3.1

1274.70

1241.41

ng/l

0.38

13806

59264

Coxarthrosis, primary

13478

85135

1.54

282.93

3.4

3.2

1431.08

1547.39

ng/l

2.60

11907

73921

Accidents

14700

54752

1.47

282.42

3.3

3.0

1486.21

1250.62

ng/l

6.36

12471

46994

Familial hypercholesterolemia, with ischemic heart disease

2336

12204

3.26

281.81

4.9

2.9

2169.48

1462.30

ng/l

9.27

2105

10481

L04AX Other immunosuppressants

10435

75453

1.57

281.37

3.9

3.0

1247.72

1192.01

ng/l

0.59

9142

64264

Hypertrophic cardiomyopathy

1214

4929

6.65

280.12

8.5

3.3

2223.94

1455.29

ng/l

6.14

1162

4275

Retention of urine

7822

43958

1.76

279.46

3.8

3.3

2145.90

1679.49

ng/l

10.00

6908

38380

Migraine

7609

39495

1.66

278.82

3.0

2.8

638.21

1071.96

ng/l

28.03

6289

33367

Migraine with aura

3670

20552

2.06

278.37

2.9

2.7

595.12

992.02

ng/l

12.81

3062

17296

Carpal tunnel syndrome

12093

77720

1.53

278.07

3.2

3.1

1188.80

1297.53

ng/l

1.79

10341

66696

Second line medication for Crohn's disease

10641

77307

1.56

276.74

3.8

3.0

1236.85

1184.54

ng/l

0.55

9306

65785

Viral pneumonia

2847

15397

2.54

276.55

4.9

2.9

2297.08

1299.80

ng/l

14.24

2582

13138

Other disorders of veins

8276

57110

1.68

276.50

3.5

3.0

1348.99

1282.23

ng/l

0.67

7127

48947

Certain disorders involving the immune mechanism

3786

22320

2.22

276.34

5.3

3.1

1732.02

1273.62

ng/l

4.08

3335

19168

Congenital malformations, deformations and chromosomal abnormalities

9434

63014

1.57

276.12

3.6

3.0

1324.43

1123.48

ng/l

3.25

8162

52817

Atherosclerosis, excluding cerebral and coronary sclerosis

9734

55796

1.68

276.11

4.4

3.2

3572.49

1557.01

ng/l

98.87

8914

48574

Other respiratory diseases principally affecting the interstitium

4382

27614

2.23

274.40

4.6

3.4

2030.51

1766.32

ng/l

2.39

4002

24137

Familial hypercholesterolemia

3622

21609

2.39

274.02

4.3

3.1

1828.59

1505.80

ng/l

4.09

3233

18726

Diseases of the digestive system

9811

70793

1.61

271.02

4.0

3.3

2156.24

1583.20

ng/l

13.91

8645

61235

Other and unspecified dermatitis

10342

75318

1.57

270.45

3.5

3.1

1480.29

1299.48

ng/l

3.17

8919

64687

Malignant neoplasm

15602

69659

1.44

269.24

3.1

1280.10

1246.77

ng/l

0.38

13533

58809

Malignant neoplasm

15606

69726

1.44

268.07

3.1

1279.50

1246.40

ng/l

0.38

13539

58865

Exposure to unspecified factor

19204

102708

1.38

267.87

3.3

3.2

1512.45

1335.71

ng/l

4.86

16104

87904

ILD, hospital admissions

3731

22846

2.41

267.23

4.4

3.4

1700.43

1740.40

ng/l

0.19

3396

20035

Mycoses, including avohilmo

17237

102076

1.41

267.14

3.4

3.1

1140.41

1341.89

ng/l

10.00

14632

87154

Degeneration of macula and posterior pole

11427

66260

1.59

266.19

3.6

3.3

1856.45

1591.93

ng/l

6.00

9989

57965

Conotruncal defects

382

635

21.72

265.98

9.3

5.2

850.52

897.60

ng/l

0.13

369

526

Genitourinary diseases

9531

33181

1.58

265.95

3.5

2.9

1662.32

929.79

ng/l

29.42

8031

27991

Other interstitial pulmonary diseases

3784

23288

2.38

265.07

4.4

3.4

1720.99

1746.55

ng/l

0.11

3448

20414

Interstitial lung disease

3784

23302

2.38

264.50

4.4

3.4

1720.99

1759.57

ng/l

0.18

3448

20435

Interstitial lung disease endpoints

3784

23302

2.38

264.50

4.4

3.4

1720.99

1759.57

ng/l

0.18

3448

20435

Liquid cancers

6602

42753

1.82

264.35

3.9

3.4

1891.75

1567.14

ng/l

5.08

5981

36954

L04AA Selective immunosuppressants

4154

25202

2.06

264.05

5.9

3.0

2665.68

1071.28

ng/l

24.77

3827

21472

Hypothyroidism, other/unspecified

16561

84255

1.42

262.05

3.4

3.1

1286.87

1431.97

ng/l

3.78

14042

72251

Rheumatoid arthritis

6285

37054

1.78

262.03

3.4

3.0

1509.63

1425.08

ng/l

0.79

5561

31881

Hypokalaemia

2803

15516

2.56

261.79

4.3

3.0

1755.54

1308.04

ng/l

6.84

2525

13276

Osteoporosis

6349

40041

1.88

261.54

4.2

3.2

1711.78

1559.44

ng/l

1.84

5651

34735

Pericarditis

842

2667

5.83

260.31

5.1

1.8

2074.67

542.99

ng/l

5.03

781

2138

Dialysis, with operation codes

2745

15176

2.60

259.66

7.0

3.1

8611.53

999.18

ng/l

102.48

2602

13026

Other reaction to severe stress, and adjustment disorders

5535

35401

1.77

257.33

3.7

2.8

1036.53

961.12

ng/l

0.51

4628

29564

Injuries to the thorax

9613

70084

1.59

257.16

3.6

3.3

1624.30

1533.13

ng/l

1.02

8326

60464

Insulin, fast-acting or short human

7201

49807

1.70

256.04

4.3

3.2

2832.49

1417.34

ng/l

39.32

6331

42788

Hypothyreosis and Thyroxine purchase for inclusion criteria

17248

88226

1.40

255.12

3.4

3.1

1286.27

1427.83

ng/l

3.77

14609

75724

Hypothyroidism, strict autoimmune, 3 medication purchases required

15716

81541

1.42

254.81

3.3

3.1

1280.16

1416.28

ng/l

3.22

13265

69939

COPD, hospital admission 2, with asthma infections

7436

45258

1.76

253.98

4.7

3.3

2219.43

1760.45

ng/l

8.90

6701

39576

L04AD Calcineurin inhibitors

2106

10522

2.81

253.71

8.5

3.0

4230.79

961.62

ng/l

29.80

2018

8889

Early onset COPD

4571

29142

2.02

252.90

4.0

3.1

1496.61

1375.41

ng/l

0.76

4037

25192

Injuries to the shoulder and upper arm

16751

101142

1.40

252.50

3.3

3.2

1351.41

1394.89

ng/l

0.61

14377

86516

Disorder of lipoprotein metabolism, unspecified

3097

18080

2.45

250.86

4.0

3.1

2113.94

1450.92

ng/l

6.67

2772

15591

Substance abuse, excluding more controls

10076

61164

1.53

250.21

3.3

3.2

1598.17

1360.97

ng/l

3.76

8535

52561

Enlarged lymph nodes

3039

17093

2.24

247.30

4.0

2.8

1363.09

1233.22

ng/l

0.60

2677

14551

Presence of other devices

5539

36406

1.87

247.23

3.7

2.9

1578.01

1620.36

ng/l

0.27

4941

31503

ILD, hospital admissions 1, main diag only

3318

20218

2.45

243.36

4.4

3.4

1685.88

1724.14

ng/l

0.16

3025

17750

Systemic sclerosis (FG)

708

2240

9.84

242.75

5.5

2.9

717.49

1009.46

ng/l

1.83

664

1901

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

16835

102919

1.39

242.57

3.5

3.1

1303.46

1331.80

ng/l

0.33

14547

87611

Other symptoms and signs involving cognitive functions and awareness

10151

66870

1.56

241.89

3.4

3.2

1657.85

1583.54

ng/l

0.71

8772

58006

Personality disorders, excluding more controls

3665

21353

1.96

241.06

2.9

2.8

921.70

874.94

ng/l

0.24

2936

17812

Other symptoms and signs involving the nervous and musculoskeletal systems

7916

56206

1.62

240.85

3.3

3.2

1084.01

1354.83

ng/l

6.32

6815

48225

Other arthritis (FG)

5789

38603

1.76

240.78

3.6

3.0

1652.94

1262.75

ng/l

5.50

5037

32954

Selective serotonin reuptake inhibitors

18529

75886

1.37

239.54

3.1

3.2

1154.99

1486.86

ng/l

18.60

15380

65547

Polycystic ovarian syndrome, consortium definition

11735

49923

1.48

237.42

3.0

2.8

1007.03

1102.64

ng/l

1.52

9721

42217

Cardiomyopathy, Hypertrophic obstructive

536

1380

12.02

237.16

10.7

1.8

2351.08

505.97

ng/l

16.78

519

1127

Diagnoses used for exclusion with ILD

5421

36358

1.85

237.15

4.8

3.3

1614.67

1651.54

ng/l

0.22

4782

31556

Other specified/unspecified arthritis

5034

32663

1.83

236.65

3.6

3.0

1644.34

1277.81

ng/l

4.41

4373

28032

External causes of morbidity and mortality

11445

42086

1.48

235.76

3.3

2.9

1434.26

1200.47

ng/l

5.06

9720

36038

Any event in cancer register

16110

73176

1.40

235.76

3.1

1287.78

1243.88

ng/l

0.55

13925

61727

Dronedarone medication

788

2707

7.69

234.65

4.9

1.9

1591.56

521.10

ng/l

13.80

712

2216

Cholecystectomy

14041

92659

1.43

233.31

3.2

3.1

1317.78

1447.20

ng/l

2.63

12035

79782

Solid cancers, including Hilmo

15442

69836

1.41

232.52

3.1

1248.46

1243.72

ng/l

0.04

13370

58925

Gingivitis and periodontal diseases

19116

78583

1.36

232.05

3.3

3.2

1384.96

1468.99

ng/l

1.44

16305

67692

Septal defects

1219

4876

3.67

231.36

5.2

3.5

1200.44

1163.08

ng/l

0.09

1072

4090

Other abnormal uterine and vaginal bleeding

4261

18995

1.95

231.20

3.3

3.0

1193.77

1464.20

ng/l

3.41

3510

16343

Unspecified kidney failure

2666

15430

2.61

230.30

5.4

3.2

5150.35

1410.63

ng/l

65.09

2478

13438

Other symptoms and signs involving the circulatory and respiratory systems

1389

6051

3.33

229.98

4.2

2.6

1649.18

1390.36

ng/l

0.68

1237

5173

Other diseases of the digestive system

7145

51011

1.69

228.21

4.3

3.3

2359.75

1706.91

ng/l

13.96

6338

44467

Paracetamol or NSAID medication

2700

6957

2.22

227.75

3.4

1770.68

1849.63

ng/l

0.27

2280

6011

Oxicams

4791

17207

1.88

227.48

3.3

3.7

1399.89

2278.76

ng/l

30.68

4105

15296

Injuries to the knee and lower leg

22136

97144

1.32

224.36

3.3

3.2

1329.75

1375.70

ng/l

0.72

18784

83008

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

10379

70071

1.48

224.12

3.5

3.0

1303.90

1141.26

ng/l

2.57

8939

58859

Volume depletion

2323

12778

2.63

223.97

4.9

3.2

2873.20

1697.64

ng/l

14.71

2081

11010

Allergic asthma (mode)

3307

18645

1.96

221.92

3.1

2.5

833.46

918.14

ng/l

0.77

2792

15482

Oter anti-inflammatory and antirheumatic agents, non-steroids

4771

16746

1.89

221.91

3.4

3.7

1551.49

2318.93

ng/l

18.48

4126

14924

Acute upper respiratory infections of multiple and unspecified sites

13822

77836

1.41

221.70

3.8

3.0

1275.50

1344.76

ng/l

1.09

11745

66349

Neoplasms

11644

45268

1.45

221.17

3.2

3.1

1272.63

1201.09

ng/l

0.71

9776

37689

Acute sinusitis

8722

57323

1.53

220.38

3.3

2.9

1121.22

1163.58

ng/l

0.33

7289

48472

Disorders of other endocrine glands

8102

57560

1.57

220.10

3.7

3.2

1959.46

1341.02

ng/l

10.94

6894

49128

Irritable bowel syndrome

4889

31916

1.79

219.92

3.1

2.9

922.38

1197.33

ng/l

8.01

4040

27105

Other diseases of anus and rectum

6372

44326

1.70

219.64

3.8

3.1

1696.43

1543.30

ng/l

1.47

5468

38329

Varicose veins

12491

72834

1.46

219.02

3.5

3.1

1470.69

1485.91

ng/l

0.14

10895

62795

Nephropathy related operations

2581

14807

2.46

217.81

6.9

3.3

8745.19

1245.88

ng/l

91.36

2459

12794

GI-bleeding

7109

51128

1.67

216.78

4.3

3.3

2378.10

1724.16

ng/l

13.96

6338

44522

Functional dyspepsia

5129

34263

1.78

215.11

3.4

3.0

1145.22

1277.77

ng/l

1.22

4346

29464

Other disorders of lacrimal gland

7215

51669

1.63

214.82

3.5

3.1

1061.89

1304.73

ng/l

5.33

6161

44453

Right bundle-branch block

887

3270

4.76

214.47

4.4

1.9

1374.35

559.13

ng/l

11.41

771

2654

Hyperkalaemia

1548

7642

3.48

213.77

6.4

3.1

4629.05

1635.75

ng/l

29.73

1445

6610

Implicit fungal Sepsis, including avohilmo

1729

8817

3.13

213.76

5.1

2.9

1999.37

1200.82

ng/l

7.75

1574

7598

Non-selective monoamine reuptake inhibitors

7325

50418

1.62

212.73

3.3

3.1

1192.89

1468.30

ng/l

5.90

6230

43834

Disorders of lacrimal system

8680

63044

1.55

212.47

3.4

3.1

1120.90

1343.78

ng/l

5.22

7411

54186

Open wound of head

10835

77331

1.47

212.19

3.5

3.3

1824.49

1462.70

ng/l

10.84

9334

66540

Reimbursement for rheumatic diseases

10635

80216

1.48

212.18

3.4

3.1

1254.04

1303.44

ng/l

0.59

9355

68515

Congenital malformations of great arteries

469

1099

8.53

211.67

8.3

3.7

1123.36

1055.36

ng/l

0.15

435

911

Solid cancers

15058

69166

1.39

211.66

3.1

1254.31

1250.78

ng/l

0.03

13055

58444

ILD, hospital admissions 3, with pneumonia sepsis

2147

12001

2.82

209.43

4.9

3.1

2009.01

1510.75

ng/l

5.03

1979

10451

Anxiety disorders, excluding more controls

14393

71695

1.39

209.03

3.3

3.1

1005.12

1222.37

ng/l

6.00

11964

61339

Dermatitis and eczema

20858

100576

1.32

208.68

3.4

3.1

1382.21

1375.01

ng/l

0.07

17721

85926

Care involving dialysis

1742

8915

2.95

207.30

5.3

2.9

11332.50

1137.76

ng/l

83.94

1655

7607

Sarcoidosis

2670

15576

2.31

206.99

5.7

3.1

1170.85

1271.44

ng/l

0.64

2334

13375

Hernia of abdominal wall

8975

67056

1.54

206.95

3.5

3.2

1546.92

1382.68

ng/l

2.03

7765

57915

Urinary track infection

9044

32635

1.51

206.88

3.1

2.7

1021.00

893.70

ng/l

2.26

7703

27180

Disease of hard tissues of teeth, NOS

10551

41353

1.49

206.31

3.2

3.1

1009.59

1566.73

ng/l

42.42

8973

35944

Injury, poisoning and certain other consequences of external causes

9183

33258

1.51

206.22

3.3

2.9

1432.69

1211.88

ng/l

3.85

7815

28355

Cervical disc disorders

6831

48757

1.62

203.36

3.2

3.1

957.77

1437.73

ng/l

29.42

5832

42026

Disorders of synovium and tendon

9451

59598

1.49

202.78

3.1

1166.35

1317.38

ng/l

2.22

8030

50904

Explicit bacterial Sepsis, including avohilmo

2386

13530

2.40

202.52

4.8

3.0

2917.59

1376.89

ng/l

19.69

2166

11631

Systemic sclerosis

708

2541

8.31

202.18

5.5

3.0

717.49

1016.05

ng/l

1.98

664

2147

Soft tissue disorders related to use, overuse and pressure

5410

37090

1.73

201.94

3.5

3.1

1209.34

1368.80

ng/l

2.08

4737

31930

Cellulitis

4256

27747

1.85

201.72

4.0

3.2

2151.91

1329.06

ng/l

12.06

3723

23802

Streptococcal septicaemia, including avohilmo

2117

11718

2.62

201.29

4.8

3.0

2949.34

1344.40

ng/l

20.00

1922

10130

Candidiasis, including avohilmo

5467

37412

1.70

200.74

3.7

3.1

1157.76

1255.13

ng/l

1.11

4674

31968

Acute upper respiratory infections

19733

96223

1.32

200.54

3.6

3.1

1270.80

1426.42

ng/l

4.95

16793

82502

Systemic sclerosis, icd10

704

2541

8.46

200.17

5.5

3.0

719.63

959.78

ng/l

1.45

660

2146

Rheumatism, unspecified

2626

15280

2.24

198.86

3.0

2.9

870.34

1182.76

ng/l

3.63

2223

13116

Fibromyalgia

1610

7788

2.67

198.85

2.7

505.91

937.78

ng/l

14.75

1307

6562

Bacterial pneumoniae

8045

51873

1.55

198.41

4.2

2.9

2267.28

1295.43

ng/l

37.76

7255

44287

Other pulmonary heart/vessel disease

1245

5933

4.25

198.03

9.6

3.4

2499.97

1813.49

ng/l

4.83

1189

5172

Substance use, excluding alcohol

3194

19239

1.96

196.97

3.3

3.1

1385.77

1073.32

ng/l

2.24

2629

16109

Subjective visual disturbances

4880

33011

1.77

196.14

3.5

3.1

1009.18

1298.56

ng/l

7.43

4198

28397

Internal derangement of knee

6493

45352

1.60

195.60

3.2

3.0

1157.13

1289.44

ng/l

1.81

5393

38760

Explicit bacterial Sepsis

2322

13226

2.39

194.15

4.8

3.0

2936.51

1387.70

ng/l

19.12

2106

11368

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

18805

98024

1.32

193.71

3.6

3.1

1607.68

1318.18

ng/l

10.05

16038

83630

COPD, hospital admissions 1, only main diagnosis

7645

48845

1.61

192.99

4.5

3.3

2020.28

1757.16

ng/l

4.14

6844

42787

Streptococcal septicaemia

2056

11424

2.60

192.98

4.9

3.0

2969.76

1338.93

ng/l

19.80

1864

9872

Chronic gastritis

5835

41446

1.71

192.95

3.7

3.2

1738.14

1608.18

ng/l

1.12

5098

36173

Other and unspecified polyneuropathies, also in other diseases

4188

28103

1.93

192.35

4.0

3.3

1984.88

1611.75

ng/l

3.44

3749

24531

Other gastritis (incl. Duodenitis)

4631

31359

1.82

192.27

4.0

3.1

1726.53

1499.33

ng/l

2.25

4094

27218

Polyneuropathies and other disorders of the peripheral nervous system

4671

32002

1.84

191.10

4.0

3.3

1925.76

1584.46

ng/l

3.38

4170

27873

Zoster [herpes zoster], including avohilmo

10557

78768

1.46

191.08

3.6

3.2

1397.44

1418.16

ng/l

0.19

9263

67908

Mood disorders

18395

95488

1.32

190.97

3.2

3.1

1064.80

1326.56

ng/l

11.64

15224

81696

Extreme obesity with alveolar hypoventilation

1020

4443

4.44

190.32

5.2

3.1

1536.44

1203.63

ng/l

1.14

892

3824

Mood [affective] disorders

18340

95385

1.32

190.13

3.1

1066.17

1322.63

ng/l

11.16

15178

81605

Secondary right heart disease

1142

5366

4.51

189.75

9.9

3.4

2490.71

1763.02

ng/l

5.25

1097

4668

Coxibs

5131

17801

1.71

189.28

3.1

3.7

1422.20

2249.23

ng/l

28.38

4271

15746

Deforming dorsopathies

5037

34283

1.70

188.42

3.4

3.1

1068.77

1352.96

ng/l

5.75

4304

29338

Injuries to the hip and thigh

10242

70731

1.47

188.17

3.6

3.3

1983.27

1593.76

ng/l

10.02

8959

61187

Pain in thoracic spine

2793

16573

2.06

187.62

3.1

3.0

871.69

1363.18

ng/l

11.68

2386

14128

Injuries to the abdomen, lower back, lumbar spine and pelvis

8058

59114

1.53

186.38

3.7

3.3

1746.43

1562.26

ng/l

2.96

7008

50861

Depression

16768

90367

1.33

186.31

3.1

1033.64

1258.45

ng/l

8.08

13859

77177

Excessive earwax

12678

90976

1.41

185.87

3.3

3.2

1179.12

1441.18

ng/l

14.40

10943

78598

Other diseases of upper respiratory tract

20660

88478

1.30

185.32

3.3

3.2

1210.86

1508.37

ng/l

16.95

17559

76115

Fracture of rib(s), sternum and thoracic spine

6446

46730

1.63

185.28

3.7

3.3

1709.21

1593.48

ng/l

1.10

5612

40571

Other disorders of skin and subcutaneous tissue, not elsewhere classified

3019

18806

2.10

184.11

4.3

3.2

2553.75

1411.45

ng/l

13.20

2596

16253

7349

47426

1.63

181.95

3.7

3.4

2035.21

1836.83

ng/l

2.57

6434

41784

Migraine without aura

2442

13640

2.01

181.68

2.9

2.6

482.32

814.35

ng/l

10.18

1993

11279

Primary_lymphoid and hematopoietic malignant neoplasms

5122

36084

1.76

180.70

4.0

3.3

1800.03

1592.84

ng/l

2.20

4670

31439

Disturbances of skin sensation

4558

30550

1.72

180.25

3.0

757.56

1110.75

ng/l

12.52

3829

25933

Cardiac murmurs and other cardiac sounds

1502

7178

2.55

179.72

3.0

2.8

1212.42

1231.76

ng/l

0.05

1260

6077

Glomerular diseases

3521

22806

1.94

179.41

4.5

3.3

5699.25

1394.90

ng/l

65.58

3226

19736

COPD-related respiratory insufficiency

2752

17184

2.26

178.74

5.6

3.3

2506.98

1847.47

ng/l

6.61

2520

15075

Recurrent or chronic depression

6219

30191

1.57

178.06

3.0

788.41

1053.89

ng/l

7.36

5028

25913

Abnormal findings on examination of blood, without diagnosis

9487

66079

1.48

177.82

3.6

3.3

1850.06

1543.26

ng/l

6.05

8405

57302

Cervicobrachial syndrome

3878

25283

1.80

177.20

3.0

861.96

1290.67

ng/l

7.66

3378

21564

Iron deficiency anaemia secondary to blood loss (chronic)

3519

23044

1.96

176.24

5.4

3.2

2623.79

1594.00

ng/l

15.72

3156

19986

Cervicalgia

3905

25697

1.81

175.21

3.4

3.1

1136.12

1483.40

ng/l

6.22

3355

22040

Disorders of vestibular function (Vertigo)

9484

71387

1.47

174.98

3.3

3.2

1175.34

1446.11

ng/l

7.72

8100

61787

Peripheral arterial reconstruction

3994

27357

1.94

173.74

4.7

3.4

4077.29

1842.67

ng/l

41.28

3683

24067

Bacterial pneumonia, not elsewhere classified

7588

49531

1.53

173.60

4.2

2.9

2287.94

1312.00

ng/l

35.47

6857

42335

Cutaneous abscess, furuncle and carbuncle

4484

30290

1.71

172.83

3.8

3.1

1942.51

1202.66

ng/l

10.33

3848

25738

COPD, hospital admissions 3, with asthma pneumonia sepsis

6147

38538

1.66

172.66

4.8

3.3

2335.63

1850.95

ng/l

8.81

5574

33766

Polyuria

4698

32706

1.76

172.65

3.5

3.3

1354.41

1552.60

ng/l

2.97

4021

28519

Malignant neoplasm of skin, including Hilmo

10817

56584

1.44

172.10

3.3

3.2

1678.39

1398.11

ng/l

6.33

9425

48592

CR(E)ST syndrome

491

1587

14.03

171.41

5.5

3.0

682.50

944.16

ng/l

1.07

462

1332

ILD medications: azathioprine

2394

13887

2.08

170.53

5.5

2.8

1776.24

1124.46

ng/l

4.18

2138

11672

Excessive, frequent and irregular menstruation

5722

21065

1.61

169.83

3.1

2.9

996.71

1370.81

ng/l

9.72

4758

17916

Supplementary factors related to causes of morbidity and mortality classified elsewhere

5637

40129

1.61

167.95

3.7

3.2

1622.62

1353.63

ng/l

3.47

4829

34340

Anosmia

363

755

6.44

167.22

3.2

1.3

739.90

324.17

ng/l

3.12

313

569

Diseases of inner ear

10814

81622

1.42

167.07

3.3

3.2

1196.13

1445.27

ng/l

6.83

9226

70601

Menorrhagia

5319

20417

1.63

164.91

3.1

2.9

978.31

1400.38

ng/l

14.32

4404

17454

Heartburn

2190

12681

2.19

164.84

3.8

3.0

1148.95

1320.31

ng/l

1.01

1856

10958

Atrial septal defect

755

2886

4.18

164.77

6.4

3.3

1320.46

1048.63

ng/l

0.72

674

2404

Unspecified fall

9841

75088

1.43

164.71

3.6

3.3

1751.74

1472.95

ng/l

6.29

8322

64704

Hyperplasia of prostate

7158

29740

1.56

164.27

3.4

1705.72

1643.20

ng/l

0.43

6200

26025

Malignant neoplasm of skin

10373

54947

1.44

163.85

3.3

3.2

1697.58

1423.22

ng/l

5.88

9007

47273

Symptoms and signs concerning food and fluid intake

2136

12319

2.23

163.78

3.9

2.9

1602.60

1410.98

ng/l

1.01

1863

10581

Mental and behavioural disorders due to psychoactive substance use

10405

74245

1.40

163.55

3.3

3.2

1603.99

1363.53

ng/l

4.01

8805

63519

Glomerular disorders in diseases classified elsewhere

2371

14346

2.22

163.40

4.9

3.3

6577.33

1423.46

ng/l

57.91

2185

12438

Acetic acid derivatives and related substances

5047

17727

1.65

163.09

3.3

3.7

1593.27

2254.34

ng/l

13.15

4264

15691

Complications of internal orthopaedic prosthetic devices, implants and grafts

4929

35182

1.73

163.02

3.6

3.2

1698.53

1500.34

ng/l

2.18

4320

30649

Sequelae of external causes of morbidity and mortality

5077

36077

1.67

162.24

3.8

3.2

1982.45

1411.10

ng/l

7.70

4545

31207

Diseases of liver

6534

48243

1.56

162.08

3.8

3.2

1764.25

1321.96

ng/l

7.12

5588

41617

Personality disorders

3665

23767

1.73

160.71

2.9

921.70

889.10

ng/l

0.16

2936

19679

9392

66572

1.49

160.52

3.5

3.3

1826.24

1698.98

ng/l

1.49

8236

58353

Chronic rhinitis, nasopharyngitis and pharyngitis

5469

38863

1.59

160.01

3.0

3.1

824.80

1196.92

ng/l

16.43

4560

33244

Other symptoms and signs involving the digestive system and abdomen

3222

20760

1.87

159.61

3.5

3.0

1137.06

1332.64

ng/l

2.18

2699

17917

Other anxiety disorders

6629

40814

1.50

159.47

3.1

2.9

923.38

1030.21

ng/l

0.94

5323

34069

Haemorrhoids and perianal venous thrombosis

6756

49835

1.53

158.78

3.6

3.1

1275.09

1478.04

ng/l

4.04

5859

43024

Type 1 diabetes, wide definition, subgroup 1

3103

19493

1.83

158.42

3.9

2.8

3517.05

1077.86

ng/l

34.34

2718

16348

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

9102

67572

1.43

158.24

3.3

3.1

1072.95

1306.36

ng/l

5.38

7537

58073

Sequelae of cerebrovascular disease

8035

52843

1.51

157.31

4.1

3.3

2247.59

1666.70

ng/l

14.63

7078

46192

Azathioprine

2394

14216

2.02

157.30

5.5

2.9

1776.24

1197.04

ng/l

3.39

2138

11924

Substance abuse

10076

73017

1.40

157.28

3.3

3.2

1598.17

1367.22

ng/l

3.63

8535

62476

Superficial injury of lower leg

4584

31707

1.66

156.90

3.6

3.2

1346.96

1295.73

ng/l

0.35

3877

27103

All influenza (not pneumonia)

2581

15726

1.98

156.55

4.5

2.9

1834.30

1164.98

ng/l

6.75

2231

13230

Chronic periodontitis, complicated

10816

83750

1.40

156.34

3.4

3.1

1464.93

1252.93

ng/l

3.74

9303

72253

Chronic sinusitis

7281

54358

1.48

156.20

3.1

971.01

1270.35

ng/l

10.04

6118

46604

Nonorganic sleeping disorders, excluding more controls

3089

19441

1.81

155.84

3.3

3.0

1005.32

1125.07

ng/l

0.95

2538

16472

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

3710

23883

1.70

155.72

2.9

992.67

991.43

ng/l

0.00

3000

20040

Skin changes due to chronic exposure to nonionizing radiation

8993

64175

1.49

155.43

3.5

3.4

1838.77

1719.36

ng/l

1.30

7888

56315

Phlebitis and thrombophlebitis (not including DVT)

4308

29862

1.72

155.13

3.4

3.1

1474.66

1414.05

ng/l

0.25

3763

25739

Other bacterial intestinal infections, including avohilmo

4556

31851

1.68

154.86

4.2

3.1

2302.01

1470.96

ng/l

14.75

4041

27440

Type of accident

5251

37477

1.61

154.82

3.7

3.2

1588.69

1373.21

ng/l

2.56

4493

32099

Other hearing loss

6220

44794

1.59

154.76

3.5

3.3

1818.62

1881.11

ng/l

0.41

5351

39248

Actinic keratosis

8799

63034

1.50

154.21

3.5

3.4

1852.41

1735.43

ng/l

1.23

7727

55338

Poisoning by drugs, medicaments and biological substances

3409

22067

1.75

153.08

3.1

3.0

1107.98

1041.58

ng/l

0.28

2792

18438

Disorders of adult personality and behaviour

3773

24887

1.69

152.20

2.8

2.9

934.43

895.90

ng/l

0.18

3029

20594

Convulsions, not elsewhere classified

3693

24095

1.71

151.16

3.2

2.9

1509.30

1300.42

ng/l

1.64

3160

20347

Other pleural conditions

2360

14762

2.23

150.93

5.0

3.3

2803.43

1806.37

ng/l

9.52

2186

12893

Exclusions for E4_PCOS_CONSORTIUM

11335

55692

1.36

150.30

3.0

1064.44

1181.04

ng/l

1.98

9473

47082

Superficial injury of head

4636

32589

1.65

149.82

3.6

3.3

1752.07

1550.38

ng/l

2.46

4000

28076

Viral infections characterized by skin and mucous membrane lesions

7461

56484

1.47

149.09

3.9

3.2

1591.43

1316.61

ng/l

4.17

6484

48289

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

9942

52990

1.43

147.39

3.4

3.2

1755.78

1452.63

ng/l

6.80

8688

45674

Other bacterial intestinal infections

3667

24969

1.79

146.89

4.4

3.2

2574.74

1568.01

ng/l

15.15

3270

21596

Anxiety (asthma-related co-morbidities)

9012

52572

1.40

145.95

3.1

3.0

942.04

1018.67

ng/l

0.66

7258

44279

Problems related to lifestyle

1683

9180

2.23

145.55

3.1

2.9

1427.92

1031.48

ng/l

2.75

1428

7742

Basal cell carcinoma, including Hilmo

9715

51948

1.43

145.16

3.4

3.2

1720.44

1464.72

ng/l

5.13

8473

44821

Hallux valgus (acquired)

5906

30825

1.55

143.90

3.1

2.9

1085.05

1323.84

ng/l

5.82

5076

26456

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

5906

43548

1.54

143.59

3.9

3.1

1218.25

1219.15

ng/l

0.01

5077

37287

Right ventricular outflow tract obstruction

212

357

17.20

143.46

10.8

5.2

712.33

868.09

ng/l

0.51

206

289

Ventral hernia

4718

33837

1.65

143.27

3.6

3.2

1620.55

1444.84

ng/l

1.41

4120

29293

Asthma and allergy, excluding more controls

1465

7349

2.21

143.23

2.9

1.9

555.15

399.23

ng/l

1.64

1194

5890

Gastroduodenal ulcer

5484

40291

1.60

143.17

4.2

3.2

2276.51

1756.46

ng/l

7.95

4904

35190

Coxarthrosis, primary, with hip surgery

10000

74448

1.42

142.01

3.4

3.3

1511.20

1593.15

ng/l

1.16

8841

64815

Sequelae with surgical and medical care as external cause

4065

28584

1.73

141.34

3.8

3.2

2059.47

1441.19

ng/l

6.72

3645

24803

Somatoform disorder

2704

17093

1.88

141.18

3.2

3.0

812.68

1161.66

ng/l

4.65

2258

14547

Mycoses

5084

36789

1.59

140.85

4.0

3.2

1468.78

1347.48

ng/l

1.16

4407

31691

Other malignant neoplasms of skin (=non-melanoma skin cancer)

9611

51646

1.42

140.70

3.4

3.2

1805.35

1470.52

ng/l

7.35

8361

44575

Use of pramipexole

4438

31836

1.69

140.08

3.6

3.2

1445.41

1493.18

ng/l

0.20

3838

27720

Other enthesopathies

5029

36052

1.57

139.95

3.0

873.91

1229.60

ng/l

14.82

4287

30781

Neurotic, stress-related and somatoform disorders

14750

83270

1.30

139.48

3.3

3.0

999.35

1178.02

ng/l

4.07

12186

70761

2147

12752

1.98

137.93

4.8

2.9

1299.95

1029.60

ng/l

1.44

1854

10771

Anxiety disorders

14948

84260

1.29

137.83

3.3

3.0

1000.69

1188.47

ng/l

4.52

12360

71641

Basal cell carcinoma

9401

50773

1.42

137.77

3.4

3.2

1748.93

1482.81

ng/l

5.22

8179

43855

Poisoning by medicine

3021

19499

1.76

137.11

3.0

3.1

1073.93

1041.71

ng/l

0.11

2480

16275

Ventricular septal defect, a heart condition

423

1270

5.42

136.15

7.4

4.3

1159.39

965.51

ng/l

0.47

393

1051

Glucosamine medication

9973

64175

1.42

135.80

3.3

1426.13

1592.09

ng/l

3.20

8602

56041

Type 1 diabetes

3752

25503

1.65

133.89

3.8

2.8

3424.93

1163.72

ng/l

36.71

3285

21485

Other diseases of blood and blood-forming organs, wide

4089

28910

1.68

133.84

3.9

3.2

1692.87

1361.85

ng/l

3.51

3612

25028

Specific personality disorders

3090

20086

1.72

133.80

2.8

2.9

911.35

903.47

ng/l

0.03

2476

16611

Other diseases of liver

3280

22140

1.77

133.32

3.6

3.1

1446.96

1226.33

ng/l

1.49

2736

19022

Chronic laryngitis and laryngotracheitis

2674

17342

1.91

133.23

3.5

3.1

946.91

1392.61

ng/l

9.86

2174

15053

Other disorders of eyelid

9226

69536

1.41

132.32

3.3

3.2

1396.47

1571.12

ng/l

3.69

7999

60490

Coagulation defects, purpura and other haemorrhagic conditions

3508

24038

1.73

132.03

4.1

3.3

1758.71

1457.18

ng/l

3.53

3093

20727

Myocardial infarction, with ST-elevation

3777

26737

1.76

131.65

4.3

3.4

2587.51

1862.79

ng/l

8.83

3490

23351

Congenital malformations of pulmonary and tricuspid valves

196

334

17.23

131.44

10.6

4.5

696.94

735.76

ng/l

0.11

190

269

Other sleep disorders

1972

11761

2.06

130.89

3.6

3.1

1271.07

1514.87

ng/l

1.15

1678

10232

All anxiety disorders

9093

55055

1.37

130.13

3.1

2.9

936.97

1044.84

ng/l

1.08

7314

46225

Paralytic ileus and intestinal obstruction

5181

38213

1.57

130.09

3.5

3.1

1778.72

1617.09

ng/l

1.18

4553

33091

Disorders of mineral metabolism

1669

9683

2.28

129.51

3.7

3.0

2523.84

1183.26

ng/l

7.86

1457

8294

Viral hepatitis, IBD co-morbidity

647

2427

3.17

129.46

3.0

2.4

1597.99

686.22

ng/l

1.65

539

2025

Special screening examination for other diseases and disorders

1992

11833

1.99

128.65

3.6

2.8

1759.35

1336.99

ng/l

2.04

1722

10101

Systemic sclerosis,strict definition

306

872

22.70

128.65

6.3

3.2

570.44

859.64

ng/l

1.82

290

740

Dermatophytosis, including avohilmo

11455

91107

1.33

128.36

3.3

3.1

1148.40

1295.91

ng/l

4.01

9711

77870

Seropositive rheumatoid arthritis

4589

32996

1.60

128.35

3.4

3.0

1545.26

1374.96

ng/l

1.90

4098

28278

Trochanteric bursitis

2800

18480

1.85

128.06

3.2

3.0

1009.46

1330.06

ng/l

3.86

2442

15934

5250

37033

1.62

127.51

3.7

3.4

1983.30

1907.71

ng/l

0.49

4565

32609

Zoster [herpes zoster]

3809

27006

1.71

127.30

4.1

3.3

1726.77

1577.48

ng/l

0.93

3360

23483

Exclusions for E4_PCOS_BROAD

2785

18153

1.80

127.16

3.7

3.3

1297.59

1223.08

ng/l

0.25

2364

15438

Thyrotoxicosis, other and/or unspecified

3460

23712

1.70

126.78

4.6

3.0

1357.08

1252.88

ng/l

0.88

3001

20352

Ovarian cyst

5026

20501

1.54

126.72

3.0

2.9

934.66

1338.79

ng/l

12.12

4208

17482

Umbilical hernia

4804

35027

1.57

126.64

3.4

3.2

1456.68

1324.11

ng/l

0.89

4095

30128

Other specified/unspecified systemic involvement of connective tissue

1126

5836

2.77

126.42

4.1

3.0

929.99

1158.31

ng/l

1.76

1020

4945

Gastric ulcer

3720

26294

1.72

125.99

4.3

3.2

2202.36

1742.41

ng/l

4.64

3324

22932

Abnormal results of function studies

1662

9664

2.22

125.87

4.1

3.1

1751.73

1268.88

ng/l

2.53

1437

8266

Extracorporeal dialysis

1273

7011

2.71

125.50

5.6

3.3

12668.44

1304.85

ng/l

65.88

1211

6072

Bipolar affective disorders

2536

16000

1.79

125.44

2.7

3.0

808.46

991.67

ng/l

1.05

2052

13415

Bacterial intestinal infections, IBD co-morbidities

3640

25575

1.71

124.67

4.5

3.3

2577.95

1610.60

ng/l

13.87

3251

22126

Other hammer toe(s) (acquired)

3397

21409

1.75

124.47

3.2

3.0

1251.65

1461.50

ng/l

2.64

2920

18518

Chronic ulcer of skin, not elsewhere classified

1543

9053

2.46

124.38

4.8

3.3

3299.13

1591.65

ng/l

10.57

1413

7871

Other diseases of intestine

3083

20982

1.79

124.37

3.8

3.1

1824.82

1445.60

ng/l

2.99

2715

18163

Combinations of oral blood glucose lowering drugs

5382

40439

1.55

124.00

3.5

3.1

1505.48

1306.92

ng/l

2.55

4646

35377

Mental and behavioural disorders due to tobacco

1599

9275

2.24

122.72

3.5

3.1

1530.54

1107.93

ng/l

2.87

1344

7916

Unspecified acute lower respiratory infection

2755

18181

1.81

122.53

4.8

3.2

1760.57

1450.70

ng/l

2.46

2461

15539

Smoking dependency

1599

9283

2.24

122.37

3.5

3.1

1530.54

1111.73

ng/l

2.82

1344

7914

Symptoms and signs involving speech and voice

6225

47630

1.48

122.20

3.5

3.2

1170.43

1417.08

ng/l

5.46

5385

41203

Open wound of lower leg

2840

18944

1.80

122.17

4.2

3.3

1879.26

1468.65

ng/l

4.48

2514

16309

Other skin changes

3989

28684

1.66

121.79

3.8

3.3

1608.82

1528.37

ng/l

0.44

3534

24956

Impingement syndrome of shoulder

4176

29984

1.61

121.32

3.2

3.0

833.67

1233.90

ng/l

15.06

3541

25891

Other noninflammatory disorders of uterus, except cervix

3883

18214

1.67

121.20

3.2

3.0

1167.56

1507.52

ng/l

7.22

3335

15768

Mouth breathing

6612

50734

1.45

121.05

3.2

966.28

1201.79

ng/l

5.15

5588

43656

Diseases of the myoneural junction and muscle

2475

16292

1.94

120.87

3.7

3.3

1926.95

1608.86

ng/l

1.72

2119

14166

Idiopathic gout

2094

13498

2.15

120.58

5.0

3.3

2908.23

1586.95

ng/l

16.80

1908

11839

Other degenerative diseases of the nervous system

5223

28091

1.52

119.57

3.0

1719.44

1586.42

ng/l

1.03

4512

24562

DVT of lower extremities

3707

26360

1.68

119.38

3.4

3.2

1566.87

1591.91

ng/l

0.09

3246

22848

Misadventures to patients during surgical and medical care

2731

18268

1.83

119.08

4.2

3.1

2032.10

1346.80

ng/l

6.36

2409

15795

Type 1 diabetes, wide definition

3178

21384

1.67

118.96

3.9

2.9

3548.31

1157.37

ng/l

33.68

2785

17982

Haemorrhage, not elsewhere classified

919

4609

3.17

118.36

5.6

3.0

3132.44

1626.83

ng/l

5.91

830

3995

Urticaria and erythema

5649

42353

1.47

117.23

3.5

3.1

1185.89

1168.17

ng/l

0.09

4745

36005

Diseases of male genital organs

8528

33616

1.38

116.65

3.3

3.4

1679.72

1558.99

ng/l

0.98

7258

28867

Fungal Sepsis

958

4917

3.06

116.17

5.8

3.0

2429.24

1187.93

ng/l

8.16

884

4229

Migraine with aura and triptan purchases

1937

11575

1.88

115.89

2.8

438.20

730.11

ng/l

6.14

1551

9513

Injuries to the elbow and forearm

12366

87403

1.30

115.85

3.3

3.1

1461.83

1280.86

ng/l

3.62

10538

74426

Postmenopausal bleeding

4817

18419

1.58

115.62

3.3

3.0

1117.93

1501.74

ng/l

11.01

4115

15971

Asthma and allergy

1465

7904

2.04

115.53

2.9

2.4

555.15

668.65

ng/l

0.84

1194

6442

Atrial septal defect, secundum type

536

2069

4.05

114.95

6.0

3.7

1315.62

1085.59

ng/l

0.59

484

1729

Osteoporosis with pathological fracture (FG)

1660

10211

2.32

114.60

4.2

3.1

1520.74

1567.39

ng/l

0.22

1467

8801

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

3114

21738

1.77

114.27

3.6

3.3

1515.79

1458.69

ng/l

0.33

2827

18845

Heart failure and hypertrophic cardiomyopathy

536

2327

6.99

113.58

13.6

3.3

3738.64

1569.09

ng/l

12.47

524

2016

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2161

13455

1.83

113.49

3.0

1095.62

904.28

ng/l

0.74

1749

11111

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1663

9970

2.12

112.90

3.9

3.1

1503.88

1234.32

ng/l

1.41

1438

8540

Hypertensive Renal Disease

838

4085

3.14

112.90

4.8

2.9

7404.78

1451.80

ng/l

26.19

763

3511

Bacterial pneumonia (organism specified)

8626

62637

1.37

112.83

4.2

3.2

2291.62

1603.49

ng/l

20.63

7770

53940

Other diseases of lip and oral mucosa

7341

57721

1.40

112.68

3.1

1063.42

1209.94

ng/l

2.25

6262

49477

Other complications of surgical and medical care, not elsewhere classified

1763

10709

2.06

112.64

3.8

3.0

1438.03

1195.79

ng/l

1.28

1537

9177

Panic disorder

1834

10888

1.89

112.51

3.1

2.8

1028.64

898.68

ng/l

0.31

1471

8943

Benign paroxysmal vertigo

5701

43803

1.50

112.09

3.3

3.2

1140.51

1455.02

ng/l

7.98

4850

38047

Implicit fungal Sepsis

891

4522

3.15

111.94

5.9

3.0

2502.68

1178.94

ng/l

8.15

822

3882

Unspecified urinary incontinence

1834

11504

2.11

111.31

3.5

3.2

1223.61

1430.20

ng/l

1.60

1429

9994

Primary coxarthrosis, bilateral

6065

47414

1.50

110.75

3.6

3.3

1477.16

1642.26

ng/l

2.67

5350

41389

Idiopathic pulmonary fibrosis

1797

11495

2.26

110.41

4.7

3.5

1639.44

1910.41

ng/l

1.96

1666

10124

Traumatic subdural haemorrhage

2777

17701

1.78

109.89

3.8

3.2

2133.45

1914.84

ng/l

1.49

2454

15625

Benign neoplasm: Colon, unspecified

5146

39338

1.54

109.80

3.6

3.3

1772.79

1526.02

ng/l

2.54

4460

34428

Other and unspecified effects of external causes

3994

28571

1.55

109.41

3.2

3.1

1201.85

1157.43

ng/l

0.23

3333

24107

Epilepsy

5049

37552

1.48

109.08

3.2

3.1

1344.83

1631.72

ng/l

4.91

4372

32515

Other shoulder lesions

1602

9480

2.06

108.59

3.4

3.0

991.13

1286.44

ng/l

2.68

1337

8101

Disorders of vitreous body and globe

10020

77894

1.34

108.50

3.3

3.1

1428.36

1328.49

ng/l

1.12

8664

67582

Necrosis of pulp, including avohilmo

9087

72182

1.33

108.40

3.0

908.97

1093.59

ng/l

3.91

7534

61188

Alcohol use disorder, Swedish definition

9381

69058

1.33

107.34

3.3

3.2

1673.21

1407.67

ng/l

4.42

8017

59275

Emotionally unstable personality disorder

1414

7889

2.03

107.25

2.5

2.8

675.04

666.40

ng/l

0.03

1090

6343

Disorders of vitreous body

9743

76094

1.35

107.09

3.3

3.1

1405.35

1311.12

ng/l

1.01

8416

66035

10297

73158

1.31

107.06

3.3

3.2

1648.73

1402.94

ng/l

4.32

8786

62691

Diabetic maculopathy, excluding more controls

1892

11834

1.96

106.78

4.2

2.9

4153.29

1330.29

ng/l

26.42

1684

10130

Benign thyroid growths and nodules

6080

43835

1.45

106.46

3.2

3.1

1229.49

1392.46

ng/l

2.51

5302

37872

Thyrotoxicosis

4354

32157

1.54

105.94

4.3

3.0

1347.68

1266.78

ng/l

0.73

3784

27588

Emphysema

1592

9793

2.21

105.75

4.2

3.2

1720.53

1833.32

ng/l

0.47

1448

8538

Other viral diseases, including avohilmo

5080

37442

1.45

105.31

3.7

3.0

1216.70

1084.96

ng/l

1.32

4339

31198

Localized swelling, mass and lump of skin and subcutaneous tissue

5649

43382

1.45

104.75

3.5

3.2

1304.68

1351.06

ng/l

0.33

4924

37321

Amputation

2202

14703

1.96

104.62

4.5

3.4

5150.41

1695.52

ng/l

33.64

2022

12848

Enthesopathies of lower limb, excluding foot

3652

26060

1.57

104.15

3.0

879.84

1257.96

ng/l

8.96

3072

22213

Endometriosis

4781

20388

1.49

102.71

2.9

937.49

1349.14

ng/l

10.00

4005

17400

Viral pneumonia (unknown virus, not influenza)

1234

6969

2.31

102.71

4.8

3.1

1809.87

1351.32

ng/l

2.29

1105

5911

Fracture of lumbar spine and pelvis

4688

35532

1.54

102.17

3.9

3.3

2009.44

1752.05

ng/l

3.04

4136

30872

Schizophrenia or delusion, excluding more controls

4375

31681

1.49

102.07

2.8

3.1

1114.68

1207.18

ng/l

0.64

3568

26901

Coarctation of the aorta

257

703

8.63

101.96

8.0

3.9

1239.86

897.68

ng/l

0.80

241

591

Nonorganic sleeping disorders

3089

21362

1.62

101.83

3.3

3.1

1005.32

1155.13

ng/l

1.32

2538

17953

Other noninfective gastroenteritis and colitis

4230

31198

1.53

101.65

3.7

3.3

1665.63

1440.73

ng/l

1.64

3660

26785

Other extrapyramidal and movement disorders in other diseases

4674

35374

1.52

101.53

3.4

3.2

1171.78

1476.58

ng/l

4.52

4005

30761

Peripheral artery operations in Hilmo

2680

18602

1.79

101.49

4.4

3.3

4545.40

1692.31

ng/l

35.94

2449

16170

Spondylolisthesis/Spondylolysis

3190

22534

1.64

101.32

3.3

3.0

1020.21

1365.14

ng/l

5.79

2745

19373

9819

71749

1.31

101.00

3.3

3.2

1676.19

1408.81

ng/l

4.71

8393

61522

Extrapyramidal and movement disorders

7570

60978

1.39

100.76

3.2

3.3

1212.72

1562.12

ng/l

10.36

6518

53013

Nonalcoholic fatty liver disease

1683

10365

1.99

100.73

3.1

3.0

984.34

1009.41

ng/l

0.08

1348

8763

Noninfective enteritis and colitis

7626

60704

1.36

100.68

3.5

3.2

1504.25

1323.77

ng/l

2.18

6544

51803

Kidney transplant status

940

4923

2.64

100.46

4.2

3.3

8012.40

878.50

ng/l

31.99

917

4176

Diabetic retinopathy, excluding more controls

5216

22384

1.53

100.44

4.1

3.7

3002.97

1241.60

ng/l

39.15

4612

18842

Generalized anxiety disorder

1913

11775

1.79

100.35

2.8

752.84

865.06

ng/l

0.35

1484

9636

Presbycusis

3315

23847

1.70

99.71

3.5

2068.90

2211.27

ng/l

0.90

2810

21074

Fracture of lower leg, including ankle

9636

77553

1.31

99.37

3.2

3.1

1482.60

1297.40

ng/l

3.03

8245

66383

Disorders of sclera, cornea, iris and ciliary body

9412

77026

1.32

99.24

3.3

3.1

1410.29

1301.82

ng/l

1.38

8057

65868

Other metabolic disorders

2073

13362

1.81

98.66

3.8

2.8

1114.35

962.39

ng/l

0.86

1801

11259

Vasomotor and allergic rhinitis

5297

39171

1.42

98.63

3.0

876.17

1127.51

ng/l

3.63

4330

33130

Unspecified mental disorder

5950

45965

1.40

98.47

2.8

3.1

998.43

1207.82

ng/l

3.37

4895

38857

Other symptoms and signs involving the urinary system

2020

13277

1.91

97.52

3.6

3.3

1694.24

1551.24

ng/l

0.44

1823

11565

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

3710

26580

1.52

97.50

2.9

992.67

1001.92

ng/l

0.04

3000

22128

Other congenital malformations of heart

176

363

12.81

97.36

10.9

3.4

823.62

930.96

ng/l

0.22

170

290

Elevated blood glucose level

1581

9775

2.07

97.34

4.0

3.2

2144.05

1422.37

ng/l

3.63

1365

8422

Diseases of external ear

6312

49686

1.41

97.29

3.3

3.2

1345.69

1421.75

ng/l

0.83

5165

42978

Urticaria

4380

32469

1.48

97.08

3.5

3.1

1011.57

1119.66

ng/l

1.10

3647

27536

Congenital aortic valve stenosis

134

213

21.70

96.85

9.0

5.5

635.11

913.90

ng/l

0.87

126

173

Radiculopathy

2996

21189

1.66

96.72

3.5

3.1

1247.38

1731.08

ng/l

9.38

2591

18385

Other bursopathies

2399

16279

1.77

96.07

3.5

3.1

1568.44

1523.92

ng/l

0.13

2090

14093

Disorders of calcium metabolism

1262

7399

2.28

95.97

3.9

3.0

2829.13

1213.48

ng/l

7.57

1119

6337

Viral and other specified intestinal infections, including avohilmo

3630

24917

1.51

95.67

4.0

3.0

1487.43

1251.02

ng/l

1.48

3117

20629

Other viral diseases, not elsewhere classified, including avohilmo

3665

26195

1.52

95.51

3.7

3.1

1105.60

1143.37

ng/l

0.23

3130

21912

Diabetic nephropathy, excluding more controls

3086

18157

1.72

95.40

4.6

3.8

5285.54

1343.61

ng/l

65.41

2846

15413

Adhesive capsulitis of shoulder

2926

20595

1.66

95.37

3.3

3.1

1212.70

1388.86

ng/l

1.71

2549

17788

Diseases of salivary glands

5458

42216

1.43

94.73

3.3

3.1

1237.34

1231.81

ng/l

0.03

4687

36164

Disorders of muscles

1741

10939

1.91

94.65

3.7

3.1

1328.43

1454.92

ng/l

0.50

1506

9388

Enterocolitis due to Clostridium difficile

2189

14799

1.85

94.32

5.0

3.4

3369.65

1738.50

ng/l

16.35

1987

12857

Leisure time condition

3121

22237

1.62

94.20

3.7

3.3

1564.77

1429.45

ng/l

1.01

2622

19152

Covid-19 suspected case

2998

20905

1.59

94.14

3.5

2.9

1192.77

1117.22

ng/l

0.41

2649

17526

Polymyalgia rheumatica

2939

21298

1.74

93.86

3.9

3.3

1641.65

1743.26

ng/l

0.70

2636

18649

Other and unspecified drugs and medicaments

1551

9629

2.04

93.52

3.9

3.2

1560.62

1309.50

ng/l

1.15

1344

8277

Exposure to other specified factors

13374

97210

1.25

92.83

3.1

1281.17

1244.49

ng/l

0.39

11148

82925

Persistent mood disorders

3092

21923

1.60

92.82

3.3

3.1

1053.55

1331.55

ng/l

4.18

2554

18763

Other or unspecified ileus, impaction or obstruction

3619

26693

1.57

92.07

3.5

3.2

1783.79

1666.03

ng/l

0.62

3187

23159

SLE (Finngen)

662

3143

3.05

91.89

3.9

2.9

1322.77

1082.40

ng/l

0.78

587

2636

Amputation of toe

1551

9922

2.17

91.81

4.4

3.4

5014.59

1708.80

ng/l

23.46

1425

8660

Lesion of ulnar nerve

2358

16020

1.73

91.72

3.4

3.1

1252.16

1300.76

ng/l

0.22

1996

13800

Childhood asthma (age<16), excluding more controls

884

3319

2.21

91.55

3.6

1.8

409.13

240.18

ng/l

1.21

662

2439

Voice disturbances

4685

35834

1.48

91.53

3.3

3.1

999.16

1337.32

ng/l

8.85

4045

30956

Mental and behavioural disorders due to alcohol

8476

65772

1.32

91.42

3.3

3.2

1651.80

1385.48

ng/l

4.01

7211

56376

Family history of certain disabilities and chronic diseases leading to disablement

686

3175

2.65

91.28

3.1

2.3

579.68

650.61

ng/l

0.38

536

2550

Non-Hodgkin lymphoma, all, including Hilmo

2631

18632

1.74

90.57

3.8

3.3

1783.56

1518.87

ng/l

1.82

2395

16155

Other general symptoms and signs

796

3905

2.50

90.50

3.1

2.8

1311.97

1179.77

ng/l

0.18

650

3279

Sulfasalazine

4502

33982

1.46

90.50

3.2

2.8

1277.84

1247.46

ng/l

0.21

3893

28747

Operations for atrial fibrillation

416

1790

7.38

90.46

5.4

3.4

1643.96

1423.04

ng/l

0.50

409

1549

Benign neoplasm: Sigmoid colon

3740

28099

1.58

90.06

3.7

3.3

1408.96

1500.44

ng/l

0.55

3346

24532

Candidiasis

2399

16413

1.72

89.93

4.1

3.1

1371.07

1254.45

ng/l

0.71

2068

14055

Conjunctivitis (acute, non atopic)

4305

32136

1.47

89.52

3.4

3.2

1181.59

1203.17

ng/l

0.12

3662

27379

Disorders of skin appendages

7504

59990

1.33

89.47

3.3

3.0

1230.53

1148.53

ng/l

0.79

6368

50766

Parkinson's disease, excluding more controls

2627

16943

1.69

88.70

3.0

3.1

1292.04

1693.73

ng/l

7.12

2287

14990

Persons with potential health hazards related to communicable diseases

4435

32796

1.43

88.59

3.4

3.0

1663.10

954.46

ng/l

6.72

3688

27126

Mental and behavioural disorders due to alcohol, excluding acute intoxication

7372

58986

1.34

88.37

3.2

1673.52

1353.65

ng/l

4.66

6280

50592

Abnormal involuntary movements

2392

16514

1.72

87.95

3.5

3.2

1161.60

1405.31

ng/l

2.54

2078

14256

Vascular disorders of the intestines

1518

9699

2.10

87.62

4.7

3.2

2998.63

1820.40

ng/l

6.50

1393

8474

Sicca syndrome [Sjögren]

1544

9779

2.02

87.55

3.4

3.0

924.87

1174.69

ng/l

2.48

1332

8380

Kela-code for severe mental illness

5347

41451

1.40

86.97

2.8

3.1

1012.33

1243.71

ng/l

3.48

4403

35090

Rheumatoid arthritis, including avohilmo

6849

55307

1.37

86.86

3.4

3.2

1462.84

1386.49

ng/l

0.78

6039

47631

Preparatory care for dialysis

905

5064

2.70

86.46

4.6

3.3

11168.32

1234.17

ng/l

43.25

861

4396

Cervicocranial syndrome

1823

11844

1.83

86.24

3.2

3.0

913.76

1425.79

ng/l

7.31

1593

10168

Flat foot [pes planus] (acquired)

1633

10371

1.90

85.88

3.0

897.86

1145.62

ng/l

2.02

1397

8921

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1109

6685

2.52

85.83

4.5

3.3

2165.30

1616.25

ng/l

2.01

1016

5812

Alcohol use disorder, ICD-based

6791

54520

1.35

85.82

3.2

1674.49

1348.25

ng/l

4.31

5778

46753

Unknown and unspecified causes of morbidity

1160

6695

2.12

85.81

3.4

2.8

1480.46

1407.28

ng/l

0.18

1050

5694

Other postsurgical states

1151

6722

2.20

85.79

4.7

2.7

1149.56

1213.91

ng/l

0.24

1048

5729

Persons encountering health services for specific procedures, not carried out

1368

8246

1.98

85.77

3.1

2.8

1810.96

923.45

ng/l

4.74

1172

6894

Wet age-related macular degeneration

4085

30493

1.57

85.21

3.7

3.5

2131.55

1976.42

ng/l

1.11

3585

26861

Inguinal hernia

10374

57488

1.28

85.12

3.5

3.3

1629.65

1524.18

ng/l

1.24

9015

49340

Other viral diseases

3863

28452

1.47

84.97

4.0

3.1

1384.23

1143.11

ng/l

2.54

3346

23748

Suicide or other Intentional self-harm

3304

23891

1.52

84.58

3.1

3.0

1081.24

1073.38

ng/l

0.03

2687

20076

Other peripheral vascular diseases

1441

8980

2.00

84.34

3.6

3.0

1225.49

1189.13

ng/l

0.13

1275

7632

Abnormal findings on diagnostic imaging of other body structures

2631

18701

1.67

84.22

3.2

3.1

1395.59

1293.41

ng/l

0.50

2292

16137

Post-traumatic stress disorder

903

4692

2.16

83.76

2.7

618.49

702.95

ng/l

0.16

706

3783

Benign neoplasm: Ascending colon

2829

20663

1.68

83.72

3.8

3.3

1532.08

1490.21

ng/l

0.20

2513

18080

Fissure and fistula of anal and rectal regions

3939

29598

1.48

82.89

3.2

3.0

1116.73

1305.82

ng/l

2.26

3343

25345

Purpura and other haemorrhagic conditions

2368

16521

1.70

82.67

4.1

3.3

1863.99

1486.19

ng/l

3.43

2120

14274

Benign neoplasm: Transverse colon

2176

15230

1.82

82.53

3.7

3.3

1595.80

1458.02

ng/l

0.50

1934

13341

Pain associated with micturition

2146

14683

1.74

82.51

3.5

3.2

1038.06

1363.78

ng/l

4.06

1780

12728

Parkinson's disease, strict definition, excluding more controls

2458

16115

1.69

82.44

3.1

1314.98

1726.67

ng/l

6.84

2142

14276

Hyperkinetic disorders, excluding more controls

929

4485

2.07

82.13

3.2

2.8

511.36

508.41

ng/l

0.01

641

3431

Other disorders of kidney and ureter

2459

17459

1.71

82.12

3.9

3.3

4392.92

1437.32

ng/l

32.42

2224

15210

Need for other prophylactic measures

1025

5925

2.27

80.40

4.1

3.3

1566.72

1264.12

ng/l

0.90

932

5079

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

3187

22649

1.50

80.39

3.9

3.0

968.85

1034.68

ng/l

0.44

2651

18741

Secondary and unspecified malignant neoplasm of lymph nodes

1650

10887

1.93

80.11

4.0

3.3

1806.32

1501.16

ng/l

1.99

1485

9420

Arthropathies in other diseases classified elsewhere

685

3489

2.78

79.95

4.2

3.2

3347.41

1249.36

ng/l

9.58

585

2999

Childhood asthma (age<16)

885

3500

2.10

79.86

3.6

2.3

416.30

385.44

ng/l

0.12

663

2616

Abnormalities of gait and mobility

2403

17149

1.73

79.78

3.3

3.4

1864.68

1664.66

ng/l

0.81

2116

15040

Osteomyelitis

1263

7833

2.13

79.78

4.4

3.3

3803.12

1553.94

ng/l

18.18

1146

6806

Adverse effects, not elsewhere classified

2817

20093

1.56

79.77

3.2

3.1

1178.19

1122.77

ng/l

0.25

2368

17011

Other and unspecified myopathies

1760

11834

1.90

79.41

3.7

3.4

2202.28

1686.53

ng/l

2.46

1512

10323

Benign neoplasm of other and ill-defined parts of digestive system

3324

24931

1.57

79.03

3.6

3.2

1451.37

1447.49

ng/l

0.02

2909

21700

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1792

12005

1.85

79.00

4.1

3.3

2248.25

1411.08

ng/l

5.84

1602

10397

Other blood glucose lowering drugs, excl. Insulins

3065

22749

1.60

79.00

3.9

3.2

1928.15

1505.54

ng/l

3.38

2656

19889

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

4752

36282

1.45

78.86

3.1

3.3

1271.43

1493.71

ng/l

2.83

4337

31534

ILD-related respiratory insufficiency

794

4494

2.99

78.79

6.1

3.4

2246.62

1721.54

ng/l

2.00

753

3946

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

2842

20833

1.67

78.46

3.7

3.6

2342.72

1992.70

ng/l

2.91

2526

18249

Propionic acid derivatives

4729

18077

1.42

77.72

3.4

3.7

1576.16

2224.20

ng/l

12.86

4017

15982

Diplopia

2333

16447

1.68

77.62

3.6

3.2

1213.64

1438.96

ng/l

1.52

2020

14221

Cholecystitis

2729

19841

1.62

77.49

3.8

3.3

1826.19

1772.68

ng/l

0.23

2404

17262

Charcot foot

357

1389

4.20

77.43

4.5

2.2

4560.47

786.41

ng/l

12.02

317

1109

Intestinal stricture

5918

47801

1.38

77.23

3.5

3.3

1763.10

1595.71

ng/l

1.44

5213

41583

Transport accidents

7225

48745

1.31

76.70

3.1

3.0

1175.92

1169.70

ng/l

0.04

6014

41762

Organic, including symptomatic, mental disorders

10830

65116

1.28

76.62

3.3

3.4

1856.67

1650.42

ng/l

3.81

9420

57122

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1848

12280

1.73

76.45

3.7

2.8

1133.15

957.74

ng/l

0.93

1602

10317

Other viral diseases, not elsewhere classified

2599

18346

1.57

76.18

4.2

3.2

1271.57

1267.58

ng/l

0.02

2266

15499

Dialysis

739

3953

2.63

75.98

4.6

3.2

11441.44

920.59

ng/l

38.74

712

3382

Other necrotizing vasculopathies (FG)

1169

7199

2.16

75.95

3.8

3.1

1674.82

1483.99

ng/l

0.77

1063

6223

Restless leg syndrome

2500

17909

1.64

75.69

3.4

3.2

1117.19

1330.74

ng/l

1.25

2120

15455

Raynaud syndrome

1403

8865

1.90

75.15

3.4

3.1

708.21

1079.98

ng/l

5.97

1222

7516

637

11844

0.45

75.00

3.0

3.4

2743.93

1770.83

ng/l

2.69

553

10295

Polyp of the female genital tract

4541

19710

1.43

74.95

3.1

2.9

1027.72

1413.62

ng/l

8.72

3822

16926

Hypertension, Pulmonary Arterial

232

753

7.86

74.89

13.8

3.0

1453.24

1141.30

ng/l

1.07

225

630

Other embolism and thrombosis

2310

16372

1.67

74.83

3.6

3.2

1702.26

1563.22

ng/l

0.56

2045

14129

Fibrosis and cirrhosis of liver

1509

9951

1.96

74.71

4.2

3.2

1977.29

1402.56

ng/l

3.17

1361

8636

Superficial injury of hip and thigh

2902

21365

1.58

74.66

3.7

3.4

1944.61

1731.31

ng/l

1.08

2525

18506

Disorders of parathyroid gland

4035

31004

1.48

74.17

3.7

3.2

2774.22

1576.59

ng/l

13.84

3509

26911

Pain and other conditions associated with female genital organs and menstrual cycle

2366

13594

1.57

74.08

2.6

2.7

760.16

942.97

ng/l

0.84

1902

11383

In situ neoplasms

7489

62119

1.32

73.90

3.5

3.2

1767.82

1521.18

ng/l

3.21

6572

53826

Systemic lupus erythematosus

662

3435

2.71

73.60

3.9

2.9

1322.77

1000.64

ng/l

1.34

587

2886

Viral and other specified intestinal infections

2562

17560

1.54

73.59

4.4

3.1

1742.54

1306.50

ng/l

2.43

2214

14450

Other disorders of adrenal gland

818

4538

2.41

73.51

4.6

3.2

1384.90

1173.01

ng/l

0.51

732

3878

Other disorders of bone

2898

21110

1.53

73.41

3.2

3.0

1068.33

1119.68

ng/l

0.27

2404

17885

Other and unspecified visual disturbances

1841

12509

1.76

73.40

3.5

3.1

1195.15

1306.64

ng/l

0.60

1603

10760

Temporomandibular joint disorders, including avohilmo

5956

46028

1.33

73.35

2.8

2.9

645.58

959.44

ng/l

15.58

4866

38648

Fibroblastic disorders

4174

32374

1.44

73.05

3.3

3.2

1477.39

1631.26

ng/l

1.50

3601

28145

Faecal incontinence

1785

12176

1.81

72.71

3.1

3.0

1382.74

1443.77

ng/l

0.16

1494

10642

Injuries to the neck

3374

25166

1.47

72.59

3.1

3.2

1164.79

1279.76

ng/l

0.98

2817

21371

Migraine without aura and triptan purchases

1767

11539

1.67

72.52

2.7

375.27

656.26

ng/l

8.36

1405

9421

Fracture of femur

5768

42190

1.38

72.46

3.7

3.4

2429.80

1875.85

ng/l

10.93

5109

36799

Glaucoma

11254

82247

1.25

72.09

3.3

1581.78

1573.11

ng/l

0.07

9709

71621

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

3652

28179

1.51

72.00

3.0

3.3

1126.40

1460.67

ng/l

8.78

3321

24467

Visual impairment including blindness (binocular or monocular)

1383

8977

1.97

71.88

3.9

3.4

2418.10

1785.20

ng/l

2.12

1171

7810

Retinal vascular occlusion

2479

18187

1.67

71.70

3.9

3.4

2324.11

1755.51

ng/l

5.00

2190

15994

Malignant neoplasm of digestive organs, including Hilmo

8326

51260

1.30

71.69

3.1

3.3

1472.38

1487.40

ng/l

0.11

7388

44226

Other and unspecified disorders of skin and subcutaneous tissue

1169

7274

2.08

71.56

4.0

3.2

1813.32

1331.43

ng/l

2.53

923

6264

Female genital prolapse

4525

19432

1.42

71.46

2.9

3.0

987.78

1449.62

ng/l

14.72

3860

16718

Other disorders of patella

2252

15659

1.59

71.32

2.9

812.16

938.43

ng/l

0.69

1816

13237

Mixed hyperlipidaemia

801

4519

2.48

71.10

4.2

3.0

2624.33

1319.10

ng/l

4.32

706

3879

Superficial injury of thorax

2584

18719

1.58

71.03

3.6

3.3

1384.53

1504.61

ng/l

0.69

2232

16094

SLE, strict definition

628

3249

2.76

70.96

3.8

2.9

1318.08

940.19

ng/l

1.61

554

2713

SLE, ICD10

628

3249

2.76

70.96

3.8

2.9

1318.08

940.19

ng/l

1.61

554

2713

Other and unspecified local infections of skin and subcutaneous tissue

1663

11116

1.79

70.94

4.1

3.3

2213.52

1299.65

ng/l

4.95

1463

9545

Other local infections of skin and subcutaneous tissue

1757

11876

1.76

70.93

4.0

3.2

2158.64

1305.49

ng/l

4.77

1541

10200

Adrenocortical insufficiency

695

3734

2.63

70.83

4.8

3.2

1203.64

1107.47

ng/l

0.22

628

3189

Acute pancreatitis

3441

26151

1.49

70.77

3.5

3.2

1768.11

1506.45

ng/l

1.69

3014

22616

Papulosquamous disorders

6689

54913

1.32

70.61

3.2

3.1

1256.50

1270.60

ng/l

0.10

5732

47233

Scoliosis

1256

7762

1.89

70.56

3.5

3.1

968.50

1351.06

ng/l

3.78

1056

6586

Keratitis

5812

46871

1.34

70.48

3.4

3.2

1370.47

1294.65

ng/l

0.66

4954

40070

Noninfectious colitis NAS

2236

15796

1.63

70.31

3.5

3.2

1720.50

1393.04

ng/l

1.64

1930

13533

Cardiomyopathy in other diseases

171

480

12.89

70.00

13.1

1.9

4825.84

470.22

ng/l

16.73

162

405

Retinal vascular disorders

2510

18506

1.65

70.00

3.9

3.4

2354.55

1773.60

ng/l

5.03

2217

16274

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

4874

37646

1.36

69.81

3.1

3.0

843.30

976.10

ng/l

1.68

3971

31295

Bronchiectasis

1574

10674

1.90

69.63

4.2

3.1

1584.85

1629.30

ng/l

0.15

1421

9304

Disorders of conjunctiva

13610

91372

1.21

69.29

3.2

3.1

1089.21

1283.10

ng/l

6.32

11474

77762

Anti-inflammatory and antirheumatic products, non-steroids

4662

18077

1.39

69.07

3.4

3.7

1672.87

2224.20

ng/l

8.93

3958

15982

Other condition

2252

15947

1.61

69.05

3.7

3.2

1532.00

1275.03

ng/l

1.55

1982

13583

Other enthesopathy of foot (+metatarsalgia)

1620

10738

1.75

68.69

3.1

2.9

833.61

1167.86

ng/l

5.66

1384

9205

Metatarsalgia

1527

10010

1.79

68.61

3.1

2.9

839.42

1169.91

ng/l

5.26

1309

8580

Benign neoplasm: Rectum, anus and anal canal

3852

30152

1.47

68.33

3.5

3.3

1501.43

1527.82

ng/l

0.14

3366

26379

Benign neoplasm: Rectum

3445

26618

1.51

68.16

3.6

3.3

1438.13

1505.33

ng/l

0.44

3012

23301

Superficial injury of abdomen, lower back and pelvis

2486

17920

1.56

68.01

3.6

3.2

1413.93

1411.48

ng/l

0.01

2135

15317

Viral pneumonia (known virus, not influenza)

611

3243

2.91

67.97

5.5

3.3

2856.78

1494.06

ng/l

4.15

567

2815

KRA_PSY_EATING, excluding more controls

684

3404

2.18

67.87

3.1

2.7

947.82

523.93

ng/l

0.65

529

2711

Neuralgia and neuritis, unspecified

884

5098

2.20

67.82

3.3

3.1

953.80

1296.86

ng/l

2.78

770

4347

Alcohol abuse, main dg, excluding more controls

2141

14971

1.60

67.68

3.3

3.2

1634.12

1209.62

ng/l

2.71

1811

12823

Congenital stenosis of pulmonary valve

158

400

8.27

67.67

7.9

4.4

715.96

735.41

ng/l

0.05

148

334

Later onset COPD

6197

41271

1.37

67.40

4.5

3.3

2489.11

1912.84

ng/l

11.74

5585

36425

Seronegative rheumatoid arthritis

1973

13819

1.68

66.74

3.4

3.0

1533.26

1335.33

ng/l

1.10

1731

11893

Synovial cyst of popliteal space [Baker]

1342

8735

1.91

66.71

3.6

3.1

1455.35

1511.02

ng/l

0.13

1174

7559

Morphin

531

2708

3.13

66.29

5.4

3.0

1558.26

1727.67

ng/l

0.45

493

2354

Mixed connective tissue disease

387

1730

3.82

66.18

4.3

3.1

865.44

1206.55

ng/l

1.46

349

1476

Irregular menses

5916

35671

1.31

65.84

2.8

2.7

730.50

838.36

ng/l

1.15

4857

29795

Thiazolidinediones

2132

15413

1.69

65.79

3.4

3.2

1896.49

1455.96

ng/l

2.81

1819

13554

Squamous cell neoplasms and carcinomas of the skin

2257

16586

1.69

65.65

3.7

3.6

2474.11

2019.79

ng/l

3.49

2005

14524

Non-follicular lymphoma

1846

13062

1.77

65.55

3.9

3.3

1844.94

1583.04

ng/l

1.68

1695

11434

Lung cancer and mesothelioma

3556

23226

1.46

65.42

3.3

2.7

1435.99

1329.37

ng/l

0.95

3274

20100

Other dialysis

596

3161

2.82

65.31

4.7

3.4

12093.15

1189.12

ng/l

29.20

575

2721

Disorders resulting from impaired renal tubular function

721

4073

2.56

65.26

4.0

3.3

8790.76

1265.07

ng/l

31.22

684

3502

Other specified congenital malformation syndromes affecting multiple systems

261

907

4.13

65.25

5.1

4.4

1030.80

806.29

ng/l

0.51

231

735

Systemic lupus erythematosus, unspecified

547

2779

2.84

65.16

3.7

2.9

1202.72

934.23

ng/l

0.87

488

2326

Excessive attrition of teeth

9124

76359

1.24

64.92

3.1

3.0

914.39

1087.85

ng/l

3.59

7616

64749

Ascites

1429

9548

1.87

64.65

5.2

3.1

3063.49

1491.12

ng/l

10.67

1325

8350

Secondary uncertain malignant neoplasm

2585

19237

1.58

64.62

3.6

3.4

1771.85

1623.31

ng/l

0.90

2310

16704

Inflammatory diseases of female pelvic organs

9106

52496

1.25

64.33

2.9

869.42

1051.05

ng/l

5.63

7451

44483

Delirium, not induced by alcohol and other psychoactive substances

2624

19676

1.59

64.02

3.7

3.6

2605.38

2026.79

ng/l

4.64

2306

17340

Drug-induced adrenocortical insufficiency

399

1838

3.67

63.97

5.4

3.4

1113.44

1066.17

ng/l

0.06

365

1571

Immunodeficiencies

793

4536

2.27

63.81

4.4

3.2

1638.25

1179.10

ng/l

1.30

715

3843

Speech therapy

4560

36486

1.39

63.75

3.5

3.2

1537.04

1449.74

ng/l

0.63

4180

31565

Cirrhosis of liver, NAS

1097

7030

2.12

63.68

4.4

3.2

1975.53

1402.75

ng/l

2.98

1001

6112

Mixed and other personality disorders

1014

6055

1.94

63.65

2.8

2.9

926.15

802.57

ng/l

0.28

809

4952

Other and unspecified disorders of vitreous body

7800

64474

1.29

63.61

3.1

963.83

1242.33

ng/l

8.87

6696

55983

Alzheimer’s disease (Atypical or mixed), excluding more controls

1992

10588

1.70

63.31

3.5

3.3

2017.32

2152.82

ng/l

0.61

1729

9401

Superficial injury of wrist and hand

2828

20888

1.47

63.28

3.2

3.1

1155.31

1158.92

ng/l

0.01

2333

17629

Failure and rejection of transplanted organs and tissues

291

1149

4.44

63.24

8.0

3.2

5062.25

770.12

ng/l

6.26

277

949

Uterine polyps

4232

19245

1.40

63.14

3.1

2.9

1059.70

1385.42

ng/l

3.98

3552

16558

Otitis externa

3554

27391

1.43

62.82

3.3

3.2

1136.17

1294.68

ng/l

1.90

2920

23498

Schizophrenia or delusion

4375

34429

1.37

62.81

2.8

3.1

1114.68

1195.97

ng/l

0.54

3568

29042

Periapical abscess

7371

61584

1.28

62.70

3.1

1174.66

1162.78

ng/l

0.07

6226

52615

Benign neoplasm: Caecum

2109

15425

1.69

62.60

3.8

3.3

1715.67

1456.22

ng/l

1.17

1867

13526

Phobic anxiety disorders

1369

8686

1.71

62.56

3.0

2.9

915.84

783.02

ng/l

0.37

1096

7030

Decubitus ulcer and pressure area

1306

8710

1.95

62.48

4.8

3.4

3609.29

1825.65

ng/l

9.88

1178

7619

Other problems related to primary support group, including family circumstances

1233

7481

1.78

62.42

5.0

3.1

991.92

813.87

ng/l

0.71

1030

6112

Pruritus

1900

13322

1.65

62.41

3.5

3.1

1677.81

1337.12

ng/l

2.00

1637

11424

Dislocation, sprain and strain of joints and ligaments at neck level

1965

13662

1.59

62.40

2.8

3.1

792.10

1013.17

ng/l

2.20

1608

11405

Asthma mixed form (mode), excluding more controls

743

4093

2.16

61.84

3.4

2.1

1156.18

656.62

ng/l

3.96

637

3424

Spontaneous rupture of synovium and tendon

1457

9796

1.80

61.79

3.3

3.1

1194.75

1471.97

ng/l

2.05

1253

8477

Multiple myeloma, including Hilmo

966

6087

2.24

61.62

5.1

3.3

2007.94

1630.84

ng/l

1.43

899

5310

Schizophrenia, schizotypal and delusional disorders

4399

34732

1.36

61.53

2.9

3.1

1099.39

1197.12

ng/l

0.71

3590

29297

Other diseases of oesophagus

1756

12326

1.71

60.96

3.9

3.3

1857.93

1712.55

ng/l

0.43

1529

10748

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1544

10690

1.82

60.85

4.2

3.3

2341.18

1667.79

ng/l

3.85

1367

9338

Fall on same level involving ice and snow

9884

84876

1.23

60.81

3.1

1255.37

1300.54

ng/l

0.47

8391

72716

Stomatitis and related lesions

3040

23035

1.46

60.68

3.5

3.2

1125.55

1265.90

ng/l

1.28

2593

19704

Other and unspecified urticaria

2735

20327

1.48

60.40

3.5

3.1

1067.70

1137.93

ng/l

0.38

2247

17246

Conjunctivitis (acute, non atopic), including avohilmo

17265

92486

1.17

60.39

3.1

3.2

1055.17

1361.98

ng/l

19.31

14655

79150

Amyloidosis

509

2662

3.08

60.26

8.0

3.2

3436.70

1464.33

ng/l

10.25

476

2292

Allergic rhinitis

3661

27778

1.38

60.11

2.9

3.0

715.86

936.31

ng/l

3.13

2939

23100

Fenamates

2332

11415

1.55

59.97

3.1

3.6

1262.37

2066.62

ng/l

11.44

1988

10143

Diffuse large B-cell lymphoma

1010

6461

2.16

59.96

4.3

3.4

1847.81

1512.87

ng/l

1.60

935

5616

Diffuse large B-cell lymphoma, helper endpoint

1010

6461

2.16

59.96

4.3

3.4

1847.81

1512.87

ng/l

1.60

935

5616

Diffuse large B-cell lymphoma, including Hilmo

1010

6461

2.16

59.96

4.3

3.4

1847.81

1512.87

ng/l

1.60

935

5616

Trigger finger

2294

16695

1.55

59.88

3.2

3.0

1280.17

1265.78

ng/l

0.04

1947

14345

Tobacco use

878

5241

2.09

59.81

3.3

3.1

1591.82

1091.72

ng/l

2.34

769

4429

Methotrexate

2220

16111

1.56

59.62

3.3

2.8

1256.06

1281.68

ng/l

0.12

1980

13732

Asthma and opportunity respiratory infection

940

5923

2.21

59.15

4.2

3.3

1367.96

1533.82

ng/l

0.63

846

5157

Inflammatory diseases of prostate (prostatitis)

2206

16143

1.59

58.99

3.5

3.4

1366.63

1604.93

ng/l

1.21

1838

14122

Diabetic retinopathy

6849

35911

1.33

58.90

4.3

3.9

3020.95

1655.66

ng/l

34.46

6062

31184

Hydronephrosis

2045

14794

1.62

58.86

3.3

3.0

2535.31

1117.25

ng/l

16.53

1821

12805

Other coagulation defects

1180

7604

1.86

58.53

4.1

3.2

1564.50

1311.57

ng/l

1.32

1006

6486

Blepharochalasis

5532

45805

1.34

58.37

3.2

1196.78

1439.49

ng/l

5.54

4786

39881

Thyroiditis, ILD-related definition

1664

11456

1.65

58.32

3.3

3.0

1166.39

1105.39

ng/l

0.20

1413

9720

Hallux rigidus

2363

17504

1.55

58.13

3.0

940.86

1310.33

ng/l

7.69

2014

15154

Other disorders of nervous system

1218

8053

1.90

58.09

3.3

3.2

1110.63

1308.56

ng/l

1.29

1044

6922

Weight loss

1840

13176

1.67

57.73

3.6

3.3

1585.08

1488.37

ng/l

0.39

1596

11448

Acute gastritis

1336

8980

1.82

57.45

3.8

3.2

2055.12

1607.66

ng/l

1.16

1172

7787

Any death

12184

74937

1.22

57.23

4.2

3.0

3026.17

899.25

ng/l

163.28

11129

64722

Brachial plexus disorders

1210

7771

1.77

57.03

2.7

2.9

597.53

859.10

ng/l

2.62

1009

6524

Other necrotizing vasculopathies

1362

9320

1.85

57.03

3.8

3.3

1821.60

1550.35

ng/l

0.96

1237

8104

Striking against or struck by other objects

4695

37611

1.33

56.88

3.4

3.2

1350.29

1217.95

ng/l

0.93

3847

31806

Other disorders of bladder

2196

16243

1.59

56.82

3.3

1600.09

1622.73

ng/l

0.07

1829

14210

Deviated nasal septum

5246

42830

1.32

56.71

3.2

1017.35

1348.26

ng/l

8.60

4357

37032

Injuries to the ankle and foot

10794

79705

1.21

56.37

3.2

3.1

1251.36

1134.58

ng/l

1.60

9021

67424

Exclusion endpoint for clefts

291

1153

3.38

56.24

5.4

4.1

1110.17

821.82

ng/l

0.73

257

934

Pleural plaque

1954

14439

1.69

55.95

4.1

3.4

1688.28

1955.98

ng/l

2.41

1738

12756

Fracture of shoulder and upper arm

6317

52682

1.29

55.92

3.3

3.2

1696.39

1468.23

ng/l

3.16

5439

45287

Special screening examination for neoplasms

1062

6719

1.88

55.91

3.2

2.8

1230.85

1356.82

ng/l

0.44

907

5738

Fentanyl

1954

14125

1.61

55.49

4.0

3.1

2006.05

1855.35

ng/l

0.39

1754

12178

Hyperparathyroidism

3495

27388

1.44

55.41

3.6

3.2

3012.08

1605.37

ng/l

14.47

3033

23783

Retinal detachments and breaks

6628

55933

1.29

55.34

3.5

3.2

1795.65

1443.22

ng/l

6.61

5772

48684

Hypermobility syndrome

600

3172

2.20

55.03

2.4

2.6

485.28

585.55

ng/l

0.33

494

2563

Immunodeficiency with predominantly antibody defects

460

2317

2.78

55.03

4.9

3.1

1445.69

976.79

ng/l

1.02

427

1945

Psoriatic and enteropathic arthropathies

1682

11729

1.62

54.99

3.1

2.9

1200.57

1107.66

ng/l

0.43

1450

9992

Lung diseases due to external agents

2641

20174

1.51

54.97

4.0

3.5

2078.36

1925.21

ng/l

0.71

2346

17672

Multiple myeloma and malignant plasma cell neoplasms

998

6532

2.11

54.78

5.0

3.4

1981.82

1646.39

ng/l

1.22

929

5735

Spondylopathies (FG)

1795

12600

1.58

54.74

3.0

1042.92

1129.02

ng/l

0.39

1504

10617

Acute pancreatitis (for exclusion)

3441

27094

1.42

54.72

3.5

3.3

1768.11

1513.34

ng/l

1.62

3014

23456

Injuries to unspecified part of trunk, limb or body region

1704

12052

1.65

54.70

4.3

3.3

2117.39

1453.66

ng/l

4.33

1500

10393

Collagenous colitis

1571

10993

1.70

54.64

3.8

3.2

1431.15

1258.84

ng/l

0.98

1365

9465

Follow-up examination after treatment for malignant neoplasms

1789

12774

1.63

54.45

3.2

2.9

1680.10

1702.90

ng/l

0.06

1595

11018

Other (seronegative) rheumatoid arthritis, wide

3286

25808

1.44

54.37

3.5

3.2

1547.38

1419.68

ng/l

0.96

2911

22358

Injury of muscle and tendon at shoulder and upper arm level

6274

52694

1.29

54.21

3.3

3.2

1078.57

1338.05

ng/l

6.32

5423

45701

Amyloidosis, other/unspecified

428

2202

3.29

54.14

8.6

3.1

3515.42

1368.52

ng/l

9.58

403

1882

Budesonide

2027

14629

1.54

53.93

3.2

2.8

1157.52

1219.90

ng/l

0.27

1714

12311

Other and unspecified nerve root and plexus disorders, also in other diseases

3182

24680

1.42

53.70

3.1

3.0

840.78

1166.58

ng/l

4.20

2642

21146

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

4463

36353

1.36

53.37

3.4

3.2

1528.76

1389.76

ng/l

1.44

3980

31475

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1597

9362

1.56

53.14

3.9

3.0

760.21

655.45

ng/l

0.34

1160

7176

Benign neoplasm of other and unspecified endocrine glands

2208

16446

1.55

53.09

3.3

3.2

1542.37

1283.24

ng/l

1.08

1944

14210

Lateral epicondylitis

1857

13240

1.56

53.03

2.7

2.9

688.07

1041.94

ng/l

6.81

1564

11259

Open wound of ankle and foot

1593

11121

1.64

52.91

4.0

3.3

2422.98

1346.05

ng/l

6.20

1390

9471

Convalescence

874

5386

2.00

52.87

3.6

2.7

1377.76

936.51

ng/l

1.38

715

4546

Mental and behavioural disorders due to sedatives or hypnotics

942

5838

1.89

52.82

3.0

3.1

1278.13

1048.55

ng/l

0.47

770

4870

Neuromuscular dysfunction of bladder

1559

10964

1.68

52.64

3.2

3.1

1365.60

1458.70

ng/l

0.36

1314

9518

Intestinal adhesions without obstruction

1563

11041

1.69

52.56

3.5

3.1

1799.78

1550.40

ng/l

0.97

1374

9579

Pyogenic arthritis

1128

7408

1.83

52.43

4.0

3.2

2132.71

1516.64

ng/l

3.89

993

6422

Seropositive rheumatoid arthritis, wide

4588

37547

1.35

52.38

3.4

3.2

1545.61

1404.46

ng/l

1.42

4097

32507

Moderate visual impairment, binocular

676

4037

2.42

52.27

4.0

3.4

2700.68

1982.93

ng/l

2.11

557

3521

Acute suppurative otitis media

2628

18207

1.42

52.23

3.5

3.0

1070.27

940.52

ng/l

0.54

2126

14694

Patent foramen ovale

375

1771

2.97

52.16

4.1

3.8

745.23

1069.27

ng/l

1.60

296

1480

Other diseases of stomach and duodenum

1180

7936

1.84

51.48

3.6

3.1

1913.95

1515.79

ng/l

0.87

1040

6897

Other and unspecified injuries of head

1315

8992

1.76

51.48

3.9

3.3

1585.27

1539.69

ng/l

0.18

1156

7772

Barrett oesophagus

958

6218

2.02

51.32

3.6

3.2

1428.42

1365.84

ng/l

0.17

816

5401

Bronchitis, not specified as acute or chronic

1374

9400

1.70

51.30

3.8

3.1

1484.39

1491.17

ng/l

0.02

1193

8006

Other specified and unspecified personality disorders

1137

7379

1.75

51.28

3.0

2.9

914.59

931.21

ng/l

0.06

926

6093

Artificial joint re-operation

1378

9747

1.82

51.04

3.4

3.3

1528.20

1447.74

ng/l

0.23

1196

8506

Other/unspecified seropositive rheumatoid arthritis

4528

37108

1.34

51.01

3.4

3.2

1555.98

1403.36

ng/l

1.58

4041

32129

Abnormal weight loss

1699

12287

1.65

50.96

3.6

3.3

1542.09

1491.99

ng/l

0.17

1477

10697

Dermatophytosis

2347

17743

1.51

50.94

3.9

3.3

1584.10

1449.09

ng/l

0.67

2033

15363

Other/unspecified synovitis and tenosynovitis

1742

12432

1.58

50.76

3.4

3.0

1355.34

1389.73

ng/l

0.09

1461

10679

Embolic stroke with flimmer

534

2947

2.55

50.74

4.8

2.6

3058.71

1249.39

ng/l

11.70

487

2538

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

922

5733

1.88

50.72

3.4

3.2

1207.28

1235.04

ng/l

0.07

770

4810

Glomerulonephritis

1570

11115

1.65

50.58

3.8

3.3

5108.25

1384.79

ng/l

20.19

1435

9562

Psoriasis

4466

36370

1.33

50.45

3.1

1345.32

1256.75

ng/l

0.62

3818

31212

Open wound of wrist and hand

6671

54239

1.25

50.38

3.2

1186.52

1252.99

ng/l

0.58

5470

46301

Psoriatic arthropathies

1471

10185

1.64

50.32

3.1

3.0

1212.04

1137.96

ng/l

0.28

1267

8733

Mental and behavioural disorders due to opioids

449

2218

2.40

50.26

3.5

3.2

1063.80

890.29

ng/l

0.31

364

1751

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2557

19672

1.49

50.25

3.8

3.3

1928.90

1480.69

ng/l

4.03

2272

17115

Vitreous haemorrhage

1774

12925

1.62

50.06

3.8

3.2

3422.20

1499.58

ng/l

14.86

1574

11204

Pneumonia due to other infectious organisms, not elsewhere classified

609

3494

2.34

50.05

5.0

2.8

2020.27

1135.55

ng/l

3.71

550

2961

Alzheimer disease, excluding more controls

3452

17664

1.41

50.01

3.0

1827.59

1712.83

ng/l

0.69

2998

15628

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

497

2582

2.35

50.01

3.4

2.9

4142.90

537.28

ng/l

6.72

438

2101

Malignant neoplasm of breast, HER2-negative, including Hilmo

6523

35070

1.27

49.93

2.8

2.9

1032.23

1042.98

ng/l

0.08

5573

29505

Other disorders of glucose regulation and pancreatic internal secretion

1336

9157

1.71

49.92

3.8

3.3

3429.67

1499.34

ng/l

8.92

1183

7838

Fracture of foot, except ankle

3453

27176

1.37

49.88

3.2

3.1

1260.64

1124.19

ng/l

0.89

2910

23029

Carbimazole or st.post thyroidectomy, condition for graves disease

3120

24390

1.40

49.82

4.2

3.0

1136.70

1121.06

ng/l

0.09

2680

20856

Malignant neoplasm of breast, HER2-negative

6441

34845

1.27

49.81

2.8

2.9

1037.45

1047.93

ng/l

0.08

5497

29321

Malignant neoplasm of breast, including Hilmo

6522

35069

1.27

49.79

2.8

2.9

1032.38

1043.01

ng/l

0.08

5572

29504

Other aneurysm

1043

6928

1.92

49.71

4.5

3.2

2172.15

1580.30

ng/l

2.65

970

6011

Malignant neoplasm of breast

6442

34861

1.27

49.52

2.9

1037.42

1047.57

ng/l

0.08

5496

29333

Fracture of forearm

9195

71567

1.21

49.42

3.2

3.1

1411.63

1270.37

ng/l

2.29

7846

61094

Other and unspecified injuries of lower leg

1106

7237

1.76

49.16

3.5

3.2

1383.21

1136.03

ng/l

1.11

920

6120

Thrombocytopenia, unspecified

1261

8688

1.77

48.69

4.2

3.2

1990.62

1488.14

ng/l

3.33

1140

7517

Spondyloarthritis

2687

20607

1.43

48.66

3.6

3.2

1537.81

1503.15

ng/l

0.13

2314

17636

Benign neoplasm: Adrenal gland

1381

9736

1.74

48.58

3.5

3.2

1540.79

1235.85

ng/l

1.22

1241

8451

Redundant prepuce, phimosis and paraphimosis

2965

22611

1.40

48.56

3.6

3.4

1550.72

1482.57

ng/l

0.31

2508

19219

Open wound of forearm

1540

10887

1.63

48.47

4.0

3.2

1951.23

1465.14

ng/l

1.67

1311

9328

Suggestive for eosinophilic asthma

1498

10614

1.66

48.21

3.4

3.1

1121.85

1392.75

ng/l

1.92

1316

9129

Plantar fascial fibromatosis

1470

10276

1.63

48.04

3.0

2.9

758.50

1178.47

ng/l

7.31

1220

8809

Nontoxic multinodular goitre

3376

27022

1.40

47.82

3.2

3.1

1257.45

1421.32

ng/l

1.47

2938

23435

Other noninfective disorders of lymphatic vessels and lymph nodes

651

3850

2.21

47.77

4.1

3.0

1180.99

1282.21

ng/l

0.38

574

3246

Other specified/unspecified soft tissue disorders

861

5461

1.96

47.58

3.7

3.1

1537.85

1667.20

ng/l

0.37

744

4691

Benign neoplasm: Stomach

1746

12878

1.63

47.54

4.0

3.2

1325.21

1440.56

ng/l

0.67

1523

11187

Other and unspecified tonsillitis

3535

23021

1.33

47.43

3.1

2.9

800.90

832.72

ng/l

0.19

2784

18815

Complications of cardiac and vascular prosthetic devices, implants and grafts

459

2529

2.85

47.21

7.3

3.2

3754.80

1633.87

ng/l

6.98

434

2205

Hydrocele

2019

15067

1.53

47.14

4.0

3.5

2254.63

1873.81

ng/l

2.06

1758

13212

Other and unspecified coagulation defects

751

4565

1.99

46.81

3.7

3.0

1176.13

1042.87

ng/l

0.47

645

3842

Hypopituitarism

998

6461

1.79

46.80

3.3

1179.21

1097.18

ng/l

0.13

807

5424

Amenorrhoea

636

3563

1.97

46.70

2.8

2.9

735.92

834.07

ng/l

0.26

514

2910

Pneumocystosis, including avohilmo

422

2298

3.10

46.56

4.9

3.2

2198.08

1297.61

ng/l

2.62

395

1980

Pneumocystosis

422

2298

3.10

46.56

4.9

3.2

2198.08

1297.61

ng/l

2.62

395

1980

Examination and encounter for administrative purposes

1371

9596

1.67

46.49

3.2

3.0

1022.98

1451.24

ng/l

6.58

1222

8277

Other and unspecified nonorganic psychotic disorders

2231

16609

1.44

46.46

2.7

3.1

976.71

1018.32

ng/l

0.17

1743

13736

Disorders of ocular muscles, binocular movement, accommodation and refraction

6875

57898

1.24

46.28

3.3

3.1

1090.85

1182.98

ng/l

0.85

5751

49124

Ulcer of oesophagus

1278

8979

1.76

46.24

3.8

3.3

2027.31

1673.97

ng/l

1.28

1115

7857

Other diseases of arteries and capillaries

1563

11282

1.63

45.96

4.2

3.1

3458.92

1378.97

ng/l

12.97

1403

9711

Inflammatory disease of uterus

1608

11381

1.54

45.92

2.7

2.8

650.67

842.42

ng/l

2.88

1288

9515

Nail disorders

1279

8818

1.68

45.83

3.6

3.2

1542.26

1156.97

ng/l

1.45

1107

7485

Tubulo-interstitial nephritis, not specified as acute or chronic

1167

7957

1.74

45.69

3.6

3.0

2355.43

1274.51

ng/l

8.65

1019

6842

Diseases of tongue

1026

6808

1.80

45.46

3.2

3.1

1078.61

1428.28

ng/l

1.85

877

5936

Dislocation, sprain and strain of joints and ligaments of knee

8645

67569

1.20

45.36

2.8

3.0

760.88

1037.89

ng/l

14.89

7145

57065

Other benign neoplasms of skin

6508

55612

1.26

45.32

3.4

3.2

1586.29

1462.53

ng/l

1.03

5569

48148

Abnormal blood-pressure reading, without diagnosis

659

3868

2.03

45.29

3.0

2.6

980.20

1143.27

ng/l

0.35

564

3290

Superficial injury of shoulder and upper arm

1849

13611

1.52

45.17

3.3

3.2

1121.09

1396.55

ng/l

3.08

1565

11628

Chondrocostal junction syndrome [Tietze]

648

3881

2.15

45.15

3.4

3.1

1031.97

1124.16

ng/l

0.26

535

3293

Fracture of skull and facial bones

3214

25467

1.37

45.06

3.4

3.2

1462.61

1342.08

ng/l

0.79

2758

21756

Conjunctivitis

11587

82314

1.18

45.05

3.1

1031.56

1211.76

ng/l

4.75

9700

69818

Other infectious diseases, including avohilmo

1546

11173

1.62

45.02

4.6

3.3

2372.46

1674.53

ng/l

4.80

1384

9676

Chronic pancreatitis

2076

15716

1.51

45.00

3.2

2051.75

1392.79

ng/l

3.22

1841

13598

Monoamine oxidase A inhibitors

1807

13306

1.54

44.93

3.3

3.1

943.01

1334.69

ng/l

5.11

1514

11585

Recurrent aphthous stomatitis , including avohilmo

2212

16775

1.47

44.89

3.5

3.2

1075.08

1302.64

ng/l

2.57

1900

14421

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

379

1837

2.49

44.80

5.0

4.0

993.16

927.37

ng/l

0.13

328

1495

Anaemia in chronic diseases classified elsewhere

501

2864

2.58

44.77

5.5

3.3

7703.43

1431.42

ng/l

23.71

479

2482

Other and unspecified vascular occlusions

1856

14016

1.59

44.68

3.9

3.4

2228.92

1764.94

ng/l

2.96

1617

12316

Car occupant injured in other and unspecified transport accidents

2450

18689

1.42

44.59

3.3

3.1

1124.67

1204.97

ng/l

0.44

2039

15754

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

1295

9103

1.70

44.51

4.2

3.2

2112.85

1404.97

ng/l

4.11

1144

7863

Disorders of breast

7127

53648

1.23

44.35

2.7

2.9

906.17

1068.44

ng/l

3.30

6081

45334

Other disorders of conjunctiva

2498

19488

1.46

44.33

3.9

3.2

1337.71

1505.31

ng/l

1.44

2179

16991

Eosinophilic disease (BM)

280

1260

3.25

44.28

4.0

2.6

1957.49

1043.65

ng/l

0.96

256

1074

Injury of unspecified body region

1266

8837

1.69

44.23

4.5

3.3

2102.30

1465.17

ng/l

3.92

1118

7625

Disorders of oesophagus in diseases classified elsewhere

452

2522

2.72

44.07

4.5

3.2

1922.68

1424.24

ng/l

1.29

404

2190

Noninflammatory disorders of female genital tract

5120

21097

1.28

43.80

3.0

2.9

982.16

1371.11

ng/l

8.76

4281

17942

Leiomyoma of uterus

9477

46345

1.20

43.77

2.9

1028.04

1150.76

ng/l

2.29

7960

39480

Colonic or urogenital fistula

4203

34555

1.31

43.64

3.2

1165.46

1348.51

ng/l

2.14

3568

29708

Other disorders of eye and adnexa

2067

15546

1.47

43.43

3.3

3.2

1256.50

1246.29

ng/l

0.03

1771

13250

Other disorders of the musculoskeletal system and connective tissue

2489

19415

1.45

43.40

3.4

3.2

1358.98

1411.34

ng/l

0.23

2176

16790

Respiratory disorders in diseases classified elsewhere

309

1529

3.52

43.36

5.8

3.2

1162.82

1269.54

ng/l

0.28

289

1318

Carcinoma in situ of skin of other and unspecified parts of face

1866

14319

1.62

43.33

3.8

3.5

2405.10

1934.35

ng/l

1.96

1669

12649

Other crystal arthropathies

426

2353

2.81

43.29

4.6

3.3

1936.08

1711.22

ng/l

0.62

374

2058

Special screening examination for infectious and parasitic diseases

2264

12233

1.41

43.27

2.5

2.6

673.01

800.67

ng/l

0.69

1668

10047

Other inflammation of eyelid

2318

17837

1.45

43.24

3.3

3.2

1103.90

1378.22

ng/l

3.09

1976

15413

Chondropathies

2081

15654

1.46

43.11

3.2

1047.91

1190.30

ng/l

0.83

1702

13325

Agranulocytosis

1781

13245

1.55

43.09

3.9

3.2

1550.57

1283.22

ng/l

1.45

1605

11410

conjunctival haemorrhage

1397

10092

1.68

43.08

4.4

3.3

1381.54

1497.51

ng/l

0.55

1225

8789

Cerebral palsy and other paralytic syndromes

1711

12570

1.54

43.00

3.6

3.3

1227.71

1487.98

ng/l

1.90

1502

10794

Degenerative macular diseases

2322

18149

1.49

42.96

3.7

3.4

1798.05

1689.73

ng/l

0.48

2018

15939

Herpesviral [herpes simplex] infections, including avohilmo

3430

27453

1.33

42.73

3.2

3.0

1155.17

1108.08

ng/l

0.27

2875

23181

Discitis, unspecified

367

1928

3.00

42.67

5.3

3.4

2569.50

1611.13

ng/l

2.25

343

1692

Isolated patent ductus arteriosus

149

469

4.47

42.64

7.7

5.6

1076.92

998.15

ng/l

0.14

135

389

Ocular pain

1225

8471

1.65

42.50

3.5

3.1

990.44

1114.61

ng/l

0.41

1051

7129

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

4548

37669

1.29

42.49

3.1

3.2

1162.81

1298.77

ng/l

1.42

3884

32161

Olecranon bursitis

1036

7022

1.77

42.33

4.1

3.3

1517.36

1577.14

ng/l

0.17

934

6085

Obsessive-compulsive disorder

638

3689

1.90

42.07

2.6

2.9

856.76

771.81

ng/l

0.11

486

2965

Other/unspecified enthesopathies of lower limb, excluding foot

1012

6720

1.72

42.05

3.1

3.0

896.75

1261.88

ng/l

3.09

847

5720

Crystal arthropathies, rheuma endpoint

426

2377

2.77

42.05

4.6

3.2

1936.08

1712.17

ng/l

0.61

374

2081

Postmenopausal osteoporosis with pathological fracture

1359

9984

1.74

41.96

3.8

3.3

1494.60

1596.37

ng/l

0.51

1196

8665

Unspecified misadventure during surgical and medical care

1000

6800

1.82

41.89

4.3

3.3

1958.98

1337.07

ng/l

1.72

888

5889

Other inflammation of eyelid, including avohilmo

6277

53348

1.23

41.87

3.0

948.84

1155.48

ng/l

4.69

5239

45105

Other other unspecified disorders of the circulatory system

677

4243

2.12

41.83

4.8

3.3

2294.48

1463.22

ng/l

1.58

610

3660

Acidosis

420

2301

2.65

41.79

4.0

3.1

3251.56

1245.15

ng/l

6.55

382

1968

Other eating disorders

426

2164

2.18

41.78

3.5

3.2

1142.02

646.16

ng/l

0.42

326

1682

Asthma mixed form (mode)

743

4603

1.88

41.42

3.4

2.7

1156.18

1319.08

ng/l

0.59

637

3931

Disorders of continuity of bone

1445

10347

1.57

41.40

3.5

3.1

1223.98

1080.90

ng/l

0.71

1272

8769

Molar incisor enamel hypoplasia, with caries

235

5.63

41.11

16.6

5.7

2291.33

1144.06

ng/l

0.95

195

Fall on and from stairs and steps

4256

35262

1.30

41.09

3.3

3.2

1401.66

1401.08

ng/l

0.00

3623

30415

Other disorders of white blood cells

911

6081

1.84

41.01

3.7

3.2

1895.57

1375.60

ng/l

1.42

802

5243

Seborrhoeic dermatitis

1616

11901

1.55

41.00

3.5

3.3

1532.73

1416.48

ng/l

0.32

1372

10256

Hyperhidrosis

435

2304

2.26

40.99

4.0

2.6

898.20

944.85

ng/l

0.14

363

1907

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

735

4492

1.82

40.85

2.9

3.1

1323.00

921.18

ng/l

0.82

582

3598

Injuries to the wrist and hand

16750

100568

1.14

40.85

3.2

1181.18

1326.13

ng/l

3.85

13964

86154

Behavioural syndromes associated with physiological disturbances and physical factors

15243

92955

1.15

40.80

3.1

3.2

1085.14

1290.26

ng/l

6.78

12673

79427

Speech and linguistic disorders, excluding more controls

793

4596

1.76

40.65

4.6

3.4

1257.86

1161.82

ng/l

0.23

667

3769

Reactive arthropathies

1225

8531

1.63

40.56

3.5

3.1

1440.83

1300.99

ng/l

0.39

1074

7313

Alcohol dependence

4147

34285

1.30

40.49

3.2

3.3

1614.66

1419.77

ng/l

1.31

3543

29543

Nontoxic goitre/thyroid nodule

5016

42446

1.28

40.45

3.2

3.1

1223.94

1343.20

ng/l

1.29

4373

36641

Other follicular disorders

988

6574

1.71

40.38

3.3

3.1

1639.30

1046.74

ng/l

1.77

830

5514

Osteonecrosis

1103

7716

1.74

40.16

3.7

3.1

1567.52

1278.03

ng/l

0.86

981

6648

Other and unspecified mood [affective] disorders

761

4710

1.79

39.97

3.0

2.9

807.73

836.11

ng/l

0.11

596

3874

Alcohol abuse, main dg

2141

16353

1.43

39.89

3.3

3.2

1634.12

1249.18

ng/l

2.28

1811

13896

Speech disturbances, not elsewhere classified

1639

12268

1.57

39.84

4.1

3.3

1620.12

1694.06

ng/l

0.26

1427

10679

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2120

16038

1.41

39.69

2.9

2.7

818.02

863.60

ng/l

0.24

1711

13434

Acute pharyngitis

1605

11462

1.48

39.62

3.3

2.9

956.80

914.71

ng/l

0.09

1268

9371

Malignant neoplasm of digestive organs

7357

48990

1.23

39.55

3.0

3.3

1487.33

1520.03

ng/l

0.25

6520

42345

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

1224

8413

1.58

39.42

3.5

3.3

896.12

964.18

ng/l

0.29

999

6979

Thyrotoxicosis with diffuse goitre

1929

14539

1.46

39.37

3.5

2.9

1179.59

1110.78

ng/l

0.34

1643

12413

Ganglion

2826

22321

1.36

39.37

2.8

2.9

870.53

1154.02

ng/l

5.05

2368

19004

Psychotic depression

819

5253

1.78

39.21

3.0

3.1

1048.88

1270.23

ng/l

0.88

696

4559

Otitis externa, unspecified

1600

11752

1.52

39.08

3.2

1014.35

1215.41

ng/l

1.67

1318

9996

Arterial embolism and thrombosis

1082

7578

1.74

39.06

4.9

3.2

3536.81

1717.44

ng/l

8.94

995

6594

Benign neoplasm: Descending colon

1306

9535

1.68

38.97

3.7

3.3

1634.64

1469.93

ng/l

0.56

1179

8312

Other peripheral vertigo

1577

11760

1.57

38.85

3.4

3.2

1050.32

1443.16

ng/l

5.55

1345

10239

Hypoplasia of dental enamel

104

270

5.15

38.73

14.9

7.1

1954.86

1019.08

ng/l

0.91

226

Hyperkinetic disorders

946

5960

1.63

38.67

3.2

3.3

556.93

548.85

ng/l

0.02

656

4496

Ingrowing nail

789

5091

1.83

38.65

3.5

3.2

1731.49

1131.22

ng/l

1.52

686

4282

Hypocalcemia

441

2515

2.47

38.50

3.7

3.3

3381.84

1193.30

ng/l

3.59

398

2164

Schizoaffective disorder

956

6379

1.70

38.49

2.7

3.1

805.42

929.57

ng/l

0.68

776

5315

Other epidermal thickening

785

5140

1.89

38.49

4.3

3.2

1849.99

1277.62

ng/l

1.92

709

4416

Achilles tendinitis

1541

11308

1.53

38.44

3.1

955.15

1325.37

ng/l

3.00

1291

9724

Other/unspecified rheumatoid arthritis

2151

16798

1.46

38.42

3.6

3.2

1779.91

1536.57

ng/l

1.73

1940

14562

Assault

1436

10256

1.51

38.37

2.8

3.1

1167.32

901.51

ng/l

1.43

1140

8366

Disturbance of activity and attention

896

5591

1.65

38.33

3.2

3.1

563.00

507.75

ng/l

0.14

616

4219

Eating disorder

688

4143

1.78

38.28

3.1

2.9

943.76

527.04

ng/l

0.64

533

3241

Spinal instabilities

450

2528

2.29

38.19

3.5

3.1

742.78

1070.26

ng/l

2.13

381

2149

Use of disulfiram, acamprosate or naltrexone

1171

8191

1.62

38.06

2.8

3.1

988.47

1019.41

ng/l

0.09

946

6853

Corns and callosities

1123

7928

1.69

37.87

3.8

3.2

2104.94

1278.52

ng/l

5.00

998

6814

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

3786

30999

1.29

37.72

2.9

3.1

1052.20

1065.46

ng/l

0.06

3081

26166

Diabetic nephropathy

3110

25339

1.40

37.65

4.6

4.0

5290.78

1786.14

ng/l

52.82

2867

22156

Other female pelvic inflammatory diseases

2216

17201

1.42

37.53

3.0

2.9

950.01

1020.01

ng/l

0.41

1802

14762

Primary hyperparathyroidism

1927

14915

1.50

37.47

3.2

1656.51

1339.48

ng/l

1.40

1641

12970

Other/unspecified cytomegaloviral diseases

350

1854

2.66

37.39

6.1

3.4

3665.36

939.84

ng/l

6.99

330

1549

Congenital malformations and deformations of the musculoskeletal system

928

6093

1.67

37.35

3.5

866.33

924.60

ng/l

0.21

765

5032

Disorders of psychological development

1063

6629

1.59

37.12

4.8

3.4

1123.73

1062.16

ng/l

0.17

861

5261

Cholangitis (primary sclerosing, PSC)

1081

7606

1.69

37.11

3.6

3.3

1526.48

1587.33

ng/l

0.19

960

6583

Cytomegalovirus infection, IBD co-morbidity

398

2200

2.47

37.11

5.8

3.4

3466.19

1028.19

ng/l

7.03

375

1855

Infective dermatitis

1780

13489

1.48

37.08

3.7

3.2

1727.60

1396.18

ng/l

1.50

1529

11634

Oesophagitis

929

6352

1.77

37.06

3.6

3.2

1533.88

1490.99

ng/l

0.11

810

5494

Ankylosing spondylitis

1177

8262

1.60

37.02

3.2

3.1

1079.59

1452.87

ng/l

2.36

979

7060

Tinnitus

3722

30775

1.31

37.01

2.9

3.1

984.86

1289.90

ng/l

3.05

3135

26612

Strabismus

3658

29948

1.30

36.87

3.4

3.2

1176.62

1273.91

ng/l

0.59

3100

25529

ILD medications: pirfenidone

265

1368

4.12

36.83

4.3

3.0

1232.49

1347.24

ng/l

0.20

248

1193

Any event in hilmo or specialist outpatient

49.46

36.81

3.7

1.0

1155.64

412.67

ng/l

—

Other diseases of blood and blood-forming organs

1156

8273

1.66

36.41

3.7

3.2

1687.24

1401.08

ng/l

1.26

968

7128

Sleep disorders

14549

90644

1.14

36.36

3.0

3.1

1048.56

1275.68

ng/l

9.22

12060

77404

Sequelae of other external causes

905

6134

1.75

36.35

3.8

3.1

2081.34

1288.48

ng/l

3.18

818

5252

Postmenopausal atrophic vaginitis

4004

18036

1.30

36.30

2.9

3.0

764.53

1396.28

ng/l

38.04

3473

15647

Hypoglycaemia, other or unspecified

1025

7099

1.67

36.26

3.8

3.4

3475.05

1524.45

ng/l

6.84

913

6070

Amputation of foot

535

3330

2.29

36.20

5.0

3.4

6752.24

1639.44

ng/l

12.36

508

2932

Marfan's syndrome

117

380

6.08

36.04

4.9

3.1

813.00

965.26

ng/l

0.34

104

315

Follow-up care involving plastic surgery

598

3692

1.99

36.01

3.3

2.6

1471.77

826.33

ng/l

2.16

450

3104

Intestinal malabsorption

740

4824

1.86

35.98

3.4

3.1

2118.42

1131.68

ng/l

2.26

660

4073

Myositis

452

2618

2.29

35.98

3.8

3.2

1528.22

1481.36

ng/l

0.08

403

2244

Pure hyperglyceridaemia

413

2332

2.39

35.97

4.3

3.1

1892.93

1215.68

ng/l

1.14

371

1985

Pleural plaque with presence of asbestos

1425

10774

1.63

35.91

4.2

3.6

1734.02

2082.79

ng/l

2.68

1256

9616

Otalgia

1182

8384

1.60

35.88

3.4

3.2

810.12

1227.84

ng/l

5.55

972

7197

Dermatitis due to substances taken internally

838

5593

1.77

35.72

3.7

3.2

1434.49

1284.28

ng/l

0.43

720

4774

Lichen simplex chronicus and prurigo

1042

7323

1.69

35.63

3.7

3.2

2243.64

1299.45

ng/l

2.64

916

6303

Psoriasis vulgaris

2768

22246

1.35

35.57

3.2

1382.36

1293.98

ng/l

0.43

2357

19103

Corneal ulcer

2625

20932

1.36

35.08

3.2

1282.90

1254.31

ng/l

0.12

2233

17845

Early lumbar disc prolapse, operated

864

5645

1.64

35.06

2.5

3.0

561.51

724.87

ng/l

0.39

661

4521

Drug-induced osteoporosis with pathological fracture

358

2025

2.84

34.97

6.0

3.3

1683.35

1207.14

ng/l

2.02

325

1731

Other noninflammatory disorders of vagina

1076

7512

1.61

34.94

3.1

2.9

1078.51

1334.89

ng/l

0.98

897

6447

Colorectal cancer, including Hilmo

5041

40317

1.26

34.75

3.0

3.4

1529.42

1624.22

ng/l

0.80

4450

35021

Autoimmune hyperthyroidism

849

5670

1.71

34.64

3.4

2.9

1300.30

1027.68

ng/l

1.08

730

4804

Orchitis and epididymitis

1454

10794

1.52

34.62

4.1

3.4

1863.14

1671.91

ng/l

0.46

1270

9429

Cytomegaloviral disease

401

2268

2.36

34.46

5.8

3.2

3448.04

1014.90

ng/l

7.08

377

1906

Other congenital malformations

983

6718

1.62

34.28

3.7

3.3

1008.97

995.66

ng/l

0.04

862

5598

Cytomegaloviral disease, including avohilmo

403

2284

2.34

34.28

5.8

3.2

3430.28

1009.55

ng/l

7.08

379

1919

Sequelae of injuries, of poisoning and of other consequences of external causes

3353

27542

1.30

34.17

3.1

3.2

1095.03

1198.90

ng/l

0.79

2819

23505

Contact with and exposure to communicable diseases

2912

23157

1.30

34.17

3.0

2.9

1005.20

822.02

ng/l

0.72

2322

18853

Herpesviral [herpes simplex] infections

1687

12788

1.46

34.01

3.5

3.1

1518.78

1255.34

ng/l

1.33

1453

10921

Appendectomy

9374

79207

1.17

33.99

3.0

3.1

999.94

1177.25

ng/l

4.15

7904

67063

Other diseases of pancreas

1433

10754

1.55

33.98

3.5

3.2

1727.97

1398.50

ng/l

1.09

1271

9319

Multiple myeloma

585

3781

2.14

33.94

5.3

3.4

2084.46

1691.20

ng/l

1.40

547

3300

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

585

3781

2.14

33.94

5.3

3.4

2084.46

1691.20

ng/l

1.40

547

3300

Erythema intertrigo

478

2893

2.23

33.84

3.9

3.2

1494.24

1332.16

ng/l

0.26

429

2522

Other mental disorders due to brain damage and dysfunction and to physical disease

2273

18238

1.43

33.83

3.6

3.5

1656.73

1812.89

ng/l

0.83

1988

16030

Personal history of other diseases and conditions

1067

7326

1.56

33.77

4.2

2.4

1233.01

744.86

ng/l

2.27

886

5934

Other noninflammatory disorders of vulva and perineum

1225

8768

1.54

33.73

3.1

2.9

963.38

1211.14

ng/l

1.32

1035

7494

Haemolytic anaemias

592

3761

2.00

33.46

4.9

3.3

1943.36

1448.21

ng/l

1.81

518

3250

Ptosis of eyelid

1984

15641

1.45

33.33

3.2

1341.64

1511.80

ng/l

1.01

1712

13642

Superficial injury of forearm

1352

9883

1.51

33.33

3.4

3.2

1468.84

1193.46

ng/l

1.10

1148

8378

Lack of expected normal physiological development

135

381

3.43

33.31

9.6

4.4

1402.59

706.60

ng/l

0.61

119

285

Superficial injury of ankle and foot

1480

10921

1.46

33.21

3.0

3.1

1171.73

989.21

ng/l

1.07

1235

9092

Hypotension due to drugs

337

1912

2.90

33.20

5.4

3.5

2615.93

1808.70

ng/l

1.42

312

1680

Panniculitis affecting regions of neck and back

553

3406

1.96

33.16

3.5

3.1

856.73

1390.04

ng/l

4.69

484

2907

Cluster headache, strict

455

2615

2.04

33.13

2.9

652.42

1013.07

ng/l

1.75

367

2230

Other specified/unspecified hearing loss

1546

11751

1.51

33.08

3.4

3.3

1559.01

1759.31

ng/l

1.12

1401

10292

Acute laryngitis and tracheitis

1137

7826

1.52

33.02

3.8

2.9

787.03

1006.13

ng/l

1.23

927

6304

Hodgkin lymphoma, hilmo

446

2617

2.17

33.00

4.2

3.2

1429.66

1264.54

ng/l

0.33

396

2228

Atypical facial pain

793

5339

1.76

32.98

2.9

3.1

630.61

1105.74

ng/l

7.20

673

4567

Drug-induced cataract

417

2441

2.32

32.88

5.3

3.2

1896.54

1032.25

ng/l

2.09

378

2060

Other diseases of biliary tract

1546

11790

1.52

32.88

3.3

1757.91

1542.73

ng/l

0.65

1370

10256

Visual field defects

1408

10574

1.54

32.79

3.7

3.2

1712.72

1570.76

ng/l

0.55

1225

9180

Cluster headache, wide

496

2936

1.97

32.70

3.0

2.9

821.19

1080.56

ng/l

0.77

404

2499

Personal history of medical treatment

210

963

3.31

32.70

3.7

2.9

2379.38

1398.10

ng/l

1.52

182

814

Nephrotic syndrome

506

3100

2.08

32.64

3.5

7277.01

1251.81

ng/l

10.47

468

2671

Iridocyclitis

3423

28387

1.30

32.55

3.4

3.2

1436.90

1331.81

ng/l

0.60

2966

24393

Lymphoid leukaemia

980

7004

1.71

32.53

3.4

1857.28

1685.96

ng/l

0.57

886

6120

Artificial opening status

878

6085

1.72

32.46

3.8

2.7

1678.12

1367.82

ng/l

0.77

791

5242

Adenomyosis (Endometriosis of uterus)

1887

14592

1.42

32.36

2.8

2.9

1002.26

1358.20

ng/l

4.81

1586

12634

Diseases of peritoneum

1633

12524

1.48

32.32

4.1

3.3

4744.22

1442.40

ng/l

18.40

1450

10831

Seborrhoeic keratosis

4507

38572

1.27

32.31

3.3

3.2

1386.99

1361.16

ng/l

0.13

4002

33505

Dissection of aorta

607

3959

2.00

32.11

4.4

3.1

2176.01

1543.83

ng/l

1.59

558

3438

Sudden idiopathic hearing loss

1640

12608

1.48

32.09

3.5

3.2

1619.59

1502.64

ng/l

0.28

1383

10990

malignant neoplasm of male genital organs, including Hilmo

5205

26871

1.25

31.96

3.2

3.5

1731.45

1679.71

ng/l

0.27

4518

23376

Malignant neoplasm of breast, ER-positive, including Hilmo

5097

32501

1.24

31.95

2.8

2.9

1003.82

1069.20

ng/l

0.65

4386

27496

Urolithiasis

5404

46800

1.23

31.93

3.2

3.3

1464.49

1592.18

ng/l

1.20

4603

40758

Gout due to impairment of renal function

255

1340

3.42

31.86

5.9

3.3

6907.45

1623.39

ng/l

10.70

243

1166

Schizophrenia

1994

15510

1.39

31.84

2.6

3.1

1003.90

1096.79

ng/l

0.36

1628

13037

Other symptoms and signs involving general sensations and perceptions

720

4822

1.82

31.79

3.7

3.4

1308.09

1574.33

ng/l

1.71

613

4175

Dissociative [conversion] disorders

447

2573

2.00

31.79

2.8

2.9

634.32

978.20

ng/l

2.06

353

2124

Unspecified privation

1615

12336

1.46

31.77

3.6

3.3

2173.58

1419.21

ng/l

4.71

1425

10597

Other infectious diseases

1265

9386

1.56

31.75

4.7

3.3

2539.81

1698.26

ng/l

5.06

1130

8129

Inflammatory bowel disease

4311

36422

1.25

31.73

3.3

3.1

1285.11

1228.41

ng/l

0.36

3668

30925

Lesion of lateral popliteal nerve

785

5337

1.76

31.69

3.5

3.1

1386.05

1368.46

ng/l

0.04

707

4605

Malignant neoplasm of breast, HER-positive

5083

32467

1.24

31.69

2.8

2.9

1004.82

1069.63

ng/l

0.64

4375

27468

Insulin, fast-acting (human)

1742

13292

1.41

31.67

3.6

3.1

3825.12

1253.58

ng/l

19.15

1530

11112

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

877

5938

1.62

31.66

2.8

3.0

897.50

977.08

ng/l

0.22

709

4960

Other specified/unspecified spondylopathies

478

2951

2.18

31.65

4.0

3.3

1440.62

1812.36

ng/l

1.00

426

2562

Pneumonia due to Streptococcus pneumoniae

647

4195

1.84

31.62

4.5

2.8

1895.42

1194.98

ng/l

3.17

561

3552

Impacted cerumen

2027

16111

1.42

31.51

3.6

3.4

1615.34

1621.77

ng/l

0.02

1600

14132

Biological medication for rheuma

2053

15998

1.37

31.48

2.8

3.0

896.53

899.37

ng/l

0.01

1742

13298

Diseases of spleen

341

1914

2.52

31.43

4.9

3.3

2087.08

1380.36

ng/l

1.53

322

1649

Erosion of teeth , including avohilmo

3280

26963

1.28

31.42

3.2

3.1

981.51

1019.21

ng/l

0.17

2727

22616

Seropositive rheumatoid arthritis, strict definition

2344

18877

1.37

30.97

3.2

3.1

1386.09

1244.79

ng/l

1.01

2097

16315

Eating disorders

945

6458

1.56

30.97

3.3

3.0

1298.47

875.18

ng/l

0.85

760

5200

Suppurative and unspecified otitis media

4002

29610

1.24

30.63

3.5

3.1

1205.96

1147.03

ng/l

0.29

3255

24535

Small fibre neuropathy

549

3544

2.04

30.62

3.8

3.3

1591.97

1315.05

ng/l

0.79

485

3061

Mental disorders, not otherwise specified

915

6308

1.59

30.45

2.7

3.0

798.47

877.00

ng/l

0.30

729

5226

Hepatic failure, not elsewhere classified

654

4367

1.88

30.35

4.9

3.3

2983.13

1384.52

ng/l

3.53

575

3766

5-aminosalicylic acid

2623

21147

1.31

30.34

3.2

2.8

1341.07

1155.17

ng/l

1.19

2196

17712

Rash and other nonspecific skin eruption

1452

11008

1.48

30.21

3.5

3.2

1460.28

1394.43

ng/l

0.15

1290

9507

malignant neoplasm of male genital organs

5113

26558

1.24

30.09

3.2

3.5

1737.30

1691.20

ng/l

0.23

4449

23119

Viral warts, including avohilmo

2789

22686

1.30

30.08

3.6

3.1

1345.59

1129.46

ng/l

1.19

2411

19132

Cramp and spasm

702

4691

1.77

30.07

3.2

1006.34

1251.19

ng/l

1.08

600

3994

Postprocedural disorders of nervous system

759

5043

1.66

30.06

2.6

2.8

374.62

750.26

ng/l

8.40

627

4109

Attention to artificial openings

720

4900

1.80

30.00

3.8

3.0

1846.87

1372.56

ng/l

1.82

654

4221

Acquired haemolytic anaemia

446

2747

2.18

29.82

4.8

3.4

2216.35

1483.93

ng/l

2.48

394

2375

Pre-eclampsia

2125

16732

1.35

29.74

2.9

2.6

870.17

683.49

ng/l

1.47

1760

13939

Allergic urticaria

1049

7498

1.55

29.73

3.9

3.2

1080.76

1141.70

ng/l

0.23

884

6316

Malignant neoplasm of urinary organs, including Hilmo

2059

16529

1.41

29.66

3.4

2321.05

1667.62

ng/l

4.97

1856

14403

Emotional disorders starting during childhood or adolecense, excluding more controls

265

1230

2.23

29.52

4.4

3.5

748.82

454.08

ng/l

0.56

184

921

Lichen ruber planus, wide definition including periferal and oral lichen planus

3627

30649

1.28

29.38

3.0

3.1

1006.25

1264.60

ng/l

3.31

3091

26483

Neuroendocrine tumor and carcinoma of small intestine

303

1714

2.78

29.34

4.6

3.1

1202.96

1330.76

ng/l

0.21

267

1465

Abscess of anal and rectal regions

1125

8160

1.53

29.30

3.1

3.0

1275.94

1164.71

ng/l

0.35

972

6888

Myeloproliferative diseases

1423

10950

1.51

29.07

3.5

3.3

2088.73

1503.60

ng/l

2.44

1262

9522

Social phobias

739

4867

1.62

28.87

2.7

2.8

788.29

691.40

ng/l

0.20

583

3883

Trigeminal neuralgia

908

6448

1.63

28.65

3.1

953.00

1322.12

ng/l

3.48

772

5543

Pre-eclampsia or eclampsia

2342

18755

1.32

28.64

2.9

2.7

948.89

695.96

ng/l

1.90

1941

15675

therapeutic use

586

3912

1.96

28.62

4.6

3.2

1558.16

1237.93

ng/l

1.13

494

3381

Mental retardation, excluding more controls

440

2511

1.95

28.61

3.8

3.5

1514.72

1062.12

ng/l

0.59

368

2132

Other ill-defined and unspecified causes of mortality

1728

13725

1.45

28.39

4.5

3.4

2834.98

1923.72

ng/l

5.60

1570

12049

Ectropion of eyelid

821

5867

1.75

28.29

3.7

3.5

1933.33

2204.60

ng/l

1.17

724

5171

Dementia, including avohilmo

9601

59337

1.17

28.23

3.2

3.4

1825.85

1745.59

ng/l

0.89

8299

52391

Vasculitis limited to skin, not elsewhere classified

474

3000

2.07

28.18

4.2

3.3

1747.09

1375.89

ng/l

1.30

427

2572

Insomnia

13973

88866

1.12

28.17

3.0

3.1

1036.85

1258.21

ng/l

8.46

11574

75785

Endometriosis of pelvic peritoneum

1740

12202

1.38

28.01

2.6

2.7

588.22

962.09

ng/l

6.99

1413

10302

Rare circulating lymphoid malignancy, including Hilmo

501

3197

1.99

27.97

3.7

3.5

1347.90

1617.55

ng/l

1.08

446

2762

Dislocation of lens

319

1829

2.48

27.86

4.0

3.2

2445.15

1833.85

ng/l

0.78

283

1606

FESS (DNB20)

1682

13090

1.40

27.85

3.0

3.1

803.72

1128.48

ng/l

4.10

1361

11101

Nasal polyp

2941

24439

1.30

27.84

3.0

3.2

1233.65

1461.07

ng/l

2.27

2536

21216

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

673

4405

1.66

27.81

2.6

2.5

782.43

411.43

ng/l

1.00

567

3567

Ethmoidectomy

1747

13669

1.40

27.76

3.0

3.1

845.41

1144.06

ng/l

3.22

1415

11604

Focal epilepsy

3175

26533

1.28

27.76

3.3

3.4

1388.01

1511.22

ng/l

0.81

2775

22922

Invasive ventilation

1145

8529

1.54

27.74

3.8

3.3

3317.40

1474.64

ng/l

7.88

986

7386

Viral warts

1290

9663

1.47

27.57

4.1

3.2

1831.14

1129.04

ng/l

3.13

1133

8157

Hypertrophy of breast in women and men

2459

19955

1.31

27.56

2.7

2.9

858.18

947.14

ng/l

0.53

2038

16866

Congenital iodine-deficiency syndrome/hypothyroidism

500

3206

1.98

27.55

4.2

3.2

1552.64

1475.84

ng/l

0.16

440

2751

Other endocrine disorders

598

3701

1.75

27.51

4.6

3.9

910.31

1156.78

ng/l

1.47

501

3139

Protozoal diseases

520

3389

1.98

27.43

4.7

3.2

1979.51

1272.22

ng/l

2.39

482

2920

Malignant neoplasm of small intestine

442

2798

2.16

27.39

4.2

3.2

1453.18

1370.24

ng/l

0.13

390

2418

Vitamin deficiency, wide

729

5004

1.70

27.37

4.0

3.2

1834.09

1509.86

ng/l

0.85

641

4301

Vitamin deficiency

729

5004

1.70

27.37

4.0

3.2

1834.09

1509.86

ng/l

0.85

641

4301

Malignant neoplasm of bladder, including Hilmo

2207

17784

1.37

27.33

3.5

2223.43

1956.07

ng/l

1.21

1962

15627

severe traumatic brain injury, does not include concussion

3997

34329

1.26

27.30

3.6

3.4

1979.80

1833.69

ng/l

1.07

3481

29944

Postprocedural musculoskeletal disorders, not elsewhere classified

1231

9377

1.54

27.24

3.4

3.3

1323.33

1422.09

ng/l

0.42

1081

8154

Speech and linguistic disorders

811

5299

1.57

27.18

4.7

3.8

1342.18

1137.38

ng/l

0.52

683

4283

Pollen allergy

1714

13019

1.36

27.12

2.9

3.1

687.42

744.15

ng/l

0.20

1300

10557

Palmar fascial fibromatosis [Dupuytren]

2629

21773

1.32

27.11

3.4

3.3

1712.20

1864.44

ng/l

0.99

2307

19067

Other strabismus

2721

22241

1.29

27.08

3.4

3.2

1066.01

1180.50

ng/l

0.58

2274

18829

Infection of intervertebral disc (pyogenic)

279

1560

2.68

27.07

4.0

3.3

2963.77

1587.00

ng/l

2.30

243

1369

Duodenal ulcer

1912

15331

1.39

27.07

4.0

3.3

2611.00

1877.08

ng/l

4.41

1716

13432

!Aliquae complicationes praecoces traumatis

687

4685

1.73

27.07

4.2

3.3

1871.27

1407.75

ng/l

1.60

604

4011

Early complications of trauma

687

4685

1.73

27.07

4.2

3.3

1871.27

1407.75

ng/l

1.60

604

4011

Excessive vomiting in pregnancy

783

5343

1.59

26.85

2.5

2.7

367.31

594.06

ng/l

5.22

603

4403

Other and unspecified vasculitis limited to skin

426

2659

2.11

26.77

4.3

3.3

1825.51

1371.55

ng/l

1.56

386

2275

Acute and subacute iridocyclitis

2760

22846

1.30

26.76

3.4

3.2

1424.13

1321.31

ng/l

0.48

2391

19646

Gluteal tendinitis

646

4339

1.74

26.75

2.7

3.0

723.97

1131.53

ng/l

3.38

535

3707

Other otitis externa (chronic)

995

7258

1.56

26.71

3.4

3.2

1132.76

1262.86

ng/l

0.66

790

6225

Other/unspecified enthesopathies, not elsewhere classified

1270

9613

1.48

26.52

3.4

3.1

1202.66

1577.96

ng/l

3.04

1089

8295

482

3161

2.09

26.48

4.7

3.3

1867.08

1764.41

ng/l

0.19

446

2769

Generalized skin eruption due to drugs and medicaments

600

4005

1.80

26.38

4.0

3.2

1506.81

1205.99

ng/l

0.81

518

3416

Lichen planus, including avohilmo

3069

25824

1.29

26.37

3.1

1074.72

1302.24

ng/l

2.10

2624

22343

Secondary parkinsonism, excluding more controls

430

2662

2.02

26.37

3.3

3.1

1249.87

1603.31

ng/l

1.07

378

2349

Pneumonitis due to solids and liquids

1474

11514

1.46

26.21

3.7

3.4

2435.47

1969.25

ng/l

1.86

1294

10060

Calculus of kidney and ureter

4887

42640

1.22

26.06

3.2

3.3

1448.16

1569.09

ng/l

1.02

4165

37074

Medial epicondylitis

517

3306

1.83

26.06

2.7

3.0

672.44

1033.46

ng/l

2.79

436

2791

Radial styloid tenosynovitis [de Quervain]

696

4710

1.65

26.05

2.9

1080.15

1018.75

ng/l

0.12

582

3963

Other congenital malformations, including avohilmo

1463

11189

1.40

26.01

3.4

3.2

1028.87

1049.60

ng/l

0.08

1272

9376

Protozoal diseases, including avohilmo

530

3504

1.92

26.01

4.7

3.2

1963.05

1260.68

ng/l

2.42

489

3009

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

7535

64241

1.16

25.96

2.9

3.0

915.83

1108.48

ng/l

4.03

6240

54173

Other specified/unspecified bacterial intestinal infections

1054

7845

1.55

25.91

3.7

3.3

1375.28

1420.32

ng/l

0.16

920

6767

Meralgia paraesthetica

540

3544

1.85

25.90

3.0

659.67

1057.11

ng/l

5.20

461

3039

Anterior Iridocyclitis

2934

24513

1.28

25.89

3.4

3.2

1443.04

1344.25

ng/l

0.47

2546

21072

Unspecified/other endometriosis

858

5849

1.53

25.88

2.8

2.7

714.88

922.90

ng/l

1.06

708

4858

348

2016

2.10

25.82

2.6

2.9

456.80

686.00

ng/l

1.77

280

1679

Dermatopolymyositis (FG)

251

1350

2.59

25.78

4.9

3.0

1156.26

1232.50

ng/l

0.15

229

1153

Endometriosis of rectovaginal septum and vagina

1034

7590

1.52

25.77

3.0

797.68

1382.92

ng/l

9.11

866

6561

Lichen planus

2111

17202

1.36

25.77

3.2

3.1

1067.03

1317.66

ng/l

2.94

1823

14898

Pre-eclampsia or poor fetal growth

2936

24154

1.26

25.73

2.8

2.6

828.63

645.98

ng/l

1.54

2404

19905

Sub-endpoint used in defining T1D endpoints

4131

34827

1.22

25.71

3.9

3.3

3506.09

1594.91

ng/l

28.88

3620

29635

Other abnormal findings of blood chemistry

743

5208

1.68

25.68

3.6

3.1

1776.53

1270.27

ng/l

1.99

637

4472

Acute appendicitis, no complications

7578

67167

1.16

25.64

3.0

993.74

1137.90

ng/l

2.37

6334

56832

Other and unspecified immunodeficiencies with predominantly antibody defects

210

1057

2.80

25.63

5.0

3.0

1300.78

931.59

ng/l

0.66

195

876

Pregnancy hypertension

4456

34152

1.21

25.62

2.8

2.6

851.42

714.71

ng/l

1.39

3719

28343

Reactive arthropathies, FINNGEN

912

6546

1.55

25.56

3.6

3.0

1479.57

1203.34

ng/l

0.73

794

5555

Toxic effects of substances chiefly nonmedicinal as to source

1455

11212

1.41

25.44

3.2

1317.35

1197.32

ng/l

0.34

1240

9459

Giant cell arteritis

798

5809

1.73

25.43

3.7

3.2

1579.68

1571.27

ng/l

0.02

723

5074

Colorectal cancer

4453

37208

1.23

25.41

3.0

3.4

1549.76

1642.97

ng/l

0.70

3929

32353

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1763

14161

1.41

25.36

3.5

3.4

2339.78

1600.26

ng/l

5.00

1584

12316

Macular pucker

2912

24696

1.31

25.30

3.5

3.3

1640.59

1450.47

ng/l

1.07

2561

21752

Sacroiliitis, not elsewhere classified

481

2986

1.78

25.30

2.7

3.1

586.81

939.51

ng/l

1.87

384

2454

Iron deficiency

318

1760

2.04

25.25

4.0

3.0

1167.46

799.26

ng/l

0.73

254

1440

Abnormal findings on examination of urine, without diagnosis

685

4753

1.71

25.24

4.3

3.3

3939.98

1449.48

ng/l

5.36

617

4118

Acute peritonitis

1028

7663

1.55

25.23

4.4

3.3

6723.01

1537.11

ng/l

19.66

937

6621

Atrioventricular septal defect

294

5.58

25.15

8.7

4.1

1073.85

1113.39

ng/l

0.07

242

Acute generalized exanthematous pustulosis

681

4711

1.70

25.11

3.8

3.2

1503.66

1220.17

ng/l

0.85

590

4011

Polyarthritis, unspecified

545

3589

1.81

25.10

3.7

3.2

1410.25

1294.65

ng/l

0.30

481

3092

Mixed conductive and sensorineural hearing loss

2025

16481

1.36

25.07

3.4

3.3

1483.92

1627.23

ng/l

0.85

1741

14405

Algoneurodystrophy

422

2589

1.92

25.02

2.6

2.7

875.65

764.99

ng/l

0.22

349

2133

Coeliac disease

1634

12847

1.38

25.00

3.4

3.2

1484.18

1179.79

ng/l

0.94

1398

10992

Cerebral cysts

763

5337

1.61

24.95

3.5

3.2

1458.30

1395.93

ng/l

0.13

655

4507

Focal epilepsy, strict definition

2971

24949

1.28

24.95

3.3

3.4

1435.74

1515.37

ng/l

0.41

2596

21571

Malignant neoplasm of prostate, including Hilmo

5092

26288

1.22

24.92

3.2

3.5

1743.66

1693.54

ng/l

0.25

4422

22939

Assault by bodily force

797

5545

1.56

24.90

2.9

3.1

1105.02

863.15

ng/l

0.79

638

4499

Drug-induced neutropenia

1090

8210

1.53

24.89

3.6

3.2

1492.12

1169.82

ng/l

1.33

990

7083

Hypoparathyroidism

629

4357

1.79

24.85

4.3

3.2

1266.80

1236.81

ng/l

0.09

552

3743

Allergic contact dermatitis

1697

13370

1.36

24.70

3.0

2.9

938.08

1018.60

ng/l

0.43

1389

11313

Dislocation, sprain and strain of joints and ligaments of thorax

533

3507

1.81

24.67

3.7

3.2

1230.09

1255.12

ng/l

0.06

466

2988

Hypercalcemia

776

5614

1.69

24.55

4.0

3.3

2374.76

1440.99

ng/l

2.69

688

4868

Other disorders starting during childhood or adolecense, excluding more controls

296

1508

2.00

24.46

7.1

3.6

1238.40

675.08

ng/l

1.22

230

1162

Malignant neoplasm of urinary organs

1730

13926

1.40

24.46

3.4

2275.01

1627.47

ng/l

4.65

1566

12115

Colectomy operation

2860

24169

1.29

24.33

3.3

1681.33

1608.01

ng/l

0.28

2512

21083

Hidradenitis suppurativa

413

2509

1.87

24.28

2.6

3.0

1002.39

709.31

ng/l

0.68

337

2048

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

5157

38949

1.19

24.22

2.8

2.6

860.54

751.96

ng/l

1.15

4314

32401

Allergic conjunctivitis

7853

67700

1.15

24.21

2.9

3.0

928.44

1105.19

ng/l

3.44

6510

57096

Oesophageal varices

690

4871

1.72

24.19

3.6

3.2

1603.89

1395.07

ng/l

0.47

616

4193

Fall involving bed

663

4709

1.79

24.14

4.5

3.5

2505.23

1910.22

ng/l

2.03

598

4149

Dermatographic urticaria

825

5865

1.56

24.14

2.9

598.79

954.67

ng/l

6.51

686

4898

Scabies, including avohilmo

1575

12248

1.36

24.14

3.3

3.1

1169.90

953.20

ng/l

1.10

1290

10084

Nonhereditary hypogammaglobulinemia

193

969

2.87

24.06

4.5

3.0

1461.23

892.00

ng/l

0.87

182

801

Acute bronchiolitis

492

2775

1.72

24.01

6.0

4.0

1946.86

1274.63

ng/l

1.16

420

2225

ILD medications: nintedanib

142

684

5.01

24.00

4.2

3.2

948.12

1410.78

ng/l

1.32

129

590

Acute alcohol intoxication, ICD10

2713

22592

1.28

24.00

3.2

1586.70

1255.60

ng/l

2.31

2273

19243

Myocardial infarction, unclassifiable

4303

33553

1.23

23.99

4.9

3.5

3238.84

2087.03

ng/l

20.51

3884

29399

Arthropathic psoriasis

1566

12346

1.39

23.96

3.1

1193.45

1177.02

ng/l

0.06

1348

10561

Restrictive cardiomyopathy

101

420

8.08

23.93

16.8

3.3

3712.98

1837.73

ng/l

1.75

360

Other orthopaedic follow-up care

842

6081

1.58

23.90

3.2

2.8

1280.37

1033.73

ng/l

1.23

718

5152

Progressive systemic sclerosis

119

523

5.37

23.79

7.3

3.4

805.81

954.39

ng/l

0.51

110

441

Myeloproliferative diseases (CML excluded)

1275

9942

1.48

23.75

3.4

3.3

2124.04

1516.26

ng/l

2.38

1122

8654

Cyst of kidney

1241

9658

1.49

23.75

3.6

3.3

2216.55

1448.48

ng/l

3.38

1093

8433

Ehlers-Danlos syndrome, including avohilmo

144

610

2.90

23.74

2.1

2.9

581.84

652.58

ng/l

0.07

115

484

Non-allergic asthma

1238

9490

1.45

23.67

3.4

1139.90

1429.91

ng/l

1.84

1076

8199

Malignant neoplasm of prostate

5008

26000

1.21

23.67

3.2

3.5

1778.52

1705.53

ng/l

0.39

4363

22694

Crohn disease

1583

12425

1.37

23.66

3.1

1306.28

1090.83

ng/l

1.12

1347

10429

Vascular diseases of the intestine

723

5190

1.70

23.65

4.4

3.2

3241.47

1588.09

ng/l

6.65

666

4492

Suppurative and necrotic conditions of lower respiratory tract

917

6803

1.57

23.59

4.3

3.3

2055.33

1588.89

ng/l

2.20

845

5924

Complications of other internal prosthetic devices, implants and grafts

719

5130

1.68

23.58

3.5

3.1

1711.88

1480.40

ng/l

0.62

636

4440

Bicipital tendinitis

698

4889

1.65

23.58

3.6

3.1

787.23

1253.74

ng/l

4.66

603

4183

Fluid overload

338

7.18

23.47

5.5

3.3

9445.54

1295.00

ng/l

3.74

290

Disorders of iron metabolism

256

1409

2.35

23.46

2.5

3.0

621.75

877.85

ng/l

1.21

203

1179

Malignant neoplasm of small intestine, including Hilmo

550

3766

1.85

23.43

4.1

3.2

1465.88

1380.44

ng/l

0.16

492

3258

Infections with a predominantly sexual mode of transmission

3092

25854

1.24

23.37

2.9

2.8

1171.18

840.36

ng/l

3.42

2459

21299

Other keratitis

1500

11754

1.38

23.25

3.2

3.1

1506.48

1215.97

ng/l

1.45

1279

9937

Carcinoma in situ of skin of trunk

669

4837

1.80

23.22

3.6

3.5

2313.00

1874.81

ng/l

1.36

596

4291

Isolated proteinuria

429

2740

1.92

23.16

4.6

3.3

4925.29

1314.27

ng/l

4.86

384

2338

Pneumothorax

1102

8386

1.49

23.15

3.9

3.2

1705.57

1615.53

ng/l

0.23

993

7244

Ulcerative colitis

3245

27513

1.24

23.14

3.3

3.2

1336.67

1223.15

ng/l

0.72

2756

23367

Malignant neoplasm of kidney, except renal pelvis

1561

12502

1.41

23.11

3.4

2268.95

1590.37

ng/l

4.41

1404

10868

Secondary polycythaemia

400

2534

2.00

23.05

4.2

3.2

1384.70

1330.58

ng/l

0.12

334

2152

Pediculosis, acariasis and other infestations, including avohilmo

1953

15703

1.31

23.02

3.3

3.2

1185.33

1040.48

ng/l

0.71

1624

13085

Carcinoma in situ of skin

1587

12838

1.43

22.98

3.8

3.4

2162.12

1632.15

ng/l

2.01

1411

11282

Other and unspecified follicular disorders

576

3896

1.71

22.95

3.8

3.2

2049.05

1180.47

ng/l

1.62

495

3317

Agoraphobia

293

1622

2.01

22.93

2.6

2.7

593.98

668.35

ng/l

0.19

230

1300

Malignant neoplasm of colon, including Hilmo

3402

29198

1.26

22.88

3.1

3.4

1618.55

1684.29

ng/l

0.34

3004

25461

Other disorders of penis

1410

11026

1.40

22.85

3.5

1512.26

1522.35

ng/l

0.02

1210

9583

Monoarthritis, not elsewhere classified

576

3890

1.70

22.82

3.8

3.1

1647.39

1324.46

ng/l

0.56

502

3348

Vitamin D deficiency

279

1582

2.19

22.62

3.7

3.1

1980.31

1071.72

ng/l

1.29

238

1315

Nummular dermatitis

1327

10395

1.43

22.55

3.6

3.3

1480.65

1378.55

ng/l

0.27

1139

8997

Other specified/unspecified dorsopathies

512

3402

1.77

22.54

3.1

3.2

1107.30

1464.54

ng/l

1.53

430

2904

Personal history of certain other diseases

188

902

2.41

22.52

4.0

2.6

1178.66

900.85

ng/l

0.48

146

693

Ehlers-Danlos syndrome

122

492

3.12

22.52

2.2

3.0

633.72

737.72

ng/l

0.09

100

389

Disorders of refraction and accommodation

3481

29562

1.22

22.51

3.2

3.1

954.91

1069.73

ng/l

0.74

2868

24955

Acquired absence of limb

191

988

2.83

22.45

4.7

2.9

5398.67

1324.97

ng/l

3.92

172

840

Chronic lymphocytic leukaemia

565

3944

1.83

22.43

3.3

1921.18

1622.69

ng/l

0.84

518

3437

Chronic lymphocytic leukaemia, helper endpoint

565

3944

1.83

22.43

3.3

1921.18

1622.69

ng/l

0.84

518

3437

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

565

3944

1.83

22.43

3.3

1921.18

1622.69

ng/l

0.84

518

3437

Bulimia nervosa (incl. atypical)

253

1336

2.07

22.41

2.2

2.7

479.72

457.99

ng/l

0.05

192

1022

Maternal care for other conditions predominantly related to pregnancy

1670

12801

1.32

22.29

2.3

2.5

596.85

445.00

ng/l

0.62

1283

10353

Tumor necrosis factor alpha inhibitors

1750

13961

1.33

22.20

2.6

3.0

866.03

871.29

ng/l

0.02

1478

11558

Other abnormalities of plasma proteins

309

1887

2.29

22.17

4.7

3.3

3128.67

1345.31

ng/l

3.39

287

1634

Other and unspecified rosacea

1277

9913

1.42

22.16

3.2

3.1

1100.40

1124.05

ng/l

0.07

1079

8491

Ménière disease

1504

12021

1.40

22.16

3.4

3.2

1237.24

1471.72

ng/l

0.86

1297

10448

Bell's palsy

1708

13738

1.35

22.13

3.3

3.2

1314.84

1391.03

ng/l

0.34

1444

11839

Prepatellar bursitis

664

4668

1.64

22.09

3.7

3.2

1345.87

1462.07

ng/l

0.29

573

4001

Other infective otitis externa

878

6475

1.54

22.08

3.1

3.2

1331.59

1243.60

ng/l

0.25

727

5573

Other and unspecified disorders of white blood cells

635

4473

1.69

22.06

3.5

3.2

1867.19

1363.16

ng/l

1.36

550

3854

Thyroiditis

950

7067

1.50

22.04

3.5

3.0

1062.20

1088.14

ng/l

0.08

824

5986

Carcinoma in situ of skin of ear and external auricular canal

341

2180

2.31

22.04

3.5

3.7

3437.52

2207.29

ng/l

1.61

309

1971

Xerosis cutis

337

2106

2.19

22.02

5.0

3.2

2082.47

1317.07

ng/l

1.59

310

1829

Focal epilepsy, mode (most common among epilepsy diagnosis)

2768

23360

1.27

21.95

3.3

3.4

1388.83

1492.50

ng/l

0.56

2430

20171

Ovarian dysfunction

587

3906

1.60

21.95

2.4

2.6

503.32

502.27

ng/l

0.00

465

3086

Calcific tendinitis of shoulder

769

5524

1.56

21.90

3.2

3.0

712.49

1147.60

ng/l

3.83

655

4723

Paralytic ileus

636

4488

1.69

21.88

4.2

3.2

2133.61

1627.46

ng/l

1.53

561

3917

Recurrent dislocation and subluxation of joint

705

4915

1.56

21.88

2.7

3.0

830.40

970.31

ng/l

0.37

562

4088

Appendicitis, broad definition

10985

90300

1.12

21.87

3.1

1099.03

1248.66

ng/l

3.30

9271

76795

Primary biliary cholangitis, wide definition

366

2287

2.00

21.87

3.6

2.9

1636.27

1125.14

ng/l

1.03

327

1944

Benign neoplasm: Skin of other and unspecified parts of face

1700

13777

1.37

21.84

3.4

3.3

1665.18

1570.20

ng/l

0.28

1444

11987

Dental pulpitis, including avohilmo

13206

77902

1.11

21.82

3.0

834.67

1120.07

ng/l

13.17

10767

66197

Benign lipomatous neoplasm

4587

40320

1.20

21.80

3.2

1170.00

1351.51

ng/l

3.02

3922

34818

Primary open-angle glaucoma

6201

53690

1.18

21.76

3.4

1697.31

1763.49

ng/l

0.50

5327

47068

Diseases of appendix

11095

90941

1.12

21.75

3.1

1101.71

1256.21

ng/l

3.51

9364

77365

Arterial embolism and thrombosis of lower extremity artery

629

4459

1.71

21.74

5.0

3.3

3752.56

1605.94

ng/l

6.17

573

3881

Ulcerative colitis, NAS

1758

14134

1.33

21.73

3.5

3.2

1322.87

1188.08

ng/l

0.59

1490

11951

Other arterial embolism and thrombosis

494

3338

1.83

21.70

4.6

3.3

3644.52

1642.18

ng/l

4.05

456

2899

Carcinoid syndrome

205

1141

3.01

21.66

5.4

3.4

866.14

1304.66

ng/l

1.91

188

993

Other deformities of toe(s)

545

3720

1.73

21.57

3.0

3.2

1159.39

1250.94

ng/l

0.23

452

3222

Ill-defined and unknown causes of mortality

1831

15077

1.37

21.57

4.5

3.4

2814.38

1949.69

ng/l

5.53

1663

13246

Orthopaedic devices associated with adverse incidents

372

2436

2.19

21.51

4.3

3.3

1708.39

1295.34

ng/l

0.96

306

2109

Oligomenorrhoea

368

2233

1.84

21.48

2.9

680.87

978.77

ng/l

1.00

297

1844

Pyothorax

726

5284

1.64

21.44

4.1

3.3

2096.25

1610.81

ng/l

1.96

662

4608

Other and unspecified primary disorders of muscles

137

631

3.32

21.43

4.2

3.6

1220.01

1185.94

ng/l

0.02

127

526

Viral infections of the central nervous system, including avohilmo

1014

7640

1.47

21.39

3.3

3.2

935.53

1261.79

ng/l

3.56

843

6473

Lesion of plantar nerve

932

7025

1.52

21.32

3.0

3.1

721.24

1161.17

ng/l

9.21

800

6050

Nonsuppurative otitis media

2403

17179

1.26

21.32

3.6

3.1

1128.15

1201.22

ng/l

0.30

1976

14278

Carcinoma in situ of skin of scalp and neck

575

4129

1.86

21.32

3.9

3.5

2313.36

1935.18

ng/l

1.01

518

3670

Cerebral aneurysm, nonruptured

1305

10263

1.42

21.30

3.0

3.1

1231.59

1197.95

ng/l

0.07

1145

8801

Benign neoplasm: Small intestine

698

5098

1.68

21.29

3.7

3.3

1987.18

1383.81

ng/l

1.46

620

4439

Alzheimer’s disease (Late onset), excluding more controls

2802

15429

1.28

21.22

3.0

3.1

2006.51

1837.56

ng/l

0.84

2431

13677

Disorders of plasma-protein metabolism, not elsewhere classified

127

565

3.39

21.20

4.3

3.2

896.49

1018.22

ng/l

0.19

113

481

Infective bursitis

449

2964

1.84

21.14

3.8

3.3

1606.65

1481.15

ng/l

0.22

393

2580

Sulfonylureas

6425

45961

1.17

21.14

4.1

3.3

3008.90

1730.63

ng/l

36.16

5620

40355

Acute appendicitis

10167

86295

1.12

21.11

3.1

1084.64

1229.85

ng/l

3.20

8577

73323

Renal tubulo-interstitial disorders in diseases classified elsewhere

191

1023

2.83

21.06

4.7

3.1

3495.45

957.20

ng/l

6.46

176

868

Effects of foreign body entering through natural orifice

3251

27817

1.23

21.05

3.3

1244.87

1289.37

ng/l

0.23

2734

23737

Atopic dermatitis, strict definition with reimbursement

3080

24996

1.22

21.03

3.1

3.0

1060.78

895.11

ng/l

0.82

2477

20643

Clear cell adenocarcinoma of kidney

821

6148

1.60

21.01

3.3

1843.98

1431.94

ng/l

1.50

748

5337

Salpingitis and oophoritis

2307

19212

1.28

20.99

2.9

2.8

999.85

917.60

ng/l

0.53

1923

16446

Eosinophilia

281

1676

2.25

20.98

4.3

3.3

1951.44

1219.30

ng/l

0.71

257

1455

Focal brain injury

921

6857

1.49

20.95

3.5

3.1

1579.71

1727.90

ng/l

0.52

780

6005

Pneumonia derived septicemia

528

3606

1.74

20.95

4.5

3.3

2460.16

1537.22

ng/l

3.44

462

3109

Muscle strain

438

2830

1.78

20.95

3.4

3.3

892.03

1191.91

ng/l

1.18

372

2402

Recurrent dislocation of patella

415

2584

1.73

20.93

2.4

2.8

900.41

725.85

ng/l

0.29

306

2058

Tracheo-bronchomalasia

171

4.73

20.79

2.9

1.6

526.56

199.20

ng/l

1.87

143

Gingival hyperplasia

545

3752

1.72

20.79

5.7

3.3

1802.15

1204.41

ng/l

1.93

483

3207

Abdominal aortic aneurysm (AAA)

1804

14687

1.35

20.75

3.9

3.4

3217.93

2040.56

ng/l

8.63

1634

12885

Other specified disorders of muscle

433

2829

1.82

20.70

4.2

3.2

1457.56

1431.89

ng/l

0.04

382

2397

Other disorders of the genitourinary system

2063

17193

1.32

20.62

3.1

1398.78

1331.04

ng/l

0.22

1744

14957

Pulmonary artery stenosis

20.01

20.50

12.3

9.3

701.10

1122.29

ng/l

0.58

Psoriatic arthropathies, ICD10

1416

11247

1.38

20.46

3.1

1210.30

1123.01

ng/l

0.33

1219

9588

Acute and transient psychotic disorders

1398

11025

1.36

20.34

2.7

3.1

935.95

1113.26

ng/l

1.33

1137

9263

Entropion and trichiasis of eyelid

1583

12932

1.38

20.27

3.4

1848.60

1909.21

ng/l

0.17

1399

11372

Temporal arteritis

689

5093

1.69

20.27

3.7

3.2

1602.57

1576.30

ng/l

0.05

624

4442

Other forms of systemic lupus erythematosus

147

709

3.00

20.27

3.3

1265.68

955.78

ng/l

0.51

133

598

Malignant melanoma, including Hilmo

2971

25553

1.25

20.22

3.2

3.3

1596.52

1546.22

ng/l

0.18

2595

22229

Urethral stricture

970

7435

1.50

20.21

3.7

3.4

2028.54

1789.79

ng/l

0.47

823

6559

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

569

3905

1.63

20.18

2.9

3.1

988.91

1133.92

ng/l

0.42

494

3294

Mental retardation

441

2838

1.74

20.16

3.8

3.9

1510.83

1126.19

ng/l

0.47

369

2376

Other specified/unspecified inflammatory spondylopathies

516

3454

1.65

20.12

2.8

3.0

986.17

1085.28

ng/l

0.19

444

2885

Injury of muscle and tendon at hip and thigh level

1406

11173

1.37

20.06

3.2

1110.85

1160.77

ng/l

0.13

1200

9517

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

941

7196

1.51

20.05

2.9

3.1

844.43

1115.81

ng/l

2.70

800

6201

Use of biperiden

740

5407

1.56

19.92

2.7

3.1

795.29

1191.22

ng/l

3.28

622

4581

Fracture at wrist and hand level

4763

41858

1.18

19.91

3.2

1305.58

1255.05

ng/l

0.24

4009

35682

Benign neoplasm: Duodenum

471

3263

1.87

19.79

3.8

3.3

2007.44

1359.80

ng/l

1.12

414

2837

Other psoriatic arthropathies

1378

10955

1.37

19.78

3.1

1228.13

1098.03

ng/l

0.54

1184

9338

Other disorders involving the immune mechanism, not elsewhere classified

432

2848

1.79

19.72

4.5

3.4

5429.31

1258.93

ng/l

7.14

391

2406

Other fall from one level to another

3020

25808

1.23

19.71

3.3

1282.58

1339.19

ng/l

0.24

2559

22076

Autoimmune hepatitis, wide definition

633

4490

1.60

19.71

3.6

3.0

1633.75

1146.21

ng/l

0.71

548

3802

Acute lymphadenitis

680

4842

1.55

19.69

3.1

3.2

1097.20

1098.77

ng/l

0.00

574

4055

Bullous disorders

955

7340

1.50

19.69

3.6

3.3

1850.89

1576.93

ng/l

0.92

838

6402

Acute alcohol intoxication

3709

32262

1.21

19.66

3.4

3.3

1675.88

1478.72

ng/l

1.22

3167

27763

Post-traumatic wound infection, not elsewhere classified

421

2779

1.82

19.64

3.9

3.3

1838.78

1336.56

ng/l

1.59

367

2365

Viral infections of the central nervous system

937

7079

1.46

19.52

3.3

3.2

968.78

1216.22

ng/l

2.13

777

5993

Acute lymphocytic leukaemia, helper endpoint

338

3.54

19.51

3.1

4.5

578.52

1116.48

ng/l

1.73

280

Acute lymphocytic leukaemia

338

3.54

19.51

3.1

4.5

578.52

1116.48

ng/l

1.73

280

Acute lymphocytic leukaemia, including Hilmo

338

3.54

19.51

3.1

4.5

578.52

1116.48

ng/l

1.73

280

Cluster headache, strict, including avohilmo

572

3953

1.61

19.49

2.8

3.1

633.96

909.71

ng/l

1.59

458

3272

Drug-induced osteoporosis

250

1492

2.36

19.45

6.0

3.2

1707.45

1099.31

ng/l

1.09

234

1260

Tongue abnormality

959

7373

1.49

19.41

3.2

1052.64

1322.84

ng/l

1.21

823

6357

Myelodysplastic syndrome, including Hilmo

564

4035

1.73

19.34

3.8

3.4

2134.16

1836.52

ng/l

0.86

523

3544

Additional codes for the location of defect, injury or illness

847

6356

1.51

19.34

3.5

3.2

1416.70

1280.73

ng/l

0.28

759

5448

Other/unspecified disorders of vestibular function

695

5117

1.61

19.21

3.6

3.3

1334.35

1484.18

ng/l

0.50

612

4436

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

1383

11118

1.38

19.17

3.1

3.2

1341.64

1277.69

ng/l

0.16

1192

9594

Other and unspecified mononeuropathies, also in other diseases

471

3220

1.77

19.16

3.7

3.2

1823.21

1386.54

ng/l

1.01

397

2777

Mixed specific developmental disorders

141

581

2.47

19.16

8.8

6.0

734.53

1020.04

ng/l

0.39

118

462

Other retinal artery occlusion

435

2974

1.88

19.10

3.9

3.4

2412.02

1727.57

ng/l

1.78

387

2597

Acute posthaemorrhagic anaemia

601

4315

1.66

19.09

5.1

3.2

2807.29

1645.02

ng/l

5.90

536

3756

Congenital malformations of the urinary system

730

5324

1.53

19.07

3.2

3.4

4153.43

1194.08

ng/l

10.84

660

4517

Dermatopolymyositis

254

1511

2.24

19.06

4.8

3.2

1157.71

1261.21

ng/l

0.21

231

1287

Hypogonadotropic hypogonadism

375

2390

1.81

19.04

2.7

3.2

501.54

998.25

ng/l

3.61

272

1948

Exposure to other and unspecified inanimate mechanical forces

974

7411

1.44

18.98

3.3

3.2

1144.38

1173.05

ng/l

0.09

806

6225

Specific development disorders of scholastic skills

293

1666

1.85

18.92

5.5

3.9

1080.03

673.64

ng/l

0.57

240

1278

Event of undetermined intent

772

5664

1.50

18.87

3.2

1557.04

1124.49

ng/l

1.27

637

4761

Other chondrocalcinosis

276

1745

2.37

18.82

4.6

3.4

2165.45

1625.09

ng/l

1.39

244

1535

Primary open-angle glaucoma, strict

5038

45123

1.19

18.80

3.4

1680.40

1761.07

ng/l

0.55

4334

39558

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

198

1048

2.22

18.77

2.4

3.2

723.41

708.97

ng/l

0.02

159

851

Bruxism

227

1266

2.14

18.75

2.9

3.1

617.47

659.34

ng/l

0.12

187

1039

Malignant melanoma of skin, including Hilmo

2431

20703

1.27

18.75

3.2

3.3

1455.47

1532.07

ng/l

0.36

2129

17959

Residual foreign body in soft tissue

646

4610

1.56

18.75

3.1

1198.54

1312.77

ng/l

0.27

560

3914

Malnutrition

368

2414

1.92

18.67

5.2

3.6

2214.61

1543.12

ng/l

2.25

335

2080

L04AC Interleukin inhibitors

752

5500

1.50

18.63

2.9

3.0

871.64

911.69

ng/l

0.13

637

4565

Haemorrhage in early pregnancy

2858

23613

1.22

18.60

2.6

2.7

497.15

721.87

ng/l

7.61

2374

19688

Gestational [pregnancy-induced] hypertension

2361

19683

1.24

18.59

2.7

2.6

759.27

660.14

ng/l

0.76

1964

16215

Vasomotor rhinitis (mode)

1028

7968

1.44

18.56

3.3

3.2

1218.88

1199.86

ng/l

0.03

867

6866

Injury of eye and orbit

1767

14443

1.30

18.55

3.1

3.2

1023.53

1222.47

ng/l

1.70

1462

12205

Rosacea

1718

14064

1.31

18.53

3.1

1004.06

1122.62

ng/l

0.66

1450

12018

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2036

10429

1.26

18.50

2.3

304.25

360.50

ng/l

0.49

1544

8113

Benign neoplasm: Skin of eyelid, including canthus

2500

21363

1.27

18.47

3.3

3.2

1493.84

1439.24

ng/l

0.22

2157

18603

Giant cell arteritis with polymyalgia rheumatica

689

5174

1.65

18.45

3.7

3.3

1602.57

1559.15

ng/l

0.09

624

4512

Malignant melanoma

2630

22587

1.26

18.37

3.3

1545.81

1523.43

ng/l

0.07

2286

19621

Fracture of neck

1001

7809

1.46

18.34

3.4

1893.07

1669.07

ng/l

0.80

871

6818

Ankylosing spondylitis, ICD10

1102

8582

1.40

18.31

3.1

974.87

1153.58

ng/l

0.98

909

7250

Cluster headache, wide,, including avohilmo

613

4350

1.56

18.24

2.8

3.1

773.09

949.14

ng/l

0.59

495

3618

Maltreatment syndromes

474

3162

1.62

18.21

3.2

3.1

1312.75

833.32

ng/l

0.65

378

2536

Atrophic disorders of skin

2285

19295

1.26

18.19

3.1

3.0

968.16

1080.66

ng/l

0.92

1943

16476

Injury of muscle and tendon at lower leg level

2107

17650

1.27

18.15

3.5

3.2

1438.40

1287.67

ng/l

0.63

1773

15192

malignant neoplasm of female genital organs, including Hilmo

2851

23462

1.24

18.13

3.1

1526.43

1261.94

ng/l

1.72

2505

20040

Contusion of other and unspecified parts of foot

576

4024

1.56

18.10

3.0

3.1

1038.20

919.37

ng/l

0.42

471

3344

Postzoster neuralgia

320

2083

2.08

18.10

4.7

3.2

1879.42

1510.68

ng/l

0.76

291

1819

Hypertrophy of breast

1984

16442

1.27

18.09

2.5

2.7

600.22

781.31

ng/l

1.98

1634

13804

Infarction of spleen

147

781

3.32

18.02

4.8

3.3

2081.53

1356.68

ng/l

1.46

138

658

Thyrotoxicosis with toxic multinodular goitre

997

7810

1.46

18.01

3.5

3.2

1394.88

1393.64

ng/l

0.00

886

6756

Inflammatory diseases of the central nervous system

1128

8858

1.40

17.95

3.1

3.2

1219.13

1312.87

ng/l

0.25

968

7564

Other obstetric conditions, not elsewhere classified

2111

10911

1.25

17.95

2.3

307.07

365.10

ng/l

0.54

1603

8515

L01XX Other antineoplastic agents

1007

7942

1.47

17.91

3.5

3.3

1980.46

1522.06

ng/l

1.30

906

6943

Disorders of optic nerve and visual pathways

1198

9452

1.37

17.89

3.3

3.2

1482.98

1283.02

ng/l

0.79

1010

8052

Other and unspecified types of non-Hodgkin lymphoma, hilmo

702

5258

1.59

17.89

4.3

3.4

2036.41

1599.21

ng/l

0.91

647

4571

Lactose intolerance

396

2597

1.75

17.86

3.1

1583.63

1017.84

ng/l

0.98

335

2148

Postviral fatigue syndrome

397

3.04

17.85

2.3

3.1

683.27

440.54

ng/l

0.24

321

Emotional disorders and disorders of social functioning with onset specific to childhood

286

1634

1.81

17.81

4.3

3.9

622.61

632.14

ng/l

0.01

196

1233

Other superficial mycoses, including avohilmo

1207

9479

1.35

17.71

3.1

928.02

1015.71

ng/l

0.44

972

7871

Congenital malformations of trachea and bronchus

179

991

2.61

17.65

6.1

3.5

649.65

1388.53

ng/l

6.40

163

834

Biological medicines for asthma

286

1745

1.94

17.64

3.2

2.9

338.97

728.82

ng/l

7.66

239

1424

Biomechanical lesions, not elsewhere classified

786

5950

1.52

17.60

3.3

3.2

1528.82

1358.29

ng/l

0.33

681

5127

Disorders of magnesium metabolism

154

815

2.84

17.51

4.1

3.1

2471.02

1087.71

ng/l

4.13

144

687

Symptoms and signs involving emotional state

376

2443

1.75

17.50

3.7

3.3

1401.70

1023.82

ng/l

1.02

313

2042

Abnormal findings in nipple discharge synovial fluid wound secretions

239

1421

2.16

17.49

3.3

3.4

2257.64

1185.75

ng/l

0.59

215

1214

201

1081

2.08

17.41

3.0

2.7

476.04

627.80

ng/l

0.67

175

875

Cystic kidney disease

461

3182

1.71

17.40

3.1

3.3

5314.23

1206.76

ng/l

10.19

422

2720

Congenital malformations of the urinary system, including avohilmo

774

5783

1.48

17.39

3.2

3.4

4034.83

1190.36

ng/l

10.99

693

4906

Colorectal adenocarcinoma

3690

32188

1.21

17.39

2.9

3.4

1592.84

1676.04

ng/l

0.50

3261

28052

Female infertility, associated with anovulation

489

3276

1.56

17.34

2.3

2.5

287.50

466.45

ng/l

1.98

389

2586

Testicular hypofunction

464

3176

1.67

17.34

3.2

873.03

1162.86

ng/l

1.04

352

2640

Retinal haemorrhage

454

3177

1.77

17.32

3.8

3.4

2198.60

1606.45

ng/l

1.06

406

2764

Kela reimbursement Agammaglobulinemia (D80-84)

133

648

2.77

17.28

5.4

2.8

1472.73

643.63

ng/l

0.77

122

528

Malignant neoplasm of colon

2767

24008

1.24

17.22

3.1

3.4

1638.44

1690.02

ng/l

0.21

2439

20957

Heterophoria

939

7191

1.41

17.16

3.5

3.2

688.64

1078.32

ng/l

4.46

774

6057

Varicose veins of other sites

900

6913

1.44

17.16

3.7

3.2

1081.90

1300.47

ng/l

1.24

768

5862

Mental retardation, wide definition

468

3166

1.64

17.12

3.8

3.9

1447.11

1147.59

ng/l

0.37

393

2670

Rheumatic fever incl heart disease

515

3670

1.67

17.03

5.4

3.4

2512.75

1906.42

ng/l

1.61

472

3185

Scabies

571

4061

1.56

17.00

4.0

3.1

1392.01

1033.21

ng/l

1.05

465

3408

Polyarteritis nodosa and related conditions

228

1351

2.19

17.00

4.2

3.3

2001.57

1332.31

ng/l

0.49

212

1165

Background retinopathy and retinal vascular changes

354

2348

1.87

17.00

3.8

3.3

2375.47

1579.31

ng/l

1.62

307

2017

Testicular dysfunction

513

3591

1.61

16.98

3.3

869.93

1122.77

ng/l

0.97

395

2995

Other and unspecified epidermal thickening

400

2698

1.76

16.94

4.2

3.3

1823.35

1250.11

ng/l

1.04

357

2307

Central retinal artery occlusion

415

2885

1.83

16.93

4.5

3.5

2876.39

1915.15

ng/l

1.88

386

2520

Vertigo of central origin

297

1917

2.04

16.89

3.5

3.4

1100.35

1523.71

ng/l

2.07

248

1649

Hyperaldosteronism

452

3159

1.74

16.86

3.6

3.2

1754.38

1182.88

ng/l

1.42

386

2727

Nonsuppurative otitis media, including avohilmo

3475

26097

1.19

16.82

3.2

3.0

1068.65

1127.76

ng/l

0.30

2891

21811

Folate deficiency anaemia

211

1259

2.41

16.81

4.1

3.3

2965.63

1495.04

ng/l

2.49

186

1094

Mitochondrial myopathy

322

4.05

16.78

2.9

3.5

2230.83

723.66

ng/l

0.73

265

Other inflammatory liver diseases

944

7343

1.43

16.77

3.7

3.2

1715.47

1273.54

ng/l

0.99

815

6286

Malignant melanoma of skin

1997

16899

1.29

16.76

3.2

3.3

1348.36

1513.95

ng/l

1.28

1734

14672

D07AA Corticosteroids, weak (group I)

1707

13996

1.28

16.76

3.2

3.3

1194.13

1233.43

ng/l

0.16

1452

11764

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

2507

21499

1.24

16.58

3.1

3.3

1222.14

1348.52

ng/l

0.88

2254

18507

Nontoxic single thyroid nodule

1015

7969

1.41

16.58

3.4

3.0

1043.69

1141.30

ng/l

0.46

868

6860

Injury of other and unspecified intrathoracic organs

958

7486

1.43

16.56

3.5

3.3

1879.61

1498.17

ng/l

1.41

839

6492

Hypertrophic disorders of skin

660

4819

1.50

16.55

3.3

3.0

1134.29

937.99

ng/l

0.35

545

4023

Complications following infusion, transfusion and therapeutic injection

250

1536

2.10

16.53

3.9

3.1

1770.88

1145.14

ng/l

1.06

225

1307

Hyperfunction of pituitary gland

540

3806

1.56

16.52

3.4

3.0

983.85

1008.09

ng/l

0.06

461

3164

Selective deficiency of immunoglobulin G [IgG] subclasses

118

566

3.00

16.52

4.1

3.1

666.42

699.15

ng/l

0.08

104

472

Other disorders of breast

1698

14027

1.29

16.50

2.7

2.9

840.49

986.97

ng/l

0.78

1417

11891

Congenital malformations of the musculoskeletal system, not elsewhere classified

172

912

2.24

16.45

2.5

3.2

766.24

755.35

ng/l

0.01

142

747

Myotonic disorders

133

666

2.75

16.44

3.0

3.3

850.32

934.62

ng/l

0.10

112

558

Congenital malformations of the respiratory system

258

1585

2.02

16.40

5.3

3.8

1052.26

1327.16

ng/l

0.41

232

1343

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

2199

18674

1.25

16.40

3.1

3.3

1241.62

1321.43

ng/l

0.43

1975

16062

Congenital malformations of the respiratory system, including avohilmo

280

1755

1.96

16.34

5.1

3.8

1045.41

1289.25

ng/l

0.38

249

1484

Carcinoma in situ of skin of upper limb, including shoulder

518

3830

1.76

16.32

3.5

2308.14

1730.85

ng/l

1.81

449

3392

Paralytic strabismus

1096

8756

1.40

16.32

3.5

3.3

1400.55

1536.71

ng/l

0.49

956

7591

Prurigo nodularis

412

2853

1.77

16.31

4.3

3.2

2468.12

1257.68

ng/l

2.05

364

2460

Dementia

8903

56372

1.13

16.30

3.2

3.4

1838.79

1754.04

ng/l

0.90

7705

49743

Somnolence, stupor and coma

632

4652

1.54

16.26

3.7

3.3

2190.77

1639.03

ng/l

0.82

551

4013

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

391

2633

1.73

16.19

4.5

3.4

5875.07

1170.54

ng/l

7.43

353

2216

L01XE Protein kinase inhibitors

846

6600

1.49

16.18

3.3

1560.79

1310.14

ng/l

0.92

778

5750

Acne

743

5425

1.42

16.13

3.6

3.1

1408.27

602.24

ng/l

2.17

583

4210

Alzheimer’s disease (Early onset)

459

6437

0.64

16.10

3.1

3.5

2206.62

2256.16

ng/l

0.06

379

5600

Other and unspecified psoriasis

982

7724

1.41

16.05

3.2

1474.21

1283.86

ng/l

0.51

854

6671

Pediculosis, acariasis and other infestations

754

5676

1.46

16.03

3.8

3.2

1332.77

1089.48

ng/l

0.86

624

4775

Sacrococcygeal disorders, not elsewhere classified

385

2568

1.70

16.02

2.8

3.1

661.61

1103.93

ng/l

2.77

314

2173

Bitten or struck by other mammals

1288

10330

1.32

16.00

3.4

3.1

1052.58

983.18

ng/l

0.26

1058

8660

Pneumococcal septicemia

501

3576

1.64

16.00

4.5

3.4

2485.49

1508.75

ng/l

3.56

436

3096

Manic episode

376

2497

1.71

15.99

2.7

3.2

950.39

1084.45

ng/l

0.39

303

2105

Other viral hepatitis

628

4559

1.49

15.91

3.0

3.1

1581.66

911.25

ng/l

0.98

522

3742

Intentional self-harm by unspecified means

141

700

2.36

15.91

2.3

3.1

576.65

716.05

ng/l

0.39

554

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

1007

7888

1.38

15.87

2.9

2.8

954.30

780.45

ng/l

0.62

850

6658

L02BX Other hormone antagonists and related agents

1032

8343

1.45

15.86

3.6

3.5

1674.26

1857.29

ng/l

0.75

953

7465

Other and specified injuries of hip and thigh

385

2636

1.78

15.84

3.9

3.4

2077.77

1612.80

ng/l

0.71

338

2274

Intermittent heterotropia

590

4231

1.51

15.82

3.6

3.5

994.76

1109.93

ng/l

0.34

487

3508

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

582

4287

1.59

15.82

4.1

3.2

1457.02

1339.91

ng/l

0.35

497

3675

Rheumatic valve diseases

389

2675

1.78

15.79

5.8

3.4

2643.40

2062.62

ng/l

1.23

356

2309

Endometriosis of ovary

1974

15579

1.25

15.79

2.8

2.9

850.63

1203.26

ng/l

5.49

1636

13348

Cushing syndrome

192

1111

2.30

15.77

3.5

3.2

1554.97

1035.75

ng/l

0.86

173

936

Bacterial, viral and other infectious agents, including avohilmo

1065

8392

1.36

15.76

3.9

3.2

1374.43

1152.77

ng/l

0.93

918

7014

Hepatomegaly and splenomegaly, not elsewhere classified

157

846

2.46

15.74

4.7

3.2

1437.98

1171.54

ng/l

0.38

136

736

Single delivery by forceps and vacuum extractor

606

5044

0.69

15.72

2.0

2.6

194.57

521.63

ng/l

5.80

456

4002

Other obstructive and reflux uropathy

548

3935

1.55

15.66

3.2

2.9

2442.32

1090.72

ng/l

5.53

472

3328

Acute myeloid leukaemia and myelodysplastic syndromes

428

3023

1.75

15.60

3.8

3.3

2025.73

1806.82

ng/l

0.47

402

2645

Vitamin B12 deficiency anaemia

1728

14523

1.30

15.59

3.4

3.2

2132.54

1740.63

ng/l

2.72

1541

12641

Other immunodeficiencies

165

901

2.35

15.58

4.1

3.3

1181.61

1055.31

ng/l

0.20

145

755

Benign neoplasm of mouth and pharynx

1597

13297

1.30

15.55

3.3

3.2

1444.69

1376.02

ng/l

0.25

1377

11480

Senility

209

1227

2.14

15.53

3.8

3.3

2861.31

2826.61

ng/l

0.02

180

1066

Specific development disorders of speech and language

578

3990

1.50

15.52

4.3

3.8

1410.74

1277.02

ng/l

0.26

496

3307

Problems related to social environment

425

2939

1.67

15.52

4.4

3.3

1719.52

1732.09

ng/l

0.02

367

2516

Other viral hepatitis, including avohilmo

660

4849

1.47

15.51

3.0

3.1

1528.85

899.42

ng/l

0.95

544

3973

Muscular dystrophy

142

754

2.67

15.51

3.7

3.5

1360.78

1182.90

ng/l

0.11

124

626

Graves disease, strict definition

1190

9520

1.34

15.51

3.1

3.0

927.19

952.58

ng/l

0.10

986

8032

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

362

2288

1.64

15.48

6.5

3.6

1673.27

681.09

ng/l

1.40

284

1784

Other specified/unspecified necrotizing vasculopathies

244

1534

2.11

15.39

4.1

3.3

2067.80

1445.34

ng/l

1.23

222

1323

Malignant neoplasm of head and neck, including Hilmo

1596

13341

1.31

15.25

3.1

3.4

1499.41

1606.43

ng/l

0.43

1445

11590

Perforation of tympanic membrane

1374

11257

1.32

15.21

3.4

3.2

1425.61

1379.95

ng/l

0.15

1173

9712

Other localized connective tissue disorders

306

2011

1.87

15.08

3.7

3.0

2411.94

1011.17

ng/l

1.37

265

1686

Early lumbar disc prolapse operation

890

6820

1.37

15.08

2.5

2.9

550.62

637.88

ng/l

0.19

684

5426

Sleep disorders, other/unspecified

385

2580

1.65

15.06

3.0

3.2

982.74

968.58

ng/l

0.02

315

2133

Kyphosis

230

1421

2.10

15.04

4.3

3.3

1068.07

1302.40

ng/l

0.69

210

1236

Persistent delusional disorders

1092

8762

1.37

15.03

3.1

3.3

1133.67

1451.53

ng/l

2.58

895

7543

Dislocation, sprain and strain of joint and ligaments of hip

614

4605

1.55

15.02

3.5

3.4

1217.49

1618.92

ng/l

2.56

537

3981

Complications predominantly related to the puerperium

2528

21678

1.21

15.01

2.5

2.6

566.94

660.28

ng/l

1.07

2066

17992

Emotional disorders starting during childhood or adolescence

270

1615

1.74

14.98

4.4

4.3

742.11

687.94

ng/l

0.07

186

1228

Other disorders of optic [2nd] nerve and visual pathways

869

6775

1.42

14.97

3.6

3.3

1696.01

1342.08

ng/l

1.28

738

5822

Neovascular glaucoma

654

4944

1.52

14.95

3.9

3.4

2867.59

1669.93

ng/l

3.85

571

4281

Cystic kidney disease, including avohilmo

487

3494

1.61

14.92

3.1

3.3

5158.40

1213.46

ng/l

10.31

443

2982

Primary biliary cholangitis (PBC)

331

2213

1.80

14.89

3.7

3.0

1808.41

1142.03

ng/l

1.38

297

1889

Secondary thrombocytopenia

215

1315

2.17

14.86

4.5

3.2

1549.83

1012.44

ng/l

1.29

198

1119

Other secondary gonarthrosis

789

6114

1.46

14.86

3.2

1738.13

1307.13

ng/l

0.98

689

5307

Other and/or unspecified nontoxic goitre

1197

9731

1.35

14.85

2.9

3.0

1046.14

1274.48

ng/l

1.38

1062

8445

Mental and behavioural disorders due to use of other stimulants, including caffeine

228

1336

1.87

14.82

2.4

3.3

1318.32

693.22

ng/l

1.00

174

1015

Juvenile arthritis (FINNGEN)

377

2502

1.62

14.78

3.2

1398.04

889.72

ng/l

1.16

321

2013

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1762

14622

1.24

14.76

2.9

860.33

756.20

ng/l

0.48

1388

11810

Respiratory conditions due to other external agents

368

2570

1.81

14.66

4.5

3.2

1290.93

1454.89

ng/l

0.53

342

2227

Other and unspecified abdominal hernia

648

4914

1.52

14.64

3.1

3.2

1533.50

1497.19

ng/l

0.07

566

4249

Dependent personality disorder

284

1836

1.87

14.63

3.1

3.0

1134.65

866.63

ng/l

0.45

242

1546

Lactose intolerance, other/unspecified

346

2306

1.71

14.62

3.2

3.0

1723.94

1022.92

ng/l

1.12

294

1916

Pemphigoid

505

3740

1.66

14.60

3.8

3.4

2263.51

1770.04

ng/l

1.06

439

3301

Alzheimer’s disease, strict definition

4495

40050

0.86

14.58

3.0

3.6

2155.26

2113.81

ng/l

0.20

3871

35416

Complications of genitourinary prosthetic devices, implants and grafts

385

2661

1.71

14.58

3.7

3.0

1683.93

1229.49

ng/l

0.95

323

2270

Other juvenile arthritis

314

2004

1.69

14.58

3.3

3.4

1426.57

899.65

ng/l

0.97

266

1627

Polycystic kidney disease

375

2580

1.72

14.57

2.8

3.3

5739.55

1197.62

ng/l

9.73

347

2195

Glaucoma secondary to other eye disorders

657

4992

1.51

14.52

3.8

3.4

2861.01

1801.00

ng/l

3.11

574

4319

Impotence

851

6680

1.43

14.47

4.0

3.4

1837.63

1565.56

ng/l

0.51

731

5862

Myotonic dystrophy (Steinert)

277

4.36

14.47

3.0

3.3

513.83

814.51

ng/l

0.61

238

Myeloid leukaemia

444

3192

1.68

14.45

3.6

3.4

1417.14

1602.79

ng/l

0.36

416

2775

Traumatic subarachnoid haemorrhage

576

4276

1.53

14.33

3.7

3.1

2393.62

1764.93

ng/l

1.12

501

3765

Abnormal serum enzyme levels

5161

45281

1.15

14.31

3.3

3.4

1669.41

1597.97

ng/l

0.46

4638

39597

Injury of muscle and tendon at wrist and hand level

1768

14890

1.26

14.26

3.1

3.2

1126.22

1223.30

ng/l

0.45

1491

12727

Aortic stenosis

130

9.04

14.24

11.0

4.8

2609.73

1497.95

ng/l

0.71

106

Other surgical follow-up care

444

3129

1.60

14.23

3.6

2.8

1904.75

1040.84

ng/l

2.18

400

2613

Endometriosis ASRM stages 1,2

1786

14967

1.25

14.22

2.6

2.7

676.63

742.11

ng/l

0.29

1455

12457

Benign neoplasm: Skin of ear and external auricular canal

630

4789

1.52

14.14

3.6

3.3

2201.10

1697.20

ng/l

1.54

533

4178

Viral hepatitis

767

5862

1.41

14.13

3.0

3.1

1553.85

993.75

ng/l

0.96

634

4856

Other abnormal immunological findings in serum

273

1749

1.84

14.13

3.4

3.1

676.77

1004.29

ng/l

2.48

229

1476

Adalimumab

1046

8311

1.33

14.08

2.6

3.0

743.59

826.19

ng/l

0.34

892

6883

Postprocedural disorders of digestive system, not elsewhere classified

505

3700

1.59

14.06

3.1

3.3

1782.25

1412.26

ng/l

0.54

452

3185

Blood alcohol or alcohol intoxication level

284

1824

1.78

14.05

3.1

1226.87

985.42

ng/l

0.40

245

1519

Chronic viral hepatitis

494

3515

1.52

14.01

3.0

3.1

1748.53

863.41

ng/l

1.03

404

2825

Viral hepatitis, including avohilmo

801

6165

1.39

13.98

3.0

3.1

1503.04

983.14

ng/l

0.92

660

5086

Drug-induced hypoglycaemia without coma

262

1695

1.92

13.92

4.3

3.3

3960.70

1668.88

ng/l

2.86

231

1446

Scleritis and episcleritis

751

5768

1.42

13.92

3.0

820.31

989.07

ng/l

0.91

635

4857

Late syphilis, including avohilmo

265

1724

1.92

13.92

4.3

3.2

3809.45

1159.21

ng/l

5.28

226

1475

Hemiplegia

705

5398

1.45

13.92

3.7

3.2

1271.34

1633.98

ng/l

1.59

613

4629

Other and unspecified injuries of shoulder and upper arm

456

3262

1.59

13.91

3.8

3.2

1535.18

1190.49

ng/l

0.82

379

2754

Mild mental retardation

285

1833

1.77

13.90

3.4

3.6

1359.23

1035.35

ng/l

0.41

237

1508

Other diseases of spinal cord

435

3102

1.63

13.90

3.2

1058.04

1267.48

ng/l

0.78

366

2640

Delayed milestone in childhood

112

468

2.37

13.89

13.6

7.8

1841.40

1463.54

ng/l

0.20

106

392

Motor disorders, excluding more controls

363

2.58

13.89

15.1

5.6

1151.27

773.95

ng/l

0.42

296

Personal history of risk-factors, not elsewhere classified

162

892

2.13

13.88

3.9

2.7

840.67

948.93

ng/l

0.21

142

719

Infections with a predominantly sexual mode of transmission, including avohilmo

3876

31409

1.15

13.86

2.9

2.8

1034.97

842.41

ng/l

1.88

3059

25745

Vulvovaginal ulceration/inflammation in other diseases

661

4936

1.43

13.85

2.8

573.92

699.58

ng/l

0.83

529

4088

Gangrene, not elsewhere classified

142

787

2.54

13.83

4.6

2.8

6741.46

1491.52

ng/l

3.69

129

689

Carcinoma in situ of other and unspecified digestive organs

730

5710

1.48

13.83

3.5

3.2

1520.43

1364.47

ng/l

0.44

661

4958

Pilonidal cyst

824

6350

1.37

13.78

2.8

3.0

1190.34

913.65

ng/l

0.49

643

5152

Glaucoma suspect

6359

58465

1.13

13.77

3.3

3.2

1407.38

1504.38

ng/l

0.91

5503

50885

Bursitis of shoulder

354

2422

1.70

13.73

3.4

3.1

1169.57

1275.45

ng/l

0.21

310

2056

Urethritis and urethral syndrome

314

2096

1.75

13.73

3.2

3.1

1044.75

1179.51

ng/l

0.35

261

1750

Corticotropin deficiency

151

855

2.43

13.68

4.5

3.4

1070.44

1070.92

ng/l

0.00

134

733

Bacterial, viral and other infectious agents

986

7841

1.35

13.66

3.9

3.2

1389.77

1153.03

ng/l

0.93

851

6539

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

186

1103

2.13

13.63

3.9

3.2

1478.24

964.95

ng/l

0.42

165

919

Sequelae of injuries of neck and trunk

412

2911

1.63

13.61

2.9

3.2

847.98

1114.80

ng/l

1.48

348

2484

Melanocytic naevi, other sites/unspecified

1060

8528

1.34

13.60

3.8

3.1

1343.22

1175.93

ng/l

0.59

920

7265

Other autoimmune haemolytic anaemias

231

1492

2.10

13.59

3.7

3.3

1993.80

1475.43

ng/l

0.99

200

1289

Inflammatory disease of cervix uteri

870

6895

1.40

13.56

3.1

3.0

1094.66

1170.03

ng/l

0.26

726

5945

Other predominantly sexually transmitted diseases, not elsewhere classified

1530

12655

1.25

13.54

2.9

931.08

766.41

ng/l

0.76

1200

10331

Arthropod-borne viral fevers and viral haemorrhagic fevers

1294

10688

1.31

13.53

3.2

1123.93

1308.60

ng/l

0.93

1153

9165

Foreign body in alimentary tract

753

5848

1.43

13.52

3.5

3.3

1840.08

1434.14

ng/l

1.02

646

5032

Polycystic ovarian syndrome

360

2394

1.58

13.51

2.3

2.5

408.56

378.31

ng/l

0.10

273

1835

Otitis media, unspecified

1046

7648

1.32

13.44

4.2

3.2

942.86

1058.04

ng/l

0.61

851

6325

Other operation for atrial fibrillation

117

651

3.43

13.44

4.9

3.6

2098.38

1585.54

ng/l

0.43

112

552

Abnormal findings on diagnostic imaging of central nervous system

640

4841

1.46

13.43

3.2

3.0

906.22

1054.86

ng/l

0.71

540

4089

Diabetic neuropathy

1994

17243

1.27

13.40

4.3

4.0

3114.31

1925.38

ng/l

6.93

1824

15069

Pleural plaque without asbestos

663

5182

1.53

13.38

3.9

3.5

1480.24

1974.22

ng/l

3.74

602

4598

Chronic nephritic syndrome

551

4118

1.53

13.36

3.8

3.2

7112.00

1258.82

ng/l

13.03

507

3536

Astigmatism

745

5729

1.41

13.32

3.8

3.4

1091.38

1174.98

ng/l

0.21

613

4831

Amputation of ankle bones

378

2686

1.72

13.31

4.5

3.3

8707.64

1723.36

ng/l

10.97

352

2346

Acne vulgaris

538

3862

1.45

13.31

3.7

3.1

1333.93

536.21

ng/l

1.45

412

2941

Essential (haemorrhagic) thrombocythaemia

602

4593

1.52

13.30

3.3

3.2

2511.55

1367.33

ng/l

2.43

532

3954

Dependence on enabling machines and devices, not elsewhere classified

166

950

2.18

13.29

8.7

3.0

5329.75

1251.90

ng/l

4.61

159

809

Chromosomal abnormalities, not elsewhere classified

186

1067

1.95

13.28

4.6

879.08

739.91

ng/l

0.26

156

870

Late syphilis

221

1398

2.02

13.21

4.6

3.2

4294.04

1231.11

ng/l

5.04

188

1191

Other disorders starting during childhood or adolescence

299

1896

1.64

13.18

7.1

4.3

1513.15

715.17

ng/l

1.25

233

1462

Use of donepezil

3532

37362

0.85

13.16

2.8

3.6

1804.96

2104.81

ng/l

3.99

2941

33009

Polymyositis

151

873

2.44

13.12

5.2

3.2

1271.70

1248.40

ng/l

0.03

139

741

Chronic hepatitis, not elsewhere classified

479

3506

1.56

13.06

2.9

3.1

1432.31

989.45

ng/l

0.73

408

2949

Osteonecrosis due to drugs

274

1860

1.95

13.02

4.4

3.3

1978.71

1280.84

ng/l

0.68

256

1618

Crohn's disease of small intestine

782

6073

1.39

13.02

3.0

3.1

1284.53

999.41

ng/l

1.08

665

5105

Malignant neoplasm of oral cavity, including Hilmo

702

5473

1.46

13.00

3.0

3.3

1248.24

1365.36

ng/l

0.35

649

4730

Benign neoplasm: Rectosigmoid junction

680

5320

1.49

12.97

3.6

3.3

2017.95

1438.09

ng/l

1.32

605

4638

Polycystic ovarian syndrome, broad definition

687

5157

1.38

12.97

2.3

2.4

343.20

390.85

ng/l

0.28

532

4029

Alzheimer’s disease (undefined)

1300

0.35

12.96

3.1

3.7

3176.44

3251.30

ng/l

0.03

1141

Collapsed vertebra, not elsewhere classified

164

987

2.42

12.96

4.7

3.4

2158.12

1877.11

ng/l

0.23

142

850

Melanocytic naevi

4154

37342

1.15

12.93

3.4

3.1

1345.18

1210.30

ng/l

0.87

3555

31890

Other misadventures during surgical and medical care

371

2622

1.68

12.93

4.0

3.2

2096.78

1278.82

ng/l

2.49

329

2261

Other and unspecified trigeminal disorders

234

1493

1.91

12.90

3.5

3.1

727.03

1044.81

ng/l

1.79

188

1266

Polycythaemia vera

570

4355

1.54

12.87

3.7

3.3

2003.84

1551.63

ng/l

1.43

510

3784

Injuries involving multiple body regions

490

3587

1.52

12.78

3.3

1764.44

1348.22

ng/l

0.59

413

3005

Lichen sclerosus et atrophicus

1676

14259

1.26

12.76

3.0

972.19

1088.81

ng/l

0.73

1427

12196

Organ-limited amyloidosis

110

591

3.03

12.76

7.1

3.3

4828.44

1657.19

ng/l

6.02

100

509

Dystonia

726

5651

1.42

12.70

3.0

3.1

1050.26

1162.23

ng/l

0.38

621

4799

Amputation of thigh

542

4121

1.55

12.68

4.8

3.5

5126.22

2119.41

ng/l

7.33

495

3626

Other bursitis of hip

327

2259

1.72

12.67

3.9

3.0

1039.20

1380.44

ng/l

1.33

274

1919

Brain glioblastoma, helper endpoint

1710

0.42

12.65

2.0

3.2

495.86

1219.11

ng/l

8.55

1470

Lesion of radial nerve

527

3932

1.51

12.65

3.4

3.1

1479.03

1320.10

ng/l

0.35

447

3369

Laparoscopic right hemicolectomy

990

8140

1.39

12.63

3.0

3.4

1526.60

1527.42

ng/l

0.00

868

7135

Non-Hodgkin lymphoma, all

767

6097

1.44

12.62

3.9

3.4

2467.30

1774.63

ng/l

1.83

703

5327

Burns and corrosions

1641

13848

1.25

12.62

3.2

3.3

1507.69

1250.58

ng/l

0.99

1379

11718

Overexertion and strenuous or repetitive movements

1238

10209

1.30

12.60

2.9

3.2

1339.98

1151.19

ng/l

0.58

1057

8633

Dentofacial anomalies [including malocclusion]

9317

67781

1.10

12.59

3.0

684.55

1039.78

ng/l

23.56

7571

57172

Other specified disorders of kidney and ureter

483

3580

1.56

12.59

4.5

3.2

3836.28

1256.90

ng/l

5.66

441

3070

Cholangitis (primary sclerosing, PSC), with reimbursement 202

246

1585

1.83

12.55

3.2

3.5

1190.90

947.23

ng/l

0.61

209

1339

Follicular cysts of skin and subcutaneous tissue

2533

22188

1.20

12.52

3.3

3.2

1249.79

1312.94

ng/l

0.36

2200

19051

All dysplastic lesions of the vulva

529

3937

1.50

12.51

3.1

3.0

1074.28

839.36

ng/l

0.48

458

3333

Other and unspecified injuries of ankle and foot

471

3408

1.51

12.49

3.4

3.1

1503.38

940.30

ng/l

1.63

380

2839

Status epilepticus

502

3716

1.52

12.49

3.6

3.1

2199.56

1677.35

ng/l

0.80

433

3226

Disorders of speech understanding and production

467

3312

1.51

12.44

4.4

4.0

1582.56

1405.94

ng/l

0.30

410

2808

Carrier of infectious disease

321

2194

1.68

12.37

3.6

3.2

2464.68

1286.28

ng/l

1.72

270

1838

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

1150

9519

1.33

12.36

3.7

3.3

1877.86

1821.64

ng/l

0.14

1020

8307

Colon adenocarcinoma

2173

19011

1.23

12.35

3.0

3.4

1708.80

1705.20

ng/l

0.01

1919

16579

Carcinoma in situ of skin, other sites/unspecified

321

2304

1.88

12.35

3.9

3.5

2151.71

1739.46

ng/l

0.83

290

2030

Other specified and unspecified retinal disorders

556

4232

1.51

12.34

3.3

3.2

2123.33

1436.25

ng/l

0.92

490

3648

Follicular lymphoma, hilmo

683

5379

1.47

12.34

3.3

3.2

1429.49

1356.83

ng/l

0.21

611

4676

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

1044

8571

1.35

12.33

3.5

3.3

1670.09

1518.50

ng/l

0.53

935

7431

Lichen simplex chronicus

490

3640

1.54

12.32

3.3

3.1

1748.71

1237.17

ng/l

1.14

430

3099

Pulmonary oedema

328

2308

1.76

12.31

6.8

3.5

5467.40

2162.03

ng/l

7.75

305

2028

Atopic dermatitis, strict definition

2805

24009

1.17

12.31

3.0

1003.03

874.39

ng/l

0.60

2255

19745

Spondylopathies in diseases classified elsewhere

226

1478

2.00

12.31

3.8

3.2

1262.44

1691.74

ng/l

1.43

201

1295

Other and unspecified glaucoma

1228

10295

1.33

12.29

3.3

3.4

2018.33

1836.52

ng/l

0.55

1074

9041

Severe visual impairment, binocular

110

591

2.83

12.29

3.7

3.6

1986.35

1796.68

ng/l

0.13

506

Nonspecific lymphadenitis

678

5215

1.41

12.26

2.9

3.0

856.36

952.28

ng/l

0.40

577

4340

Other and unspecified injuries of thorax

267

1771

1.79

12.26

3.5

3.2

1978.17

1262.15

ng/l

0.64

225

1504

Crohn's disease NAS

739

5752

1.39

12.22

3.2

1635.37

1088.19

ng/l

2.14

633

4834

Poisoning by narcotics and psychodysleptics [hallucinogens]

166

953

1.99

12.22

3.7

3.3

1102.06

1121.51

ng/l

0.02

128

769

Nosocomial condition (hospital)

121

675

2.71

12.21

4.2

3.5

2775.55

1676.18

ng/l

0.68

104

580

Personal history of malignant neoplasm

1075

8770

1.31

12.19

3.1

2.5

1029.83

916.40

ng/l

0.36

940

7447

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1044

8531

1.33

12.16

3.3

3.2

1119.47

1283.49

ng/l

0.67

928

7294

Hypertrophic scar

579

4357

1.44

12.07

3.3

3.0

1208.91

939.09

ng/l

0.45

480

3621

IBD patients in KELA-register

2656

23297

1.18

12.05

3.0

3.1

1274.22

1101.74

ng/l

1.08

2201

19586

Melanocytic naevi of trunk

1571

13300

1.25

12.04

3.4

3.2

1341.21

1263.79

ng/l

0.28

1373

11382

Prolonged pregnancy

634

7160

0.73

12.04

1.8

2.4

216.26

389.21

ng/l

3.35

501

5674

Idiopathic thrombocytopenic purpura

432

3159

1.57

12.04

4.0

3.3

1431.69

1389.09

ng/l

0.09

383

2724

Necrotizing fasciitis

103

540

2.81

12.01

3.4

3.5

4275.92

1224.85

ng/l

2.29

461

Anankastic personality disorder

396

2798

1.54

11.96

3.0

2.9

508.73

714.51

ng/l

1.29

324

2293

Puerperal sepsis

1485

12514

1.26

11.96

2.5

2.8

646.84

745.78

ng/l

0.74

1240

10610

Etanercept

730

5688

1.38

11.93

2.9

3.0

1065.25

870.22

ng/l

0.68

631

4754

Other disorders of cornea

1404

11833

1.27

11.92

3.2

1428.69

1355.48

ng/l

0.25

1204

10167

Deep endometriosis

1137

9355

1.30

11.86

2.9

3.0

785.42

1121.69

ng/l

3.71

944

7931

Hordeolum and other deep inflammation of eyelid

747

5861

1.38

11.86

3.3

3.2

1097.15

1157.69

ng/l

0.20

632

4940

Embolic stroke

809

6503

1.40

11.86

4.1

3.4

2605.77

1949.23

ng/l

2.10

722

5722

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

311

2159

1.72

11.85

3.3

1317.66

1384.12

ng/l

0.14

261

1847

Eustachian salpingitis and obstruction

739

5732

1.36

11.83

2.9

3.0

684.45

825.47

ng/l

0.72

580

4657

Chalazion

1473

12422

1.26

11.81

3.1

1003.59

1318.17

ng/l

2.61

1249

10603

Chronic tubulo-interstitial nephritis

545

4136

1.48

11.81

3.7

2.8

2972.38

1080.79

ng/l

8.69

477

3508

Viral encephalitis, not elsewhere classified/unspecified

304

2103

1.73

11.79

3.3

1320.37

1393.01

ng/l

0.16

254

1800

Enteropathic arthropathies

267

1762

1.71

11.75

3.2

3.1

1055.37

1001.52

ng/l

0.11

234

1484

Dislocation, sprain and strain of joints and ligaments of head

442

3199

1.51

11.74

3.1

1125.13

1008.46

ng/l

0.20

363

2681

Carcinoma in situ of skin of lower limb, including hip

428

3237

1.68

11.71

3.7

3.4

2100.62

1597.31

ng/l

1.39

382

2850

Hyperosmolality and hypernatraemia

242

1614

1.88

11.69

3.8

3.2

2500.60

1715.97

ng/l

0.79

220

1391

Papilloedema, unspecified

294

2000

1.69

11.61

3.6

3.3

1468.44

1121.89

ng/l

0.81

247

1665

Other noninflammatory disorders of cervix uteri

673

5264

1.42

11.59

3.0

924.87

1369.72

ng/l

4.54

561

4593

Malignant neoplasm of head and neck

1298

10934

1.29

11.57

3.0

3.4

1506.83

1604.22

ng/l

0.32

1176

9503

Single spontaneous delivery

4786

27768

0.88

11.55

2.9

3.1

1040.94

1263.17

ng/l

4.55

4075

23791

Preterm labour and delivery

2668

23475

1.18

11.50

2.6

2.7

613.08

738.26

ng/l

1.80

2194

19652

Acute nasopharyngitis (common cold)

1297

10703

1.26

11.42

3.0

2.9

1099.27

918.12

ng/l

0.47

1087

8854

Hypothyroidism due to medicaments and other exogenous substances

198

1267

1.98

11.37

4.2

3.1

1785.01

1176.56

ng/l

1.49

182

1085

Benign neoplasm: Pituitary gland, craniopharyngeal duct

670

5236

1.41

11.35

2.7

3.1

1150.17

1160.57

ng/l

0.02

567

4442

Oesophageal obstruction

565

4369

1.48

11.33

3.1

3.2

1737.27

1616.55

ng/l

0.27

497

3818

Alcohol-induced chronic pancreatitis

872

7063

1.35

11.30

3.1

3.2

2159.46

1282.66

ng/l

2.63

763

6044

Other disorders of iris and ciliary body

427

3161

1.56

11.27

3.6

3.3

2781.65

1539.74

ng/l

2.35

372

2724

Spermatocele

1153

9628

1.30

11.16

3.7

3.4

1489.60

1738.88

ng/l

1.28

1002

8491

Panniculitis, unspecified

164

996

2.07

11.16

3.4

3.1

1261.16

1425.99

ng/l

0.21

147

842

Other/unspecified soft tissue disorders related to use, overuse and pressure

363

2580

1.57

11.16

3.0

1039.29

1080.02

ng/l

0.07

311

2160

Primary Sclerosing Cholangitis, IBD and UDCA required

260

1731

1.71

11.15

3.6

3.4

1419.93

1034.37

ng/l

0.53

224

1441

Hypersensitivity pneumonitis due to organic dust

257

1754

1.81

11.14

3.9

3.4

1079.07

1379.74

ng/l

0.83

233

1507

6-mercaptopurine

323

2215

1.58

11.14

2.6

2.8

698.41

1033.95

ng/l

1.51

256

1788

Congenital deformities of feet, including avohilmo

401

2879

1.51

11.12

4.2

3.2

873.20

924.85

ng/l

0.11

325

2371

Hypertrichosis

194

1187

1.80

11.08

2.2

2.7

400.44

511.68

ng/l

0.58

152

952

Hypoplasia of dental enamel, prenatal

6.02

11.08

15.4

12.1

4001.00

1154.04

ng/l

1.23

Other disorders of prostate

546

4203

1.48

11.07

3.3

3.4

2197.74

1884.48

ng/l

0.48

488

3733

Blindness, monocular

175

1105

2.10

11.04

4.1

3.5

3717.62

1520.08

ng/l

0.99

153

954

Bullous pemphigoid

393

2934

1.65

11.02

3.8

3.5

2084.96

1835.11

ng/l

0.40

339

2593

Myelodysplastic syndrome

245

1681

1.89

11.00

4.2

3.3

2648.10

1969.71

ng/l

1.15

229

1465

Need for immunization against other single viral diseases

268

1828

1.74

10.98

4.7

3.3

7593.34

1180.94

ng/l

6.07

248

1537

Causalgia

204

1296

1.84

10.96

2.6

3.0

516.22

770.47

ng/l

1.07

169

1083

Other and unspecified haemorrhagic conditions

238

1588

1.81

10.96

3.7

3.3

2099.29

1344.99

ng/l

1.14

206

1350

Other specified/unspecified deforming dorsopathies

227

1477

1.78

10.96

3.5

3.2

829.98

1212.41

ng/l

1.17

185

1244

Superficial injuries involving multiple body regions

343

2430

1.59

10.95

3.3

1258.74

1293.03

ng/l

0.08

288

2041

Infection due to other mycobacteria, including avohilmo

280

1946

1.75

10.93

4.4

3.1

1404.73

1258.77

ng/l

0.24

257

1674

Ankylosing hyperostosis [Forestier]

222

1474

1.88

10.93

3.2

3.3

849.65

1386.75

ng/l

2.76

196

1278

Femoral hernia

678

5382

1.41

10.91

3.6

3.2

1663.91

1521.44

ng/l

0.39

604

4672

Campylobacter enteritis

372

2688

1.58

10.91

3.6

3.3

1607.54

1243.11

ng/l

0.94

318

2275

Pedal cyclist injured in other and unspecified transport accidents

1409

11914

1.25

10.90

3.1

3.2

1216.37

1265.00

ng/l

0.17

1182

10094

Family history of other conditions

147

840

1.97

10.90

2.9

2.4

942.26

715.24

ng/l

0.36

116

676

Aneurysms, operations, SAH

2509

22253

1.19

10.89

3.0

3.2

1573.27

1445.43

ng/l

0.53

2207

19288

Other and unspecified acquired haemolytic anaemias

167

1044

2.12

10.87

6.2

3.3

2207.77

1554.62

ng/l

1.27

146

891

Sequelae of injuries of upper limb

1229

10283

1.27

10.85

2.9

3.1

807.51

1116.63

ng/l

4.08

1027

8690

Impetigo

464

3424

1.46

10.83

4.0

3.4

1344.07

1004.86

ng/l

0.75

394

2857

Mixed disorders of conduct and emotions, excluding more controls

107

539

2.10

10.77

4.3

3.6

1290.50

414.09

ng/l

0.89

390

Malignant neoplasm of oral cavity

547

4246

1.48

10.74

2.9

3.2

1291.25

1356.76

ng/l

0.14

506

3670

Hypersomnia

189

1192

1.89

10.72

4.0

3.3

976.28

982.73

ng/l

0.01

160

1006

Persons encountering health services in circumstances related to reproduction

6015

43780

0.90

10.70

3.1

3.0

651.66

908.50

ng/l

6.64

4958

36521

Delivery

4824

27809

0.89

10.67

2.9

3.1

1043.04

1264.34

ng/l

4.37

4112

23821

Benign neoplasm of meninges

1578

13613

1.25

10.66

3.4

3.2

1420.45

1362.90

ng/l

0.21

1360

11817

Episcleritis

615

4772

1.40

10.63

2.8

3.0

751.04

965.75

ng/l

1.14

519

4006

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

1100

9177

1.30

10.62

3.2

3.1

1113.65

1183.41

ng/l

0.24

922

7885

Intentional self-harm by sharp object

215

1362

1.72

10.62

2.7

3.2

485.17

858.88

ng/l

1.62

157

1062

Other diseases of gallbladder

691

5511

1.40

10.61

3.5

3.2

1339.20

1505.52

ng/l

0.60

604

4767

Other specified disorders of external ear

583

4575

1.46

10.60

3.2

3.4

1616.15

1507.01

ng/l

0.23

480

4021

Specific developmental disorder of motor function

432

2.25

10.59

15.0

6.3

1146.40

1070.05

ng/l

0.05

347

Conductive hearing loss, unspecified

1067

8841

1.29

10.58

3.6

3.2

1415.92

1389.82

ng/l

0.05

908

7615

Autonomic disorders

342

2453

1.60

10.58

2.9

3.1

778.82

1256.95

ng/l

3.99

295

2070

Malignant immunoproliferative diseases

198

1325

2.07

10.56

4.1

3.7

1946.60

1487.15

ng/l

0.71

178

1154

Endocrine disorders, other/unspecified

264

1806

1.71

10.53

3.4

3.1

1036.61

1064.51

ng/l

0.05

204

1531

Unspecified protein-energy malnutrition

115

659

2.52

10.53

4.8

3.7

2574.41

1666.05

ng/l

1.11

106

552

Behavioural disorders, excluding more controls

148

843

1.89

10.51

3.5

3.7

712.93

740.05

ng/l

0.04

123

666

Pyoderma gangrenosum

126

725

2.25

10.50

3.4

1407.65

1245.92

ng/l

0.23

116

613

Other renal tubulo-interstitial diseases

313

2202

1.62

10.49

3.3

2.9

2879.66

954.62

ng/l

5.24

272

1836

Disturbances of smell and taste

577

4487

1.43

10.47

3.1

3.0

685.91

1063.63

ng/l

4.84

499

3831

Disorders of tooth development and eruption

1824

12757

1.20

10.45

3.1

3.0

1103.13

1194.29

ng/l

0.43

1561

10914

Lesion of sciatic nerve

715

5766

1.40

10.42

3.6

3.4

1529.13

1898.63

ng/l

1.40

637

5055

Medical abortion

8551

43191

1.09

10.41

2.9

1016.61

1102.47

ng/l

1.16

7170

36718

Infection due to other mycobacteria

264

1836

1.76

10.40

4.5

3.1

1448.65

1293.58

ng/l

0.24

245

1575

Malignant neoplasm of bladder

1175

9916

1.29

10.39

3.3

3.5

2388.53

2079.23

ng/l

0.94

1050

8695

Other and unspecified iridocyclitis

616

4823

1.40

10.30

3.2

1427.78

1142.69

ng/l

0.65

528

4098

Brain glioblastoma

1612

0.46

10.30

2.0

3.1

495.86

1246.11

ng/l

8.62

1365

Magnesium deficiency

358

3.41

10.30

3.6

3.2

2415.18

1155.25

ng/l

1.33

299

Other/unspecified reactive arthropathies

804

6490

1.34

10.27

3.6

3.1

1450.72

1214.30

ng/l

0.56

700

5518

Spirochaetal infections, other/unspecified

1255

10634

1.27

10.26

3.0

3.2

873.54

1269.56

ng/l

4.81

1002

9223

Nontoxic diffuse goitre

456

3457

1.50

10.25

3.3

3.0

1023.04

1256.25

ng/l

0.87

406

2976

Hirsutism in women

162

964

1.85

10.25

2.0

2.7

397.13

490.99

ng/l

0.37

123

766

Autism spe, excluding more controls

137

764

1.89

10.21

2.9

3.4

539.32

405.31

ng/l

0.16

579

Other specific arthropathies, wide

282

1961

1.65

10.12

3.3

3.0

1112.86

1164.94

ng/l

0.12

245

1663

Simple and mucopurulent chronic bronchitis

603

4736

1.41

10.11

4.3

3.2

2035.66

1960.61

ng/l

0.09

523

4102

Peritonsillar abscess

2241

19647

1.18

10.10

3.2

3.0

1122.64

1127.34

ng/l

0.01

1873

16539

Maternal care related to the fetus and amniotic cavity and possible delivery problems

3500

22853

0.88

10.10

2.4

2.6

451.04

636.22

ng/l

4.95

2821

18844

Inflammatory bowel disease, strict (require KELA)

2656

23580

1.16

10.09

3.0

3.1

1274.22

1114.65

ng/l

0.96

2201

19828

Disorders of myoneural junction and muscle in diseases classified elsewhere

136

821

2.21

10.07

5.3

3.2

2329.71

1128.58

ng/l

1.17

118

691

Paranoid personality disorder

233

1559

1.73

10.06

2.6

3.3

1129.81

1099.39

ng/l

0.03

188

1307

Benign neoplasm of other and unspecified intrathoracic organs

185

1210

1.97

10.04

3.9

3.3

903.35

1295.90

ng/l

1.80

165

1011

Vascular syndromes of brain in cerebrovascular disorders

743

6058

1.39

9.99

4.1

3.4

1941.55

1848.70

ng/l

0.21

679

5352

Diseases of middle ear and mastoid

7384

56100

1.09

9.99

3.3

3.1

1220.11

1261.12

ng/l

0.28

6095

47377

Cervical polyps

1177

9875

1.26

9.98

2.8

2.9

958.07

1178.37

ng/l

1.58

978

8502

Shock, not elsewhere classified

160

1001

2.02

9.97

8.7

3.1

4053.74

1519.26

ng/l

3.26

153

854

Cauda equina syndrome

200

1316

1.85

9.93

3.4

3.2

1045.21

1102.16

ng/l

0.08

168

1114

Stenosis and insufficiency of lacrimal passages

1377

11790

1.25

9.92

3.2

1400.18

1494.25

ng/l

0.31

1173

10170

Mantle cell lymphoma, including Hilmo

248

1737

1.80

9.91

3.6

3.3

1478.28

1637.25

ng/l

0.34

231

1507

Fall on and from ladder

1123

9481

1.29

9.91

3.3

1320.55

1477.97

ng/l

0.61

967

8266

Benign neoplasm: Heart

388

3.33

9.90

4.0

3.4

1063.73

1442.75

ng/l

0.70

329

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

576

4338

1.37

9.90

3.6

3.4

653.64

927.73

ng/l

1.91

464

3504

Carcinoma in situ of colon

477

3703

1.51

9.88

3.5

3.2

1363.60

1317.34

ng/l

0.11

429

3224

Amblyopia ex anopsia

453

3400

1.45

9.82

3.7

3.5

1654.22

1214.13

ng/l

0.90

381

2866

Evidence of alcohol involvement determined by blood alcohol level

190

1222

1.82

9.81

3.0

3.1

990.17

968.00

ng/l

0.04

168

1028

Malignant neoplasm of other connective and soft tissue, including Hilmo

633

5051

1.40

9.81

3.4

3.3

1720.63

1447.76

ng/l

0.82

562

4348

Burns and corrosions of external body surface, specified by site

1274

10768

1.24

9.81

3.3

3.2

1591.59

1265.80

ng/l

1.06

1077

9099

malignant neoplasm of female genital organs

2453

21422

1.18

9.80

3.1

3.2

1503.85

1300.21

ng/l

1.07

2164

18349

Carcinoma in situ of other and unspecified genital organs

285

2016

1.66

9.80

3.6

3.0

1341.56

920.31

ng/l

0.48

247

1708

Aortic stenosis, including avohilmo

233

4.44

9.79

9.8

5.1

2790.48

1737.51

ng/l

0.79

191

Symptoms and signs involving appearance and behaviour

120

687

2.16

9.79

3.1

3.4

907.70

1093.53

ng/l

0.24

575

Herpesviral keratitis and keratoconjunctivitis

609

4819

1.40

9.78

3.4

3.2

1534.71

1335.96

ng/l

0.50

527

4135

Drug-induced obesity

118

669

2.15

9.78

3.6

3.2

1088.81

887.37

ng/l

0.41

551

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

403

2978

1.48

9.77

2.8

3.1

688.62

1059.47

ng/l

2.03

329

2493

Spinal osteochondrosis

144

864

1.99

9.76

3.2

3.5

1949.95

1299.26

ng/l

0.46

128

724

Viral meningitis, including avohilmo

386

2823

1.49

9.76

3.5

3.0

773.39

919.24

ng/l

0.52

316

2323

Other and unspecified injuries of wrist and hand

449

3371

1.45

9.75

3.0

3.2

1280.20

992.92

ng/l

0.56

354

2844

Infections of genitourinary tract in pregnancy

917

7489

1.29

9.74

2.7

2.8

840.56

735.11

ng/l

0.44

782

6253

Erosion and ectropion of cervix uteri

382

2831

1.53

9.73

3.0

896.61

1346.54

ng/l

2.58

321

2449

Benign neoplasm of eye and adnexa

1562

13542

1.23

9.71

3.3

3.2

1440.44

1397.50

ng/l

0.10

1337

11739

Brain glioblastoma and astrocytoma

110

1882

0.51

9.71

2.1

3.1

455.96

1192.66

ng/l

10.95

1588

Erythema nodosum

391

2906

1.52

9.71

4.2

3.1

1870.19

1108.11

ng/l

0.68

332

2463

Alzheimer’s disease (Late onset)

4272

38138

0.88

9.70

3.0

3.6

2169.88

2163.74

ng/l

0.02

3682

33770

Other congenital malformations of the digestive system, including avohilmo

580

4487

1.39

9.66

4.0

3.7

1186.83

1251.37

ng/l

0.15

510

3800

Gastrojejunal ulcer

207

1388

1.83

9.65

3.9

3.3

2276.31

1597.52

ng/l

0.85

188

1200

Toxic effect of carbon monoxide

258

1797

1.69

9.64

3.0

3.3

1494.61

1283.96

ng/l

0.27

237

1536

Complications of labour and delivery

6561

39278

0.91

9.62

2.6

2.8

684.25

852.57

ng/l

3.94

5415

33096

Malignant neoplasm of other and unspecified parts of tongue

246

1721

1.76

9.61

2.7

3.2

1096.96

1303.36

ng/l

0.51

228

1477

Disorders of purine and pyrimidine metabolism

110

641

2.45

9.59

6.1

3.3

3209.10

1250.13

ng/l

2.18

545

Progressive vascular leukoencephalopathy

771

6396

1.39

9.58

3.1

3.5

2593.15

1991.23

ng/l

1.63

697

5649

Outcome of delivery

758

5852

0.77

9.54

2.2

2.4

228.51

442.99

ng/l

3.78

601

4656

Abnormal findings in secretions and smears from cervix uteri vagina vulva

4734

38007

0.90

9.51

2.7

882.99

807.50

ng/l

0.41

3946

31637

Wide developmental disorders, excluding more controls

176

1050

1.72

9.49

3.2

3.7

552.30

548.83

ng/l

0.00

124

812

Abnormal spermatozoa

2037

18104

1.21

9.48

3.3

3.5

1695.50

1711.32

ng/l

0.04

1690

16022

Chronic Coagulation defects

268

1857

1.62

9.47

3.1

3.2

1207.88

994.15

ng/l

0.40

215

1550

Open wound of abdomen, lower back and pelvis

365

2673

1.50

9.43

3.3

1860.96

1255.80

ng/l

1.11

313

2255

Other and unspecified diseases of blood and blood-forming organs

394

2971

1.53

9.42

3.9

3.2

2173.32

1297.71

ng/l

2.03

327

2563

Habit and impulse disorders

163

1003

1.82

9.41

2.4

3.1

1105.08

834.83

ng/l

0.19

128

810

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

336

2484

1.60

9.40

2.8

3.3

1112.11

1408.57

ng/l

1.10

308

2136

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

542

2.62

9.38

6.2

3.2

3240.45

1149.86

ng/l

2.07

456

Other erythematous conditions

501

3890

1.44

9.38

3.6

3.1

1605.09

1225.72

ng/l

1.34

444

3332

Thyrotropin deficiency

146

893

1.96

9.35

2.8

3.1

2309.48

844.72

ng/l

0.46

116

753

111

618

2.10

9.33

2.8

3.2

739.30

1003.92

ng/l

0.65

505

Anorexia (incl.atypical)

501

3804

1.39

9.32

3.0

3.1

1881.57

1070.64

ng/l

0.91

407

3114

Achalasia of cardia

268

1899

1.67

9.29

4.2

3.3

1291.17

1564.11

ng/l

0.81

235

1645

Routine general health check-up of defined subpopulation

182

1144

1.72

9.26

2.7

2.4

1098.60

785.27

ng/l

0.35

158

938

Assault by unspecified means

200

1299

1.70

9.21

2.8

3.3

1086.19

789.38

ng/l

0.58

147

1040

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

282

1969

1.56

9.20

2.8

2.9

1041.52

1053.31

ng/l

0.02

249

1648

Other congenital malformations of the digestive system

483

3670

1.41

9.20

4.1

3.7

1227.25

1248.50

ng/l

0.04

433

3112

Chronic iridocyclitis

634

5061

1.37

9.16

3.2

1348.21

1223.48

ng/l

0.27

545

4311

Defects in the complement system

524

2.31

9.15

3.8

3.4

455.97

801.53

ng/l

1.79

432

Fistulae involving female genital tract

222

1509

1.72

9.15

3.1

3.0

1282.88

1128.32

ng/l

0.17

191

1298

Other lesions of median nerve

437

3371

1.49

9.14

3.4

3.2

1674.02

1501.78

ng/l

0.34

375

2909

Benign neoplasm of urinary organs

724

5920

1.36

9.13

3.3

3.2

1981.35

1439.84

ng/l

1.02

623

5141

Turner's syndrome

109

4.12

9.13

2.2

4.5

462.77

395.12

ng/l

0.10

Carcinoma in situ of other and unspecified sites

678

5553

1.40

9.13

3.7

3.4

2081.41

1827.52

ng/l

0.44

611

4917

Viral meningitis

369

2714

1.48

9.07

3.5

3.0

775.15

932.97

ng/l

0.55

299

2230

HSIL lesion of the vulva

249

1744

1.68

9.06

2.9

3.1

1301.41

964.15

ng/l

0.31

210

1490

Benign lipomatous neoplasm of other sites/unspecified

1301

11205

1.25

9.06

3.4

3.3

1479.60

1564.42

ng/l

0.32

1127

9744

Crushed, pushed or stepped on by crowd or human stampede

703

5614

1.31

9.06

3.4

3.3

1045.42

1038.94

ng/l

0.02

567

4628

Vestibular neuronitis

1248

10687

1.25

9.05

3.4

3.2

1218.06

1334.29

ng/l

0.35

1083

9264

Otorrhagia

128

785

2.18

9.05

5.0

3.2

2141.63

1569.66

ng/l

0.51

115

677

Complications following abortion and ectopic and molar pregnancy

446

3424

1.46

9.04

3.2

3.0

939.81

929.46

ng/l

0.02

372

2935

Male infertility

390

2870

1.44

9.04

3.4

3.2

1435.96

971.24

ng/l

0.49

325

2263

Other contact dermatitis

977

8133

1.27

9.04

3.4

3.1

1199.23

1297.81

ng/l

0.34

825

6911

Other prurigo

183

1214

1.87

9.03

3.6

3.2

3688.86

1380.87

ng/l

1.14

166

1043

Retinal detachment with retinal break

1988

17620

1.20

9.02

3.5

3.3

1724.18

1467.02

ng/l

1.39

1739

15348

Juvenile rheumatoid arthirtis

189

1213

1.70

8.98

2.6

3.2

1108.03

901.28

ng/l

0.28

165

983

Open wound of shoulder and upper arm

262

1837

1.62

8.97

4.5

3.2

2352.13

1154.09

ng/l

1.11

217

1533

Other factor of the environment

180

1179

1.83

8.97

3.9

3.2

3215.71

1134.18

ng/l

1.57

164

1003

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

153

1004

2.13

8.94

4.0

3.4

1752.04

1477.82

ng/l

0.38

136

866

Implicit parasitic Sepsis, including avohilmo

104

600

2.33

8.93

4.4

3.1

1375.10

1164.71

ng/l

0.36

504

Disorder of the sleep-wake schedule

196

1285

1.71

8.90

3.4

3.6

1088.94

992.23

ng/l

0.06

146

1060

Congenital deformities of feet

255

1760

1.59

8.88

3.9

3.3

740.47

838.62

ng/l

0.29

210

1435

Parkinson's disease, including avohilmo

2768

25105

1.17

8.87

3.0

3.4

1287.41

1777.35

ng/l

11.28

2415

22083

Chronic myeloproliferative disease

247

1779

1.76

8.85

3.5

3.3

2757.64

1448.45

ng/l

2.79

225

1553

Benign neoplasm: Cerebral meninges

1417

12307

1.24

8.84

3.3

3.2

1400.57

1352.23

ng/l

0.16

1217

10667

Use of other anti-dementia drugs

5790

43589

1.12

8.84

3.1

3.6

1988.65

2106.89

ng/l

1.04

4954

38595

Use of memantine

5790

43589

1.12

8.84

3.1

3.6

1988.65

2106.89

ng/l

1.04

4954

38595

Other and unspecified mental retardation

156

959

1.81

8.80

4.7

5.2

1679.85

1122.01

ng/l

0.28

134

796

Other specified and unspecified disorders of lens

168

1122

2.00

8.80

3.9

3.3

2061.76

1950.92

ng/l

0.08

129

993

Endometriosis ASRM stages 3,4

2712

24359

1.15

8.78

2.8

2.9

858.13

1019.79

ng/l

2.10

2251

20711

Benign intracranial hypertension

494

2.13

8.74

3.8

3.1

1075.82

768.34

ng/l

0.23

386

Toxic effect of other and unspecified substances

136

818

1.89

8.73

2.8

3.3

1488.71

883.33

ng/l

0.53

114

659

Motor disorders

476

2.08

8.73

15.0

6.8

1146.40

1315.81

ng/l

0.12

389

Diffuse brain injury

414

3119

1.43

8.73

3.1

3.0

1367.94

1521.37

ng/l

0.34

339

2705

Localized scleroderma [morphea]

211

1443

1.74

8.71

3.3

3.0

694.70

980.58

ng/l

1.48

181

1221

Anogenital herpesviral [herpes simplex] infection, including avohilmo

915

7527

1.26

8.70

2.7

2.9

525.20

766.26

ng/l

1.69

699

6096

Oral lichen planus, including avohilmo , including avohilmo

952

7994

1.28

8.64

2.6

3.1

628.36

1038.97

ng/l

7.31

799

6843

Carcinoma in situ, bladder

625

5112

1.40

8.61

3.7

3.4

2102.03

1812.92

ng/l

0.47

560

4530

Alzheimer’s disease (undefined), excluding more controls

1082

0.42

8.61

3.1

3.5

3176.44

3140.25

ng/l

0.01

936

Drug-induced systemic lupus erythematosus

104

605

2.26

8.57

3.8

3.3

1322.78

859.18

ng/l

0.72

511

Abrasion of teeth

5060

46887

1.11

8.56

2.9

3.0

786.52

1066.46

ng/l

11.32

4302

40055

Explicit fungal Sepsis, including avohilmo

121

740

2.15

8.56

6.2

3.0

2632.08

1165.86

ng/l

1.66

114

629

Alzheimer’s disease (Atypical or mixed)

2208

19623

1.19

8.56

3.4

3.7

2119.29

2364.55

ng/l

1.50

1904

17391

Alcohol withdrawal state with delirium

934

7844

1.29

8.55

3.0

3.3

1561.89

1440.51

ng/l

0.40

826

6730

Deficiency of other B group vitamins

319

2361

1.56

8.53

3.7

3.3

1735.00

1605.48

ng/l

0.21

279

2047

Benign neoplasm: Parotid gland

1129

9654

1.26

8.52

3.3

3.2

1554.60

1434.88

ng/l

0.30

1000

8353

Mantle cell lymphoma

170

1144

1.95

8.52

3.5

3.4

1338.69

1711.05

ng/l

0.89

156

986

Use of antiglaucoma preparations and miotics

1353

11783

1.24

8.52

3.4

2083.41

1925.88

ng/l

0.48

1180

10322

Benign neoplasm of middle ear and respiratory system

1121

9572

1.26

8.52

3.4

3.3

1245.37

1521.58

ng/l

1.86

969

8282

Other salmonella infections

483

3770

1.41

8.52

3.5

3.0

1630.93

1268.39

ng/l

0.49

398

3196

Hyphaema and other vascular disorders of iris and ciliary body

323

2405

1.56

8.49

3.9

3.4

3160.86

1551.75

ng/l

2.57

287

2091

Anomalies of dental arch relationship, including avohilmo

1968

15635

1.17

8.49

3.5

3.1

786.60

950.67

ng/l

0.97

1591

12970

Granulomatous disorders of skin and subcutaneous tissue

332

2451

1.51

8.48

3.4

3.1

1116.11

956.96

ng/l

0.57

289

2052

Haemangioma, any site

1098

9328

1.25

8.46

3.2

1012.15

1215.01

ng/l

1.09

923

7997

Procreative management

3572

26723

1.12

8.46

3.4

3.0

656.10

936.88

ng/l

4.77

2978

22144

Previous suicide attempt

118

690

1.97

8.46

2.8

3.0

786.69

817.51

ng/l

0.04

102

555

Unspecified event, undetermined intent

297

2146

1.54

8.46

3.3

1981.55

1157.86

ng/l

1.22

241

1798

Any dementia, excluding more controls

7174

46366

1.10

8.44

3.2

3.4

2000.51

1805.71

ng/l

2.55

6249

40933

Other acquired deformities of ankle and foot

122

738

2.05

8.44

3.0

3.3

721.09

1107.26

ng/l

1.86

106

633

Other ulcerative colitis

645

5181

1.33

8.43

3.0

3.2

1546.11

1069.06

ng/l

1.22

540

4361

Migraine, single triptan purchase ok & required. ICD-code if available is included

9738

62236

1.07

8.42

2.7

3.0

622.64

992.18

ng/l

22.79

7926

52327

Triptan medication for migraine, single purchase ok

9738

62236

1.07

8.42

2.7

3.0

622.64

992.18

ng/l

22.79

7926

52327

Disorder of external ear, unspecified

462

3601

1.43

8.40

3.3

3.2

1478.58

1256.13

ng/l

0.56

391

3103

Sequelae of injuries of lower limb

1127

9580

1.24

8.38

3.1

1248.82

1159.45

ng/l

0.34

954

8114

Encephalitis

381

2885

1.47

8.36

3.2

3.3

1176.42

1260.33

ng/l

0.24

327

2455

Prolapse and hernia of ovary and fallopian tube

641

5200

1.38

8.34

3.5

3.4

1649.56

2164.87

ng/l

2.75

562

4523

Effects of other external causes

285

2031

1.52

8.33

2.9

3.4

736.56

1096.37

ng/l

1.20

235

1677

Family history of malignant neoplasm

1159

9832

1.23

8.33

2.5

2.4

719.51

778.55

ng/l

0.15

985

8181

Other and unspecified paralytic syndromes

203

1389

1.73

8.32

3.8

3.2

1277.58

1331.10

ng/l

0.08

181

1181

Acquired absence of organs, not elsewhere classified

181

1212

1.79

8.31

3.3

2.8

2215.39

1306.61

ng/l

1.08

163

1032

Other and unspecified nail disorders

321

2378

1.53

8.31

4.0

3.1

1208.13

1005.81

ng/l

0.58

279

2015

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

294

2097

1.49

8.26

4.4

3.6

848.88

895.54

ng/l

0.11

244

1703

Explicit fungal Sepsis

119

733

2.13

8.20

6.3

3.0

2652.46

1166.57

ng/l

1.67

113

623

Syphilis, including avohilmo

336

2507

1.51

8.20

4.0

3.2

3246.02

1251.28

ng/l

4.63

286

2123

Syphilis

336

2507

1.51

8.20

4.0

3.2

3246.02

1251.28

ng/l

4.63

286

2123

Contusion of ankle

439

3367

1.40

8.16

3.1

3.2

1248.58

1018.56

ng/l

0.67

369

2807

Benign neoplasm: salivary glands, exclude unknown (D119)

1252

10834

1.24

8.12

3.4

3.2

1534.18

1438.04

ng/l

0.25

1104

9389

Isolated proteinuria with specified morphological lesion

175

1177

1.82

8.12

4.5

3.3

5094.06

1185.90

ng/l

4.53

163

1000

Malignant neoplasm of rectum, including Hilmo

1969

17582

1.19

8.11

2.9

3.4

1419.67

1585.18

ng/l

1.23

1742

15312

Benign neoplasm: Pancreas

452

3581

1.46

8.08

3.1

3.2

1333.17

1285.00

ng/l

0.09

412

3092

Total colectomy

505

3982

1.38

8.07

3.2

1865.85

1259.87

ng/l

0.82

432

3392

Total colectomy operation

505

3982

1.38

8.07

3.2

1865.85

1259.87

ng/l

0.82

432

3392

Unspecified chronic bronchitis

508

4020

1.39

8.06

4.8

3.2

1454.76

1841.07

ng/l

1.04

455

3479

Other diseases of peritoneum

615

4993

1.35

8.05

3.5

3.1

1245.60

1272.93

ng/l

0.07

523

4273

Other superficial mycoses

263

1875

1.56

8.03

4.1

3.2

1448.08

949.94

ng/l

1.01

234

1570

Disorders of porphyrin and bilirubin metabolism

153

987

1.83

8.01

2.9

3.3

1839.95

1075.57

ng/l

0.34

131

822

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

689

5591

1.30

8.00

2.6

3.1

1052.92

987.43

ng/l

0.16

575

4664

Diabetes insipidus

136

861

1.94

8.00

3.5

3.2

1171.53

1002.57

ng/l

0.30

119

719

Implicit parasitic Sepsis

510

2.40

8.00

4.4

3.2

1476.51

1264.97

ng/l

0.31

431

Primary adrenocortical insufficiency

158

1035

1.84

7.99

4.6

3.4

1116.46

1009.70

ng/l

0.19

141

878

Malignant neoplasm of corpus uteri, including Hilmo

1493

13148

1.22

7.99

3.1

3.2

1633.43

1369.98

ng/l

0.98

1299

11370

Torticollis

176

1154

1.70

7.98

3.4

3.3

1242.14

1123.36

ng/l

0.11

141

968

Glaucoma, exfoliation

1979

17757

1.19

7.97

3.3

3.5

1866.17

2011.22

ng/l

0.66

1715

15599

Hyperprolactinaemia

314

2290

1.47

7.97

3.7

3.0

656.44

740.93

ng/l

0.33

261

1888

Alcoholic liver disease

1445

12641

1.21

7.97

3.3

1816.40

1431.61

ng/l

2.01

1274

10931

Psoriasis (vulgaris), strict definition

412

3165

1.42

7.96

3.1

3.2

909.80

1081.83

ng/l

0.72

341

2677

Dermatopolymyositis, unspecified

551

2.36

7.93

5.8

3.2

1092.06

1171.62

ng/l

0.10

461

Toxic effect of ethanol

409

3121

1.41

7.92

3.2

1178.18

1212.40

ng/l

0.06

340

2601

Unspecified nephritic syndrome

311

2320

1.53

7.92

3.7

3.2

3822.70

1321.40

ng/l

3.73

285

1985

Dissocial personality disorder

171

1121

1.72

7.91

2.6

3.3

649.42

1043.84

ng/l

1.17

141

910

Childhood allergy (age < 16)

616

3999

1.29

7.88

3.8

3.5

498.88

617.46

ng/l

0.33

421

2881

Atopic conjunctivitis

479

3736

1.37

7.88

2.8

3.1

1551.89

929.42

ng/l

0.81

402

3103

Fourth [trochlear] nerve palsy

335

2544

1.52

7.84

3.6

3.3

1098.97

1384.47

ng/l

0.86

286

2217

Diastasis of muscle

113

672

1.97

7.84

3.4

3.6

700.52

1155.26

ng/l

1.51

570

Other encephalitis

358

2714

1.47

7.84

3.2

3.4

1205.99

1265.43

ng/l

0.15

309

2311

IgA nephropathy (IgA glomerulonephritis)

294

2162

1.53

7.83

4.5

3.2

7172.68

1146.21

ng/l

7.42

266

1823

Other Crohn's disease

707

5774

1.29

7.75

2.7

3.1

1286.17

945.83

ng/l

1.27

603

4813

Other and unspecified mononeuropathies of lower limb

394

3051

1.45

7.74

4.0

3.0

1003.04

1132.38

ng/l

0.48

321

2597

Haemangioma and lymphangioma, any site

1157

9944

1.23

7.73

3.2

1085.34

1219.40

ng/l

0.53

977

8521

Lifestyle-related condition

168

1125

1.79

7.72

3.8

3.2

3447.10

1177.32

ng/l

1.60

152

953

Diabetes mellitus in pregnancy

2223

12498

1.15

7.72

2.2

2.4

541.17

413.12

ng/l

0.90

1703

9985

Paraplegia, diplegia of upper limbs

310

2322

1.53

7.69

3.7

3.4

990.08

1402.38

ng/l

1.88

277

1996

Other benign neoplasms of connective and other soft tissue

1272

11022

1.22

7.69

3.2

1280.07

1264.28

ng/l

0.05

1118

9443

Other disorders of electrolyte and fluid balance, not elsewhere classified

152

1007

1.88

7.69

3.8

3.2

2875.35

1336.72

ng/l

1.31

140

844

Congenital malformation syndromes predominantly affecting facial appearance

114

3.58

7.69

3.8

5.3

1695.75

1029.53

ng/l

0.21

Inflammatory disorders of male genital organs, not elsewhere classified

189

1292

1.71

7.68

3.6

3.4

1572.49

1798.43

ng/l

0.38

175

1121

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

790

6636

1.30

7.65

3.3

3.4

1472.87

1663.83

ng/l

0.52

704

5792

Pyoderma

259

1879

1.57

7.65

4.2

3.2

1894.79

1194.33

ng/l

1.06

219

1606

Other drug-induced secondary parkinsonism

171

1174

1.85

7.65

3.5

3.3

1157.67

1130.41

ng/l

0.05

150

997

Unspecified visual impairment (binocular)

223

1581

1.64

7.65

3.6

3.5

1868.14

1357.82

ng/l

0.57

195

1356

Malignant neoplasm of corpus uteri

1372

12060

1.23

7.64

3.1

3.2

1622.28

1368.45

ng/l

0.90

1204

10431

Fibrosis of liver

126

805

2.03

7.63

4.4

3.1

1014.67

1001.02

ng/l

0.02

104

688

Arnold-Chiari syndrome

462

2.10

7.60

4.4

3.5

975.89

742.86

ng/l

0.22

370

Nonalcoholic steatohepatitis

130

822

1.92

7.60

3.0

3.1

807.58

725.78

ng/l

0.12

100

683

Allergic purpura

349

2636

1.45

7.57

3.8

3.3

1542.08

1196.14

ng/l

0.70

297

2229

Myopia

1246

10702

1.20

7.57

3.5

3.0

1050.05

925.92

ng/l

0.26

998

8848

Sequelae of injuries of head

647

5284

1.31

7.55

3.2

1359.40

1271.68

ng/l

0.16

522

4506

Calculus of lower urinary tract

821

6938

1.30

7.51

3.4

1583.72

1896.30

ng/l

1.09

707

6108

Disorders of synovium and tendon in diseases classified elsewhere

288

2130

1.53

7.51

2.8

3.2

2368.21

1359.72

ng/l

1.06

250

1836

Myasthenia gravis

259

1906

1.60

7.50

3.4

3.3

1336.29

1298.50

ng/l

0.06

219

1641

Hepatocellular carcinoma, including Hilmo

473

3787

1.41

7.48

3.3

3.4

1482.70

1747.77

ng/l

0.49

424

3304

Subacute thyroiditis

438

3423

1.39

7.48

2.9

786.16

1114.27

ng/l

1.41

380

2892

Injury of nerves at wrist and hand level

435

3390

1.39

7.47

3.0

3.3

1042.53

1106.96

ng/l

0.12

356

2862

Disorders of orbit

550

4428

1.35

7.47

2.9

3.1

1256.26

1103.57

ng/l

0.39

472

3749

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

1058

9125

1.25

7.46

3.3

3.4

1454.65

1697.94

ng/l

0.92

944

7960

Metabolic disorder, other/unspecified

221

3.02

7.46

4.0

3.3

1351.32

893.82

ng/l

0.38

181

Unspecified threat to breathing

123

763

1.90

7.45

4.4

3.7

824.67

939.58

ng/l

0.22

107

634

Thyroiditis, unspecified

191

1311

1.67

7.45

3.5

2.9

2213.82

991.26

ng/l

1.88

159

1111

Volvulus

413

3234

1.43

7.45

3.5

3.2

2199.13

1571.81

ng/l

0.67

363

2825

Other congenital malformations of nervous system

516

2.02

7.44

4.3

3.6

927.33

730.98

ng/l

0.20

411

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1791

15920

1.18

7.44

3.2

3.1

1003.70

1244.52

ng/l

2.54

1520

13695

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

193

1334

1.68

7.43

3.7

3.1

1759.88

1230.49

ng/l

0.87

174

1136

Secondary parkinsonism+Parkinsonism in other disease

440

3496

1.43

7.41

3.3

1229.95

1673.50

ng/l

1.55

388

3051

Malignant neoplasm of breast, ER-negative, including Hilmo

3201

27452

1.13

7.39

3.0

1249.09

1199.46

ng/l

0.30

2740

23364

Cerebral palsy

144

913

1.74

7.38

3.3

3.6

1191.69

768.61

ng/l

0.32

117

748

Exposure to other and unspecified animate mechanical forces

316

2344

1.45

7.37

3.2

3.3

1314.53

994.90

ng/l

0.48

260

1925

Malignant neoplasm of bone and articular cartilage

153

1023

1.84

7.37

5.0

3.3

1284.80

1336.11

ng/l

0.06

141

860

Triptan medication for migraine, min. 3 purchases

6128

42759

1.09

7.36

2.6

2.8

527.14

821.89

ng/l

10.77

4911

35528

Non-small cell lung cancer, adenocarcinoma

1030

8888

1.26

7.35

3.2

3.4

1322.67

1632.16

ng/l

2.33

947

7772

Other vitreous opacities

597

4887

1.34

7.34

3.2

1325.83

1293.46

ng/l

0.07

498

4225

Acute epiglottitis

192

1321

1.66

7.34

2.9

3.0

1342.49

1186.71

ng/l

0.18

164

1125

Calcaneal spur

181

1241

1.71

7.32

3.0

670.87

1169.33

ng/l

3.77

158

1050

Inflammatory disorders of breast

594

4781

1.30

7.31

2.8

1148.75

724.63

ng/l

1.52

491

3937

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

103

650

2.33

7.29

4.0

3.5

1609.39

1496.59

ng/l

0.10

557

Secondary parkinsonism

430

3417

1.43

7.25

3.3

1249.87

1679.67

ng/l

1.42

378

2972

Chorioretinal inflammation

367

2825

1.44

7.25

3.6

3.1

1403.43

1124.39

ng/l

0.63

321

2393

Crohn disease (strict definition, require KELA)

640

5212

1.29

7.24

2.6

3.1

1031.89

981.51

ng/l

0.12

534

4345

Crohn disease (strict definition, require KELA, min 2 HDR)

630

5122

1.30

7.23

2.6

3.1

1021.64

985.47

ng/l

0.08

525

4268

Contact with sharp object, undetermined intent

274

2004

1.50

7.23

3.1

3.3

1097.01

1130.69

ng/l

0.05

227

1673

Other and unspecified acne

131

818

1.77

7.17

3.8

3.2

1231.36

689.66

ng/l

1.07

103

647

Neuroendocrine tumor and carcinoma of pancreas

113

716

2.07

7.16

3.8

3.2

792.77

1102.07

ng/l

0.59

102

591

Other intracranial haemorrhages

532

4347

1.38

7.14

4.2

3.4

1885.52

1886.42

ng/l

0.00

482

3829

Monosomies and deletions from the autosomes, not elsewhere classified

3.69

7.13

5.0

7.2

401.76

787.17

ng/l

1.11

Atypical mycobacterium lung infection

203

1459

1.71

7.13

3.8

3.2

1251.09

1467.89

ng/l

0.54

186

1247

Oral lichen planus and hypothyroidism or thyroxine medication

281

2110

1.54

7.12

2.6

3.0

665.90

877.68

ng/l

0.83

233

1786

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

128

4.28

7.11

2.7

3.1

1634.09

1154.19

ng/l

0.47

109

Inguinal hernia, unilateral

408

3221

1.43

7.09

3.5

3.1

1536.60

1394.50

ng/l

0.36

365

2780

Femoral hernia, unilateral

408

3221

1.43

7.09

3.5

3.1

1536.60

1394.50

ng/l

0.36

365

2780

Inguinal of femoral hernia, unilateral

408

3221

1.43

7.09

3.5

3.1

1536.60

1394.50

ng/l

0.36

365

2780

Disorders of adrenal gland, other and/or unspecified

511

2.25

7.08

4.0

3.2

1029.00

1001.11

ng/l

0.04

430

Other and unspecified erythematous conditions

443

3517

1.39

7.08

3.5

3.1

1588.66

1208.22

ng/l

1.22

393

3007

Parkinson's disease, strict definition

2459

22442

1.16

7.07

3.1

3.4

1314.55

1806.63

ng/l

9.69

2143

19768

Parkinson's disease

2628

24056

1.15

7.05

3.0

3.4

1291.64

1779.62

ng/l

10.46

2288

21158

Right hemicolectomy

913

7835

1.27

7.04

3.7

3.3

1907.40

1710.07

ng/l

0.46

811

6841

Multifocal fibrosclerosis

116

752

2.10

7.04

3.4

1595.71

1727.48

ng/l

0.14

100

642

Portal vein thrombosis

237

1732

1.59

7.00

2.8

3.3

1561.17

1347.30

ng/l

0.28

194

1480

Chronic suppurative otitis media, including avohilmo

959

8182

1.24

6.99

3.8

3.4

1444.65

1472.69

ng/l

0.08

802

7028

Benign mammary dysplasia

1976

17766

1.17

6.99

2.9

3.1

1031.62

1233.45

ng/l

1.71

1727

15295

Adenocarcinoma of pancreas

294

3840

0.69

6.97

2.3

3.3

1221.91

1576.35

ng/l

0.87

267

3327

Chronic myeloid leukaemia, including Hilmo

148

999

1.84

6.96

4.0

3.2

1805.72

1308.04

ng/l

0.37

140

846

Benign neoplasm of major salivary glands

1395

12303

1.20

6.95

3.5

3.2

1620.90

1475.54

ng/l

0.45

1229

10679

Shoulder region

219

1583

1.62

6.92

3.5

3.3

2091.79

1228.53

ng/l

1.86

191

1346

Microscopic polyangiitis

111

716

2.13

6.91

4.1

3.4

2276.25

1151.31

ng/l

2.11

102

599

Pedestrian injured in transport accident

889

7551

1.25

6.91

3.0

3.3

1581.86

1371.75

ng/l

0.43

735

6436

Pustulosis palmaris et plantaris

532

4311

1.34

6.90

3.1

3.0

1414.05

983.87

ng/l

1.26

441

3681

Molar incisor enamel hypoplasia

214

1412

1.51

6.89

10.1

4.7

1534.90

758.37

ng/l

1.55

188

1114

Localized skin eruption due to drugs and medicaments

167

1146

1.73

6.88

3.2

3.1

1194.40

1145.85

ng/l

0.08

141

977

Other osteochondropathies

779

6527

1.26

6.88

3.1

1195.68

1180.39

ng/l

0.03

643

5492

Autoimmune thyroiditis

208

1464

1.58

6.86

3.2

2.9

655.36

862.31

ng/l

1.00

174

1218

525

1.87

6.86

3.5

3.9

1221.06

377.24

ng/l

0.89

394

Open wound of hip and thigh

372

2870

1.40

6.86

3.1

3.3

1130.97

1214.80

ng/l

0.17

314

2396

Erythema multiforme

300

2267

1.48

6.85

3.6

3.1

1436.18

1216.88

ng/l

0.37

264

1914

Haemorrhagic disorder due to circulating anticoagulants

253

1908

1.62

6.85

6.1

3.4

2873.43

2081.68

ng/l

1.76

219

1683

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

169

1141

1.65

6.83

4.1

3.7

1065.55

1018.65

ng/l

0.05

145

958

Scleritis

173

1189

1.68

6.83

3.5

3.1

858.44

964.41

ng/l

0.25

148

994

Malignant neoplasm of mesothelium and soft tissue

612

5077

1.33

6.82

3.4

1636.66

1520.98

ng/l

0.29

553

4419

Malignant neoplasm of gum, including Hilmo

166

1160

1.79

6.80

3.1

3.2

880.63

1533.44

ng/l

2.55

150

984

Mucosal proctocolitis

1375

12030

1.18

6.78

3.0

3.2

1248.06

1072.95

ng/l

0.68

1125

10091

Other bursitis of knee

190

1332

1.64

6.77

3.9

3.4

1817.44

1345.11

ng/l

0.67

158

1148

Other proliferative retinopathy

432

2.29

6.77

3.4

2219.62

1344.83

ng/l

0.95

362

Macular hole

937

8104

1.26

6.77

3.6

3.3

1619.41

1411.06

ng/l

0.77

817

7107

Other and unspecified hypertrophic disorders of skin

570

2.03

6.74

3.0

2.9

747.71

773.58

ng/l

0.05

476

Other salmonella infections, including avohilmo

531

4302

1.33

6.73

3.4

3.0

1542.52

1210.35

ng/l

0.49

439

3638

Type 1 diabetes, definitions combined

694

5692

1.25

6.64

3.0

2.9

1907.64

655.80

ng/l

5.24

593

4571

Benign leiomyoma with endometriosis

2169

19657

1.15

6.64

3.0

1069.88

1169.28

ng/l

0.66

1812

16979

Chronic constrictive pericarditis

354

3.08

6.63

7.5

3.6

3095.44

1568.90

ng/l

0.87

295

Car occupant injured in noncollision transport accident

378

2932

1.38

6.63

3.0

3.3

1223.36

1150.25

ng/l

0.12

316

2449

Other and unspecified disorders of adult personality and behaviour

328

2.28

6.62

2.6

3.0

250.89

735.22

ng/l

3.51

266

Colon adenocarcinoma, helper endpoint

2173

19775

1.16

6.61

3.0

3.4

1708.80

1753.81

ng/l

0.15

1919

17358

Other or unspecified immunodeficiency

318

2.51

6.58

4.4

3.8

1649.64

945.69

ng/l

0.74

264

Other deformity of hallux (acquired)

124

812

1.89

6.57

2.8

3.3

1023.41

1186.13

ng/l

0.31

104

692

Adenocarcinoma and papilloma adenocarcinoma of rectum

1567

13995

1.19

6.56

2.7

3.4

1445.18

1569.48

ng/l

0.67

1388

12214

Primary ovarian failure

165

1110

1.62

6.54

2.6

2.9

627.88

540.90

ng/l

0.16

144

909

Gilbert syndrome

588

1.97

6.52

2.8

3.0

655.62

860.31

ng/l

0.56

489

Schizotypal disorder

225

1615

1.52

6.51

2.5

3.1

942.46

725.79

ng/l

0.23

181

1316

Antenatal screening

1283

8291

0.85

6.50

2.3

2.4

371.20

492.41

ng/l

0.63

1039

6685

Drug-induced headache, not elsewhere classified

448

2.16

6.47

2.7

3.1

727.37

697.73

ng/l

0.03

372

Other and unspecified aplastic anaemias

169

1182

1.70

6.47

4.1

3.2

2700.22

1362.95

ng/l

2.05

153

1002

Unspecified jaundice

714

6010

1.28

6.46

3.3

1970.25

1788.93

ng/l

0.33

620

5265

Other appendicitis

1017

8774

1.22

6.44

3.3

3.1

1321.58

1127.42

ng/l

0.48

862

7465

Failure of sterile precautions during surgical operation

346

2.68

6.44

6.1

3.5

1478.72

1311.62

ng/l

0.15

290

Listeriosis

575

2.21

6.43

4.4

3.2

5012.32

1194.01

ng/l

1.80

490

Hypermetropia

822

6953

1.24

6.43

3.2

3.3

1014.13

1172.26

ng/l

0.87

693

5901

Listeriosis, including avohilmo

591

2.18

6.41

4.4

3.2

4924.38

1176.13

ng/l

1.81

502

Inguinal or femoral hernia, bilateral

1648

14771

1.18

6.41

3.3

3.4

1625.20

1670.03

ng/l

0.16

1447

12921

Type 1 diabetes, strict (exclude DM2)

685

5635

1.25

6.38

3.1

3.0

1923.06

665.67

ng/l

5.20

588

4529

Malignant neoplasm of endocrine gland, including Hilmo

1038

8989

1.22

6.37

3.1

3.2

1417.19

1163.73

ng/l

0.64

887

7678

Hypoplasia of dental enamel , including avohilmo

200

1332

1.51

6.37

9.6

4.8

1324.18

757.30

ng/l

1.04

175

1049

Chronic suppurative otitis media

810

6871

1.25

6.37

3.8

3.3

1560.28

1490.10

ng/l

0.20

681

5930

Other disorders of male genital organs

453

3622

1.34

6.34

3.8

3.5

1857.46

1449.52

ng/l

0.52

386

3095

Other congenital malformations, not elsewhere classified

501

1.97

6.33

5.5

4.0

756.41

779.96

ng/l

0.05

397

Injury of nerves at lower leg level

137

914

1.76

6.33

2.5

3.2

1184.17

1147.48

ng/l

0.04

115

772

Use of ropinirole

538

4467

1.35

6.32

3.1

3.2

1003.94

1341.47

ng/l

1.97

459

3890

Pustular psoriasis

585

4837

1.30

6.30

3.3

3.0

1513.62

1042.97

ng/l

1.53

488

4131

Other rupture of muscle

590

1.98

6.29

3.2

3.3

1231.02

1334.97

ng/l

0.11

503

Other and unspecified mononeuropathies of upper limb

370

2904

1.39

6.28

2.8

3.2

1021.73

1137.21

ng/l

0.33

320

2479

Crohn's disease of large intestine

533

4336

1.30

6.28

3.0

3.1

1523.76

1012.70

ng/l

1.62

451

3634

Contact with sharp glass

369

2866

1.37

6.25

2.7

3.2

1085.23

947.01

ng/l

0.21

305

2345

Contusion of toe(s) without damage to nail

271

2019

1.45

6.25

3.0

1180.53

840.83

ng/l

0.59

232

1676

Congenital malformations of the nervous system

193

1352

1.54

6.25

3.8

3.9

1249.08

859.66

ng/l

0.78

159

1111

Dislocation, sprain and strain of joints and ligaments of elbow

651

5396

1.27

6.25

3.1

942.82

927.35

ng/l

0.04

539

4518

Benign neoplasm: Liver

278

2097

1.46

6.24

2.9

3.1

1219.36

1014.41

ng/l

0.33

234

1762

Other and unspecified bullous disorders

167

1178

1.70

6.23

4.1

3.4

1398.25

1291.66

ng/l

0.12

150

1015

Allergic contact dermatitis due to drugs in contact with skin

290

2217

1.47

6.23

3.3

3.2

1452.73

1140.50

ng/l

0.66

237

1894

Use of rivastigmine

2667

28786

0.88

6.21

2.8

3.6

1747.22

2112.33

ng/l

3.87

2296

25338

Carcinoma in situ of vulva

129

861

1.81

6.20

3.4

3.1

1631.34

902.47

ng/l

0.39

111

738

Transient global amnesia

1450

12971

1.19

6.18

3.2

3.3

930.17

1469.17

ng/l

12.90

1259

11357

Palindromic rheumatism

142

962

1.74

6.17

3.6

3.2

1234.90

1177.91

ng/l

0.08

125

818

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1626

14608

1.18

6.16

2.7

3.4

1444.80

1569.14

ng/l

0.69

1441

12741

Acute drug-induced interstitial lung disorder

139

966

1.87

6.16

4.9

3.5

1312.32

1649.01

ng/l

0.78

128

841

Impacted teeth

1283

9568

1.17

6.14

3.1

2.9

756.64

697.12

ng/l

0.20

1021

7427

Perichondritis of external ear

275

2114

1.51

6.14

3.8

3.2

1488.04

1577.82

ng/l

0.15

245

1833

Drug-induced polyneuropathy

144

1000

1.79

6.08

4.0

3.4

978.07

1214.51

ng/l

0.54

127

852

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

316

2.51

6.06

4.4

4.0

2453.94

1088.36

ng/l

0.56

269

Foreign body entering into or through eye or natural orifice

933

8034

1.22

6.05

3.4

3.3

1494.42

1259.47

ng/l

0.73

775

6810

Sexual dysfunction

208

1502

1.53

6.02

2.9

3.4

880.62

1137.43

ng/l

0.62

182

1269

Acute myeloid leukaemia, helper endpoint

205

1510

1.60

6.02

3.1

3.4

1171.24

1638.19

ng/l

1.88

193

1301

Acute myeloid leukaemia, including Hilmo

205

1510

1.60

6.02

3.1

3.4

1171.24

1638.19

ng/l

1.88

193

1301

Acute myeloid leukaemia

205

1510

1.60

6.02

3.1

3.4

1171.24

1638.19

ng/l

1.88

193

1301

Crossbite

569

4274

1.27

6.02

5.3

3.5

884.50

835.65

ng/l

0.12

450

3523

Cutaneous lupus erythematosus

328

2568

1.43

6.01

3.4

3.0

1154.60

1044.48

ng/l

0.28

294

2175

Vascular dementia

1793

15649

1.17

5.99

3.4

3.7

2450.87

2481.32

ng/l

0.09

1568

13868

Other bursal cyst

215

1584

1.55

5.96

2.9

3.2

1258.10

1282.37

ng/l

0.03

183

1351

Malignant neoplasm of bone and articular cartilage, including Hilmo

265

2020

1.49

5.96

4.1

3.3

1416.78

1479.98

ng/l

0.08

234

1720

Dyshidrosis [pompholyx]

177

1244

1.58

5.95

3.0

1333.08

829.45

ng/l

0.48

132

1023

Malignant neoplasm of lip, including Hilmo

186

1355

1.64

5.94

4.0

3.3

2901.38

1957.12

ng/l

1.10

165

1187

Traumatic ischaemia of muscle

177

1259

1.61

5.93

4.2

3.1

1812.40

1049.06

ng/l

0.83

154

1041

Unspecified lump in breast

2021

18319

1.14

5.92

2.8

3.0

1020.46

1090.87

ng/l

0.44

1787

15659

Deformity of finger(s)

573

1.99

5.91

3.0

3.3

843.29

1116.35

ng/l

0.51

496

Scar conditions and fibrosis of skin

459

3708

1.32

5.90

3.4

2.9

776.87

917.72

ng/l

0.86

387

3100

Benign neoplasm: Liver/bile ducts

314

2432

1.41

5.89

2.9

3.1

1223.13

1056.97

ng/l

0.29

267

2054

Vascular dementia (subcortical)

642

5467

1.31

5.88

3.3

3.7

2079.09

2356.04

ng/l

0.86

573

4878

Other benign neoplasms of uterus

849

7383

1.26

5.88

3.4

3.3

1532.49

1526.24

ng/l

0.01

719

6418

Malignant neoplasm of brain

268

3508

0.71

5.88

2.6

3.2

715.58

1308.37

ng/l

4.21

237

2977

Pneumoconiosis due to asbestos and other mineral fibres

346

2755

1.43

5.88

4.7

3.6

2212.10

2544.64

ng/l

0.70

310

2469

Spasmodic torticollis

393

3140

1.37

5.87

2.9

3.0

895.56

994.80

ng/l

0.35

326

2639

Androgenic alopecia

116

756

1.79

5.86

2.6

3.0

647.90

790.13

ng/l

0.27

632

Polyhydramnios

305

2310

1.38

5.86

2.4

2.6

865.16

440.54

ng/l

0.75

246

1838

Acne, including avohilmo

1441

10246

1.16

5.84

3.3

2.9

1210.69

726.27

ng/l

1.45

1097

8059

Mental and behavioural disorders due to cannabinoids

183

1273

1.51

5.83

2.7

3.6

1235.10

673.07

ng/l

0.63

137

967

Intercostal neuropathy

125

846

1.82

5.83

3.7

3.3

1398.28

1223.18

ng/l

0.22

103

709

Corneal scars and opacities

389

3121

1.38

5.82

4.0

3.3

1560.06

1340.62

ng/l

0.55

345

2675

Other acute viral hepatitis

145

989

1.66

5.81

3.0

3.4

995.10

844.50

ng/l

0.26

130

812

Iridocyclitis in diseases classified elsewhere

255

1935

1.48

5.80

3.7

3.3

1476.39

1215.90

ng/l

0.54

220

1650

Conduct disorder

154

1041

1.57

5.80

3.6

719.20

947.98

ng/l

0.37

128

826

Retained placenta and membranes, without haemorrhage

1217

10687

1.18

5.80

2.5

2.7

652.75

742.23

ng/l

0.60

992

9006

Poisoning by medicine, drug-induced

151

1041

1.64

5.79

2.3

3.2

1033.37

800.63

ng/l

0.23

123

853

Malignant neoplasm of tongue, including Hilmo

384

3091

1.39

5.78

3.0

3.3

1334.18

1403.33

ng/l

0.11

352

2655

Ectopic pregnancy

1747

15672

1.15

5.78

2.7

620.26

711.92

ng/l

0.78

1452

13233

Pyogenic granuloma

223

1652

1.51

5.76

3.3

3.2

1825.79

1172.30

ng/l

1.07

186

1391

Malignant neoplasm of rectum

1572

14152

1.17

5.76

2.8

3.4

1480.69

1566.75

ng/l

0.40

1392

12338

Female infertility, tubal origin

392

3089

1.33

5.76

2.6

2.5

631.78

655.37

ng/l

0.04

324

2561

Assault by blunt object

149

1018

1.62

5.72

3.3

3.1

1229.78

789.28

ng/l

0.49

113

822

Other mycoses, not elsewhere classified/unspecified, including avohilmo

239

1799

1.49

5.70

3.1

3.2

1349.93

1065.72

ng/l

0.56

213

1536

Certain conditions originating in the perinatal period

488

3478

1.28

5.70

4.6

3.9

1411.53

705.82

ng/l

1.18

390

2687

Sequelae of infectious and parasitic diseases, including avohilmo

953

8274

1.21

5.68

3.6

3.2

1416.52

1527.56

ng/l

0.36

822

7061

Disorders of puberty, all

558

1.77

5.68

3.5

4.8

841.14

861.82

ng/l

0.01

435

Behavioural disorders

148

997

1.58

5.66

3.5

3.9

712.93

954.72

ng/l

0.38

123

787

Delivery, wide proxy

4148

23567

0.91

5.65

3.0

3.2

1177.43

1374.39

ng/l

2.94

3557

20236

Behçet disease

250

2.62

5.65

2.8

3.2

508.76

1056.54

ng/l

1.60

205

Meningitis

580

4835

1.28

5.64

3.0

3.2

1196.38

1182.00

ng/l

0.02

494

4101

Hereditary deficiency of other clotting factors

110

714

1.79

5.63

3.1

3.3

1395.46

1053.86

ng/l

0.40

597

Benign neoplasm: Other and unspecified parts of mouth

452

3705

1.34

5.63

3.3

3.2

1368.67

1203.36

ng/l

0.40

394

3187

LSIL lesion of the vulva

310

2407

1.40

5.63

3.2

2.8

890.96

774.37

ng/l

0.32

273

2039

Anxious personality disorder

161

1111

1.56

5.63

2.6

3.0

1575.90

796.28

ng/l

0.46

125

893

Malignant neoplasm of other connective and soft tissue

370

2977

1.39

5.61

3.5

3.3

1803.00

1479.36

ng/l

0.72

329

2572

Injury of nerves at forearm level

160

1124

1.61

5.61

3.8

3.3

1214.07

868.22

ng/l

0.44

132

943

Thyrotoxicosis factitia

328

2.48

5.60

4.3

3.5

1255.00

912.78

ng/l

0.34

272

Idiopathic urticaria

228

1688

1.47

5.60

2.9

971.64

908.43

ng/l

0.11

195

1384

Benign neoplasm: Kidney

524

4375

1.32

5.60

3.2

1991.97

1316.65

ng/l

0.94

451

3788

Fitting and adjustment of external prosthetic device

336

2.45

5.58

3.7

2.9

12366.00

1245.59

ng/l

1.83

284

Acquired clawhand, clubhand, clawfoot and clubfoot

382

2.10

5.57

2.9

3.3

1280.88

970.59

ng/l

0.27

320

Other nonautoimmune haemolytic anaemias

261

3.31

5.56

7.9

3.5

2890.28

1212.94

ng/l

0.91

226

Crohn disease (strict definition, all UC cases excluded)

517

4248

1.28

5.55

2.7

3.2

1078.24

1040.81

ng/l

0.07

431

3569

Supervision of normal pregnancy

1222

7980

0.86

5.55

2.1

2.4

327.01

495.35

ng/l

0.95

941

6433

Varicella [chickenpox]

456

3697

1.30

5.55

4.5

3.2

1411.42

1005.85

ng/l

0.71

382

3027

Foreign body on external eye

1696

15256

1.15

5.55

3.2

1033.02

1177.43

ng/l

0.84

1415

12914

Inguinal hernia, bilateral

1607

14508

1.16

5.54

3.3

3.4

1562.36

1670.06

ng/l

0.49

1412

12697

Granuloma annulare

196

1436

1.54

5.54

3.5

3.1

1076.06

908.59

ng/l

0.45

171

1207

Pedal cyclist injured in transport accident

2728

25099

1.11

5.52

3.2

1080.82

1215.27

ng/l

1.20

2279

21299

Foreign body in respiratory tract

601

5037

1.27

5.51

3.4

3.3

1095.06

1237.92

ng/l

0.51

504

4283

Chronic mastoiditis

374

3021

1.38

5.51

3.6

3.3

1919.41

1592.92

ng/l

0.76

320

2623

Benign neoplasm of bone and articular cartilage

954

8288

1.20

5.51

3.0

3.1

1021.21

1121.05

ng/l

0.37

800

7034

Malignant neoplasm of gum

636

2.07

5.50

3.0

3.2

1021.77

1554.77

ng/l

0.92

537

Other disorders of pigmentation

622

5257

1.27

5.50

3.3

3.2

1507.80

1238.58

ng/l

0.34

528

4487

Contact with machinery

1432

12818

1.17

5.49

3.3

3.4

1174.32

1423.18

ng/l

1.57

1233

11083

Use of levodopa decarboxylase inhibitor

2406

22209

1.14

5.49

3.0

3.4

1440.77

1822.10

ng/l

2.90

2086

19584

Viral agents as the cause of diseases classified to other chapters, including avohilmo

298

2316

1.41

5.49

4.0

3.3

1516.68

1089.96

ng/l

1.20

266

1959

Calcific tendinitis

131

897

1.71

5.46

3.3

3.2

749.29

1124.89

ng/l

0.97

118

769

Foreign body or object entering through skin

687

5818

1.24

5.46

3.2

1148.56

1174.51

ng/l

0.06

587

4884

Horner syndrome

174

1262

1.60

5.46

2.7

3.1

939.90

1178.30

ng/l

0.64

148

1073

Other neurotic disorders

632

5348

1.27

5.45

3.1

1723.47

1366.75

ng/l

0.57

550

4578

Generalized epilepsy

398

3182

1.32

5.44

2.9

3.3

713.07

1135.17

ng/l

3.14

329

2665

Congenital malformations of eye, ear, face and neck

578

4798

1.26

5.42

3.8

3.4

1269.86

1050.82

ng/l

0.32

485

3990

Small cell lung cancer, helper endpoint

258

3324

0.71

5.42

2.8

3.4

1640.27

2130.43

ng/l

0.56

237

2919

Protein-energy malnutrition of moderate and mild degree

147

1044

1.70

5.42

5.1

3.9

1954.06

1560.55

ng/l

0.65

128

905

Intracranial and intraspinal abscess and granuloma

173

1260

1.61

5.41

3.5

3.4

2279.94

1268.49

ng/l

0.60

156

1079

Hypertrophy of tongue papillae

192

1415

1.55

5.40

3.0

3.4

957.01

1059.87

ng/l

0.22

154

1208

Atopic dermatitis

7202

54401

1.07

5.40

2.9

3.0

974.25

1024.72

ng/l

0.43

5819

45647

Contact with heat and hot substances

595

4981

1.26

5.39

3.1

3.4

1615.11

1282.26

ng/l

0.55

498

4236

Marginal zone B-cell lymphoma, including Hilmo

253

1965

1.49

5.36

3.1

3.2

1700.54

1402.99

ng/l

0.48

225

1685

Severe visual impairment, monocular

162

1173

1.64

5.34

4.8

3.4

1800.53

1523.53

ng/l

0.41

138

1000

Complications peculiar to reattachment and amputation

115

784

1.83

5.34

4.0

3.1

4030.54

1488.88

ng/l

1.63

101

659

Calcinosis cutis

221

3.05

5.32

5.9

3.5

13298.53

1130.87

ng/l

1.87

189

Short stature, not elsewhere classified

104

603

1.68

5.31

5.6

7.7

662.84

1252.26

ng/l

1.09

488

Encephalopathy

153

1097

1.66

5.31

3.0

3.2

1772.80

1454.71

ng/l

0.35

140

942

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1752

15806

1.14

5.30

3.2

3.1

1376.68

1132.36

ng/l

1.16

1449

13315

Secondary malignant neoplasm of other and unspecified sites

298

2373

1.45

5.30

2.8

3.2

1560.75

1460.17

ng/l

0.16

267

2049

Pulmonary eosinophilia, not elsewhere classified

186

1383

1.59

5.29

4.7

3.3

1525.27

1387.38

ng/l

0.21

173

1190

Disorders of eyelid in diseases classified elsewhere

405

3287

1.33

5.29

4.0

3.2

1574.98

1386.95

ng/l

0.47

353

2795

Abscess of tendon sheath

571

1.89

5.28

3.2

3.3

3318.87

1110.58

ng/l

1.22

486

Thrombotic microangiopathy

576

1.92

5.26

4.2

3.2

2270.38

1443.90

ng/l

0.59

483

Impaction of intestines

110

739

1.81

5.26

3.4

3.3

2125.13

1455.42

ng/l

0.75

100

650

Ankylosing spondylitis, strict definition

418

3378

1.31

5.25

3.0

3.2

521.85

929.69

ng/l

3.16

341

2774

Mixed disorders of conduct and emotions

107

677

1.65

5.24

4.3

4.2

1290.50

656.05

ng/l

0.51

497

L02BB Anti-androgens

1559

14144

1.17

5.24

3.4

3.6

2106.54

2108.65

ng/l

0.01

1429

12552

Struck by thrown, projected or falling objec

582

4878

1.26

5.21

3.5

3.3

1072.18

1159.36

ng/l

0.26

502

4118

Allergic colitis

130

864

1.58

5.21

4.9

5.3

1891.30

937.24

ng/l

0.38

108

687

Alcoholic gastritis

207

1557

1.52

5.21

3.9

3.3

1511.69

1357.83

ng/l

0.21

180

1345

Malignant neoplasm of breast, HER-negative

2951

26315

1.11

5.21

3.0

1258.46

1216.75

ng/l

0.24

2520

22417

Assault by sharp object

165

1170

1.54

5.19

2.9

3.1

1403.94

986.04

ng/l

0.43

134

956

Other benign neoplasm of uterus: Other parts/unspecified

686

5961

1.28

5.19

3.5

3.3

1673.78

1646.52

ng/l

0.06

591

5214

Von Willebrand disease

133

910

1.63

5.18

2.9

1186.35

779.96

ng/l

0.56

110

770

Occupational exposure to risk-factors

437

3598

1.32

5.17

3.9

3.3

959.97

1373.51

ng/l

3.21

385

3125

Need for immunization against other single infectious diseases

3.88

5.14

8.5

3.4

15503.04

1008.02

ng/l

2.26

Other specified/unspecified disorders of bone/cartilage

350

2810

1.36

5.13

3.6

3.0

1017.34

1102.38

ng/l

0.23

305

2383

Malignant neoplasm of tongue

293

2323

1.42

5.12

2.6

3.3

1283.40

1400.83

ng/l

0.16

269

2000

Macular cyst

494

4159

1.32

5.10

3.1

3.3

1314.69

1429.32

ng/l

0.29

428

3614

Suppurative otitis media, unspecified

281

2180

1.39

5.10

3.7

3.3

1710.96

1294.12

ng/l

0.83

238

1840

Atlantoaxial subluxation

103

690

1.84

5.07

3.3

3.4

1202.50

1311.03

ng/l

0.14

593

Distal bite

253

1895

1.38

5.07

4.6

3.9

1160.94

703.87

ng/l

0.46

200

1544

Adenocarcinoma and ductal carcinoma of pancreas

397

4813

0.76

5.06

2.3

3.4

1270.56

1545.16

ng/l

0.69

362

4162

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

7101

57905

0.94

5.06

2.9

1174.13

1121.93

ng/l

0.30

5929

49205

Long labour

1535

14529

0.88

5.04

2.3

2.5

469.37

543.73

ng/l

0.48

1246

11832

Colitis, primary sclerosing

147

1032

1.58

5.04

2.4

3.3

1013.19

870.66

ng/l

0.20

120

844

Hyperkinetic disorders (excl. ADHD)

115

740

1.62

5.04

3.2

4.0

645.05

656.31

ng/l

0.01

592

Monoplegia

218

1662

1.49

5.03

5.0

3.3

1149.74

1333.45

ng/l

0.42

206

1420

Autism

140

951

1.53

5.02

2.9

3.4

541.30

676.23

ng/l

0.14

705

Other inflammation of vagina/vulva

318

2493

1.34

5.01

2.9

2.8

553.14

693.44

ng/l

0.92

267

2066

Narcolepsy and cataplexy

461

1.90

5.00

4.0

2.9

1055.24

1197.81

ng/l

0.10

387

Ulcerative colitis (strict definition, require KELA)

1812

16432

1.13

4.99

3.2

1373.58

1130.79

ng/l

1.21

1498

13852

Abnormality of white blood cells, not elsewhere classified

132

930

1.69

4.99

4.3

3.2

1451.61

1102.25

ng/l

0.35

115

788

Other puerperal infections

461

3749

1.26

4.98

2.1

2.6

381.35

456.77

ng/l

0.36

366

2958

Ankle and foot

123

851

1.70

4.98

4.0

3.4

2046.30

1113.86

ng/l

0.37

116

715

Benign neoplasm of breast

1508

13608

1.15

4.98

2.9

3.0

1063.58

1135.76

ng/l

0.29

1277

11689

Malignant neoplasm of heart, mediastinum and pleura

210

1603

1.52

4.98

3.4

1004.31

1793.07

ng/l

4.92

196

1409

Sixth [abducent] nerve palsy

477

3990

1.31

4.98

3.5

3.4

1397.73

1503.93

ng/l

0.21

421

3458

Malignant neoplasm of thyroid gland, including Hilmo

906

7922

1.20

4.97

3.1

1104.56

1110.76

ng/l

0.02

777

6758

Varicella [chickenpox], including avohilmo

501

4144

1.27

4.97

4.6

3.3

1412.41

1023.16

ng/l

0.74

419

3410

Flatulence and related conditions

140

987

1.62

4.96

4.2

3.1

1031.91

1274.97

ng/l

0.62

122

856

Other bullous disorders

365

2965

1.35

4.96

3.6

3.3

1252.97

1263.06

ng/l

0.02

326

2554

Other nonthrombocytopenic purpura

150

1088

1.64

4.96

4.5

3.5

1851.91

1361.30

ng/l

0.67

136

924

Oral lichen planus

379

3101

1.35

4.95

2.7

3.0

673.83

1006.53

ng/l

2.36

327

2634

Sequelae of infectious and parasitic diseases

917

8023

1.20

4.95

3.6

3.2

1422.23

1515.85

ng/l

0.28

793

6839

Pigmented purpuric dermatosis

162

1189

1.61

4.95

3.6

3.1

2370.62

1056.59

ng/l

0.52

142

1013

Chronic hepatitis NAS

173

1274

1.56

4.94

3.0

3.2

2290.75

1044.54

ng/l

0.96

164

1078

Other disorders of central nervous system

153

1095

1.58

4.93

2.8

3.4

1060.27

1203.19

ng/l

0.15

129

924

Optic neuritis

402

3262

1.30

4.91

2.7

3.0

854.97

915.29

ng/l

0.20

339

2718

Chronic conjunctivitis

367

2972

1.34

4.91

3.2

1032.54

1058.17

ng/l

0.04

316

2501

Primary amenorrhea

248

2.12

4.90

3.4

2.8

225.58

542.68

ng/l

1.49

192

Injury of intra-abdominal organs

275

2142

1.39

4.90

3.6

3.4

1813.91

1152.75

ng/l

1.75

233

1800

Premenstrual syndrome

100

640

1.66

4.87

2.2

2.7

339.62

560.16

ng/l

0.63

505

Contact with other sharp object(s)

635

5377

1.23

4.86

3.0

3.2

857.27

1003.64

ng/l

0.62

507

4447

Pectus excavatum, including avohilmo

202

2.26

4.83

4.0

3.3

634.07

1598.33

ng/l

0.59

153

Autoimmune hepatitis

119

819

1.68

4.81

3.3

2.8

728.79

870.25

ng/l

0.47

109

694

Other disorders of Eustachian tube

375

3052

1.33

4.81

3.0

3.1

1019.86

1109.52

ng/l

0.23

328

2586

Erectile dysfunction

1222

11000

1.18

4.79

10.3

3.5

1789.55

1840.77

ng/l

0.15

1080

9748

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

367

2966

1.31

4.73

2.8

3.1

922.39

994.67

ng/l

0.20

311

2459

Anorexia

172

1261

1.51

4.73

3.0

3.3

1885.98

1063.39

ng/l

1.65

150

1045

Malignant neoplasm of eye, brain and central nervous system

388

4725

0.77

4.73

2.9

3.3

923.20

1352.31

ng/l

2.53

341

4034

Other and unspecified vaccines and biological substances

455

1.89

4.72

3.1

3.0

386.52

798.53

ng/l

4.00

369

Cysts of oral region, not elsewhere classified

721

6232

1.22

4.71

3.4

3.2

1350.05

1197.98

ng/l

0.44

617

5322

Ulcerative rectosigmoiditis

898

7856

1.19

4.71

3.2

3.1

1113.26

1133.51

ng/l

0.06

761

6632

Adhesive middle ear disease

186

1383

1.48

4.70

3.4

3.2

1156.68

1168.47

ng/l

0.02

149

1162

Other complications of labour and delivery, not elsewhere classified

415

4536

0.80

4.70

2.0

2.4

196.34

356.50

ng/l

2.48

313

3473

Disorder of thyroid, unspecified

180

1345

1.52

4.68

2.9

3.0

795.11

1098.17

ng/l

1.40

153

1143

Effects of heat and light

118

825

1.71

4.68

2.7

3.5

1366.92

1559.43

ng/l

0.23

105

708

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

516

1.75

4.67

2.1

2.7

566.19

445.80

ng/l

0.24

420

Loose body in joint

283

2234

1.38

4.67

3.1

3.3

1310.88

1394.18

ng/l

0.13

228

1929

Malignant neoplasm of endocrine gland

876

7678

1.20

4.66

3.1

3.2

1423.28

1116.05

ng/l

0.75

748

6539

Benign neoplasm: Tongue

380

3128

1.33

4.66

3.2

1237.71

1182.75

ng/l

0.12

332

2680

Other/unspecified crystal arthropathies

119

853

1.79

4.66

5.0

3.5

1606.75

1598.75

ng/l

0.01

106

746

Unspecified contracted kidney

606

1.86

4.66

3.6

3.5

6790.56

1236.49

ng/l

2.31

507

Alzheimer disease

6183

46250

0.93

4.66

3.1

3.5

2189.92

2006.64

ng/l

1.88

5337

40910

Infectious mononucleosis

540

4497

1.23

4.65

3.3

3.0

765.70

652.08

ng/l

0.30

425

3511

Infectious mononucleosis, including avohilmo

540

4497

1.23

4.65

3.3

3.0

765.70

652.08

ng/l

0.30

425

3511

Chondromalacia

327

2633

1.35

4.64

2.7

3.1

807.30

955.89

ng/l

0.24

255

2231

Other and unspecified localized connective tissue disorders

317

2.31

4.64

3.4

3.2

833.03

1088.85

ng/l

0.42

266

Caught, crushed, jammed or pinched in or between objects

555

4682

1.24

4.63

3.1

3.3

939.74

1108.72

ng/l

0.83

450

3937

Cachexia

581

1.87

4.63

3.8

3.4

5275.96

1948.33

ng/l

1.75

500

Somnolence

154

1116

1.55

4.63

4.2

3.2

1675.02

1265.38

ng/l

0.40

127

934

Disorders in reading

608

1.65

4.60

5.2

4.8

318.87

704.49

ng/l

0.78

474

Ulcer of vagina/vulva

310

2473

1.35

4.59

3.5

3.0

971.29

961.68

ng/l

0.02

258

2067

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1957

17893

1.12

4.59

3.2

1398.04

1148.01

ng/l

1.33

1621

15083

Adenocarcinoma and Papillary adenocarcinoma of kidney

183

1394

1.55

4.58

3.1

3.2

3168.57

1372.55

ng/l

1.85

157

1198

Gastrointestinal stromal tumor and sarcoma

197

1520

1.53

4.58

3.4

3.1

1312.67

1371.14

ng/l

0.09

175

1286

Exposure to unspecified smoke, fire and flames

123

861

1.64

4.57

3.0

3.4

1546.84

1300.11

ng/l

0.25

104

713

Endometriosis of intestine

107

707

1.60

4.55

2.3

2.7

518.62

582.92

ng/l

0.06

557

Circumscribed brain atrophy

228

2889

0.71

4.55

2.9

3.3

847.03

1684.41

ng/l

10.00

194

2539

Open bite

366

2942

1.29

4.54

4.4

3.2

578.46

597.62

ng/l

0.06

297

2366

Evidence of alcohol involvement determined by level of intoxication

103

686

1.66

4.54

3.2

3.3

1626.86

801.13

ng/l

0.64

550

LSIL lesion of the cervix uteri, vagina or vulva

1209

10761

1.15

4.54

2.7

674.56

694.96

ng/l

0.10

1007

8863

Ovarian dysfunction, other/unspecified

373

1.94

4.53

2.3

2.8

585.95

653.85

ng/l

0.16

309

Disorders of puberty

484

1.72

4.53

3.7

4.7

960.92

940.09

ng/l

0.01

372

Mature T/NK-cell lymphomas, hilmo

212

1650

1.49

4.52

3.4

3.3

2211.21

1475.56

ng/l

0.50

197

1431

Separation of retinal layers (serosa)

522

4417

1.26

4.51

3.1

1043.80

1080.36

ng/l

0.11

443

3730

Maxillary retrognathism

139

976

1.52

4.51

3.8

3.6

723.40

639.35

ng/l

0.16

106

798

Tooth eruption problems

924

7776

1.17

4.49

3.6

3.2

1078.02

769.57

ng/l

1.20

736

6138

Trichomoniasis, including avohilmo

133

959

1.63

4.49

3.0

2.9

1900.32

946.95

ng/l

0.95

104

814

Other injuries of lower limb, level unspecified

135

970

1.61

4.48

3.7

3.3

1820.28

1204.59

ng/l

0.78

127

820

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

148

1096

1.62

4.47

4.4

3.2

1904.96

1577.84

ng/l

0.50

136

930

Traction detachment of retina

116

811

1.67

4.47

3.4

3.3

3429.57

1302.74

ng/l

2.29

106

676

Golimumab

324

2592

1.32

4.47

2.3

3.0

723.85

807.01

ng/l

0.16

280

2138

Acromegaly and pituitary gigantism

631

1.78

4.47

2.5

3.2

935.03

1053.72

ng/l

0.19

533

Malignant neoplasm of brain, including Hilmo

446

5329

0.79

4.46

2.9

3.3

778.15

1350.71

ng/l

6.66

396

4569

Other and unspecified corneal deformities and disorders

398

3289

1.30

4.44

3.2

1153.21

1112.51

ng/l

0.09

359

2787

IBD (strict) with PSC

100

667

1.67

4.44

2.3

3.3

715.43

672.66

ng/l

0.05

541

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

179

1357

1.52

4.42

4.0

3.3

1085.00

1550.42

ng/l

1.56

162

1158

Lumbosacral root disorders, not elsewhere classified

171

1286

1.53

4.42

3.6

3.1

2045.06

1130.95

ng/l

0.48

149

1111

Leiomyosarcoma

118

841

1.71

4.42

3.0

3.2

2417.97

1471.80

ng/l

1.15

105

713

Thyrotoxicosis with toxic single thyroid nodule

123

874

1.65

4.42

2.8

3.2

1181.04

1133.80

ng/l

0.07

103

749

Torsion of ovary, ovarian pedicle and fallopian tube

190

1413

1.43

4.42

3.0

2.8

1038.45

795.75

ng/l

0.32

162

1160

Hereditary corneal dystrophies

511

4360

1.28

4.41

3.3

3.2

1616.47

1264.22

ng/l

0.73

425

3761

Viral agents as the cause of diseases classified to other chapters

262

2069

1.38

4.41

4.0

3.3

1603.27

1105.41

ng/l

1.29

237

1762

807

7038

1.20

4.40

4.0

3.4

2082.63

2203.16

ng/l

0.25

714

6057

Sequelae of other and unspecified effects of external causes

536

1.84

4.39

3.7

3.4

1999.77

1246.95

ng/l

0.27

435

Fasciculation

144

1043

1.55

4.38

2.8

3.2

589.51

1026.00

ng/l

1.87

116

872

Alcohol abuse counselling and surveillance

190

1436

1.46

4.38

2.5

3.0

1414.68

895.70

ng/l

1.18

148

1189

Acute appendicitis, with complications

2589

24061

1.10

4.37

3.3

3.2

1341.33

1373.70

ng/l

0.17

2243

20759

Donors of organs and tissues

145

1040

1.52

4.37

3.7

2.5

450.50

577.16

ng/l

0.81

122

843

Other conjunctival vascular disorders and cysts

317

2579

1.35

4.36

3.3

3.1

1463.54

1184.26

ng/l

0.50

271

2200

Autism spe

137

956

1.49

4.36

2.9

4.3

539.32

634.32

ng/l

0.10

718

Other sideroblastic anaemias

419

2.08

4.34

6.7

3.2

1942.10

1525.94

ng/l

0.40

353

Varus deformity, not elsewhere classified

132

942

1.57

4.34

2.8

3.3

695.21

993.15

ng/l

1.17

115

801

Endovascular or surgical operations to intracerebral aneurysms

814

7162

1.20

4.34

2.8

3.1

1249.19

1257.96

ng/l

0.02

729

6142

Mononeuritis multiplex

303

2.33

4.32

2.5

3.3

1032.74

1342.04

ng/l

0.26

264

Shigellosis, including avohilmo

521

1.77

4.32

3.1

2.9

1817.99

1022.32

ng/l

0.57

432

Syndrome of inappropriate secretion of antidiuretic hormone

684

1.83

4.32

3.6

3.4

1733.48

1568.81

ng/l

0.13

582

Migraine with aura, drug-induced

126

895

1.59

4.30

2.6

3.2

830.33

804.36

ng/l

0.03

114

747

Schizoid personality disorder

195

1482

1.44

4.30

3.0

3.2

1315.47

905.74

ng/l

0.26

161

1234

Other specified and unspecified disorders of eyelid

206

1598

1.46

4.30

3.1

3.2

750.22

1304.80

ng/l

5.22

181

1371

Tetraplegia

110

773

1.70

4.29

3.5

3.8

1114.32

1285.60

ng/l

0.30

655

Other facial nerve disorders

354

2903

1.31

4.29

2.9

3.0

902.79

1115.46

ng/l

0.96

295

2466

Injury of cranial nerves

587

1.78

4.28

2.9

3.0

861.19

892.56

ng/l

0.04

503

Histrionic personality disorder

462

1.93

4.27

3.6

3.2

634.56

1141.82

ng/l

1.65

385

Tibial collateral bursitis [Pellegrini-Stieda]

145

1060

1.55

4.26

3.3

3.2

1136.42

1127.24

ng/l

0.01

128

903

Other bursitis of elbow

130

942

1.62

4.26

4.7

3.5

1683.66

1541.86

ng/l

0.15

120

822

Other secondary coxarthrosis

454

3830

1.28

4.25

3.1

1334.55

1256.93

ng/l

0.21

401

3275

Pectus excavatum

164

2.31

4.25

4.6

3.2

717.38

1857.18

ng/l

0.54

121

Measles

103

696

1.63

4.24

2.8

3.0

708.79

592.72

ng/l

0.13

555

Disorders of puberty, other/unspecified

159

2.37

4.23

3.9

5.0

280.22

857.45

ng/l

1.33

129

Embedded teeth, including avohilmo

640

5466

1.20

4.22

3.0

3.1

1300.35

820.50

ng/l

1.47

526

4364

Benign neoplasm: Skin of trunk

527

4493

1.25

4.21

4.0

3.2

1575.65

1253.95

ng/l

0.44

441

3837

Anomalies of pupillary function

234

1826

1.39

4.21

2.8

3.2

926.86

924.43

ng/l

0.00

189

1521

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

275

2217

1.38

4.20

3.6

3.3

1194.99

1764.43

ng/l

2.58

260

1940

Wegener granulomatosis

207

1609

1.45

4.20

3.5

3.2

1658.99

1261.43

ng/l

0.64

189

1379

Lesion of femoral nerve

106

739

1.68

4.20

2.9

3.1

819.69

909.11

ng/l

0.18

625

Other bursitis, not elsewhere classified

130

937

1.58

4.19

3.1

3.2

944.82

1561.48

ng/l

2.43

111

806

Failed attempted abortion

474

1.71

4.19

2.7

2.5

443.34

467.17

ng/l

0.03

372

Peroneal tendinitis

182

1368

1.44

4.18

2.6

3.0

381.81

891.45

ng/l

7.70

151

1142

Toxic effect of corrosive substances

369

1.93

4.18

2.2

3.5

525.02

770.78

ng/l

0.89

307

Disorders of phosphorus metabolism and phosphatases

429

1.91

4.18

3.7

2.9

3369.10

1122.57

ng/l

0.86

355

Other congenital malformations of upper alimentary tract

108

764

1.70

4.15

4.7

3.5

920.53

1212.31

ng/l

0.63

647

Abnormality of red blood cells

538

1.83

4.15

3.1

3.2

1298.95

1175.44

ng/l

0.16

444

Other or unspecified common variable immunodeficiency

245

2.23

4.14

3.6

2.5

987.44

791.62

ng/l

0.19

198

Wide developmental disorders

177

1297

1.40

4.14

3.2

4.7

548.32

801.48

ng/l

0.40

125

996

Primary angle-closure glaucoma

681

5976

1.23

4.13

3.1

3.3

1480.14

1678.63

ng/l

0.79

594

5209

Vascular dementia (mixed)

354

2959

1.34

4.12

3.2

3.7

2262.23

2301.72

ng/l

0.06

306

2654

Anogenital herpesviral [herpes simplex] infection

499

4192

1.23

4.12

2.8

2.9

662.19

718.03

ng/l

0.13

391

3409

conjunctival degenerations and deposits

298

2428

1.36

4.12

2.9

3.2

916.88

1218.68

ng/l

1.15

265

2085

Poor fetal growth

711

6127

1.18

4.11

2.2

2.4

562.53

358.22

ng/l

0.51

551

4847

Other disorders of bone density and structure

286

2294

1.34

4.11

3.9

3.0

1095.72

1003.21

ng/l

0.21

232

1925

Aphakia

195

1492

1.43

4.10

3.4

3.2

1732.88

1501.45

ng/l

0.40

171

1286

Measles, including avohilmo

103

701

1.61

4.10

2.8

3.0

708.79

602.00

ng/l

0.11

560

Pre-eclampsia superimposed on chronic hypertension

238

2.07

4.09

2.4

2.8

1594.00

331.48

ng/l

0.68

201

Assault by hanging, strangulation and suffocation

109

2.69

4.08

1.6

2.9

272.44

576.59

ng/l

0.81

Other and unspecified injuries of abdomen, lower back and pelvis

184

1399

1.44

4.08

4.3

3.4

1303.21

1242.49

ng/l

0.07

157

1176

Impacted maxillary molar

325

2602

1.28

4.07

3.1

575.04

604.15

ng/l

0.06

252

1946

Other specified and unspecified strabismus

140

1021

1.53

4.07

2.7

3.6

1322.96

920.67

ng/l

0.32

121

868

Other and unspecified pemphigoid

158

1209

1.57

4.07

3.6

2328.81

1658.08

ng/l

0.66

140

1060

Contact with nonpowered hand tool

490

4159

1.25

4.06

3.2

3.3

946.21

1233.13

ng/l

1.53

405

3540

Malignant neoplasm of ovary, including Hilmo

858

7617

1.19

4.06

3.2

3.1

1177.28

1155.25

ng/l

0.04

768

6524

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

145

1091

1.59

4.06

3.6

3.3

1093.97

1556.33

ng/l

1.54

133

922

Malignant neoplasm of bone and articular cartilage of limbs

412

1.95

4.05

4.8

3.3

1585.39

1095.41

ng/l

0.39

344

Failed induction of labour

313

2498

1.28

4.05

1.9

2.7

275.21

382.19

ng/l

0.38

211

1927

Phantom limb syndrome with pain

260

2.31

4.04

4.6

3.4

5838.35

1999.02

ng/l

0.57

223

Injury of muscle and tendon at forearm level

218

1700

1.40

4.04

2.9

3.3

1274.48

968.64

ng/l

0.47

186

1441

Localized adiposity

458

1.87

4.03

4.2

3.1

664.52

970.34

ng/l

0.77

387

Undescended testicle

553

1.67

4.03

4.8

5.8

1367.41

1659.71

ng/l

0.23

457

Leukaemia of unspecified cell type

141

1049

1.57

4.02

3.5

3.4

1184.99

1412.04

ng/l

0.46

126

894

Other disorders of carbohydrate metabolism

369

1.95

4.02

3.0

3.3

4979.69

1069.16

ng/l

0.57

298

Unequal limb length (acquired)

427

1.76

4.02

3.5

3.9

995.43

827.67

ng/l

0.16

343

Actinomycosis, including avohilmo

404

1.94

4.02

4.6

3.3

952.36

1046.86

ng/l

0.19

337

Endometriosis diagnosis and infertility diagnosis occurring together

818

7161

1.17

4.00

2.4

2.6

581.02

542.32

ng/l

0.11

671

5861

Congenital deformities of hip

140

1006

1.48

4.00

3.8

4.0

755.97

911.39

ng/l

0.36

115

824

Carcinoma in situ of rectum

203

1601

1.46

3.99

3.5

3.4

1508.78

1352.32

ng/l

0.26

187

1384

Other congenital malformations of skin

408

3402

1.26

3.97

3.1

3.2

1288.93

1076.70

ng/l

0.40

358

2844

Small cell lung cancer, including Hilmo

258

3198

0.75

3.97

2.8

3.3

1640.27

1889.61

ng/l

0.24

237

2782

Small cell lung cancer

258

3198

0.75

3.97

2.8

3.3

1640.27

1889.61

ng/l

0.24

237

2782

Abscess of Bartholin gland

236

1845

1.35

3.96

2.4

2.7

997.89

719.81

ng/l

0.37

186

1529

Precocious central puberty

240

2.02

3.95

2.8

3.5

1534.08

856.23

ng/l

0.29

191

Retinal breaks without detachment

2280

21218

1.11

3.95

3.1

1093.36

1204.15

ng/l

0.83

1959

18425

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

174

1332

1.47

3.94

4.8

3.5

2001.78

1274.00

ng/l

1.14

157

1134

Demyelinating diseases of the central nervous system

797

6995

1.18

3.93

2.7

2.9

734.82

886.38

ng/l

1.01

665

5815

Alopecia areata

277

2221

1.33

3.93

3.0

3.1

1189.72

825.81

ng/l

0.57

235

1848

Other abnormal findings in urine

239

1917

1.40

3.92

3.9

3.4

2447.06

1595.77

ng/l

1.22

218

1675

Use of entacapone

1040

0.58

3.91

3.0

3.5

1473.83

1985.04

ng/l

0.49

893

Normotensive glaucoma

1453

13359

1.15

3.89

3.4

3.3

1522.60

1632.62

ng/l

0.38

1264

11717

Excessive and redundant skin and subcutaneous tissue

142

2.61

3.89

2.4

2.7

223.53

412.35

ng/l

0.95

116

Galactorrhea

602

1.64

3.89

2.9

599.38

576.90

ng/l

0.04

491

Peripheral retinal degeneration

392

3287

1.28

3.89

3.1

1153.51

1189.18

ng/l

0.06

349

2815

Panhypopituitarism

229

1818

1.39

3.88

3.2

3.4

1683.06

1376.69

ng/l

0.35

197

1560

Tic and related disorders

611

1.60

3.88

3.6

3.7

401.95

963.22

ng/l

4.14

496

Actinomycosis

353

2.00

3.88

4.9

3.3

909.35

1064.64

ng/l

0.32

295

Other dermatomyositis

465

1.86

3.87

4.4

3.5

1062.65

1389.58

ng/l

0.54

400

Osteomyelitis of vertebra

351

2.09

3.85

6.2

3.7

3603.37

1478.26

ng/l

0.96

303

Other hereditary haemolytic anaemias

534

1.76

3.85

5.9

3.4

1442.50

1024.24

ng/l

0.38

442

Familial chondrocalcinosis

163

3.42

3.85

4.6

3.6

1810.46

1678.64

ng/l

0.07

142

Crowding of teeth, including avohilmo

536

3753

1.21

3.84

4.2

3.5

738.54

734.18

ng/l

0.01

406

2936

Other and unspecified disorders of orbit

543

1.81

3.84

2.8

3.4

1292.85

1398.35

ng/l

0.08

463

Use of rotigotine

170

1316

1.50

3.84

2.8

3.2

1041.20

1087.49

ng/l

0.07

143

1127

Other disorders of optic disc

168

1277

1.46

3.83

3.5

3.2

1554.87

1050.72

ng/l

0.60

135

1073

Diabetic retinopathy, strict definition

2628

21899

1.10

3.82

4.3

4.0

4333.83

1663.31

ng/l

28.86

2302

18936

Trichomoniasis

122

900

1.62

3.82

3.2

2.8

2051.92

983.58

ng/l

1.01

766

Other disorders of thyroid

186

1445

1.44

3.81

2.8

3.1

801.65

1038.91

ng/l

1.02

157

1236

Retinoschisis and retinal cysts

345

2888

1.32

3.80

3.4

3.3

1337.14

1380.60

ng/l

0.08

293

2514

Colitis due to radiation

169

1313

1.51

3.79

3.9

3.4

2272.49

1811.86

ng/l

0.34

150

1157

All dysplastic lesions of the vagina

288

2336

1.32

3.78

3.1

2.9

769.72

814.16

ng/l

0.11

241

1973

Malignant neoplasm of pancreas

907

10105

0.86

3.77

2.7

3.4

1401.28

1707.36

ng/l

1.23

814

8802

Nystagmus and other irregular eye movements

161

1216

1.46

3.76

3.1

3.7

1049.88

1092.16

ng/l

0.06

141

1031

Other injuries of upper limb, level unspecified

159

1205

1.47

3.76

3.6

3.3

2629.28

1248.01

ng/l

0.80

135

1006

Other specified and unspecified disorders of iris and ciliary body

363

1.95

3.76

2.4

3.4

1773.38

874.38

ng/l

0.44

311

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

613

1.75

3.75

5.2

3.4

1074.76

1297.08

ng/l

0.34

518

Perineal laceration during delivery

811

7468

0.86

3.75

2.1

2.5

247.33

425.74

ng/l

3.37

624

5873

Ulcerative enterocolitis

329

2710

1.29

3.71

3.5

3.2

1125.22

1103.91

ng/l

0.04

277

2268

Benign neoplasm: Anus and anal canal

406

3451

1.28

3.71

3.0

3.3

1832.62

1549.63

ng/l

0.42

357

3001

Leiomyosarcoma, including Hilmo

141

1066

1.54

3.70

3.1

3.2

2260.62

1392.94

ng/l

1.29

127

907

Other bacterial agents as the cause of diseases classified to other chapters

150

1140

1.51

3.70

5.2

3.5

2170.88

1288.07

ng/l

1.25

136

972

Peptic ulcer

141

1058

1.52

3.70

3.4

3.3

1955.97

1578.35

ng/l

0.39

124

909

Disorders of optic nerve, not elsewhere classified

298

2464

1.34

3.70

3.8

3.3

2296.27

1438.07

ng/l

1.44

260

2125

Findings of drugs and other substances, not normally found in blood

441

1.89

3.70

3.8

3.2

1404.06

1292.02

ng/l

0.11

362

Other nonscarring hair loss

119

856

1.53

3.69

4.1

3.0

997.48

806.90

ng/l

0.27

101

710

Non-small cell lung cancer, adenocarcinoma, helper endpoint

1030

9331

1.17

3.68

3.2

3.4

1322.67

1721.57

ng/l

3.37

947

8187

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

148

1102

1.46

3.67

2.8

3.2

1098.11

981.13

ng/l

0.15

125

908

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

371

2.00

3.66

3.4

2.9

1312.65

1180.10

ng/l

0.14

297

Premature rupture of membranes

1217

9623

0.89

3.65

2.3

2.5

398.23

465.73

ng/l

0.39

904

7725

Benign neoplasm: Conjunctiva

421

3579

1.26

3.65

3.1

3.2

1446.74

1276.90

ng/l

0.23

362

3070

Other maltreatment syndromes

260

2079

1.31

3.65

2.6

3.0

956.80

860.70

ng/l

0.23

213

1688

Burn and corrosion of trunk

345

2869

1.28

3.64

3.5

3.4

1184.03

1272.60

ng/l

0.22

306

2458

Malignant neoplasm of adrenal gland, including Hilmo

100

710

1.64

3.64

3.2

3.5

2785.91

1303.98

ng/l

0.95

598

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

135

994

1.48

3.62

3.6

3.3

2042.61

998.96

ng/l

0.90

116

818

Exposure to smoke, fire and flames

287

2345

1.31

3.62

3.0

3.4

1450.21

1371.24

ng/l

0.12

245

1992

Congenital deformities of hip, including avohilmo

158

1180

1.41

3.61

3.6

3.9

920.79

881.89

ng/l

0.06

128

967

Other articular cartilage disorders

280

2285

1.32

3.60

3.1

1008.35

1244.71

ng/l

0.58

245

1970

Common variable immunodeficiency

509

1.73

3.60

3.3

2.7

1377.89

1126.28

ng/l

0.15

416

Congenital malformations of genital organs

708

6146

1.17

3.59

3.2

3.1

667.67

793.71

ng/l

0.80

570

5014

Vertical strabismus

410

3472

1.26

3.59

2.9

3.1

1688.68

1203.85

ng/l

0.59

337

2950

Respiratory tuberculosis, confirmed, including avohilmo

264

2155

1.34

3.58

4.2

3.3

2649.35

1959.93

ng/l

1.21

237

1858

Other and unspecified nonscarring hair loss

619

1.62

3.58

3.2

2.9

952.28

766.76

ng/l

0.21

516

Mental and behavioural disorders associated with the puerperium

553

1.61

3.58

2.1

2.8

566.19

680.49

ng/l

0.18

444

Benign neoplasm of ovary

2306

21553

1.10

3.57

3.1

3.0

1095.48

1165.64

ng/l

0.39

1980

18556

Valgus deformity, not elsewhere classified

605

1.64

3.57

4.7

3.4

938.36

1105.97

ng/l

0.27

513

Other specified and unspecified disorders of conjunctiva

133

992

1.51

3.56

4.3

3.2

1512.51

1131.54

ng/l

0.45

115

844

Hypothyroidism, autoimmune, DX-based

278

1.98

3.54

2.5

3.4

289.46

822.76

ng/l

4.28

231

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

525

4556

1.23

3.54

3.3

3.2

1275.02

1351.18

ng/l

0.19

456

3927

Malignant neoplasm of testis

164

1248

1.42

3.54

3.5

3.4

1088.46

1370.56

ng/l

0.60

139

1034

Open wound of thorax

175

1352

1.41

3.51

3.2

3.3

1327.56

1179.31

ng/l

0.22

149

1143

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

553

4786

1.20

3.50

3.5

3.1

1096.09

1081.66

ng/l

0.03

463

4022

Tic disorders

603

1.57

3.49

3.6

4.0

408.65

1275.88

ng/l

2.15

473

Benign neoplasm of other and unspecified female genital organs

526

4565

1.22

3.49

2.8

3.1

937.76

1077.05

ng/l

0.46

439

3890

Exposure to other and unspecified man-made environmental factors

202

1587

1.37

3.49

3.5

3.4

1020.58

965.81

ng/l

0.09

180

1314

Sequelae of other and unspecified infectious and parasitic diseases

547

4733

1.20

3.47

3.6

3.1

1103.98

1078.95

ng/l

0.05

459

3974

Other and unspecified disorders of autonomic nervous system

353

1.89

3.47

3.8

3.2

549.54

1069.60

ng/l

2.14

290

Benign neoplasm of other and unspecified sites

420

3587

1.25

3.47

3.4

3.2

903.82

1282.91

ng/l

2.34

353

3077

Tic and related disorders

629

1.55

3.46

3.6

4.7

401.95

1364.74

ng/l

2.65

488

Malignant neoplasm of other and unspecified parts of mouth

104

767

1.67

3.45

3.3

3.4

1196.09

1512.84

ng/l

0.64

646

Henoch-Schönlein purpura nephritis (HSPN)

299

1.98

3.44

3.5

3.1

2103.79

1274.24

ng/l

0.74

249

156

1197

1.45

3.44

3.3

3.2

1672.42

1411.08

ng/l

0.39

127

1012

Injury of blood vessels at lower leg level

455

1.81

3.44

4.2

3.2

2110.73

1241.06

ng/l

0.94

383

Malignant neoplasm of renal pelvis, including Hilmo

185

1470

1.43

3.42

3.3

3.4

3408.44

1761.45

ng/l

1.97

171

1276

Diabetic maculopathy

1874

16493

1.12

3.42

4.3

4.0

4156.71

1677.27

ng/l

20.60

1669

14254

Crystalline deposits in vitreous body

154

1202

1.51

3.42

4.0

3.4

1206.18

1391.37

ng/l

0.40

136

1057

Benign neoplasm: Skin of lower limb, including hip

352

2963

1.28

3.42

3.6

3.1

1252.55

1209.26

ng/l

0.08

306

2534

Contact with other hot fluids

312

2576

1.28

3.41

3.3

3.4

1747.52

1104.71

ng/l

0.60

255

2158

Arthropathy in Crohn disease

110

794

1.53

3.41

2.7

3.1

916.48

785.41

ng/l

0.21

665

Unspecific neurodegenerative disorder

8416

55732

1.05

3.40

3.1

3.5

1918.46

1847.97

ng/l

0.65

7251

49295

Superficial injury of neck

179

1381

1.37

3.39

3.3

1418.47

996.39

ng/l

0.46

145

1134

Mandibular retrognathia

510

4363

1.20

3.39

2.8

3.2

528.59

690.98

ng/l

0.89

405

3574

Dementia in Alzheimer disease

3580

28462

1.08

3.38

3.4

3.7

1973.35

2246.38

ng/l

2.97

2975

25240

Pedestrian injured in other and unspecified transport accidents

158

1219

1.44

3.36

2.8

3.5

1238.16

1239.58

ng/l

0.00

131

1028

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

125

909

1.44

3.34

2.3

2.7

298.14

374.95

ng/l

0.35

724

Convergent concomitant strabismus

502

4315

1.20

3.34

3.0

3.1

1220.82

952.93

ng/l

0.41

422

3576

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

382

3231

1.25

3.34

2.9

3.2

718.84

1034.43

ng/l

1.41

326

2728

Divergent concomitant strabismus

800

7123

1.16

3.34

3.4

3.2

961.71

1119.91

ng/l

0.84

678

6016

Acanthosis nigricans

263

2.02

3.33

3.3

1484.39

928.52

ng/l

0.65

224

Whooping cough, including avohilmo

139

1035

1.43

3.32

2.8

3.1

952.99

642.72

ng/l

0.50

118

846

Sequelae of tuberculosis, including avohilmo

286

2380

1.32

3.32

4.1

3.6

1994.97

2312.45

ng/l

0.59

261

2081

Non-small cell lung cancer

1722

15810

1.12

3.32

3.2

3.4

1375.07

1826.83

ng/l

7.31

1584

13824

Hydrocephalus

1126

10283

1.15

3.32

2.7

3.3

1137.59

1740.90

ng/l

6.17

964

8966

Patellar tendinitis

143

1070

1.42

3.31

2.6

3.4

343.07

1114.56

ng/l

6.76

119

873

Other acute skin changes due to ultraviolet radiation

445

3835

1.24

3.29

3.4

3.2

1669.14

1478.88

ng/l

0.38

388

3304

Malignant neoplasm of thyroid gland

797

7117

1.17

3.29

3.2

3.1

1181.04

1111.45

ng/l

0.21

683

6069

Medicines for HER+ breast cancer

5375

47976

1.06

3.29

2.8

3.0

1014.38

1156.98

ng/l

2.21

4622

41088

Osteosarcoma, including Hilmo

312

1.94

3.29

7.5

3.2

916.20

1234.19

ng/l

0.59

261

Abnormal findings on diagnostic imaging of breast

199

1592

1.38

3.27

3.3

2.8

814.53

928.36

ng/l

0.42

180

1352

Benign neoplasm: Larynx

419

3602

1.25

3.27

3.5

3.3

1191.09

1636.47

ng/l

2.22

361

3103

Benign neoplasm: Choroid

920

8325

1.16

3.26

3.4

3.2

1545.22

1334.29

ng/l

0.41

785

7237

Benign neoplasm: Skin, unspecified

498

4327

1.22

3.24

3.3

3.1

1508.10

1244.85

ng/l

0.75

413

3718

Melanoma in situ

676

6034

1.20

3.24

3.3

2058.38

1500.27

ng/l

0.91

584

5273

Adult respiratory distress syndrome

183

1456

1.41

3.24

4.3

3.3

2794.50

1659.99

ng/l

1.19

169

1251

Inflammatory myopathy

233

2.49

3.22

3.8

3.9

1264.95

1837.06

ng/l

0.67

189

Melanocytic naevi of lower limb, including hip

500

4336

1.21

3.21

3.4

3.1

1457.97

1104.71

ng/l

0.77

424

3666

Toxic liver disease

193

1538

1.38

3.21

2.9

3.3

2653.76

1087.38

ng/l

0.85

170

1302

Aggressive periodontitis

289

2409

1.30

3.20

2.9

3.2

1770.57

1143.49

ng/l

1.20

250

2064

Sequelae of tuberculosis

278

2316

1.31

3.20

4.1

3.6

2031.65

2331.65

ng/l

0.53

255

2028

Other and unspecified injuries of neck

590

1.58

3.19

3.5

3.3

614.95

935.02

ng/l

1.28

478

Undescended testis, unilateral

423

1.67

3.19

4.5

6.0

987.84

1614.39

ng/l

0.71

350

Motorcycle rider injured in other and unspecified transport accidents

491

4228

1.20

3.18

3.0

3.3

1128.20

1021.93

ng/l

0.18

389

3457

Drug-induced dystonia

260

2.02

3.18

2.8

3.0

2585.37

946.17

ng/l

0.57

213

Epileptic seizures related to drugs

181

2.15

3.18

3.1

3.3

593.42

757.19

ng/l

0.20

148

Other and unspecified myoneural disorders

392

1.86

3.17

3.6

3.0

1107.89

981.97

ng/l

0.15

322

Degenerative diseases of the nervous system

6820

50779

0.95

3.17

3.1

3.5

2125.32

1931.69

ng/l

2.18

5887

44830

Migraine without aura, drug-induced

109

794

1.50

3.16

3.7

3.1

425.47

782.34

ng/l

1.75

655

Malignant neoplasm of lip

128

978

1.51

3.16

3.9

3.4

2891.91

2091.99

ng/l

0.62

110

859

Hereditary nephropathy, not elsewhere classified

308

2.07

3.16

4.0

3.4

2919.07

1168.99

ng/l

0.96

263

Moderate visual impairment, monocular

481

1.75

3.16

3.3

1086.92

1244.52

ng/l

0.13

418

Abscess of lung

212

1717

1.36

3.15

4.5

3.3

1685.32

1464.39

ng/l

0.31

203

1476

Immunodeficiency associated with other major defects

224

2.14

3.15

3.5

4.2

5115.61

1033.55

ng/l

0.72

188

Female infertility

2575

14432

1.08

3.15

2.5

2.7

530.50

935.56

ng/l

12.15

2125

12130

Hypothermia

254

2099

1.32

3.14

3.5

3.4

2055.73

1690.63

ng/l

0.74

220

1822

Spinal enthesopathy

403

3439

1.23

3.13

3.9

3.3

1824.39

2657.91

ng/l

3.74

369

2975

Pregnancy with abortive outcome

8693

43715

1.05

3.13

3.0

2.9

1022.95

1124.64

ng/l

1.58

7300

37154

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

103

755

1.55

3.12

5.8

3.5

2191.76

1315.61

ng/l

0.84

634

Burn and corrosion of hip and lower limb, except ankle and foot

257

2108

1.30

3.12

3.5

3.4

1830.24

1186.40

ng/l

0.48

212

1766

Other meningitis

181

1429

1.37

3.11

3.1

3.3

952.77

1023.77

ng/l

0.14

152

1205

Alcohol-induced acute pancreatitis

431

3718

1.23

3.10

3.1

3.3

2079.18

1259.89

ng/l

1.75

365

3165

Other congenital malformations of limb(s)

321

1.74

3.10

6.3

4.2

1279.17

754.59

ng/l

0.39

262

Disorders of glycoprotein metabolism

3.08

3.10

2.9

2.5

752.05

759.15

ng/l

0.01

Mild or no visual impairment, binocular

429

1.75

3.10

3.2

3.4

1658.01

1201.54

ng/l

0.44

363

Non-small cell lung cancer, including Hilmo

2521

22307

1.09

3.10

3.3

3.4

1296.89

1756.80

ng/l

10.67

2308

19469

Benign neoplasm of thyroid gland

421

3635

1.24

3.10

3.1

945.84

1108.55

ng/l

0.50

360

3092

Serous carcinoma of ovary

888

0.60

3.09

2.8

3.2

917.10

1408.23

ng/l

1.41

763

Psoas tendinitis

477

1.68

3.08

3.0

3.2

816.95

959.59

ng/l

0.26

407

Iliotibial band syndrome

127

956

1.45

3.07

2.9

3.1

1053.82

1018.21

ng/l

0.03

114

809

Burn and corrosion of ankle and foot

167

1312

1.39

3.06

3.4

3.3

2637.49

1126.91

ng/l

1.63

142

1115

Third [oculomotor] nerve palsy

264

2203

1.32

3.06

3.6

3.3

1627.68

1522.55

ng/l

0.13

234

1907

340

1.83

3.06

2.3

3.0

422.42

661.58

ng/l

0.94

283

Benign neoplasm: Long bones of lower limb

332

2793

1.25

3.05

3.1

3.2

1039.30

1051.32

ng/l

0.02

274

2334

Periodontal disease, other/unspecified

323

2721

1.26

3.05

3.0

3.2

922.15

1093.39

ng/l

0.30

271

2342

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

212

1743

1.38

3.03

4.1

3.3

2059.35

1767.83

ng/l

0.35

180

1527

Traumatic amputation of wrist and hand

534

4692

1.20

3.03

3.5

3.3

1199.71

1483.39

ng/l

0.88

473

4088

Contact with hot air and gases

598

1.61

3.01

2.6

3.4

1655.77

1312.83

ng/l

0.47

513

Disorders of pituitary gland, other and/or unspecified

577

1.64

2.99

3.0

3.1

4573.92

1334.06

ng/l

0.64

485

Tarsal tunnel syndrome

135

1042

1.46

2.99

2.8

3.1

1448.28

1062.47

ng/l

0.37

121

895

Hepatocellular carcinoma

337

2879

1.27

2.98

3.2

3.4

1714.93

1830.94

ng/l

0.13

301

2524

Ulcerative proctitis

625

5520

1.17

2.98

3.1

1544.92

1110.73

ng/l

1.04

534

4641

All dysplastic lesions of the cervix uteri, vagina or vulva

2543

23285

1.08

2.97

2.7

2.6

774.69

690.29

ng/l

0.38

2102

19143

Respiratory tuberculosis, confirmed

253

2101

1.31

2.96

4.3

3.3

2670.66

1978.34

ng/l

1.16

228

1812

Drug-induced myopathy

303

1.99

2.96

3.3

3.4

2336.26

1811.62

ng/l

0.40

255

Other acquired deformities of musculoskeletal system and connective tissue

543

4778

1.19

2.96

3.4

3.2

1115.89

1182.95

ng/l

0.18

476

4067

Benign neoplasm: Pelvic bones, sacrum and coccyx

369

1.78

2.94

2.8

3.3

583.68

1246.19

ng/l

1.90

309

Intentional self-harm by hanging, strangulation and suffocation

583

0.54

2.92

3.2

723.76

1398.48

ng/l

1.29

477

Benign neoplasm: Endocrine pancreas

100

752

1.59

2.92

3.1

3.5

1404.43

1343.91

ng/l

0.06

633

Meretoja disease

360

1.87

2.91

4.0

3.3

1532.91

1435.21

ng/l

0.07

305

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

162

1274

1.38

2.91

2.6

3.2

617.67

1045.30

ng/l

1.86

132

1070

Recurrent and persistent haematuria

111

834

1.49

2.90

4.0

3.3

3134.62

1300.28

ng/l

1.23

704

Viral conjunctivitis, including avohilmo

379

3235

1.22

2.90

2.8

2.9

957.07

917.01

ng/l

0.08

329

2693

Disorder of pancreatic internal secretion, other and/or unspecified

100

743

1.54

2.90

2.9

3.5

1708.70

1081.58

ng/l

0.71

635

Factitial dermatitis

505

1.67

2.90

3.8

3.1

2952.35

1191.77

ng/l

0.42

428

Exophthalmic conditions

140

1090

1.43

2.89

3.0

3.2

1340.64

1282.39

ng/l

0.05

121

918

Arthropathy in ulcerative colitis

132

1008

1.42

2.89

3.5

3.3

1093.24

787.88

ng/l

0.64

112

840

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

175

1381

1.34

2.88

3.6

1981.63

884.80

ng/l

1.48

154

1136

Other congenital malformations of skin, including avohilmo

821

7385

1.14

2.88

3.0

3.2

1103.81

1068.99

ng/l

0.09

706

6227

Deep bite

1017

8096

1.13

2.88

3.6

3.4

835.82

925.44

ng/l

0.31

839

6747

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

171

2.07

2.88

5.3

3.2

657.88

827.67

ng/l

0.18

131

Malignant neoplasm of parotid gland, including Hilmo

144

1133

1.44

2.87

2.8

3.2

1086.70

1488.49

ng/l

1.20

129

963

Benign neoplasm: Connective and other soft tissue of thorax

475

1.71

2.87

3.1

3.4

1455.36

1107.08

ng/l

0.27

395

Contracture of joint

151

1182

1.39

2.86

3.7

3.2

923.07

1286.04

ng/l

1.65

129

1002

Other disorders of amino-acid metabolism

439

1.71

2.85

3.8

3.2

3349.98

1412.36

ng/l

0.78

374

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

3.71

2.85

4.9

3.8

2530.14

761.65

ng/l

0.91

Benign neoplasm: Other and unspecified parts of small intestine

235

1960

1.33

2.84

3.4

3.3

1841.74

1292.53

ng/l

0.69

213

1695

Other corneal oedema

136

1072

1.47

2.84

3.3

2241.02

1373.86

ng/l

1.04

119

925

Pedestrian injured in collision with pedal cycle

362

3101

1.23

2.84

3.2

3.3

1777.90

1270.60

ng/l

0.56

311

2649

Ulcerative colitis (strict) with PSC

547

1.57

2.84

2.4

3.4

838.14

662.19

ng/l

0.19

444

Exposure to other and unspecified forces of nature

588

1.59

2.83

3.5

3.1

832.02

1152.82

ng/l

0.86

491

Contracture of muscle

363

1.76

2.83

2.6

3.3

941.40

1038.49

ng/l

0.12

302

Guillain-Barre syndrome

203

1655

1.34

2.83

3.3

3.2

1673.00

1306.52

ng/l

0.41

175

1425

Use of rasagiline

376

3270

1.25

2.83

2.7

3.2

976.86

1304.84

ng/l

2.16

326

2847

Drug-induced gout

580

1.71

2.82

6.9

3.6

3004.38

1907.94

ng/l

1.58

497

Cyst of Bartholin Gland

354

3011

1.23

2.82

2.5

2.9

561.52

715.90

ng/l

1.16

290

2539

Respiratory tuberculosis, bacteriologically and histologically confirmed

261

2185

1.29

2.82

4.3

3.3

2618.53

1995.59

ng/l

1.03

235

1883

Polyarteritis nodosa

722

1.55

2.82

4.0

3.3

3074.75

1565.16

ng/l

0.48

619

Left side

531

1.76

2.81

3.6

3.5

1853.51

1393.91

ng/l

0.31

447

Lagophthalmos

189

1544

1.37

2.79

2.9

3.4

1859.97

1474.89

ng/l

0.55

161

1343

Generalized epilepsy, mode (most common among epilepsy diagnosis)

279

2325

1.26

2.79

2.7

3.3

744.89

1054.37

ng/l

1.40

231

1933

Bacterial meningitis

390

3366

1.22

2.79

3.0

3.2

1208.15

1147.89

ng/l

0.05

333

2872

Combined immunodeficiencies

139

1088

1.42

2.79

4.0

3.2

1813.18

1338.20

ng/l

0.67

124

930

Other injuries of spine and trunk, level unspecified

115

874

1.47

2.78

4.3

3.4

3409.15

1159.90

ng/l

0.84

731

Infliximab

151

1168

1.35

2.78

2.3

3.2

279.22

769.58

ng/l

2.56

116

924

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

121

933

1.47

2.78

3.0

3.5

2048.75

1411.92

ng/l

0.79

106

796

Phakomatoses, not elsewhere classified

109

813

1.45

2.78

2.6

3.5

767.81

822.22

ng/l

0.08

102

672

Benign neoplasm: Connective and other soft tissue, unspecified

151

1194

1.40

2.77

3.0

3.2

1574.54

1217.31

ng/l

0.34

133

1017

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

107

791

1.44

2.77

3.2

3.6

605.69

1163.49

ng/l

1.60

643

Benign neoplasm: Oesophagus

170

1372

1.39

2.76

3.4

3.2

1328.16

1343.37

ng/l

0.02

140

1175

Pathological resorption of teeth

418

3626

1.21

2.76

3.2

1163.43

1094.73

ng/l

0.12

357

3064

Epidural haemorrhage

106

791

1.47

2.75

3.5

2.9

1665.93

1421.86

ng/l

0.19

675

Other hyperalimentation

314

1.87

2.74

3.2

897.00

1321.23

ng/l

0.69

268

Social disorders starting during childhood or adolecense, excluding more controls

214

1.82

2.74

3.3

3.5

1044.45

578.17

ng/l

0.25

170

Other infective (teno)synovitis

367

1.75

2.74

3.5

3.4

1875.45

1072.49

ng/l

0.57

312

Urticaria due to cold and heat

576

1.54

2.74

3.0

471.26

748.03

ng/l

1.37

476

Epiphora

303

2581

1.26

2.73

3.0

3.2

1078.23

1335.68

ng/l

0.72

258

2205

Disorders of male genital organs in diseases classified elsewhere

565

1.58

2.73

4.2

3.6

1498.08

1339.55

ng/l

0.11

482

Congenital musculoskeletal deformities of head, face, spine and chest

699

1.47

2.73

3.4

3.5

640.65

1206.74

ng/l

1.36

562

Fatigue fracture of vertebra

503

1.65

2.73

3.2

4.0

1688.37

1395.46

ng/l

0.21

441

LSIL lesion of the vagina

157

1238

1.36

2.73

2.8

2.9

810.05

829.40

ng/l

0.03

133

1047

Paget disease

624

1.64

2.72

3.4

3.1

1804.16

1399.12

ng/l

0.44

534

Osteitis due to dental implant

120

934

1.49

2.72

3.3

1852.83

1202.07

ng/l

0.49

110

796

Other and unspecified injuries of forearm

639

1.52

2.71

4.3

3.2

1992.82

1108.33

ng/l

0.59

531

Use of galantamine

1426

13321

1.12

2.71

3.1

3.6

1890.19

2169.89

ng/l

1.63

1214

11797

Disorders of other and unspecified cranial nerves

547

1.62

2.70

3.2

3.1

3773.20

1296.91

ng/l

1.21

473

Endometriosis of fallopian tube

502

1.57

2.69

2.6

2.9

2477.22

1035.61

ng/l

0.37

426

Unspecified abortion

435

3773

1.19

2.69

2.2

2.7

646.62

621.84

ng/l

0.03

354

3180

Intussusception

261

2187

1.27

2.69

2.4

2.9

735.07

1027.20

ng/l

1.93

231

1857

Brain meningioma

662

5948

1.17

2.68

2.9

3.1

1291.76

1270.23

ng/l

0.05

573

5109

Onychogryphosis

262

2.00

2.68

3.3

3.5

1723.61

1184.71

ng/l

0.44

219

Maternal care for other known or suspected fetal problems

1424

8209

1.10

2.68

2.1

2.4

295.71

372.17

ng/l

0.89

1038

6473

Liposarcoma, including Hilmo

141

1117

1.42

2.68

3.3

3.1

2095.50

1444.58

ng/l

0.82

127

953

Deaf mutism, not elsewhere classified

497

1.64

2.67

3.0

3.1

3300.55

1395.53

ng/l

0.90

428

Injury of nerves and spinal cord at thorax level

461

1.65

2.66

2.7

3.4

734.30

1035.24

ng/l

0.54

383

Polyglandular dysfunction

196

2.08

2.66

3.4

3.5

1120.79

766.48

ng/l

0.56

168

Brain meningioma, including Hilmo

681

6132

1.16

2.65

2.9

3.1

1277.18

1277.43

ng/l

0.00

590

5269

Defects in post-translational modification of lysosomal enzymes

4.89

2.64

3.3

2.1

574.58

796.94

ng/l

0.18

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

126

990

1.46

2.63

3.5

3.3

2110.03

1544.63

ng/l

0.51

108

840

Perioral dermatitis

215

1758

1.28

2.63

2.9

2.8

836.56

789.12

ng/l

0.10

176

1455

Assault by other specified means

620

1.49

2.62

3.3

3.1

1244.62

641.03

ng/l

0.91

498

Myositis ossificans

269

1.91

2.61

2.6

3.4

1132.33

1476.14

ng/l

0.50

222

Phantom limb syndrome

305

1.91

2.61

4.6

3.1

5691.96

1135.02

ng/l

0.75

256

Complications associated with artificial fertilization

629

1.45

2.61

1.9

2.6

146.17

639.20

ng/l

2.52

478

Optic atrophy, wide definition

224

1860

1.30

2.61

3.5

3.4

1292.43

1300.47

ng/l

0.01

194

1585

Other lack of coordination

221

1837

1.31

2.61

3.3

3.5

839.26

1427.14

ng/l

3.11

190

1583

Generalized epilepsy, strict definition

194

1569

1.30

2.60

2.6

3.5

733.69

991.60

ng/l

0.89

150

1308

Parapsoriasis

221

1828

1.29

2.60

3.2

1233.78

1264.77

ng/l

0.05

183

1568

Lower leg

642

1.53

2.60

3.4

908.21

1119.50

ng/l

0.50

530

Ulcerative colitis (strict definition, all Crohn cases excluded)

1507

14004

1.10

2.60

3.3

3.2

1236.67

1158.60

ng/l

0.26

1242

11795

Familial erythrocytosis

465

1.65

2.59

3.0

3.2

1649.52

1278.51

ng/l

0.26

396

Type 1 diabetes, strict definition, subgroup 1

386

3295

1.19

2.59

2.7

3.1

1552.24

368.88

ng/l

3.33

316

2537

Malignant neoplasm of cervix uteri, including Hilmo

272

2292

1.26

2.59

3.1

3.0

2475.02

1091.52

ng/l

1.45

240

1940

593

1.45

2.59

5.8

7.9

1541.50

1105.82

ng/l

0.39

486

Benign neoplasm: Spinal cord

180

1466

1.34

2.58

3.3

3.2

794.07

1085.77

ng/l

0.97

151

1248

Presbyopia

870

7914

1.13

2.57

2.7

3.0

606.78

920.77

ng/l

3.58

718

6661

Injury of blood vessels of thorax

334

1.78

2.57

4.1

3.3

2417.11

1414.50

ng/l

0.71

285

HSIL lesion of the vagina

155

1235

1.36

2.57

3.3

3.0

817.02

906.56

ng/l

0.25

127

1034

Malignant neoplasm of bronchus and lung

2935

25743

0.93

2.57

3.2

3.4

1476.58

1736.87

ng/l

3.08

2692

22503

Burn and corrosion, body region unspecified

479

1.60

2.56

3.1

3.4

3800.23

1160.26

ng/l

0.60

401

Muscle wasting and atrophy, not elsewhere classified

630

1.55

2.56

4.0

3.5

1747.36

1508.85

ng/l

0.27

548

Injury of urinary and pelvic organs

244

2042

1.27

2.56

3.6

3.5

1934.72

1506.02

ng/l

0.59

207

1739

Disorders of globe

353

3063

1.23

2.55

3.5

3.2

2075.04

1538.86

ng/l

1.07

317

2663

Other adrenocortical overactivity

318

1.69

2.53

3.9

4.2

851.63

969.47

ng/l

0.15

259

Pneumonia due to Haemophilus influenzae

376

1.72

2.53

4.5

2.6

1015.51

992.87

ng/l

0.04

311

Mental and behavioural disorders of puerperium, not classified elsewhere

597

1.48

2.53

2.1

2.6

566.19

500.64

ng/l

0.12

480

Other osteochondrodysplasias, including avohilmo

130

1015

1.39

2.52

3.3

3.4

1710.51

973.70

ng/l

0.83

108

859

Embedded and impacted teeth

1856

14050

1.08

2.52

3.0

923.99

794.17

ng/l

0.61

1483

11102

Acute otitis externa, noninfective

210

1740

1.30

2.51

4.0

3.2

1163.06

1082.07

ng/l

0.16

185

1494

Optic atrophy

212

1759

1.30

2.50

3.5

3.4

1313.74

1263.91

ng/l

0.07

185

1503

Other congenital malformations of posterior segment of eye (coloboma)

3.14

2.49

3.3

3.1

479.14

1785.72

ng/l

0.64

Postpartum haemorrhage due to anatomy

532

4675

1.15

2.49

2.1

2.3

231.87

338.21

ng/l

1.60

382

3656

Drug-induced tremor

740

1.51

2.48

3.5

3.4

2481.76

1212.54

ng/l

0.72

626

Tuberculosis, wide, including avohilmo

1081

9990

1.12

2.48

4.0

3.4

2019.17

1924.41

ng/l

0.26

948

8725

Dacryoadenitis

103

788

1.47

2.48

3.2

3.4

1122.39

1561.33

ng/l

0.80

671

Injury of nerves and spinal cord at neck level

283

2416

1.25

2.48

3.9

3.3

1033.45

1233.21

ng/l

0.70

250

2081

Colitis, primary sclerosing, strict definition

102

768

1.43

2.48

2.2

3.3

1132.31

824.52

ng/l

0.35

626

Maternal care for known or suspected fetal abnormality and damage

775

7292

0.89

2.48

2.4

326.37

390.16

ng/l

0.23

607

5817

Other congenital malformations of intestine, including avohilmo

135

1067

1.39

2.48

3.3

3.6

1340.38

1062.26

ng/l

0.24

112

912

Malignant neoplasm of testis, including Hilmo

181

1468

1.31

2.47

3.5

3.3

1289.66

1511.08

ng/l

0.38

155

1229

Burns and corrosions of multiple and unspecified body regions

245

2054

1.26

2.47

3.3

3.5

2143.32

1265.47

ng/l

0.70

213

1738

Tuberculosis, IBD comorbidity

1028

9485

1.12

2.46

4.0

3.4

2050.89

1901.17

ng/l

0.44

900

8283

Postinfectious hypothyroidism

557

1.57

2.45

3.0

3.1

1768.64

1127.05

ng/l

0.48

479

Benign neoplasm: Pharynx, unspecified

104

797

1.46

2.45

3.4

3.3

2096.53

1190.34

ng/l

0.51

676

Congenital malformations of oesophagus, including avohilmo

593

1.56

2.45

3.1

3.5

787.66

1578.18

ng/l

3.56

503

MS-disease / Multiple Sclerosis

635

5681

1.15

2.45

2.7

2.9

644.01

860.89

ng/l

2.08

522

4691

Type 1 diabetes, strict definition

416

3590

1.17

2.44

2.9

3.0

1486.41

397.41

ng/l

3.28

341

2783

Benign neoplasm: Other parts of oropharynx

117

912

1.43

2.44

3.6

3.2

1129.16

1192.42

ng/l

0.06

102

763

Benign neoplasm: Other/unspecified site

203

1687

1.31

2.44

3.2

1045.30

1192.08

ng/l

0.29

166

1437

Whooping cough

337

1.64

2.43

3.0

3.2

1636.84

645.32

ng/l

0.64

267

Malignant neoplasm of parotid gland

123

973

1.43

2.42

2.7

3.2

1137.36

1438.53

ng/l

0.68

109

825

Drug-induced autoimmune haemolytic anaemia

129

2.48

2.42

2.6

2.7

1860.46

1166.87

ng/l

0.40

108

Disorders of parathyroid gland, other and/or unspecified

108

845

1.48

2.41

4.3

3.2

2078.30

1477.97

ng/l

0.71

725

Universal erythroderma, KELA reimbursement

174

1423

1.33

2.41

3.6

3.3

2570.04

1249.47

ng/l

0.72

145

1212

Exfoliative dermatitis

146

1175

1.37

2.40

3.3

3.4

2752.28

1630.11

ng/l

0.54

138

1013

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

553

1.58

2.40

3.8

3.2

1566.24

1308.54

ng/l

0.25

466

Lipoprotein deficiency

205

2.05

2.39

3.5

3.1

841.65

1304.59

ng/l

0.67

173

Villonodular synovitis (pigmented)

646

1.48

2.39

2.9

3.4

644.12

1091.74

ng/l

2.28

541

Aspergillosis

126

1002

1.42

2.39

5.0

3.3

1402.78

1315.32

ng/l

0.11

120

852

Lichenoid drug reaction

351

1.88

2.38

4.0

3.7

1642.65

1290.40

ng/l

0.26

301

Chlamydial lymphogranuloma (venereum), including avohilmo

0.00

2.38

0.0

3.9

—

845.12

—

Reduction defects of lower limb, including avohilmo

272

1.79

2.38

3.0

3.4

413.70

950.17

ng/l

2.55

229

Other protozoal intestinal diseases, including avohilmo

213

1765

1.27

2.35

2.9

3.1

624.56

1032.32

ng/l

3.24

176

1476

Chronic thyroiditis

384

1.69

2.34

3.7

3.0

1531.04

1090.75

ng/l

0.33

329

Congenital malformations of breast

111

845

1.37

2.34

2.4

2.8

394.41

590.57

ng/l

0.70

675

Other disorders of amniotic fluid and membranes

832

7278

1.12

2.34

2.3

2.5

326.11

416.79

ng/l

0.83

634

5807

Congenital malformations of posterior segment of eye

439

1.60

2.34

6.3

3.4

1309.79

1306.16

ng/l

0.00

369

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

4025

31826

1.06

2.33

3.3

3.4

1456.90

1659.24

ng/l

2.57

3688

27746

HSIL lesion of the cervix uteri, vagina or vulva

1579

14731

1.09

2.33

2.8

2.6

861.16

659.45

ng/l

0.68

1296

12047

Personal history of allergy to drugs, medicaments and biological substances

114

881

1.39

2.32

3.0

2.5

1423.46

832.14

ng/l

0.37

725

Dementia due to Parkinsons disease, excluding more controls

344

3005

1.22

2.32

3.2

1462.76

1987.74

ng/l

1.78

297

2680

Secondary lactase deficiency

2.65

2.31

1.8

2.9

954.64

987.15

ng/l

0.02

Complications following myocardial infarction

112

874

1.42

2.31

4.2

2.7

2068.31

1607.64

ng/l

0.62

101

732

Sequelae of intentional self-harm, assault and events of undetermined intent

417

1.57

2.30

4.5

2.9

575.40

811.60

ng/l

0.68

343

Other disorders of peripheral nervous system

723

1.49

2.30

3.8

3.3

710.09

1197.86

ng/l

2.21

607

Benign neoplasm: Scapula and long bones of upper limb

112

870

1.40

2.29

3.4

3.3

965.85

936.17

ng/l

0.04

731

Congenital hypothyroidism without goiter

432

1.60

2.29

4.2

4.0

1595.34

1125.67

ng/l

0.33

360

Pemphigus

740

1.48

2.29

3.8

3.4

2004.06

1242.10

ng/l

0.97

627

Aspergillosis, including avohilmo

128

1025

1.40

2.29

5.0

3.3

1381.88

1303.57

ng/l

0.10

122

871

Heberden's nodes [with arthropathy]

125

1001

1.41

2.27

3.2

771.44

1105.40

ng/l

0.80

115

852

Polypectomy (DHB20)

829

7599

1.13

2.27

2.8

3.2

1168.72

1384.92

ng/l

0.96

738

6562

Impacted maxillary canine

466

1.51

2.26

4.0

4.6

911.86

892.56

ng/l

0.02

388

Ankyloglossia

543

1.44

2.26

7.6

5.9

608.33

1270.82

ng/l

1.09

426

Labyrinthine fistula

333

1.79

2.26

3.1

3.8

2127.37

1333.56

ng/l

0.41

292

Unspecified transport accident

356

1.64

2.26

2.2

3.3

573.16

1103.76

ng/l

1.51

294

Other and unspecified acute skin changes due to ultraviolet radiation

345

3023

1.22

2.26

3.4

3.2

1909.12

1627.59

ng/l

0.47

303

2614

Abnormal reflex

469

1.58

2.26

2.8

3.3

1395.52

935.35

ng/l

0.35

382

Seronegative juvenile rheumatoid arthritis

113

867

1.36

2.25

3.2

3.3

1812.96

600.55

ng/l

1.21

679

Osteopathy in diseases classified elsewhere

108

850

1.44

2.24

4.9

3.5

1825.90

1004.24

ng/l

0.84

732

Benign neoplasm: Bladder

141

1147

1.38

2.23

4.1

3.4

1833.40

1671.95

ng/l

0.21

123

996

Acquired keratosis [keratoderma] palmaris et plantaris

465

1.60

2.23

2.8

3.2

573.72

1033.10

ng/l

2.60

391

Bullous keratopathy

132

1071

1.40

2.22

3.2

3.5

2642.08

1513.47

ng/l

0.81

113

926

Benign neoplasm: Lip

280

2417

1.24

2.22

3.3

1653.88

1422.80

ng/l

0.45

233

2082

Malignant neoplasm of ureter, including Hilmo

136

1109

1.40

2.22

2.7

3.4

2845.39

1841.91

ng/l

0.68

124

964

Vascular dementia (undefined)

700

6322

1.14

2.22

3.6

3.8

2840.67

2718.19

ng/l

0.23

606

5598

Enteritis due to Yersinia enterocolitica

425

1.58

2.22

4.1

3.5

573.44

1211.39

ng/l

2.38

359

Acute inflammation of orbit

526

1.51

2.22

3.1

3.4

1115.73

1192.13

ng/l

0.06

439

Hereditary sideroblastic anaemia

408

1.67

2.22

3.7

3.3

1777.07

1659.46

ng/l

0.09

351

Femoral hernia, bilateral

342

1.75

2.21

3.3

3.5

3765.79

1638.19

ng/l

0.71

291

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

385

3409

1.21

2.21

3.0

3.1

1585.28

1166.97

ng/l

0.48

356

2911

Benign neoplasm: Prostate

113

906

1.46

2.21

3.5

3.6

1643.73

1753.13

ng/l

0.16

798

Chronic diseases of tonsils and adenoids

10446

64168

1.03

2.21

3.0

3.1

818.14

1150.83

ng/l

14.98

8623

54646

L02BG Aromatase inhibitors

4484

42717

1.05

2.20

2.9

3.0

1022.75

1155.37

ng/l

1.66

3871

36761

Otorrhoea

248

1.83

2.19

4.1

3.4

1056.71

1255.67

ng/l

0.17

208

Toxic effect of other gases, fumes and vapours

512

1.53

2.19

4.9

3.8

1568.28

1192.09

ng/l

0.41

434

Congenital malformations of oesophagus

465

1.58

2.18

3.1

3.5

684.52

1593.43

ng/l

4.04

390

Adenocarcinoma and papillary adenocarcinoma of stomach

314

3598

0.83

2.17

2.9

3.3

1832.47

1771.95

ng/l

0.08

291

3120

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

834

7668

1.13

2.17

3.1

3.2

1261.71

1284.96

ng/l

0.07

730

6602

Ankylosis of joint

524

1.53

2.17

3.2

3.3

1476.23

1588.22

ng/l

0.11

453

Enduring personality changes

328

1.67

2.16

3.6

3.1

661.43

904.43

ng/l

0.62

273

Chlamydial lymphogranuloma (venereum)

0.00

2.16

0.0

4.0

—

553.32

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

769

7062

1.14

2.15

3.3

3.5

1496.51

1710.12

ng/l

0.60

681

6168

Benign neoplasm: Retina

571

1.52

2.15

3.2

3.5

722.54

1377.71

ng/l

2.73

476

Thalassaemia

253

1.74

2.15

3.9

3.6

582.35

1298.01

ng/l

1.46

213

Tuberculosis, wide

1060

9857

1.11

2.13

4.0

3.4

2029.46

1933.67

ng/l

0.26

929

8615

Isolated growth hormone deficiency

273

1.64

2.13

5.1

8.4

874.33

859.62

ng/l

0.01

235

Lumbosacral plexus disorders

326

1.72

2.12

2.9

3.1

1022.48

1259.90

ng/l

0.29

264

Congenital malformations of breast, including avohilmo

115

893

1.34

2.12

2.4

2.9

389.54

604.61

ng/l

0.84

710

Tuberculosis of other organs

300

2621

1.23

2.12

4.1

3.4

1877.70

1870.14

ng/l

0.01

257

2284

Hypertrophy of (infrapatellar) fat pad

745

1.40

2.12

4.5

3.3

847.61

1083.39

ng/l

0.32

620

Benign neoplasm: Bronchus and lung

178

1488

1.31

2.12

3.5

3.2

1014.09

1432.50

ng/l

1.91

154

1274

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

472

1.60

2.11

2.7

3.3

2535.20

1622.02

ng/l

0.94

401

Cholera, including avohilmo

179

1.99

2.11

2.6

2.9

1253.71

1310.49

ng/l

0.04

147

Juvenile Open Angle Glaucoma

420

1.56

2.11

2.7

3.0

592.36

875.38

ng/l

0.77

344

Delayed puberty

216

1.69

2.11

4.4

5.8

191.78

1230.17

ng/l

0.65

150

Congenital malformations of anterior segment of eye

707

1.43

2.10

2.8

3.7

622.02

1092.07

ng/l

2.59

601

Complications of the puerperium, not elsewhere classified

245

2066

1.22

2.09

2.9

2.6

636.14

435.91

ng/l

0.37

188

1648

Contusion of toe(s) with damage to nail

113

887

1.36

2.09

2.7

3.0

1648.94

1045.78

ng/l

0.54

734

Colour vision deficiencies

261

1.69

2.09

3.0

3.7

599.21

1187.45

ng/l

1.72

211

Secondary malignant neoplasm of respiratory and digestive organs

269

2339

1.25

2.08

2.9

3.3

1127.85

1617.19

ng/l

2.53

239

2020

Diseases caused by chlamydiae

674

1.41

2.08

2.5

2.8

681.51

495.89

ng/l

0.25

547

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

121

968

1.37

2.08

5.5

3.3

1798.59

1255.81

ng/l

0.46

106

823

Burn and corrosion of other internal organs

258

1.76

2.08

2.4

3.3

346.10

776.93

ng/l

2.79

214

Diseases of thymus

245

1.84

2.07

3.0

3.3

930.22

1178.85

ng/l

0.38

198

Burns and corrosions confined to eye and internal organs

256

2187

1.22

2.07

2.7

3.2

1133.65

977.26

ng/l

0.22

203

1817

Neuroendocrine tumor and carcinoma of lung

119

958

1.39

2.07

2.8

3.1

1096.50

1374.21

ng/l

0.52

103

811

666

1.37

2.07

5.5

7.7

1265.35

1076.26

ng/l

0.17

539

Shigellosis

250

1.76

2.05

3.9

3.1

2754.99

1105.38

ng/l

0.60

213

Livedoid vasculitis

478

1.60

2.05

3.4

3.5

1176.74

1200.10

ng/l

0.03

409

Beningn neoplasm: Meninges, unspecified

220

1883

1.27

2.04

3.6

3.1

1858.56

1362.66

ng/l

0.61

185

1608

Renal cell carcinoma of kidney

469

4218

1.17

2.04

3.8

3.3

2595.73

1786.28

ng/l

2.02

426

3676

Other and unspecified disease of Bartholin gland

336

2953

1.20

2.04

2.7

3.1

1159.65

1098.93

ng/l

0.10

294

2527

Blepharospasm

131

1067

1.36

2.04

3.3

1005.50

1231.33

ng/l

0.43

112

909

Tuberculosis of other organs, strict

341

3012

1.21

2.04

4.0

3.4

1815.85

1990.63

ng/l

0.31

294

2619

Other superficial injuries of ankle and foot

481

1.49

2.03

2.7

3.4

830.00

915.70

ng/l

0.17

391

Other and unspecified parapsoriasis

567

1.55

2.03

3.4

1319.57

1304.71

ng/l

0.02

489

Other diseases caused by chlamydiae

102

792

1.37

2.03

2.7

2.9

715.07

653.46

ng/l

0.08

640

Toxic encephalopathy

251

1.90

2.02

4.1

3.8

2202.89

1503.08

ng/l

0.34

211

Carcinoma in situ of oral cavity, oesophagus and stomach

716

1.47

2.02

4.4

3.6

1771.23

1770.16

ng/l

0.00

611

Tuberculosis

890

8240

1.12

2.02

4.0

3.4

2175.59

2004.00

ng/l

0.46

796

7182

Relapsing polychondritis

222

1.87

2.02

3.0

2.9

590.66

1008.83

ng/l

0.50

182

Motor- or nonmotor-vehicle accident in traffic area

542

1.46

2.02

3.2

3.5

756.35

1069.21

ng/l

0.70

453

Tuberculosis of other organs, strict, including avohilmo

345

3052

1.20

2.01

4.0

3.4

1805.84

1973.29

ng/l

0.30

298

2655

Melanocytic naevi of upper limb, including shoulder

267

2305

1.22

2.00

3.6

3.2

1416.22

1187.13

ng/l

0.38

226

1968

LSIL lesion of the cervix uteri

842

7718

1.11

2.00

2.6

2.7

545.67

591.47

ng/l

0.26

686

6311

Other and unspecified disorders of psychological development

353

1.51

2.00

6.1

5.4

2253.55

1129.20

ng/l

0.46

276

Inhalation and ingestion of other objects causing obstruction of respiratory tract

539

1.48

1.99

3.4

3.3

1240.71

1308.62

ng/l

0.06

443

Other menopausal disorders

3228

17221

1.06

1.99

2.5

2.9

591.34

1216.70

ng/l

37.18

2730

14848

Hypersensitivity angiitis

528

1.53

1.99

3.6

3.2

4269.43

1368.26

ng/l

0.70

446

Other, unspecified and serous retinal detachments

419

3746

1.18

1.98

4.2

3.3

1995.17

1418.56

ng/l

1.37

372

3233

Inflammation of lacrimal passages (chronic)

220

1887

1.26

1.98

3.4

3.3

1299.83

1647.91

ng/l

0.95

201

1629

Chromophobe cell carcinoma of kidney

656

1.49

1.98

4.4

3.3

2021.40

1301.17

ng/l

0.67

564

Benign neoplasm of brain and other parts of central nervous system

787

7248

1.12

1.97

3.1

3.2

967.03

1336.02

ng/l

2.62

676

6261

Gestational diabetes (for exclusion)

2514

16418

1.06

1.97

2.1

2.4

476.01

426.43

ng/l

0.23

1881

13206

Necrobiosis lipoidica, not elsewhere classified

417

1.53

1.96

3.1

2.9

965.25

877.01

ng/l

0.12

352

Obstructed labour due to malposition and malpresentation of fetus

1396

13818

0.93

1.96

2.2

2.4

376.43

482.68

ng/l

1.17

1111

11178

Cholesteatoma of external ear

117

950

1.39

1.96

3.3

3.5

1179.99

1520.06

ng/l

0.58

105

822

Selective deficiency of immunoglobulin A [IgA]y

326

1.61

1.95

4.8

3.4

1478.75

820.02

ng/l

0.79

274

Other fibroblastic disorders

329

1.64

1.94

2.0

3.4

4391.63

1254.93

ng/l

0.83

278

N06DA Anticholinesterases

6624

52415

0.96

1.93

2.9

3.5

1770.84

1968.12

ng/l

3.14

5646

46318

Use of anticholinesterases

6624

52415

0.96

1.93

2.9

3.5

1770.84

1968.12

ng/l

3.14

5646

46318

Acute nephritic syndrome

249

2151

1.23

1.93

4.0

3.3

6087.46

1221.30

ng/l

3.40

225

1845

Postpartum haemorrhage due to retained placenta

780

7131

1.11

1.92

2.1

2.3

295.41

371.66

ng/l

0.58

609

5727

Certolizumab pegol

143

1161

1.28

1.92

2.2

2.8

641.14

640.89

ng/l

0.00

122

931

Seminoma of testis

644

1.41

1.92

2.8

3.2

968.85

1241.19

ng/l

0.46

525

Benign neoplasm: Vagina

155

1288

1.30

1.91

3.0

3.1

586.21

995.56

ng/l

2.97

134

1100

Use of tolcapone

0.00

1.91

0.0

3.5

—

1503.11

—

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

475

1.51

1.91

3.7

3.2

948.35

1032.78

ng/l

0.11

408

Other specified and unspecified disorders of eye and adnexa

445

3992

1.16

1.90

3.2

2113.45

1370.56

ng/l

1.03

390

3397

Contact urticaria

246

1.71

1.90

3.4

3.2

2077.80

1092.98

ng/l

0.36

205

Malignant neoplasm of vulva, including Hilmo

197

1685

1.27

1.90

3.5

3.2

1558.06

1208.86

ng/l

0.68

162

1447

Glaucoma secondary to drugs

352

1.65

1.90

3.8

2.9

1049.69

1074.02

ng/l

0.02

291

Serous carcinoma of ovary, including Hilmo

441

3972

1.17

1.89

3.1

721.19

1129.37

ng/l

4.42

399

3398

Seminoma of testis, including Hilmo

751

1.38

1.89

3.0

3.3

954.67

1352.80

ng/l

0.83

616

Accessory breast

375

1.52

1.89

1.9

2.6

475.76

751.19

ng/l

0.45

303

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

112

877

1.32

1.88

6.4

4.8

805.82

1187.07

ng/l

0.79

714

Other demyelinating diseases of the central nervous system

302

2628

1.19

1.88

2.5

3.1

634.90

770.61

ng/l

0.50

251

2165

Cholesteatoma of middle ear

677

6222

1.13

1.88

3.6

3.3

1790.75

1571.73

ng/l

0.30

586

5416

Malignant neoplasm of liver and intrahepatic bile ducts

453

4088

1.17

1.88

3.3

3.4

1425.21

1755.26

ng/l

0.76

400

3573

Congenital myopathies

145

2.00

1.87

3.7

3.3

815.88

1071.74

ng/l

0.19

122

Other congenital malformations of tongue, mouth and pharynx

590

1.38

1.87

7.8

5.6

772.65

1362.20

ng/l

0.95

470

Defect, injury or illness of lumbar spine

238

1.70

1.86

2.0

2.6

627.66

749.63

ng/l

0.11

186

Malignant neoplasm of rectosigmoid junction, including Hilmo

406

3646

1.18

1.86

2.9

3.3

1391.90

1670.46

ng/l

0.99

360

3170

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

638

5800

1.12

1.86

2.7

2.6

611.28

570.66

ng/l

0.10

517

4744

Motor neuron disease (with DMD)

240

2070

1.22

1.86

3.1

960.67

1550.04

ng/l

2.35

202

1834

Lordosis

242

1.75

1.86

5.0

3.0

4088.21

1166.37

ng/l

0.77

202

Nonpyogenic thrombosis of intracranial venous system

105

835

1.36

1.86

2.6

3.3

1834.23

864.72

ng/l

1.16

698

Other abnormal auditory perceptions

122

986

1.32

1.85

3.3

538.49

972.04

ng/l

3.38

103

840

Melanoma in situ of other and unspecified parts of face

204

1767

1.28

1.85

3.2

3.4

2338.51

1536.89

ng/l

0.51

177

1553

Toxic effect of contact with venomous animals

455

4089

1.15

1.85

3.1

3.2

974.45

1130.72

ng/l

0.31

388

3451

Contact with lifting and transmission devices, not elsewhere classified

199

1693

1.25

1.84

2.7

3.3

808.21

1112.49

ng/l

1.20

162

1432

Xanthelasma of eyelid

115

934

1.36

1.84

2.8

3.3

1066.87

1388.94

ng/l

0.65

100

805

Perforation of oesophagus

599

1.48

1.84

2.7

3.4

2166.67

1499.49

ng/l

0.32

506

Other protozoal intestinal diseases

148

1221

1.28

1.84

2.9

3.3

687.58

1172.50

ng/l

2.94

120

1034

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

419

3719

1.15

1.83

2.5

2.4

289.96

396.38

ng/l

0.89

329

2971

Short Achilles tendon (acquired)

280

2438

1.20

1.83

2.6

2.9

692.26

1031.52

ng/l

2.07

256

2041

Syndactyly, including avohilmo

214

1.72

1.83

7.3

3.4

855.85

729.50

ng/l

0.17

173

Any dementia

7776

52493

1.04

1.83

3.2

3.5

2070.64

1853.19

ng/l

3.22

6776

46347

Disorder of carbohydrate metabolism, other/unspecified

258

1.69

1.82

3.1

3.0

5899.68

941.06

ng/l

0.44

203

Hydrocephalus in other diseases

596

1.45

1.81

3.1

3.4

674.97

1069.35

ng/l

1.79

501

Labour and delivery complicated by umbilical cord complications

374

3309

1.16

1.81

2.4

2.7

369.73

558.46

ng/l

1.90

309

2740

Normal-pressure hydrocephalus

772

7178

1.13

1.81

2.7

3.5

1089.46

1858.92

ng/l

8.84

654

6348

Other and unspecified neuropathies

458

1.53

1.80

3.3

610.71

1301.67

ng/l

2.44

385

Nail dystrophy

640

1.43

1.80

2.9

3.2

783.23

1187.10

ng/l

1.13

533

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

109

885

1.37

1.80

2.9

3.3

940.34

1384.80

ng/l

1.47

741

Burn and corrosion of head and neck

210

1792

1.23

1.80

2.6

3.4

1279.01

1112.67

ng/l

0.24

174

1499

Other disorders affecting eyelid function

1052

0.73

1.80

3.4

3.3

1299.66

1267.14

ng/l

0.03

902

Respiratory and cardiovascular disorders specific to the perinatal period

647

1.33

1.79

7.6

7.7

1556.11

1093.45

ng/l

0.43

543

Other specified/unspecified nutritional deficiencies

646

1.41

1.79

4.1

3.2

1343.85

1381.71

ng/l

0.04

547

Effects of air pressure and water pressure

391

1.52

1.79

1.7

2.7

251.09

853.08

ng/l

5.78

318

Acquired pure red cell aplasia [erythroblastopenia]

441

1.54

1.78

4.5

3.4

2828.89

1427.76

ng/l

1.19

369

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

233

2028

1.24

1.78

3.4

3.2

1841.15

1368.50

ng/l

0.72

209

1729

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

513

4655

1.14

1.78

3.0

3.1

1063.05

1107.76

ng/l

0.10

458

3956

Use of selegiline

645

5944

1.13

1.77

3.1

3.3

1085.23

1709.49

ng/l

5.93

551

5167

Other congenital malformations of peripheral vascular system

121

978

1.30

1.77

3.7

3.3

1126.57

913.63

ng/l

0.38

805

Diseases caused by chlamydiae, including avohilmo

104

822

1.32

1.76

2.5

2.9

619.00

458.34

ng/l

0.24

654

Felty syndrome

620

1.45

1.76

4.1

3.5

1900.06

1350.41

ng/l

0.70

532

Anuria and oliguria

101

816

1.38

1.75

4.0

3.5

2713.63

1740.58

ng/l

0.92

708

Ovarian dysfunction: estrogen excess

2.25

1.75

1.5

3.3

256.51

832.56

ng/l

—

Glaucoma secondary to eye inflammation

107

864

1.35

1.75

3.4

3.3

1903.48

1374.48

ng/l

0.43

728

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

749

8099

0.90

1.74

3.3

1012.30

1466.59

ng/l

5.59

667

6957

Glaucoma-related operations

875

8177

1.11

1.74

3.2

3.4

1787.24

1679.35

ng/l

0.25

743

7167

Certain zoonotic bacterial diseases, including avohilmo

359

3204

1.17

1.73

3.3

3.2

1425.94

1340.41

ng/l

0.15

312

2742

Corneal degeneration

228

1983

1.23

1.73

3.1

3.2

1169.27

1157.23

ng/l

0.02

195

1695

Fractures involving multiple body regions

206

1.80

1.72

2.7

3.2

1632.49

1209.59

ng/l

0.29

168

Exposure to excessive natural heat

242

1.79

1.72

2.9

3.5

2453.65

1922.13

ng/l

0.15

200

Social disorders starting during childhood or adolescence

245

1.58

1.72

3.3

4.1

1044.45

542.17

ng/l

0.27

191

Abscess of external ear

139

1150

1.28

1.71

3.8

3.3

1500.40

1054.50

ng/l

0.69

115

968

Postpartum hemorraghe, all women as controls

1723

15892

1.07

1.71

2.2

2.4

426.22

475.86

ng/l

0.32

1354

12782

Drowning and submersion while in natural water

533

0.63

1.70

2.7

3.4

1136.84

1391.49

ng/l

0.41

457

Cystic disease of liver

746

1.39

1.70

2.3

3.2

1847.26

1134.07

ng/l

0.72

633

194

1.72

1.70

2.7

2.8

6422.21

520.46

ng/l

0.57

161

Drowning to ice

135

0.35

1.68

2.5

3.4

2656.18

956.93

ng/l

—

112

Postpartum care and examination

780

4492

1.10

1.67

2.1

2.3

313.55

366.60

ng/l

0.32

573

3498

Habitual aborter

707

1.32

1.67

2.9

2.7

251.66

425.33

ng/l

0.66

537

Renal agenesis and other reduction defects of kidney, including avohilmo

468

1.47

1.67

3.4

7192.86

1266.46

ng/l

2.32

381

Toxic effect of alcohol

225

1949

1.21

1.66

3.3

1848.82

1196.26

ng/l

0.46

190

1649

Infections of breast associated with childbirth

230

1976

1.19

1.66

2.5

2.6

359.87

480.20

ng/l

0.73

186

1586

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

268

2371

1.21

1.66

3.3

2080.18

1751.88

ng/l

0.55

239

2057

Cerebral atherosclerosis

203

1756

1.24

1.65

3.3

3.5

2206.20

2058.20

ng/l

0.14

180

1539

Traumatic spondylopathy

251

1.71

1.65

3.3

3.4

1180.88

1633.91

ng/l

0.70

219

Inflammation of lacrimal passages (acute and unspecified)

212

1835

1.22

1.64

3.7

3.1

1398.38

1374.39

ng/l

0.03

186

1554

Eccrine sweat disorders

251

1.70

1.63

2.3

3.3

1094.68

1094.60

ng/l

0.00

215

Other congenital malformations of intestine

752

1.35

1.63

3.0

3.6

1640.86

1026.32

ng/l

0.40

633

Clubfoot

621

1.36

1.63

4.7

3.5

651.91

810.70

ng/l

0.30

511

Alzheimer’s disease (Early onset), excluding more controls

456

4742

0.88

1.63

3.0

3.2

2205.93

2248.56

ng/l

0.05

377

4181

Other and unspecified medical devices associated with adverse incidents

648

1.43

1.63

3.8

3.3

1367.19

1337.88

ng/l

0.03

543

Overjet

143

1173

1.25

1.63

3.4

4.3

672.33

668.78

ng/l

0.00

114

968

Malignant neoplasm of adrenal gland

438

1.49

1.62

2.7

3.3

2097.30

1217.77

ng/l

0.84

365

Sexual assault by bodily force

109

1.93

1.62

2.4

2.8

818.29

766.07

ng/l

0.03

Carcinoma in situ of vagina

487

1.44

1.61

4.1

3.1

1869.72

734.50

ng/l

0.83

408

Neuropathic heredofamilial amyloidosis

3.86

1.61

2.8

2.7

1535.24

2806.76

ng/l

—

Osteomalacia

745

1.35

1.61

3.2

1006.17

931.59

ng/l

0.13

624

Polyneuropathy due to other toxic agents

102

2.48

1.61

3.2

4.5

2388.82

1577.92

ng/l

0.18

Other diseases caused by chlamydiae, including avohilmo

117

951

1.28

1.60

2.6

3.0

656.57

602.02

ng/l

0.08

760

Ulcerative ileocolitis

373

3339

1.15

1.60

2.8

3.1

1305.78

1057.90

ng/l

0.57

306

2779

Colorectal neuroendocrine tumor and carcinoma

171

1460

1.25

1.60

3.9

3.1

1068.56

1147.79

ng/l

0.11

140

1217

Malignant neoplasm of base of tongue

675

0.68

1.60

2.3

3.2

2135.32

1222.89

ng/l

0.28

560

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

304

2716

1.19

1.59

3.3

1475.11

1600.95

ng/l

0.17

272

2347

Melanoma in situ, other sites/unspecified

429

1.55

1.59

2.9

3.5

1732.78

1232.80

ng/l

0.28

370

Foreign body in genitourinary tract

104

843

1.32

1.59

3.7

3.1

1196.66

1113.53

ng/l

0.14

706

LeFortI or BSSO operation

302

2662

1.16

1.59

2.2

2.8

384.79

640.84

ng/l

1.86

240

2159

Congenital malformations of larynx

165

1.75

1.59

4.2

6.2

569.35

1038.23

ng/l

1.34

145

Medullary carcinoma of thyroid gland, including Hilmo

203

1.78

1.59

2.4

3.0

691.50

1009.82

ng/l

0.55

171

Traumatic amputation of ankle and foot

253

1.68

1.57

3.0

3.3

3371.17

1236.04

ng/l

0.63

219

Papillary adenocarcinoma of thyroid gland

574

5270

1.12

1.57

3.3

3.1

1203.75

1094.38

ng/l

0.27

493

4469

Other cranial nerve disorders in other disorders

262

1.67

1.57

4.8

2.9

833.60

1326.56

ng/l

0.69

222

Autonomic dysreflexia

3.54

1.56

1.6

3.5

318.50

587.86

ng/l

—

Oral leukoplakia, including avohilmo

349

3139

1.17

1.56

2.8

3.2

1093.18

1155.37

ng/l

0.18

295

2679

Disorders of lacrimal system and orbit in diseases classified elsewhere

268

2365

1.18

1.55

2.7

3.0

1271.22

986.30

ng/l

0.49

226

1990

Single delivery by caesarean section

1091

6658

0.93

1.55

2.2

2.6

392.43

579.91

ng/l

1.32

861

5359

Acute mastoiditis

710

1.34

1.55

3.7

3.4

989.32

992.45

ng/l

0.00

592

Benign neoplasm: Vulva

248

2185

1.20

1.55

2.6

3.0

1053.98

944.14

ng/l

0.17

206

1849

Q fever, including avohilmo

3.08

1.54

3.5

2.8

777.48

941.18

ng/l

—

Follicular adenocarcinoma of thyroid gland, including Hilmo

130

1089

1.29

1.54

3.1

3.3

1132.87

1345.95

ng/l

0.40

112

916

Benign neoplasm of male genital organs

268

2378

1.19

1.54

3.6

3.5

1976.22

1898.50

ng/l

0.08

227

2094

Contact with other and unspecified heat and hot substances

588

1.38

1.54

2.9

3.2

3408.59

1265.48

ng/l

0.53

486

Congenital malformations of gallbladder, bile ducts and liver

116

961

1.30

1.53

2.6

3.8

1792.98

1089.11

ng/l

0.86

109

819

Other osteochondrodysplasias

648

1.35

1.53

3.4

3.5

2246.16

811.53

ng/l

1.10

546

Tympanosclerosis

188

1.79

1.52

2.9

3.1

1334.95

1337.73

ng/l

0.00

161

Unspecified parasitic disease, including avohilmo

102

836

1.33

1.52

3.8

3.2

1331.87

1230.58

ng/l

0.15

710

Benign neoplasm: Rectum/anal canal icd-9

132

1114

1.29

1.52

3.6

3.4

1947.42

1975.50

ng/l

0.02

112

960

Sickle-cell disorders

237

1.67

1.52

3.7

3.5

673.64

1888.63

ng/l

2.52

198

Other nutritional anaemias

135

1137

1.28

1.52

4.3

3.3

2745.73

1779.96

ng/l

1.35

125

972

Toxic effect of other noxious substances eaten as food

293

1.55

1.51

3.3

3.2

786.33

1115.96

ng/l

0.77

242

Marginal zone B-cell lymphoma

143

1219

1.28

1.51

3.0

3.3

1808.39

1365.12

ng/l

0.57

129

1042

Hereditary retinal dystrophy

157

1335

1.24

1.51

3.0

3.4

1588.22

1141.35

ng/l

0.52

131

1128

Nontraumatic intracranial haemmorrhage

3223

31166

1.05

1.51

3.4

3.3

1812.57

1752.43

ng/l

0.29

2829

27198

Retarded development following protein-energy malnutrition

2.75

1.50

18.1

3.6

1423.67

1713.59

ng/l

—

Gonococcal infection

326

2913

1.16

1.50

2.7

3.0

949.60

825.52

ng/l

0.34

268

2436

Renal agenesis and other reduction defects of kidney

389

1.47

1.50

3.3

3.5

8027.33

1179.25

ng/l

2.35

318

Exclusion endpoint for supernumerary teeth

654

1.32

1.49

4.9

4.0

1098.90

842.68

ng/l

0.25

517

Other congenital malformations of urinary system

343

1.48

1.49

3.3

3.5

1652.23

1007.11

ng/l

0.39

280

Occupant of special vehicle mainly used on industrial premises injured in transport accident

491

1.45

1.48

4.1

3.2

1122.00

1175.51

ng/l

0.05

409

Senile degeneration of the brain, not elsewhere classified

528

0.66

1.48

3.3

3.6

2092.76

2185.78

ng/l

0.04

458

Use of glatiramer acetate

113

924

1.27

1.48

2.3

2.8

598.13

527.69

ng/l

0.13

753

Small plaque parapsoriasis

310

1.60

1.48

2.2

3.7

1365.44

1335.46

ng/l

0.02

263

Other obstructed labour

633

5836

1.11

1.47

2.4

2.7

810.13

628.26

ng/l

0.61

515

4885

Cutis laxa senilis

104

862

1.33

1.46

2.9

3.0

993.80

1084.59

ng/l

0.13

737

Exposure to ignition or melting of other clothing and apparel

240

1.66

1.46

3.6

1087.89

1103.40

ng/l

0.01

201

Crushing injury of lower leg

249

1.65

1.46

3.0

2178.13

1583.74

ng/l

0.27

208

Vascular dementia (other)

124

1054

1.31

1.45

3.6

3.7

2796.92

2342.47

ng/l

0.47

103

945

Congenital malformations of ovaries, fallopian tubes and broad ligaments

403

3637

1.13

1.44

2.3

2.7

385.60

627.27

ng/l

3.65

315

2979

Retinoblastoma

2.88

1.44

4.3

6.5

202.50

500.86

ng/l

—

Gender identity disorders

444

0.66

1.43

2.6

3.6

1510.51

932.39

ng/l

0.18

331

Hypopituitarism after medical therapy

4.14

1.43

29.1

4.7

1286.49

995.02

ng/l

—

Other/unspecified mastoiditis and related conditions

519

1.42

1.43

4.3

3.4

1506.56

1334.09

ng/l

0.17

447

Glaucoma secondary to eye trauma

756

1.35

1.43

3.3

3.4

2399.62

1805.97

ng/l

0.34

645

Dysplasia of cervi uteri

2149

14450

1.05

1.43

2.8

2.7

796.43

1055.78

ng/l

2.78

1788

12183

Benign neoplasm: Appendix

153

1317

1.26

1.43

3.4

3.3

1099.68

1347.60

ng/l

0.57

134

1129

Injury of blood vessels at hip and thigh level

410

1.52

1.42

4.0

3.3

1060.64

1333.96

ng/l

0.47

348

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

772

1.33

1.42

2.7

3.2

1497.31

1164.14

ng/l

0.26

657

Moderate mental retardation

451

1.40

1.41

3.5

4.2

890.26

1087.54

ng/l

0.30

375

Unspecified multiple injuries

264

1.56

1.41

3.5

3.1

1519.69

1590.99

ng/l

0.04

218

Other benign neoplasm of uterus: Corpus uteri

104

863

1.31

1.41

2.6

3.1

957.96

914.43

ng/l

0.05

743

Vascular dementia (multiple infarctions)

149

1738

0.82

1.40

3.3

3.7

2202.95

2723.51

ng/l

0.74

130

1547

Malignant neoplasm of pancreas, including Hilmo

1189

12522

0.93

1.40

3.0

3.4

1492.81

1695.83

ng/l

0.74

1068

10880

Carcinoma in situ of skin of eyelid, including canthus

310

1.65

1.39

4.1

3.5

2038.48

1722.87

ng/l

0.28

262

Anoxic brain damage

179

1558

1.22

1.39

4.6

3.4

2640.20

1791.16

ng/l

0.95

167

1355

Injury of nerves at shoulder and upper arm level

125

1052

1.27

1.39

2.9

3.2

1013.81

988.04

ng/l

0.03

110

877

461

4185

1.11

1.39

2.1

2.5

345.10

301.55

ng/l

0.28

365

3281

Bilateral sagittal split ramus osteotomy operation

250

2201

1.16

1.39

2.3

2.8

394.57

610.62

ng/l

1.19

200

1780

Scissor bite

148

1234

1.21

1.38

4.2

4.3

522.05

648.39

ng/l

0.32

120

992

Q fever

3.26

1.38

3.8

2.8

847.42

971.24

ng/l

—

Viral infections of central nervous system, not elsewhere classified/unspecified

115

959

1.27

1.38

2.5

3.2

706.74

932.50

ng/l

0.50

799

Non-small cell lung cancer, squamous, helper endpoint

646

6932

0.90

1.37

3.2

3.5

1477.77

2202.71

ng/l

7.47

595

6093

False labour

2012

11917

1.05

1.37

2.3

2.5

221.85

462.98

ng/l

9.19

1545

9557

Labour and delivery complicated by fetal stress [distress]

1215

8384

0.94

1.37

2.1

2.3

328.02

381.44

ng/l

0.37

931

6571

Malignant neoplasm of ovary

614

5707

1.11

1.37

3.1

980.73

1160.76

ng/l

0.73

549

4886

Blindness or visual impairment, binocular

523

1.40

1.37

3.5

3.6

2181.96

1534.99

ng/l

0.48

434

Major anomalies of jaw size

237

2088

1.17

1.37

3.3

3.2

477.85

780.96

ng/l

2.87

202

1730

Family history of other specific disorders

109

899

1.26

1.36

2.6

642.40

786.18

ng/l

0.32

729

Acute poliomyelitis

168

1460

1.23

1.36

3.8

3.2

1150.72

1215.05

ng/l

0.15

142

1241

Disorders of amino-acid transport

160

1.79

1.36

2.3

3.0

2296.47

1629.73

ng/l

0.25

133

Unspecified parasitic disease

821

1.31

1.36

3.9

3.2

1355.86

1236.02

ng/l

0.18

697

Hereditary spastic paraplegia

2.03

1.35

2.5

3.4

1941.90

607.69

ng/l

—

Malignant neoplasm of eye and adnexa, including Hilmo

212

1873

1.20

1.35

3.8

3.3

1558.25

1527.77

ng/l

0.05

191

1596

Certain zoonotic bacterial diseases

215

1895

1.19

1.35

3.3

3.2

1420.91

1280.72

ng/l

0.18

188

1612

Other acantholytic disorders

353

1.56

1.35

2.9

3.5

1867.36

1906.60

ng/l

0.02

297

Multiple delivery

614

6631

0.91

1.35

2.4

2.8

629.87

732.79

ng/l

0.50

492

5593

Injury of nerves at ankle and foot level

590

1.35

3.0

3.1

966.33

1161.90

ng/l

0.31

490

Venous complications and haemorrhoids in the puerperium

107

888

1.28

1.34

2.5

3.0

482.24

671.35

ng/l

1.04

750

Dissection of cerebral arteries, nonruptured

691

1.32

1.34

3.5

3.2

1385.39

944.46

ng/l

0.46

569

Prophylactic surgery

498

1.36

1.33

2.0

2.5

443.49

549.28

ng/l

0.29

406

Intrahepatic Cholestasis of Pregnancy (ICP)

419

3802

1.12

1.33

2.5

289.96

429.03

ng/l

1.31

329

3059

Use of dimethyl fumarate

397

0.65

1.33

1.4

2.8

566.09

372.26

ng/l

0.48

325

Carcinoma in situ of breast, intraductal

1048

9920

1.08

1.33

2.7

3.0

806.10

1000.62

ng/l

1.77

869

8548

Sequelae of inflammatory diseases of the central nervous system

314

1.53

1.32

3.4

3.2

1070.71

1104.38

ng/l

0.02

263

Toxic colitis

340

1.50

1.31

4.1

3.3

1993.41

1119.68

ng/l

0.35

288

Abnormal findings in cerebrospinal fluid

261

1.56

1.31

2.8

2.9

826.80

716.57

ng/l

0.14

222

Burn and corrosion of respiratory tract

105

1.99

1.30

3.5

3.8

2643.43

1094.70

ng/l

0.34

Defect, injury or illness of neck

504

1.37

1.30

2.6

3.3

761.42

1268.17

ng/l

0.82

429

Viral conjunctivitis

194

1693

1.19

1.30

2.6

3.0

1298.88

959.11

ng/l

0.48

174

1403

Unspecified renal colic

579

1.36

1.29

3.5

3.1

2127.93

1352.06

ng/l

0.46

484

Cytomegaloviral pneumonitis

225

1.71

1.29

4.5

3.3

2611.96

1036.17

ng/l

1.19

181

Acute poliomyelitis, including avohilmo

168

1467

1.22

1.29

3.8

3.2

1150.72

1227.58

ng/l

0.18

142

1248

Pseudomembranous colitis

777

1.30

1.29

3.0

3.3

1577.40

1284.02

ng/l

0.19

664

Unattended death

1156

0.78

1.29

4.0

3.4

2370.92

1834.64

ng/l

0.51

994

Intermittent hydrarthrosis

212

1.64

1.28

3.5

3.3

537.28

961.60

ng/l

1.46

185

Rhinophyma

816

1.33

1.28

3.7

3.4

1362.18

1607.63

ng/l

0.38

705

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

638

5921

1.09

1.27

2.7

611.28

588.40

ng/l

0.05

517

4866

Benign lipomatous neoplasm of of intra-abdominal organs

363

1.49

1.25

3.0

3.3

1522.81

1252.01

ng/l

0.19

294

Testicular dysfunction, other/unspecified

436

1.39

1.25

4.0

3.2

919.57

793.39

ng/l

0.16

358

Nezelof syndrome

451

1.42

1.25

3.2

1038.63

1186.23

ng/l

0.20

389

Injury of nerves at hip and thigh level

415

1.44

1.24

2.7

3.0

644.46

1301.07

ng/l

1.94

339

Keratoconus

230

2039

1.17

1.24

2.9

3.3

1318.79

926.68

ng/l

0.84

191

1694

Noise effects on inner ear

492

4551

1.12

1.24

3.2

3.3

1140.50

1552.05

ng/l

1.77

411

3947

Neuralgic amyotrophy

224

1.64

1.24

2.6

3.2

1244.92

1163.37

ng/l

0.04

187

Bus occupant injured in other and unspecified transport accidents

682

1.32

1.24

2.8

3.3

1225.05

1221.35

ng/l

0.00

568

Idiopathic hypoparathyroidism

310

1.51

1.23

11.1

3.6

2010.57

1277.13

ng/l

0.66

260

Apocrine sweat disorders, other sweat gland disorders

424

1.42

1.23

5.1

3.4

1460.86

1176.83

ng/l

0.33

359

Other specified/unspecified disorders of ear

299

1.49

1.23

2.5

3.1

899.10

1207.82

ng/l

0.52

246

Adult-onset Still disease

332

1.45

1.23

5.4

2.8

590.81

871.69

ng/l

1.19

276

Acquired stenosis of external ear canal

133

1147

1.25

1.23

3.3

1265.04

1350.89

ng/l

0.10

115

991

Esophageal diverticulum (pouch), including avohilmo

449

1.46

1.23

3.3

3.4

982.16

1567.20

ng/l

1.95

380

Ulcer of oesophagus, drug-induced

620

1.37

1.22

5.1

3.7

1589.46

1871.92

ng/l

0.45

533

Dementia due to Parkinson's disease

344

3745

0.88

1.21

3.2

3.5

1462.76

1989.55

ng/l

1.80

297

3325

Transient acantholytic dermatosis [Grover]

273

1.63

1.21

2.4

3.6

1323.70

1754.31

ng/l

0.52

229

Other and unspecified intracranial injuries

359

3278

1.13

1.21

3.6

3.3

2083.97

1705.45

ng/l

0.65

307

2818

Congenital dislocation of hip, unilateral

391

1.38

1.20

3.7

3.6

855.70

1121.01

ng/l

0.37

330

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

274

2473

1.15

1.20

3.7

3.2

1340.92

1183.99

ng/l

0.38

226

2120

Other endophthalmitis

644

1.34

1.20

3.9

3.3

2760.05

1506.46

ng/l

0.88

556

Choroidal haemorrhage and rupture

384

1.46

1.19

3.8

3.6

2506.73

1799.15

ng/l

0.71

314

Need for immunization against combinations of infectious diseases

2.26

1.19

3.7

3.3

6557.00

721.81

ng/l

—

Postprocedural disorders of eye and adnexa, not elsewhere classified

469

1.44

1.19

3.0

3.7

1468.06

1688.66

ng/l

0.21

397

Birth trauma

260

1.45

1.19

4.3

5.3

1956.64

823.60

ng/l

0.54

212

Frostbite

115

976

1.24

1.18

3.2

3.4

2061.61

1271.78

ng/l

0.62

818

Other or unspecified paralytic strabismus

733

1.30

1.18

2.6

3.4

1081.55

1338.89

ng/l

0.36

636

Exposure to other specified electric current

142

1650

0.84

1.18

4.2

3.3

681.45

762.70

ng/l

0.18

116

1345

Congenital lens malformations

351

1.41

1.17

4.2

3.7

718.95

1161.29

ng/l

0.88

293

Hand

468

1.36

1.17

3.4

3.3

738.52

1048.41

ng/l

0.61

389

Injury of muscle and tendon at ankle and foot level

249

2230

1.15

1.17

3.1

850.93

1033.94

ng/l

0.53

204

1872

Crushing injury of ankle and foot

383

1.43

1.17

3.3

3.0

2059.03

1445.73

ng/l

0.25

311

Other congenital malformations of circulatory system

280

2530

1.15

1.17

3.1

872.17

1053.13

ng/l

0.60

246

2146

Tooth agenesis EXCLUDE clefts and syndromes

199

1742

1.16

3.9

3.7

816.97

705.44

ng/l

0.14

152

1356

Other specified acquired deformities of limbs

361

1.41

1.16

2.4

3.7

1290.01

1077.45

ng/l

0.09

299

Antepartum haemorrhage, not elsewhere classified

492

4535

1.10

1.14

2.5

305.23

426.80

ng/l

0.96

396

3638

Foreign body in ear

193

1705

1.17

1.14

3.5

3.3

1223.79

1061.10

ng/l

0.27

164

1438

Cervical root disorders

718

1.30

1.14

2.9

3.2

1097.36

929.85

ng/l

0.18

615

Transient retinal artery occlusion

237

1.58

1.14

4.1

3.2

1116.15

1566.07

ng/l

0.57

200

Idiopathic peripheral autonomic neuropathy

394

1.42

1.13

3.0

3.4

611.35

1627.59

ng/l

3.69

337

Spontaneous abortion

4740

32531

0.97

1.13

2.6

2.7

706.52

841.85

ng/l

2.04

3913

27364

Torsion of testis

114

961

1.22

1.13

4.0

4.2

1502.43

938.99

ng/l

0.35

759

Congenital malformations of uterus and cervix

122

1035

1.21

1.13

4.0

2.8

632.16

679.46

ng/l

0.11

100

828

Other and unspecified postprocedural disorders of eye and adnexa

338

1.51

1.11

3.1

3.6

1423.26

1643.51

ng/l

0.17

279

Juvenile osteochondrosis

249

2230

1.14

1.11

3.2

3.4

1122.17

992.10

ng/l

0.22

205

1813

Injury of blood vessels at forearm level

323

1.45

1.11

3.2

3.1

3941.78

1004.05

ng/l

0.92

267

Benign neoplasm: Skin of lip

172

1523

1.20

1.11

3.2

1464.46

1291.40

ng/l

0.21

152

1310

Striae atrophicae

822

1.25

1.11

3.5

3.1

725.93

859.48

ng/l

0.33

683

Malaria

453

0.70

1.11

3.9

3.0

684.29

1077.32

ng/l

1.02

367

Communicating hydrocephalus

221

2457

0.86

1.10

2.6

3.3

1273.54

1577.84

ng/l

0.40

197

2127

Other disorders of binocular movement

191

1687

1.17

1.10

3.2

3.3

1313.27

1037.88

ng/l

0.35

148

1409

Methaemoglobinaemia

2.44

1.10

3.4

2.9

318.80

1587.51

ng/l

—

Malignant neoplasm of anus and anal canal, including Hilmo

169

1497

1.20

1.10

3.1

3.2

1297.51

1486.37

ng/l

0.24

155

1273

Benign neoplasm: Brain, supratentorial

167

1470

1.19

1.09

3.1

3.3

829.14

1142.50

ng/l

1.35

146

1251

Transitory endocrine and metabolic disorders specific to fetus and newborn

393

1.33

1.09

8.8

9.3

543.89

1522.48

ng/l

3.04

336

Immunodeficiency with increased immunoglobulin M [IgM]

3.11

1.09

5.7

3.0

546.50

1320.93

ng/l

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

221

1.57

1.08

3.0

3.5

881.21

1831.71

ng/l

1.63

189

Neuroendocrine tumor and carcinoma of stomach

589

1.33

1.08

3.4

3.2

1530.90

1486.63

ng/l

0.04

492

Superficial frostbite

581

1.30

1.08

3.3

2000.29

1357.04

ng/l

0.33

473

Pedestrian injured in collision with car, pick-up truck or van

276

2505

1.14

1.08

3.1

3.2

1739.64

1234.04

ng/l

0.80

220

2135

Pregnancy examination and test

906

5290

1.07

2.4

323.32

391.53

ng/l

0.43

702

4167

Female infertility, cervical, vaginal, other or unspecified origin

2295

14157

1.04

1.06

2.5

2.7

532.61

931.20

ng/l

12.69

1894

11897

Congenital vesicoureteral reflux

163

1.52

1.06

2.7

3.7

427.14

454.95

ng/l

0.04

124

Other disorders originating in the perinatal period

361

1.35

1.06

4.2

8.7

885.55

1145.71

ng/l

0.22

307

Alopecia universalis

210

1.52

1.06

4.4

3.6

1017.67

823.86

ng/l

0.11

177

Nutritional marasmus

169

1.62

1.06

3.6

4.2

2205.88

1212.55

ng/l

0.43

151

Melanoma in situ of trunk

219

1980

1.17

1.05

3.5

3.3

1980.08

1466.07

ng/l

0.71

189

1735

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

466

1.33

1.05

4.3

3.4

1629.85

1098.37

ng/l

0.27

382

Cerebral amyloid angiopathy

735

1.31

1.04

2.7

3.4

1558.89

1333.34

ng/l

0.22

641

Malignant neoplasm of penis, including Hilmo

709

1.29

1.04

3.5

3.4

4918.32

1710.26

ng/l

0.99

614

Malignant neoplasm of floor of mouth, including Hilmo

114

988

1.24

1.04

2.9

3.3

1722.87

1485.94

ng/l

0.26

107

845

Gonococcal infection, including avohilmo

333

3048

1.12

1.04

2.7

3.1

931.43

841.30

ng/l

0.23

275

2542

Other papulosquamous disorders

132

1150

1.21

1.04

3.0

3.3

1184.02

1309.46

ng/l

0.18

118

988

Human immunodeficiency virus [HIV] disease resulting in other conditions

113

1315

0.83

1.03

2.5

3.3

888.58

958.09

ng/l

0.14

102

1085

Meckel's diverticulum

578

1.30

1.03

2.6

3.5

943.53

1130.03

ng/l

0.18

484

Pterygium

400

3716

1.12

1.02

3.4

3.3

1302.16

1627.89

ng/l

1.59

344

3250

Macrocephaly

0.00

1.02

0.0

9.1

—

793.12

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

277

1.49

1.01

4.2

4.0

733.02

1269.66

ng/l

1.45

222

Endometriosis in cutaneous scar

176

1.51

1.00

1.4

3.1

205.22

580.13

ng/l

2.51

146

Malignant neoplasm of other and unspecified major salivary glands

394

1.39

1.00

2.9

3.1

967.84

1203.17

ng/l

0.29

333

Conditions involving the integument and temperature regulation of fetus and newborn

2.06

0.99

17.7

6.5

2123.57

573.31

ng/l

—

Other and unspecified disorders of binocular movement

433

1.33

0.98

3.1

3.9

2448.00

1146.15

ng/l

0.65

357

Malignant neoplasm of rectosigmoid junction

226

2053

1.15

0.97

2.7

3.3

1152.45

1643.20

ng/l

2.23

202

1774

Graves ophthalmopathy

262

2387

1.13

0.97

2.8

3.0

1294.57

873.22

ng/l

0.82

221

2005

Pemphigus vegetans

2.62

0.97

2.6

3.4

1284.30

1301.35

ng/l

—

Burns classified according to extent of body surface involved

102

875

1.23

0.97

3.0

3.3

2770.63

1193.14

ng/l

0.52

725

Chloasma

491

1.32

0.97

2.6

2.7

604.13

818.83

ng/l

0.91

414

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

416

0.70

0.97

3.2

3.4

2345.85

1292.91

ng/l

0.63

362

Disorders of tyrosine metabolism

106

1.80

0.97

4.3

3.2

4274.38

1630.92

ng/l

0.64

Degeneration of the brain due to alcohol

286

2628

1.13

0.96

3.2

3.4

2538.10

1504.07

ng/l

1.28

247

2295

Injury of blood vessels at abdomen, lower back and pelvis level

458

1.34

0.96

3.9

3.7

1365.87

1617.87

ng/l

0.21

389

Melanocytic naevi of other and unspecified parts of face

626

5897

1.08

0.96

2.9

3.1

1091.09

1160.82

ng/l

0.16

510

5002

Severe bullous disorders, KELA reimbursement

237

1.54

0.96

2.9

3.8

2042.36

1339.64

ng/l

0.69

209

Chronic myringitis

518

0.74

0.96

2.9

3.5

631.66

1133.14

ng/l

1.66

439

Malignant neoplasm of vulva

141

1251

1.20

0.96

3.6

3.2

1744.95

1342.59

ng/l

0.57

118

1076

All dysplastic lesions of the cervix uteri

1976

18776

1.04

0.95

2.6

2.5

739.44

595.96

ng/l

0.57

1617

15275

Benign neoplasm: Nasopharynx

114

995

1.22

0.95

3.5

3.3

1371.76

1298.07

ng/l

0.09

105

849

Dermatitis herpetiformis

206

1861

1.15

0.95

3.4

3.2

1112.95

1176.78

ng/l

0.15

183

1603

Malignant neoplasm of base of tongue, including Hilmo

1003

0.81

0.95

3.3

3.2

1882.05

1393.31

ng/l

0.24

841

Liposarcoma

856

1.24

0.94

3.2

3.1

1883.11

1360.92

ng/l

0.67

722

Caries of enamel

14094

90989

1.02

0.94

3.1

864.93

1177.20

ng/l

17.96

11694

77745

Atypical virus infections of central nervous system

110

956

1.22

0.94

3.7

3.2

756.52

974.15

ng/l

0.68

806

Amyloidosis of skin

1.95

0.94

5.7

4.2

998.35

1485.84

ng/l

0.60

Other infective spondylopathies

237

1.51

0.94

3.5

1139.10

1581.66

ng/l

0.92

201

Other and unspecified papulosquamous disorders

660

1.27

0.93

3.6

3.2

1192.96

1471.27

ng/l

0.29

563

Intracerebral haemorrhage

2006

19452

1.05

0.93

3.5

3.3

1778.43

1922.83

ng/l

0.70

1761

16977

Disorder of mineral metabolism, other/unspecified

182

1.53

0.92

3.3

3.0

3355.40

978.22

ng/l

0.59

149

Burns and corrosions of multiple body regions

786

1.23

0.92

3.8

3.4

1939.20

1118.04

ng/l

0.92

650

Benign neoplasm: Ciliary body

353

1.40

0.92

3.8

3.4

884.95

993.29

ng/l

0.20

296

Mandibular retrognathia AND surgery (BSSO)

186

1661

1.15

0.92

2.2

2.8

438.38

647.81

ng/l

0.75

147

1341

Cicatricial alopecia [scarring hair loss]

855

1.23

0.92

3.0

3.2

857.32

901.71

ng/l

0.04

721

Pneumoconiosis due to dust containing silica

446

1.36

0.91

4.3

3.6

1801.86

1857.46

ng/l

0.04

389

Frontotemporal dementia, wide, incl. Pick's disease

877

0.79

0.91

2.6

3.3

756.72

1564.42

ng/l

3.25

754

Benign neoplasm: Lower jaw bone

386

1.35

0.91

3.4

3.5

1490.04

1162.82

ng/l

0.26

328

Toxic effect of organic solvents

286

1.39

0.91

3.4

3.6

1407.91

1201.72

ng/l

0.14

230

Human immunodeficiency virus [HIV] disease

131

1490

0.85

0.90

2.6

3.3

858.75

1002.85

ng/l

0.36

118

1233

Malignant neoplasm of other and unspecified parts of biliary tract

216

1968

1.15

0.90

3.7

3.2

1489.87

1665.80

ng/l

0.25

193

1698

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

115

1320

0.84

0.90

2.5

3.3

886.33

956.06

ng/l

0.14

103

1088

Malignant neoplasm of anus and anal canal

629

1.28

0.90

2.8

3.2

1418.46

1417.07

ng/l

0.00

535

Polyp of middle ear

150

1.62

0.90

3.6

3.2

669.89

931.64

ng/l

0.39

116

Contact with other specified venomous animals

633

1.26

0.90

2.6

3.4

650.25

1144.45

ng/l

1.80

524

Degeneration of nervous system due to alcohol

286

2639

1.13

0.90

3.2

3.3

2538.10

1479.71

ng/l

1.33

247

2298

Adrenomedullary hyperfunction

290

1.41

0.89

3.2

3.3

5756.94

1074.09

ng/l

0.89

240

Neuroendocrine tumor and carcinoma of rectum

418

1.35

0.89

4.4

2.8

746.93

1091.51

ng/l

0.77

348

Pedestrian injured in collision with heavy transport vehicle or bus

334

1.37

0.89

2.0

3.5

1622.74

1266.27

ng/l

0.22

276

Congenital ovarian cysts

287

2625

1.11

0.89

2.2

2.6

329.68

553.36

ng/l

3.01

222

2139

Meningitis, viral

368

1.34

0.89

2.7

3.1

1480.59

1118.88

ng/l

0.30

306

Benign neoplasm: Skin of scalp and neck

299

2758

1.12

0.89

3.5

3.2

1974.56

1357.02

ng/l

0.43

266

2384

Mesial bite

545

1.25

0.89

2.7

3.1

534.87

706.55

ng/l

0.25

453

Multiple superficial injuries of ankle and foot

1.79

0.89

3.5

2.6

1093.23

517.33

ng/l

0.43

Melanocytic naevi of scalp and neck

240

2187

1.13

0.89

3.4

3.3

2533.14

1184.00

ng/l

1.23

215

1850

Other congenital malformations of ear

488

1.26

0.88

4.2

3.3

970.25

534.26

ng/l

0.46

374

Other congenital malformations of skull and face bones

138

1.53

0.88

2.6

9.9

985.68

942.33

ng/l

0.03

113

Benign neoplasm: Orbit, unspecified

665

1.26

0.88

3.5

3.4

1062.43

1406.99

ng/l

0.54

563

Exposure to excessive natural cold

101

1160

0.83

0.87

3.9

3.5

2329.57

1562.04

ng/l

0.59

986

Malignant neoplasm, without specification of site, including Hilmo

679

6445

1.08

0.87

3.3

3.4

2061.43

1830.99

ng/l

0.50

596

5608

Increased muscle tone

653

1.25

0.87

3.1

3.6

1284.17

1136.08

ng/l

0.10

546

Mastocytosis

451

1.30

0.87

2.8

3.3

1124.75

915.18

ng/l

0.16

374

Noninfective disorders of pinna

202

1.49

0.87

2.4

3.6

957.23

1026.17

ng/l

0.06

172

Tick-borne viral encephalitis, including avohilmo

544

1.28

0.87

2.7

3.2

758.21

1172.59

ng/l

1.07

449

Superficial injury of ankle and foot, unspecified

377

1.32

0.86

3.6

3.0

890.30

1059.96

ng/l

0.27

302

Induced delusional disorder

2.01

0.86

3.0

3.5

417.89

535.04

ng/l

—

Hereditary motor and sensory neuropathy

812

1.22

0.86

3.3

1144.46

1125.14

ng/l

0.02

684

Amoebiasis

479

1.29

0.86

3.5

3.4

1406.14

1219.35

ng/l

0.16

397

Disorders of endocrine glands in diseases classified elsewhere

142

1.59

0.86

9.6

3.2

1990.72

1551.50

ng/l

0.25

118

Atypical virus infections of central nervous system, including avohilmo

111

973

1.20

0.86

3.6

3.2

749.04

997.26

ng/l

0.83

819

Immunodeficiency with short-limbed stature

2.26

0.85

1.9

2.5

13971.49

369.58

ng/l

—

Supervision of high-risk pregnancy

1371

7910

1.05

0.85

2.4

245.27

505.92

ng/l

6.86

1088

6384

Hypertensive encephalopathy

478

1.32

0.84

3.8

3.4

3492.46

1690.82

ng/l

0.92

406

Food allergy

166

1.49

0.84

2.0

3.2

721.33

532.31

ng/l

0.25

139

Malignant neoplasm of retroperitoneum and peritoneum

104

913

1.22

0.84

3.2

1807.19

1347.14

ng/l

0.47

773

Acne varioliformis

230

1.44

0.84

3.1

5797.09

1302.10

ng/l

0.89

197

Cyst of spleen

160

1.54

0.84

5.5

3.1

1396.23

856.14

ng/l

0.44

134

Benign neoplasm: Brain, unspecified

593

1.26

0.84

3.0

3.6

1020.85

1330.23

ng/l

0.56

509

Internuclear ophthalmoplegia

337

1.35

0.83

3.8

2.9

1389.17

1059.55

ng/l

0.24

280

Graves ophthalmopathy, strict

234

2141

1.13

0.83

2.7

3.0

1352.98

864.69

ng/l

0.86

195

1794

Other congenital malformations of face and neck

241

2200

1.12

0.83

3.2

3.3

1492.90

970.80

ng/l

0.38

203

1825

Meningococcal infection, including avohilmo

571

1.25

0.82

4.4

3.2

1389.37

806.28

ng/l

0.62

480

Onycholysis

639

1.24

0.82

3.9

3.1

1358.33

986.49

ng/l

0.40

535

Tularaemia

146

1306

1.17

0.82

3.3

3.2

1416.21

1251.03

ng/l

0.15

129

1107

Mental and behavioural disorders due to hallucinogens

235

1.38

0.82

2.0

2.9

373.67

549.46

ng/l

0.46

185

Systemic atrophies primarily affecting the central nervous system

487

5158

0.92

0.81

2.9

3.3

1347.69

1544.85

ng/l

0.36

408

4461

Other disorders of choroid

181

1643

1.15

0.81

3.9

3.3

1946.55

1405.26

ng/l

1.50

161

1419

Laparoscopic left hemicolectomy

230

2117

1.13

0.81

2.7

3.2

998.75

1208.26

ng/l

0.76

202

1829

Respiratory tuberculosis

727

6936

1.07

0.80

4.0

3.4

2150.40

1930.46

ng/l

0.55

645

6029

Respiratory tuberculosis, confirmed and not-confirmed

727

6936

1.07

0.80

4.0

3.4

2150.40

1938.55

ng/l

0.52

645

6029

Other melanin hyperpigmentation

298

2770

1.12

0.80

3.2

1373.13

1297.68

ng/l

0.13

252

2400

Disorders of visual cortex

2.05

0.80

4.6

5.8

686.14

1449.71

ng/l

—

Vitiligo

113

993

1.18

0.80

2.7

3.0

679.16

862.36

ng/l

0.66

828

Maternal care for known or suspected abnormality of pelvic organs

1692

11816

0.96

0.79

2.3

2.5

431.12

504.84

ng/l

0.65

1332

9580

Maternal care for known or suspected malpresentation of fetus

961

7174

0.95

0.79

2.1

2.4

357.82

369.89

ng/l

0.04

719

5639

Malignant neoplasm of cervix uteri

157

1408

1.15

0.79

2.5

2.8

2705.23

1023.00

ng/l

1.12

137

1166

Unspecified dementia

1953

17039

1.04

0.79

3.4

3.7

2418.22

2442.72

ng/l

0.07

1674

15044

Carcinoma in situ of breast, lobular

805

1.22

0.78

2.8

3.0

605.86

935.92

ng/l

1.20

684

Other effects of reduced temperature

206

1.45

0.78

4.3

3.3

1894.65

1439.60

ng/l

0.23

169

Bicornuate uterus

344

1.30

0.78

2.3

2.6

871.42

603.71

ng/l

0.37

274

Nail disorders in diseases classified elsewhere

2.02

0.78

3.4

2.9

958.29

1121.12

ng/l

—

Other acute disseminated demyelination

676

1.21

0.77

2.9

3.2

867.91

717.08

ng/l

0.12

554

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

378

1.32

0.77

4.2

3.1

2273.11

1063.74

ng/l

1.37

328

Idiopathic hypercalciuria

533

1.26

0.77

2.8

3.2

473.79

863.49

ng/l

1.27

447

Enterobiasis, including avohilmo

1096

0.85

0.77

2.2

3.5

414.00

640.40

ng/l

1.11

868

Slow fetal growth and fetal malnutrition

183

1.40

0.77

5.6

8.3

1025.77

1100.89

ng/l

0.05

157

Other and unspecified hydrocephalus

226

2080

1.13

0.76

2.9

3.3

1045.87

1439.95

ng/l

1.04

193

1795

Other inherited muscular atrophy

173

1.51

0.76

1.7

3.3

3282.31

1503.23

ng/l

0.44

147

Cellulitis of external ear

122

1083

1.17

0.76

3.7

3.3

748.66

1040.34

ng/l

0.78

107

932

Cleft hard palate NOS

212

1.38

0.76

3.2

3.6

989.10

605.27

ng/l

0.54

173

Benign neoplasm: Skin of upper limb, including shoulder

226

2078

1.12

0.76

3.2

1491.02

1202.92

ng/l

0.37

192

1778

Lichen planopilaris

370

1.32

0.76

2.1

3.3

313.35

852.96

ng/l

4.69

312

Unspecified organic or symptomatic mental disorder

379

1.31

0.76

4.2

3.2

1855.42

1833.29

ng/l

0.01

307

Other cestode infections

389

0.73

0.76

2.9

3.6

3095.52

1830.79

ng/l

0.48

325

Memory loss

1365

13228

1.05

0.75

3.0

3.5

1635.30

1786.75

ng/l

0.66

1187

11651

Human immunodeficiency virus [HIV] disease, including avohilmo

136

1520

0.87

0.75

2.6

3.3

844.94

996.23

ng/l

0.39

121

1258

Subarachnoid haemorrhage

1421

13765

1.05

0.75

3.1

3.2

1776.21

1583.59

ng/l

0.78

1254

11921

Degenerative myopia

741

1.22

0.75

2.8

3.1

809.96

1125.85

ng/l

1.07

619

Victim of lightning

1.79

0.75

4.9

2.9

688.82

1116.92

ng/l

0.49

Benign neoplasm: Spinal meninges

140

1265

1.17

0.73

3.3

3.2

1376.81

1181.07

ng/l

0.25

130

1086

Disorders of urea cycle metabolism

1.87

0.72

4.5

2.6

3077.96

887.03

ng/l

—

Open wound of neck

664

1.21

0.72

3.7

3.2

1378.85

985.69

ng/l

0.46

551

Medical treatment for female infertility

1172

12059

0.96

0.72

2.2

2.4

273.52

394.69

ng/l

2.33

946

9589

Benign neoplasm: Bones of skull and face

106

938

1.18

0.72

3.2

3.1

1353.22

1024.34

ng/l

0.33

783

Burn and corrosion confined to eye and adnexa

200

1828

1.12

0.72

2.7

3.2

1192.65

902.79

ng/l

0.38

159

1517

Telogen effluvium

183

1.44

0.71

7.8

3.2

947.17

733.55

ng/l

0.16

152

Mesothelioma, including Hilmo

177

1623

1.14

0.71

3.9

3.3

1247.15

1786.97

ng/l

1.85

164

1427

Disorders of peritoneum in infectious diseases classified elsewhere

2.32

0.71

3.5

3.9

741.50

734.75

ng/l

—

Other abortion

561

1.22

0.71

2.8

3.2

521.31

669.45

ng/l

0.34

464

Benign neoplasm: Hypopharynx

504

1.26

0.70

2.8

3.5

2120.04

1352.65

ng/l

0.49

424

Open wounds involving multiple body regions

335

1.31

0.70

3.5

6810.41

1022.21

ng/l

0.79

277

Pediculosis and phthiriasis, including avohilmo

470

1.24

0.70

2.7

3.2

983.64

898.91

ng/l

0.10

391

Synovial hypertrophy, not elsewhere classified

636

1.20

0.70

2.5

3.2

764.42

880.33

ng/l

0.22

515

Guttate psoriasis

140

1261

1.15

0.70

3.5

3.2

1704.60

1142.49

ng/l

0.34

118

1073

Hypergammalglobulinemia, unspecified

1.69

0.70

1.9

3.2

1085.56

943.97

ng/l

0.08

Malignant neoplasm of stomach, including Hilmo

844

8113

1.06

0.70

3.1

3.4

1755.70

1804.89

ng/l

0.12

767

7071

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

385

1.24

0.70

9.2

9.5

525.14

1539.27

ng/l

3.20

332

Acne keloid

131

1.53

0.69

2.1

2.9

271.30

983.13

ng/l

—

113

Degenerative conditions of globe

578

1.24

0.69

3.4

2079.56

1842.42

ng/l

0.17

480

Ankylosis of teeth

180

1.40

0.69

4.5

3.2

844.89

1067.63

ng/l

0.28

152

Frostbite involving multiple body regions and unspecified frostbite

202

1.42

0.69

2.8

3.3

2020.11

1243.39

ng/l

0.30

171

Toxic myoneural disorders

1.90

0.69

2.4

4.1

1534.11

951.36

ng/l

—

Degenerative macular diseases, drug-induced

395

1.30

0.69

3.3

3.5

1630.16

1839.28

ng/l

0.18

327

Maternal care for cervical incompetence

364

3418

1.09

0.68

3.3

2.9

699.91

788.54

ng/l

0.48

301

2868

Human immunodeficiency virus [HIV] disease resulting in other specified diseases, including avohilmo

1.80

0.68

2.4

3.7

1318.38

1750.38

ng/l

—

Tick-borne viral encephalitis

476

1.26

0.68

2.9

3.3

829.05

1209.91

ng/l

0.83

392

Pregnancy, childbirth and the puerperium

3932

20914

0.97

0.68

3.2

3.3

1386.68

1574.10

ng/l

2.49

3345

18011

Congenital malformations of ear causing impairment of hearing

236

1.35

0.68

3.8

4.1

3186.19

825.30

ng/l

0.50

198

Congenital glaucoma

123

0.57

0.68

4.1

5.8

3086.25

2081.58

ng/l

—

Underdevelopment of the second kidney

1.66

0.67

5.0

4.2

13164.97

1335.28

ng/l

1.17

Benign neoplasm: Mediastinum

377

1.30

0.67

3.7

3.4

698.86

1080.14

ng/l

1.25

303

Degenerative and vascular disorders of ear

160

1.50

0.67

2.8

3.0

732.50

1122.73

ng/l

0.68

137

Acute alcohol intoxication ICD-9

402

3798

1.08

0.67

3.7

3.3

1718.94

1634.95

ng/l

0.14

356

3272

Exposure to controlled fire, not in building or structure

256

1.35

0.67

2.8

3.4

615.23

1181.65

ng/l

1.27

210

Use of amantadine

196

1806

1.12

0.67

2.8

3.3

917.98

1264.91

ng/l

1.75

173

1541

Sequelae of malnutrition and other nutritional deficiencies

231

1.39

0.67

5.4

3.5

6111.46

1948.36

ng/l

0.46

198

Burn and corrosion of shoulder and upper limb, except wrist and hand

207

1906

1.11

0.67

2.9

3.3

1566.77

1164.00

ng/l

0.49

184

1591

Venous complications and haemorrhoids in pregnancy

804

1.16

0.67

1.9

2.8

350.07

387.50

ng/l

0.08

658

Yaws, including avohilmo

347

1.29

0.66

3.7

3.3

1310.14

859.30

ng/l

0.35

288

Use of peginterferon beta-1a

164

0.64

0.66

1.6

2.9

190.97

367.53

ng/l

—

130

Anisometropia and aniseikonia

343

3225

1.09

0.65

3.5

3.3

1400.38

1245.91

ng/l

0.27

286

2740

Explosion of other materials

263

0.71

0.65

2.8

3.5

758.50

1222.82

ng/l

0.85

214

Multiple congenital exostoses

114

1.50

0.65

3.6

3.5

2527.74

705.86

ng/l

0.45

HSIL lesion of the cervix uteri

1275

12331

1.04

0.64

2.7

2.6

861.78

558.82

ng/l

0.92

1049

9986

Rheumatic fever without mention of heart involvement

351

1.30

0.64

3.5

3.2

1628.46

1233.32

ng/l

0.56

296

Other disorders of breast and lactation associated with childbirth

732

1.17

0.64

2.1

2.7

206.76

433.00

ng/l

4.21

568

Acute thyroiditis

377

1.27

0.63

3.7

3.2

765.67

1178.19

ng/l

0.80

319

Hypospadias with an incomplete glans penis

106

1.51

0.63

6.0

4.3

1040.30

993.90

ng/l

—

Hyperprolactinaemia, drug-induced

479

1.23

0.63

4.0

2.7

898.85

711.42

ng/l

0.20

393

Other congenital malformations of eye

130

0.62

0.63

3.9

5.7

2747.78

1993.43

ng/l

—

104

Hereditary erythropoietic porphyria

1.79

0.63

3.6

3.1

1116.60

2034.98

ng/l

—

Injury of blood vessels at wrist and hand level

667

1.20

0.62

3.0

3.3

2611.66

1144.49

ng/l

0.67

568

Tularaemia, including avohilmo

207

1916

1.11

0.62

3.4

3.3

1148.35

1182.31

ng/l

0.04

181

1621

Sunburn

197

1.40

0.62

3.2

3.1

1445.86

851.16

ng/l

0.30

165

Other mosquito-borne viral fevers, including avohilmo

590

1.20

0.62

2.6

3.2

706.09

894.49

ng/l

0.39

474

Congenital malformations of eyelid, lacrimal apparatus and orbit

438

1.22

0.62

4.4

5.0

598.61

1084.75

ng/l

0.92

363

Other/unspecified postprocedural disorders of ear and mastoid process

365

0.75

0.61

4.4

3.5

2432.23

1409.22

ng/l

0.45

319

Complications of anaesthesia during labour and delivery

167

1.37

0.61

2.7

3.1

1898.05

686.25

ng/l

0.43

129

Squamous cell neoplasms and carcinoma of cervix

553

1.20

0.61

2.7

3.0

5029.33

1226.22

ng/l

1.03

466

Congenital malposition of the kidney

1.63

0.60

2.4

2.7

248.65

408.37

ng/l

0.86

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

128

1.53

0.60

5.8

4.0

2172.94

1359.31

ng/l

0.40

112

Traumatic subcutaneous emphysema

146

1.50

0.60

3.6

3.4

692.42

1157.31

ng/l

0.71

124

UC patients in KELA-register (code 208), prior to 1994

493

4705

1.07

0.59

3.2

3.1

1657.49

1202.61

ng/l

1.14

423

4028

Localized hypertrichosis

1.60

0.59

3.4

2.5

211.83

307.13

ng/l

—

Pityriasis rosea

544

1.20

0.59

3.6

3.0

504.45

1019.86

ng/l

2.57

450

Interstitial emphysema and related conditions originating in the perinatal period

1.65

0.59

13.8

9.6

1098.22

1527.90

ng/l

—

Meningococcal infection

564

1.19

0.59

4.4

3.2

1431.38

808.28

ng/l

0.65

473

Functional disorders of polymorphonuclear neutrophils

1.69

0.59

7.8

4.4

644.24

1150.03

ng/l

0.99

Drug-induced nonautoimmune haemolytic anaemia

1.88

0.59

2.0

3.0

4253.29

789.73

ng/l

—

Lymphocyte function antigen-1 [LFA-1] defect

112

1.61

0.58

4.3

3.7

3273.73

2589.69

ng/l

0.22

Non-seminoma of testis, including Hilmo

322

1.25

0.58

2.5

3.0

551.64

1473.54

ng/l

0.93

243

Migraine, unspecified, drug-induced

585

1.20

0.58

3.0

3.2

674.51

795.89

ng/l

0.32

491

Right side

736

1.20

0.58

3.9

3.4

770.46

1415.01

ng/l

2.35

627

Transient synovitis

470

1.20

0.57

4.6

3.4

1681.15

914.18

ng/l

0.41

386

Acute hepatitis B, including avohilmo

362

1.25

0.57

3.4

3.3

820.84

648.63

ng/l

0.30

301

690

1.18

0.57

2.3

3.0

625.65

779.75

ng/l

0.37

580

Dermatitis due to ingested food

144

1250

1.11

0.57

3.6

5.1

1239.95

872.77

ng/l

0.22

102

979

Human immunodeficiency virus [HIV] disease resulting in other specified diseases

1.80

0.57

2.6

3.8

1442.57

1961.74

ng/l

—

Other diseases of appendix

137

1255

1.13

0.56

2.9

3.2

1239.35

1109.09

ng/l

0.15

119

1058

Typhoid and paratyphoid fevers, including avohilmo

626

1.19

0.56

2.4

3.2

524.71

1298.50

ng/l

4.32

536

Staphylococcal scalded skin syndrome

1.64

0.55

2.2

5.9

836.00

798.18

ng/l

—

Malignant neoplasm of uterus, part unspecified, including Hilmo

602

1.20

0.55

4.3

3.5

3742.85

1835.10

ng/l

0.35

523

Pervasive developmental disorders excl. Autism + Asperger

464

1.19

0.55

3.9

5.0

429.55

1076.24

ng/l

0.89

356

Other congenital malformations of integument, including avohilmo

320

1.28

0.54

2.5

3.4

2743.51

1368.50

ng/l

0.56

270

Rare circulating lymphoid malignancy

707

1.19

0.54

3.8

3.7

1710.69

1917.53

ng/l

0.25

611

Burn and corrosion of wrist and hand

326

3080

1.07

0.53

3.3

1158.18

1125.57

ng/l

0.06

266

2558

Motor neuron disease ALS

218

2038

1.10

0.53

2.9

3.1

1004.27

1549.73

ng/l

1.81

182

1807

Disseminated intravascular coagulation [defibrination syndrome]

321

1.27

0.53

2.4

3.5

1650.90

1076.63

ng/l

0.77

262

Benign neoplasm: Peripheral nerves and autonomic nervous system

186

1732

1.11

0.53

3.4

3.3

741.87

1158.26

ng/l

2.07

158

1476

Other and unspecified cicatricial alopecia

294

1.28

0.52

3.2

3.3

1790.90

902.79

ng/l

0.41

249

Malignant neoplasm of oropharynx, including Hilmo

252

2374

1.09

0.52

3.3

3.2

1552.28

1327.59

ng/l

0.29

231

2033

Accidental poisoning by and exposure to alcohol

124

1360

0.89

0.52

3.2

1428.03

1341.09

ng/l

0.06

106

1107

Febrile neutrophilic dermatosis [Sweet]

158

1.42

0.52

4.0

3.4

1972.66

1111.48

ng/l

0.63

133

Abnormal findings in peritoneal fluid saliva

358

1.24

0.52

3.8

3.7

1110.71

1667.27

ng/l

0.53

308

Erythema in diseases classified elsewhere

231

1.33

0.51

4.0

3.1

773.43

847.52

ng/l

0.09

195

Radiodermatitis

278

1.30

0.51

5.7

2.7

1659.99

1003.93

ng/l

0.44

232

Acute necrotizing ulcerative gingivitis, including avohilmo

1.57

0.51

1.5

2.7

1751.50

1299.60

ng/l

—

Ovarian hyperstimulation (induction)

681

1.15

0.50

1.7

2.4

91.72

405.92

ng/l

1.99

508

Malignant neoplasm of oropharynx

201

1883

1.10

0.50

3.4

3.2

1170.17

1294.29

ng/l

0.24

184

1607

Mandibular prognathia

114

1036

1.12

0.50

4.2

3.6

930.72

801.36

ng/l

0.19

867

Maxillary prognathism

273

1.25

0.50

5.9

3.2

560.92

670.85

ng/l

0.14

217